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Abstract 
 
The primary aim of this thesis was to assess the differences in response to a 3 x 1 minute 
SLR tensioner treatment between 3 sub-groups of individuals with spinally referred leg 
pain (somatic referred pain, radicular pain and radiculopathy).  
Preliminary studies of the 3 outcome measures were required prior to the main study. 
These were: validity of the method to measure nerve excursion using ultrasound 
imaging (UI) which was assessed in pig nerves; repeatability of sciatic nerve excursion 
during a side-lying modified SLR measured with UI in the posterior thigh, and 
repeatability of pressure pain thresholds (PPT) and vibration thresholds (VT). The 3 
outcome measures were repeatable and the sciatic nerve excursion technique was valid.  
Sixty seven participants were placed into one of the 3 sub-groups and further assessed to 
identify the presence of central sensitisation (CS). Five questionnaires were completed 
by participants to assess disability and psychological characteristics. Sciatic nerve 
excursion, PPT and VT were measured prior to and after a 3 x 1 minute SLR tensioner 
technique.  
No significant differences (p>0.05) were found for any of the 3 outcome measures 
between the 3 groups. Slight improvements in VT were seen in the radiculopathy group 
after treatment, which were not significant, but indicated that even in individuals with 
conduction loss, no detrimental changes to nerve conduction occurred after treatment.   
A varied response to nerve excursion was seen. Longitudinal nerve excursion at the 
posterior thigh decreased after treatment in individuals with pain below the knee; this 
location of pain being more common in the radiculopathy and radicular groups. The 
decrease in nerve excursion suggests regional changes to nerve compliance after 
treatment, which may have occurred at the nerve root. Since it was not possible to 
measure nerve root excursion, these findings are speculative.  
Only 2 participants were identified with CS, suggesting a low prevalence of the 
condition in individuals with spinally referred leg pain. This may be due to individuals 
with CS choosing not to participate in the study, or a limitation of the method used to 
identify CS. 
Disability and psychological factors were not significantly different at baseline between 
the 3 sub-groups, and were not correlated with the outcome measures.     
A 3 x 1 minute SLR tensioner technique in individuals with spinally referred leg pain of 
greater than 3 months of duration is not effective in improving pain or nerve conduction. 
However, it is not harmful, even in individuals with loss of nerve conduction. Changes 
to nerve excursion after treatment may be related to individual differences in nerve 
compliance, and possibly restriction of the nerve root.  
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Chapter 1 Introduction 
 
1.1 Motivation for the study 
 
The researcher is a neuromusculoskeletal (NMS) physiotherapist who has been qualified 
for 22 years. For the last 12 years she has been a lecturer at the University of Brighton, 
teaching NMS physiotherapy to undergraduate and postgraduate students. The 
development internationally of the theory and understanding of neurodynamics has 
rapidly developed during the researcher’s career, with an initial over consideration of 
the biomechanics of nerve with minimal consideration for the neurophysiology, and 
later an over reliance on animal physiology studies. Hence in the early stages of her 
career, strong tensioner neural mobilisations were the mainstream of neurodynamic 
management, with a later denouncement of the benefits of these techniques and even 
suggestions of harm (Dilley et al., 2005; Hall and Elvey, 2004, pg 425). However such 
assertions were based on a few innovative, but limited animal studies in the absence of 
robust clinical trials, and the researcher undertook a preliminary study looking at the 
effects of a SLR treatment technique on vibration thresholds (VT) (a measure of 
conduction of the large diameter afferents) in asymptomatic participants, including a 
small cohort of runners (Ridehalgh et al., 2005). It was postulated that runners may be 
predisposed to a minor peripheral nerve injury because of the repeated nature of 
running, and high incidence of ankle sprains. The results of the study found no 
significant increases in VT in either the runners or non-runners, indicating no evidence 
for detrimental changes to nerve conduction after the technique. 
 
More recently, evidence has emerged of the potential benefits of such treatments (see 
chapter 4), but little is known about immediate changes after neurodynamic treatment 
particularly in individuals with a condition where neurodynamics is an important 
treatment modality; spinally referred leg pain. Since the postulated effects include 
changes to the mechanics of the nerve, changes to pain, and potentially changes to 
conduction (either positively or negatively), a study was required which addressed how 
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a neurodynamic mobilisation affected these parameters in this sub-group of low back 
pain. However, since the presentation and underlying pathophysiology of individuals 
with spinally referred leg pain is varied, a system of sub-grouping was necessary to 
assess how such measures responded to a standard treatment in individuals with 
different causes of the condition. This introduction and subsequent introductory chapters 
provides the rationale for the study by exploring the current body of work on nerve 
treatment for individuals with spinally referred leg pain, and identifying the gaps in the 
literature. 
1.2 Incidence and prognosis of Low back pain and spinally 
referred leg pain 
 
 Low back pain is a major problem in many Westernised countries. It constitutes over 
£12.3 billion in expenditure in the UK per year, with £1.6 billion attributable to health 
care, £1.6 billion to informal care and around £9.1 billion due to loss of economic 
productivity (Whitehurst et al., 2012). The aetiology of LBP is wide and varied; ranging 
from localised tissue damage to widespread diffuse areas of symptoms with no known 
cause (Billis et al., 2007; Dunn and Croft, 2005). Referred leg pain due to lumbar spine 
dysfunction can occur as a result of nerve root compression (radiculopathy), nerve root 
irritation (radicular pain), or somatic referred pain from non-neural structures (Bogduk, 
2009; Feinstein, 1987; Kellgren, 1977; Schäfer et al., 2009). Individuals with spinally 
referred leg pain are considered to have poorer prognosis than individuals with LBP 
alone (Haugen et al., 2012; Hill et al., 2011; Kongsted et al., 2012).  Reasons for the 
poorer prognosis for these individuals include higher levels of pain, disability, and 
certain psychological characteristics in this group (Hill et al., 2011; Jensen et al., 2010; 
Walsh and Hall, 2009a).  
 
1.3 Pathophysiology and presentation of spinally referred leg pain 
 
Individuals who have nerve root compression or irritation have a predominant 
neuropathic pain mechanism, where the pain emanates from the nervous tissues 
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themselves (Berger et al., 2012). However, pain can be referred into the lower limb from 
non-neural structures of the spine, and is described as mechanical nociceptive pain, or 
somatically referred leg pain (Bogduk, 2009). With respect to the neuropathic pain 
causes of spinally referred leg pain, radiculopathy differs from radicular pain in that 
there is a loss of conduction to either the sensory or motor nerve fibres, or a combination 
of both in a radiculopathy, whereas conduction is preserved in radicular pain (Bogduk, 
2009). The presence of a radiculopathy can be identified by the loss or absence of 
sensation within a dermatomal region, weakness in the muscles supplied by the 
corresponding nerve root or spinal nerve, and a reduction or absence of the tendon reflex 
of the corresponding segment (Bogduk, 2009). Individuals with radicular pain have 
normal neurological integrity tests (sensation, muscle strength and reflexes) but display 
sensitivity to palpation of the peripheral nerve trunks which extend from the nerve roots 
and to movements of these nerves, such as during a straight leg raise test (SLR) (Schäfer 
et al., 2009). Patients with somatic referred leg pain have normal neurological integrity 
tests and normal nerve motion and nerve palpation tests, but the individual’s pain is 
reproduced by movements to the lumbosacral spine (Petty, 2011a; Refshauge and Gass, 
2004).  
 
Some individuals with referred leg pain may develop a complex pain presentation called 
central sensitisation (Giesecke et al., 2004; Schmidt-Wilcke et al., 2006). According to 
the International Association for the Study of Pain (IASP), central sensitisation is “an 
enhanced responsiveness of nociceptive neurons in the CNS to their normal afferent 
input” (Sandkühler, 2007). It has been suggested that patients with central sensitisation 
can be identified using a number of subjective questions and physical tests, and these 
can be applied in the clinical setting without the need for expensive equipment (Jensen 
et al., 2010; Nijs et al., 2010).  
 
1.4  Neurodynamic tests: SLR and slump tests 
 
The SLR is a common nerve motion test used by physiotherapists to assess and treat 
patients with low back and leg pain (Butler, 2000; Shacklock, 1995; Shacklock, 2005a; 
4 
 
Shacklock, 2005b). This and other tests such as the slump test are termed neurodynamic 
tests, and use sequences of joint movements which lengthen the nerve bed and result in 
nerve excursion through the nerve bed (Butler, 2000; Shacklock, 2005a). The SLR test 
consists of hip flexion, knee extension and dorsi or plantar flexion with inversion or 
eversion to emphasise a particular nerve (tibial, peroneal or sural), as it passes close to 
the ankle (Breig and Troup, 1979).  
 
The motion that occurs during the SLR test has been analysed in animal and cadaveric 
studies (Boyd et al., 2005; Boyd et al., 2013; Breig and Marions, 1963; Breig and Troup, 
1979; Coppieters et al., 2006; Fleming et al., 2003; Goddard and Reid, 1965) in the 
sciatic nerve and lumbosacral nerve roots, but limitations of these studies exist since 
they are not representative of humans in vivo.  
 
Nerve motion has been difficult to measure in vivo in the past, due to the lack of 
sensitive equipment available to perform such measurements. Recently, longitudinal 
nerve motion has been measured in the upper and lower limb using ultrasound imaging 
which has been shown to be a reliable and valid measuring tool (Dilley et al., 2001; Ellis 
et al., 2008; 2012; Erel et al., 2003; Hough et al., 2000; 2007).  However, none of these 
studies have investigated any changes to nerve excursion after a neurodynamic 
treatment technique. 
 
1.5 Neurodynamic Treatment 
 
The SLR or slump tests can be converted into neurodynamic treatment techniques by 
placing the limb in the test position and repeatedly oscillating one of the joint sequences. 
For example, a SLR treatment could consist of positioning the individuals in supine, 
with their hip flexed, ankle dorsiflexed (to influence the tibial nerve), and flexing and 
extending the knee joint. Such a treatment could be described as a tensioner technique as 
studies have found that adding a sequence of joint movements together which lengthen 
the nerve bed increase the strain, and tensile stress on the nerve (Coppieters and Butler, 
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2008; Coppieters et al., 2009; Ellis et al., 2012). An alternative approach is to use a 
slider technique, where joints at one end of the test manoeuvre increase nerve bed 
length, whilst the ones at the opposite end reduce the nerve bed length. It is thought that 
greater excursion and less strain occurs during a slider technique (Coppieters and Butler, 
2008; Coppieters et al., 2009; Ellis et al., 2012).  The theoretical benefits of such 
treatments are to remove inflammatory exudates and oedema, increase venous return, 
improve the  nerve’s viscoelastic behaviour (Butler, 2000; Shacklock, 2005a), improve 
axoplasmic flow (Butler, 2000) and have an effect on segmental and descending pain 
inhibitory pathways (Katavich, 1999). There are limited clinical studies that have shown 
the effectiveness of such techniques; however all have used different treatment doses. 
Slump tensioner techniques (the slump test consists of the same leg movements as SLR 
but with the addition of cervical and thoracic flexion) or SLR alongside lumbar 
mobilisations and exercise was more effective than just lumbar mobilisations and 
exercise in patients with LBP and non-radicular leg pain (Adel, 2011; Cleland et al., 
2006; Nagrale et al., 2012). It is not known if all patients with referred leg pain behave 
in the same way to neurodynamic treatments, although a recent study suggests that 
people with nerve root pain, may benefit more from neurodynamic treatment than 
individuals with other forms of referred leg pain (Schäfer et al., 2011). The method of 
group allocations and small numbers of patients recruited within the nerve root pain 
group (9), make the results less conclusive, warranting further research in this area.  
 
Some authors have suggested that longitudinal nerve techniques, particularly tensioner 
techniques are not appropriate for patients with neuropathic pain as they may cause 
ectopic firing of nociceptors (Dilley et al., 2005), or reduce blood flow, and potentially 
nerve conduction (Boyd et al., 2005). Such events could contribute to central pain 
processes occurring (Dilley et al., 2005). The rationale for this is predominantly based 
on laboratory studies on animals, and it is not known if these effects occur in humans. 
One study suggests that this may not be the case in human subjects, as temporal 
summation was found to reduce in patients with carpal tunnel syndrome (CTS) treated 
with a tensioner technique compared to a sham movement treatment (Bialosky et al., 
2009). Such improvements in temporal summation indicate that the excitability of the 
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cells within the dorsal horn has been dampened down; and this may be important in 
preventing central pain processes from occurring (Rygh et al., 2005). It is important 
therefore, that studies which investigate the effects of neurodynamic treatment 
techniques, observe the effects of both pain and nerve conduction. 
1.6  Measuring effectiveness of neurodynamic treatments 
 
Monitoring the amount of nerve excursion in the sciatic nerve may help to provide some 
useful information about what happens to the nerve mechanically after a SLR. 
Ultrasound imaging is currently one of the most accessible methods of assessing nerve 
excursion, and has been shown to have considerable repeatability (Dilley et al., 2001; 
Ellis et al., 2008). However such measurements do not demonstrate any changes to the 
neurophysiology. Measuring nerve conduction through electrophysiological testing are 
often negative in neuropathic pain conditions where no major insult has affected the 
nerve (Atroshi et al., 2003; Finsen and Russworm, 2001; Greening and Lynn, 1998). VT 
have been advocated to detect minor nerve dysfunction such as upper limb work related 
disorder (Greening and Lynn, 1998), and lumbosacral radicular pain (Freynhagen et al. 
2008). It is a valid and reliable measure of the activity of the large diameter afferent 
nerves, and this sensation has been shown to be an early sign of nerve dysfunction 
(Dellon, 1980; Phillips et al., 1987).  
 
Measurements of pain are often the most important measure to the patient, but can be 
difficult to quantify and are subject to bias. Pressure pain thresholds (PPTs) are used to 
assess the pain perception of an individual to pressure over particular areas. 
Deterioration in an individual’s pain response would result in a lowering of their pain 
threshold, whereas an elevation in PPT would suggest an improvement in pain response 
(Antonaci et al., 1998). A number of studies have used PPT to analyse changes to pain 
after manual therapy (De-Le Llave-Ricon et al., 2012; Krouwel et al., 2010; Moss et al., 
2007; Silva et al., 2013; Sterling et al., 2001; Willett et al., 2010).  It has substantial 
repeatability (Antonaci et al., 1998; Kinser et al., 2009; Persson et al., 2004; Walton et 
al., 2011; Ylinen et al., 2007), and validity (Kinser et al., 2009). 
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1.7 Central Sensitisation 
 
 It has been demonstrated that patients with chronic low back pain have a lowering of 
PPT (Giesecke et al., 2004; Laursen et al., 2005; O'Neill et al., 2007) at the site of pain 
and in other regions around the body. Such widespread mechanical hyperalgesia is one 
of the features of a condition known as central sensitisation (Jensen et al., 2010; Woolf 
and Mannion, 1999). The prevalence of CS in individuals with spinally referred leg pain 
is not known. This condition is associated with higher levels of pain, disability and 
psychosocial factors (Meeus and Nijs, 2007), which may further augment CS processes.  
 
1.8   Disability and psychosocial factors 
 
Less favourable prognoses have been associated with higher levels of disability and 
certain psychological and social factors such as fear avoidance, depression, stress and 
anxiety (Haggman et al., 2004; Vlaeyen and Linton, 2000). In subjects with neuropathic 
pain; such as radicular pain or radiculopathy, catastrophising has been found to be high 
(Sullivan et al., 2005). Interestingly, even asymptomatic subjects who have greater 
responses to neurodynamic testing have been found to have higher scores on the pain 
catastrophising scale (PCS) (Beneciuk et al., 2010). For these reasons, several 
psychosocial scales are useful to assess if any of these characteristics have an interaction 
on the effects of treatment. Higher levels of disability may also play a role in how 
subjects behave to LBP treatments, and can be associated with poorer outcome (Grotle 
et al., 2004). 
 
1.9  Overall Focus of the Study  
 
There is a need to establish if individuals with different causes of their referred leg pain 
behave in the same way to neurodynamic treatment techniques, considering factors such 
as disability, presence of central sensitisation and other key psychosocial factors. The 
optimal treatment dose has not been established in the literature, but commonly 3 sets of 
mobilisation varying between 30 seconds to a minute have been advocated. The overall 
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focus of the study was to explore the difference in responses of individuals with spinally 
referred leg pain to a 3 x 1 minute SLR tensioner treatment.  
1.10 Outline of the thesis 
 
The thesis is divided into 9 chapters. In chapters 2-5, the justification for the study is 
provided by synthesising and evaluating the relevant literature of the most pertinent 
topics closely related to the subject matter. In chapter 2, the justification for the method 
of sub-grouping individuals into the 3 sub-groups chosen for the clinical study is 
discussed. In order for this to be achieved, a review of the literature around the 
pathobiological mechanisms for each sub-group is discussed, before a detailed analysis 
of methods of sub-grouping and justification of the sub-grouping system chosen is 
given. In addition, the processes which are thought to occur, giving rise to central 
sensitisation, and the method of identifying this presentation in individuals with spinally 
referred leg pain are critiqued. Finally, in chapter 2 the impact of psychosocial factors 
on prognosis in individuals with spinally referred leg pain is detailed. 
 
In chapters 3 and 4 the principles behind neurodynamic assessment and treatment are 
explained. In chapter 3 the evidence behind the use of such tests, with particular 
reference to the SLR and slump test is critiqued. Chapter 4 includes the current evidence 
for the effects resulting from neurodynamic treatment and the effectiveness of such 
treatments, and a justification of the particular SLR technique used in the clinical study 
is given.   
 
The choice, validity and reliability of potential outcome measures to assess the effects of 
a neurodynamic treatment are detailed in chapter 5. Chapter 6 presents the rationale for 
the study and the aims and objectives.  
 
Chapter 7 consists of the preliminary studies to ensure valid and repeatable outcome 
measures were used in the study. It discusses the limitations and considerations of these 
outcome measures. 
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Chapter 8 forms the main clinical study. It presents the results of the study and discusses 
the results in light of other literature. Limitations of the work are addressed and put into 
context for extrapolation into clinical practice. Chapter 9 provides an overall summary 
of the study, main conclusions, original contribution to current knowledge and 
suggestions for future work.   
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Chapter 2 Spinally referred Leg Pain  
 
Individuals with spinally referred leg pain do not all have the same aetiology for their 
pain. The cause of this type of pain, like all forms of low back pain is often multifaceted 
and links both physical or biological and psychosocial elements, and as such the 
approach taken to assessment and management should be biopsychosocial (Waddell, 
2004). The neuromusculoskeletal structures responsible for this leg pain can be both 
neural (neuropathic pain) and non-neural (somatic referred pain) (Bogduk, 2009). 
Spinally referred leg pain that is neuropathic in origin can result from a number of 
causes, but is predominantly due to some irritation on either the nerve roots themselves, 
or the dorsal root ganglion (DRG) (Bogduk, 2009). If the nerve root is sufficiently 
compromised, a loss of nerve conduction may occur (Takahashi et al., 2003.; Yoshizawa 
et al., 1995). A common cause for nerve root and DRG compromise is a herniated 
intervertebral disc1 (Bogduk, 2009; Bono and Garfin, 2004). 
 
The alteration of nerve conduction will only occur if there is sufficient disruption of the 
nerve signals, but in some cases there may be pain only, without alteration to nerve 
conduction. This is thought to be due to irritation of the dorsal nerve root or DRG since 
the protruded intervertebral disc material produces an inflammatory response (Bogduk, 
2009; Chatani et al., 1995; Kawakami et al., 1994; McLain and Weinstein, 1994). The 
pain described due to irritation in the nerve root or DRG is called radicular or nerve root 
pain (Bogduk, 2009). When the nerve signals are disrupted, the condition is described as 
a radiculopathy (Bogduk, 2009). 
 
The non-neural cause of spinally referred leg pain is termed somatic referred pain, 
emanating from the ligaments, capsules and muscles surrounding the spinal segments. 
The type of pain that these individuals experience is usually either a mechanical 
nociceptive pain or inflammatory nociceptive pain. Nociceptive pain is “Pain that arises 
                                                 
1 A herniated intervertebral disc consists of the nucleus pulposus (the inner aspect of the disc) bulging or 
extruding from the annulus fibrosus (the outer layer of the disc). The traversing nerve root is more at risk 
from a herniated disc because it passes posterolateral to the disc before exiting through the intervertebral 
foramen of the level below. 
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from actual or threatened damage to non-neural tissue and is due to the activation of 
nociceptors” (Merskey and Bogduk, 1994). In mechanical nociceptive pain, the 
activation of pain is related to the mechanical load on the tissue, and hence tends to be 
intermittent pain, related to specific activities (Loeser and Melzack, 1999; Petty, 2011a; 
van Griensven, 2005). With inflammatory nociceptive pain, the stimuli irritating the 
sensory nerve endings and causing pain are the inflammatory mediators released from 
the damaged soft tissue cells (Loeser and Melzack, 1999; Petty, 2011a; van Griensven, 
2005).   
 
Some patients with chronic LBP have been found to exhibit complex and abnormal 
processing of pain, sometimes referred to as central sensitisation (Jensen et al., 2010). 
This is thought to occur when the dorsal horn which normally acts to mediate pain either 
by amplifying it when needed (this may be appropriate at times of extreme danger where 
further movement could result in damage to structures) or diminishing it via descending 
pain mechanisms, acts in an over amplified way (van Griensven, 2005). The result of 
such amplification is sensitisation of neurones within the dorsal horn (Jensen et al., 
2010) and long lasting enhancement (potentiation) of synapses within the anterior 
cingulate cortex (Arendt Nielsen and Henriksson, 2007; Li et al., 1999; Nijs, et al., 
2010; Yunus, 2007). Certain manifestations of this pain are widespread allodynia (pain 
response to innocuous stimuli) and hyperalgesia (exaggerated pain on response to 
painful stimuli). It has been suggested that patients who have this condition may benefit 
less from manual based treatment than those without (Fernandez-de-las-Penas et al., 
2010).  
 
Individuals with different causes for their spinally referred leg pain may not only present 
differently, but are likely to behave differently to clinical interventions (Hill et al., 2011; 
Kongsted et al., 2013; Nee et al., 2013; Schäfer et al., 2009). It is crucial therefore to 
utilise a sub-classification system which is clinically viable, and able to discriminate 
between individuals with different causes of their leg pain. This chapter aims to evaluate 
the evidence for the aetiology and typical presentations of the sub-group categories of 
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spinally referred leg pain, and to identify the optimal clinical strategies for classifying 
individuals with referred leg pain.  
 
 
2.1 Nerve root dysfunction  
Nerve root compression alone does not appear to produce pain; compression or 
squeezing normal nerve roots with forceps is painless (Norlen, 1944; Rydevik et al., 
1984), and therefore it is likely that the cause of pain is due to inflammatory mediators 
(Olmarker and Rydevik, 1991). Chemical substances involved in this process include 
phospholipase A2 and cytokines which are released from the nucleus pulposus 
(Kawakami et al., 1996; Omarker and Myers, 1998). An understanding of how pain and 
dysfunction due to nerve root compression and chemical irritation occur, is necessary to 
predict how individuals with these conditions can be identified, and establish the best 
methods for detecting radiculopathy and radicular pain.  
 
2.1.1 Nerve root pathology  
 
The two most common causes of nerve root dysfunction are compression or chemical 
irritation of the nerve root and/or DRG due to herniated disc material or central or lateral 
spinal canal stenosis (Sharma et al., 2012). Lateral canal stenosis occurs due to 
degenerative changes affecting the zygapophyseal joint, such as enlargement of these 
joints which directly compresses the DRG or nerve root. Central spinal canal stenosis is 
predominantly a degenerative condition which often results in bilateral leg pain and /or 
paraesthesia. Individuals with central canal stenosis are commonly over 60 years of age, 
have bilateral leg pain or pins and needles/numbness, have difficulty walking 
(particularly downhill) or prolonged standing, and their pain is relieved on lumbar 
flexion (Sengupta and Fischgrund, 2004). Such individuals would have pathology of the 
spinal canal commonly with progressive neurological loss due to narrowing of the spinal 
canal. In these cases, neurodynamic interventions (such as a SLR test) would not be a 
suitable intervention, since the optimal treatment techniques recommended for this 
condition include flexion exercises to open the spinal canal, and offload the neural 
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structures, and improve physical fitness and strength around the trunk and pelvis (Fritz 
et al., 1998; Overdevest et al., 2011).  
 
Effects of Nerve root compression and chemical irritation on pain 
 
Most methods exploring the pathophysiological mechanisms of how pain and 
dysfunction occur in nerve root disorders, consist of animal studies where controlled 
application of substances (Hashizumi et al., 1997; Hou et al., 2003; Kawakami et al., 
1996; 2000; Obata et al., 2002, Omarker and Myers, 1998; Rothman and Winkelstein, 
2007), or increasing amounts of compression, over increasing amounts of time (Hu and 
Xing, 1998; Hubbard and Winkelstein, 2008) are applied to the nerve root. However, 
whilst these studies are helpful in the understanding of animal models, they may not 
truly represent the mechanisms that occur in the human in vivo. For example it has been 
demonstrated that nerve root compression is often visible on myelography or MRI scans 
in the absence of pain or neurological deficit (Boden et al., 1990; Falconer et al., 1948; 
Rydevik et al., 1991; van Rijn et al., 2006), yet there is no mention of animals who 
display normal pain behaviours after experimental nerve root irritation. This indicates 
that the exact mechanisms of nerve root irritation cannot be entirely replicated in animal 
studies. However, since it is not possible to apply the same sorts of methods to humans, 
these are currently the most feasible options of assessing how nerve roots respond to 
simulated disc injury.  
 
Radicular pain was previously believed to be related to the direct compression of nerve 
roots, but this has been refuted (Bogduk, 2009; Howe et al., 1977; Hu and Xing, 1998). 
Whilst it has been demonstrated that compression of the DRG leads to repetitive firing 
in a number of sensory nerves after mechanical stimulation, compression of the dorsal 
nerve root does not provoke such firing after mechanical stimulation (Howe et al., 
1977). In addition, pain related behaviour (withdrawal of paws from painful stimuli) 
after a transient compression of the L5 dorsal nerve root was no different to a sham 
condition in rats (Hu and Xing, 1998). However, if the compression remains in situ, an 
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increase in pain related behaviours and sensory nerve firing occurs (Hou et al., 2003; 
Howe et al., 1977; Hu and Xing, 1998; Omarker and Myers, 1998). 2  
 
Applying disc material to the nerve root (i.e. nucleus pulposus and annulus fibrosus) 
alone has an immediate and longer term effect on rat pain behaviours (Hou et al., 2003; 
Kawakami et al., 1996; 2000; Obata et al., 2002; Omarker and Myers, 1998). Increasing 
signs of pain behaviour seem to occur when compression is combined with the 
application of disc material to the nerve roots (Hou et al., 2003; Omarker and Myers, 
1998), which might better reflect the pathological processes that occur in vivo. 
Heightened mechanical behavioural changes such as paw withdrawal to a mechanical 
stimulus, seem to occur more readily after placing nucleus pulposus material on dorsal 
nerve roots, but pain behaviour changes due to thermal stimuli seem to be more resilient, 
requiring a combination of mechanical compression with disc material (Hou et al., 2003; 
Kawakami et al., 1996; Kawakami et al., 2000; Omarker and Myers et al., 1998) (see 
figs 2.1 and 2.2 for schematic drawings of the location of where individual researchers 
have applied compression or chemical irritants to the nerve root complex). There are 
however, some exceptions to these studies. Hu and Xing (1998) found thermal 
hyperalgesia after an injection of carrageenan alone, and Chatani et al., (1995) found 
thermal hyperalgesia after circumferentially exposing the DRG and after loosely ligating 
the DRG with chromic gut suture. Both carrageenan and chromic gut suture impose mild 
inflammatory effects on tissues. There are two possible explanations for this; firstly the 
DRG was targeted rather than dorsal nerve root alone, which may have resulted in 
greater sensory changes, and secondly the substances used may have had different 
effects from nucleus pulposus material.  
 
Whilst most studies have generally shown a hyperalgesic response to nerve root 
compression or irritation, some have shown an initial hypoalgesic response (Kawakami 
et al., 1996; Kawakami et al., 2000). These changes were found after placing the nucleus 
pulposus and annulus fibrosus onto the nerve root (Kawakami et al., 1996), and after the 
application of silk around the nerve root (Kawakami et al., 2000). This suggests that 
                                                 
2 The details of these studies can be found in appendix 1. 
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pain may not always be an initial finding in radiculopathy, a finding which supports that 
of Howe et al., (1977), who found that only the acutely irritated DRG, not the nerve 
root, showed repetitive nociceptor firing to a light mechanical stimuli. 
 
There are number of important issues to consider when extrapolating this animal data 
into human scenarios. In animal studies, the spinal canal was exposed and material was 
placed on the nerve root in a controlled manner, or compression applied, and this 
resulted in an event which is unlikely to occur in the same way as in human subjects 
with disc protrusion. The application of the disc material was very specifically applied 
to a small aspect of the nerve root or DRG, which is unlikely to be reflected in typical 
pathological herniated intervertebral disc protrusions.  In addition, the pain response is 
assumed to accurately detect when a hyperalgesic response is occurring, but it is 
unknown if the same higher centre activation associated with pain (Wiech et al., 2008) 
occur to the same extent in rats, making it difficult to assess how well this relates to pain 
behaviour in humans.   
 
Some studies obtained the disc material after excising the tail and using the coccygeal 
disc material (Hou et al., 2003; Kawakami et al., 2000; Obata et al., 2002), whereas 
others utilised other substances such as carrageenan or chromic gut suture (substances 
used to induce inflammation) (Hu and Xing, 1998; Rothman and Winkelstein, 2007), 
which may have had different effects on the nerve root.  Whilst the effects of excising 
the tail might be expected to change the normal behaviour of rats, the studies compared 
the behaviours to rats who had the same initial excision of tail procedures (without the 
added nerve root compression/irritation) and their findings were not different to baseline 
measures (Hou et al., 2003; Kawakami et al., 2000; Obata et al., 2002). However, 
regardless of the procedure, the application of the substances into the canal is unlikely to 
best reflect situations in vivo, but it is the only option for assessing how separate events 
with regards to pain are likely to occur in humans at present.  
 
The explanation for why such pain related behaviours occur in these animals after nerve 
root or DRG irritation has been debated by a number of authors. Some have suggested 
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that the deterioration in pain is related to structural changes (Hou et al., 2003) or 
endoneurial oedema (Chatani et al., 1995), whilst other have considered that it is related 
to expression of neurotrophic factors in the DRG (Obata et al., 2002), increased 
production of nitrous oxide (Hashizumi et al., 1997), or increase in PLA2 
immunoreactivity (Kawakami et al. 1996). In addition microglial and astrocyte activity 
has been found to increase after application of chromic gut suture and compression to 
the C7 nerve root in rats (Rothman and Winkelstein, 2007).  It is likely therefore, that 
the pain occurring in individuals with radicular pain is multifaceted and involves 
changes to nerve structure, as well as inflammatory and other immune system responses. 
The inflammatory and immune system changes will be discussed further in the next 
section.  
 
 
 
 
Fig 2.1 Transverse view of a spinal motion segment showing the relationship of cauda equina, 
traversing, exiting nerve roots and dorsal root ganglion. References shown demonstrate 
where on the nerve root the compression or irritation occurred, but not necessarily at this 
nerve root level 
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Fig 2.2 Sagittal view of L3-L5 vertebral segments showing the relationship of the cauda 
equina, traversing and exiting nerve roots and their relationship with the intervertebral disc. 
References shown demonstrate where on the nerve root the compression or irritation 
occurred, but do not necessarily reflect the actual nerve root level. 
 
Inflammation after nerve root compression and chemical irritation  
 
Both direct contact of nucleus pulposus and compression to the nerve root have been 
shown to cause inflammation and resultant oedema within the endoneurial space. It has 
been established that animal models which mimic nerve compression result in 
inflammatory events that are greater than those caused by nerve transection (Hu et al., 
2007), and evoke both local and remote immune-mediated inflammatory changes 
(Schmid et al., 2013). There are a number of methods that can be used to assess such 
changes including the observation of oedema in and around the nerve roots (Olmarker et 
al., 1993; Omarker and Myers, 1998 Pedowitz et al., 1992; Rydevik et al., 1991), using 
protein tracers to identify oedema (Kobayashi et al., 1993: Kobayashi et al., 2004a; 
Kobayashi and Yoshizawa, 2002), and the identification of various immune system and 
inflammatory markers (Hubbard and Winkelstein, 2008; Kobayashi et al., 2004b; Obata 
et al., 2002; Rothman and Winkelstein, 2007).  
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Nucleus pulposus placed on the nerve roots in rats (Omarker and Myers, 1998) and pigs 
(Olmarker et al., 1993), was found to produce endoneurial oedema between 5- 7 days 
post intervention (details of the studies can be found in appendix 2). A more severe 
effect on oedema and fibrosis was found with a combination of nerve root compression 
and nucleus pulposus (Omarker and Myers, 1998). However, the compression was 
created through medially displacing the nerve root in an attempt to reproduce the sort of 
compression that might occur during a herniated nucleus pulposus. It was not clear how 
much pressure was applied to the nerve root in this instant making it difficult to compare 
to comparable studies in both the periphery and within the vertebral canal. Both Rydevik 
et al., (1991) and Pedowitz et al., (1992) assessed the effect of specific amounts of 
compression applied to the nerve roots within the cauda equina. Oedema was found to 
occur with pressures over 50 mm Hg (Rydevik et al., 1991) with more severe changes at 
200 mm Hg (Pedowitz et al., 1992). However in these, like the former mentioned 
studies, the presence of oedema was made from histological assessment which is an 
observational method, subject to bias.   
 
Using a method of assessing oedema through the identification of protein tracers (Evans 
blue albumin (EBA) or horseradish peroxidase (HRP), studies have demonstrated that 
low levels of compression (50mm Hg) held for longer periods of time (> 1week), or 
higher pressures (> 200 mmHg) held for short periods of time (1hour), are equally 
deleterious with regards to oedema proximal and distal to site of compression 
(Kobayashi et al., 1993: Kobayashi et al., 2004a). In addition, compression of the DRG 
itself shows similar changes (Kobayashi and Yoshizawa, 2002). 
The presence of oedema suggests an inflammatory response, as it is one of the 5 cardinal 
signs of inflammation (DeLeo and Yezierski, 2001). A more direct way of assessing the 
immune system response is to look directly for the presence of cells which indicate that 
an inflammatory response has occurred. Such cells include glial cells, such as astrocytes, 
microglia and oligodendrocytes, which are the macrophages of the central nervous 
system (DeLeo and Yezierski, 2001). Macrophages produce a neurotrophic factor called 
nerve growth factor (NGF), and increases in retrograde transport of NGF lead to 
increase in production of substance P, calcitonin gene related peptides (CGRP), and 
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brain derived neurotrophic factor (BDNF) (Donnerer et al., 1992; Obata et al., 2002). In 
addition, glial cells synthesise proinflammatory cytokines, glutamate and nitrous oxide 
which act through N- methyl-D-Aspartate (NMDA) receptors (DeLeo and Yezierski, 
2001). The opening of NMDA receptors are thought to enhance central sensitivity (Chen 
and Huang, 1992).  
 Increases in NGF and BDNF have been found in the DRG after nerve root irritation 
with nucleus pulposus and annulus fibrosus (Obata et al., 2002). Such changes may 
result in increased release of substance P and CGRP. However, Kobayashi et al., 
(2004b) found a decrease in substance P and CGRP after compression of the dorsal 
nerve root which was associated with chromatolysis of the axons within the DRG, 
suggesting a greater painful response after irritation rather than compression. Similar 
immune responses suggestive of chromatolysis were found to occur by Hubbard and 
Winkelstein, (2008) with the increased presence of macrophages as indicated by the 
increased presence of CD68. Another method of assessing the occurrence of 
macrophages is to evaluate staining for 2 proteins; Glial fibrillary acidic protein (GFAP) 
and CR3/CD11b, which indicate astrocyte and microglial activity respectively (Rothman 
and Winkelstein, 2007). Significant increases in GFAP were found in rats with 
compressed nerve roots and in rats with compressed nerve roots and application of  
chromic gut suture 1 and 7 days post nerve root injury, and in animals with chromic gut 
suture alone at 7 days. CR3/CD11b however, was only significantly different in the 
compressed and combined compressed and chromic gut suture groups, but not the 
chromic gut suture group alone. Such changes in glial cell activation with greater nerve 
root insult also resulted in greater pain responses from the rats, which seem to be in 
contrast to Kobayashi et al., (2004b). However, whilst substance P and CGRP reduced 
in the DRG (Kobayashi et al., 2004b), pain behaviours were not concurrently monitored, 
and therefore the direct link between reduction in the production of these 
neurotransmitters and changes to pain cannot be made. Generally small numbers of rats 
were used to analyse the immune system changes, for example Rothman and 
Winkelstein, (2007) used 4, 4 and 6 rats in each sub-group to assess for changes to glial 
cells. The subsequent use of statistical testing on such small numbers may have resulted 
in an inability to detect a significant change, so it is possible that for incidences where 
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statistical significance was not found (e.g. for chromic gut suture alone), that a false 
acceptance of the null hypothesis was made. In addition, such small numbers make it 
difficult to extrapolate the results to a greater population. 
 
The inflammatory processes presented above coincide with the changes in pain 
behaviour discussed in the preceding section. Such changes to pain behaviour not only 
represent inflammatory responses but also possible changes to nerve structure and 
function. In animal studies, function of nerve fibres is typically measured using methods 
of assessing nerve conduction, whereas structural changes to the nerve are observed 
through histological analyses. 
  
Effects of Nerve root compression and irritation on nerve conduction and structure  
 
It has been postulated that the early behavioural changes previously described are 
related to aberrant firing of afferent nerves, but later are due to structural changes and 
immunoreactivity (Hubbard and Winkelstein, 2008). Detrimental changes can occur in 
the presence of disc material with or without compression, and this has been 
demonstrated by alteration in nerve conduction as well as by observing changes to nerve 
structure (Olmarker et al., 1993; Omarker and Myers, 1998; Takahashi et al. 2003). 
Olmarker et al., (1993) found that the application of nucleus pulposus alone to the nerve 
roots within the cauda equina was sufficient to cause an early (after 1 day), and 
prolonged (7 days) reduction in motor nerve conduction velocity compared to control 
animals who had fat applied to the nerve roots only. Takahashi et al., (2003) also found 
a marked reduction in cauda equina action potentials 1 week after application of nucleus 
pulposus to the sacrococcygeal nerve roots in dogs. However, greater changes to nerve 
conduction were demonstrated with a combination of compression and application of 
nucleus pulposus (Takahashi et al., 2003). Histological changes were also most severe in 
the combination group with greater nerve fibre injury (Takahashi et al., 2003), which 
was similarly demonstrated by Omarker and Myers, (1998) with evidence of  axonal 
demyelination and Schwann cell hypertrophy in Sprague-Dawley rats (see appendix 2 
for details of studies). These findings support the behavioural studies discussed in the 
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previous section, in that a combination of compression and chemical irritation affect 
pain behaviour greater than either compression or irritation alone. Some of the potential 
limitations with these studies relate to the way that a sham or control group was used as 
comparison. For example, in Olmarker et al.,’s (1993) study, control animals had the 
same procedure as the experimental animals, but fat was placed on the nerve roots 
instead of nucleus pulposus. However, there was no control group who had surgery 
without the application of any substances to the nerve roots. Whilst the NP group 
showed worsening nerve conduction compared to the fat group, it would be useful to see 
the contribution of the surgical procedure alone to ensure that this was not responsible 
for any of the changes found. 
 
Whilst it is clear that both compression and chemical irritation together are more 
provocative than either alone, it is also useful to assess what magnitude of compression 
is needed to cause negative changes to structure and function. Lower levels of 
compression (<75 mm Hg) applied for short periods of time (4 hours or less), did not 
cause a change to nerve conduction or nerve structure  (Pedowitz et al., 1992; Rydevik 
et al., 1991). Increasingly larger amounts of compression caused cumulative 
deterioration in nerve conduction and structural changes. Sensory nerve conduction 
appeared to be more greatly affected than motor conduction and recovery was slower in 
the sensory nerves (Pedowitz et al., 1992; Rydevik et al., 1991). Pedowitz et al., (1992) 
demonstrated only 1 out of 5 animals showed any sign of sensory compound nerve 
action potential recovery 1.5 hours after 200mm Hg compression was applied, compared 
to all animals showing partial recovery of motor function (Pedowitz et al., 1992). 
Normally, pressure exerted from a prolapsed intervertebral disc occurs ventrally on the 
exiting or traversing nerve roots (Maus, 2002), however in Pedowitz et al.’s (1992) 
study, the pressure was exerted dorsally which may not produce the same effects as in 
vivo. Pedowitz et al., (1992) and Rydevik et al., (1991) compressed the nerve roots in 
the cauda equina which do not contain the same amount of connective tissue as the 
exiting or traversing nerve roots (Rydevik et al., 1991). This may mean that greater 
pressures are required outside of the cauda equina to cause the same changes. 
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Whilst lower pressures did not result in detrimental changes in the 2 studies described 
above, the length of time that the compression remains in situ is critical in determining 
the effect on nerve structure. Compression of the 7th spinal nerve root in dogs at low 
levels (7.5gf, equivalent to 50 mm Hg) for 1 week, caused Wallerian degeneration in the 
dorsal nerve root proximal to the compression site and distal to the compression site in 
the ventral nerve root (Kobayashi et al., 2004a).  By 3 weeks, the myelin sheaths were 
deplete of axons, and on electron microscopy, breakdown of the blood-nerve barrier was 
seen. In addition, a further study by Kobayashi et al., (2004b) demonstrated 
chromatolysis occurring in the DRG 1 week after compression of 7th lumbar dorsal 
nerve root with 7.5gf. Chromatolysis is often a precursor to apoptosis (cell death) 
(Stoica and Faden, 2010). As mentioned in the previous section, support for these 
structural changes on light microscopy was shown by the reduction in neurotransmitters 
such as CGRP, substance P and somatostatin. It has been previously shown that 
chromatolysis inhibits the production of these neurotransmitters (Wells and Vaidya, 
1989), but facilitates the production of structural proteins responsible for axonal 
regeneration, such as cytoskeleton and nerve growth factor. Consequently it appears that 
1 week after sustained compression at low levels, degenerative and regenerative 
processes occur at sites distal to the compression.  
 
Relating these figures to humans with disc pathology is important to understand the 
relevance of such pressures. Takahashi et al., (1999) looked at the nerve root pressures 
in 34 individuals diagnosed with lumbar disc herniation by myelogram. The pressures 
were taken with a pressure transducer inserted between the nerve root and the disc 
herniation (after laminectomy). An extensive range in pressures was found from 
between 7-256 mmHg (mean 53.2). No studies have looked at such low pressures as 7 
mmHg, but the mean value of 53.2mm Hg is around the lowest level that researchers 
have looked at. Since most individuals with disc herniation will have a more chronic 
involvement of herniated disc material than the week or less in some of the short term 
studies, such low levels of pressure may be of sufficient magnitude to cause detrimental 
changes. 
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Deterioration in axonal fibres as described above may not be the same for large and 
small diameter nerves. Changes to the constitution of small compared to large nerve 
fibres have been found in a number of studies. Chatani et al., (1995) found exposure of 
the DRG, or the application of chromic gut suture to the L4 and L5 DRG of rats for 6 
weeks, resulted in marked deterioration in the large diameter fibres, with increase in the 
small diameter fibres. In agreement, a dramatic increase in small fibres, and decrease in 
large fibres in the DRG and dorsal nerve root were found 2 and 12 weeks after loose 
ligatures of chromic gut suture and silk were applied to the nerve roots (Kawakami et 
al., 1994). Relating these findings to in vivo, Freynhagen et al., (2008) found that 
patients with radicular pain had greater changes to vibration thresholds (VT), a measure 
of the large diameter afferents (Greening and Lynn, 1998; Greening et al., 2003) than 
thermal testing. 
 
In summary, animal studies have demonstrated the complex changes that occur in 
structure and conduction in nerve roots exposed to irritants or compression. It is possible 
that nerve conduction may be affected by the chemical irritation of the nerve root, 
although much greater changes occur with the added component of compression. Larger 
pressures, or low pressures prolonged over time, or the combination of pressure and the 
application of nucleus pulposus, are most deleterious to nerve structure and function. 
Limitations of the studies mean that whilst a similar model may occur in humans, the 
mechanism of the nerve root irritation is likely to be substantially different since the disc 
material or compression is not applied in an experimental situation. In addition, human 
beings may behave differently to animals when they have pain due to such factors as 
previous experience and thoughts and beliefs about pain. Caution must therefore be 
taken when extrapolating the type and level of dysfunction after nerve root irritation in 
vivo.  
2.1.2 Summary of nerve root pathology studies and relevance 
 
In animals, a combination of the compression and chemical irritation from either 
nucleus pulposus, annulus fibrosus or other irritants such as carrageen or chromic gut 
suture have been shown to cause greater deleterious effects on pain behaviours, 
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inflammation, large diameter nerve fibre loss and deterioration in both sensory and 
motor nerve conduction, but with more prolonged and less reversible changes to sensory 
nerve conduction. Such changes may coincide with the development of large diameter 
fibre loss and mechanical hyperalgesia. 
 
Clinically, patients may present with a neuropathic referred leg pain which is due to 
nerve root irritation. Deterioration in nerve conduction as measured by reflexes, 
myotomes and dermatome testing may help to distinguish between those with a 
neurological compromise and those without. Therefore, for the purposes of this study 
those identified with a neurological compromise will be termed radiculopathy and those 
without will be termed radicular pain. In individuals with radiculopathy, measurements 
of nerve conduction of the sensory large diameter afferents such as through the use of 
VT is particularly useful (Freynhagen et al., 2008). In addition, since heightened 
mechanical hyperalgesia occurs after damage to the nerve root, measures of pressure 
pain threshold may be useful.  
 
This section has identified the structural, conduction and behavioural changes that occur 
within the nerve root and DRG after a pathological event. However spinally referred leg 
pain may also occur in the absence of any pathology associated with the nerve root; 
known as somatic referred pain. 
 
2.2 Somatic Referred Leg pain 
Individuals with spinally referred leg pain that is not due to irritation or compression of 
the nervous tissue can be described as having somatic referred pain (Bogduk et al., 
2009; Robinson, 2003). This form of referred pain is due to stimulation of nociceptors in 
somatic tissues such as muscle, disc, or zygapophyseal joint structures (Jung et al., 
2007; Laplante et al., 2012; O’Neill et al., 2002; Robinson, 2003; Seaman and 
Cleveland, 1999), and is also known as nociceptive pain (Robinson, 2003; Seaman and 
Cleveland, 1999).  Therefore somatic referred leg pain may occur due to dysfunction in 
the spinal joints (zygapophyseal, interbody, sacroiliac joints) or myogenic structures 
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(Robinson, 2003; Seaman and Cleveland, 1999). However the aetiology, pathology and 
clinical presentations are varied.  
 
 The mechanisms for somatic referred pain are not well understood, but are thought to 
be due to convergence of primary afferent nerves on second order neurones in the dorsal 
horn (Robinson, 2003). Somatosensory neurones respond to stimulus of local lumbar 
tissues, hip and proximal thigh tissues in the same way. If a lumbar structure such as 
zygapophyseal joint is injured, these neurones are activated, the information is projected 
to the contralateral somatosensory cortex, but the cortex cannot differentiate the injured 
tissue, and the individual feels the pain in the back and leg (Gillette et al., 1993). This 
has been demonstrated in studies that have injected hypertonic saline into spinal joints 
and followed the distribution of symptoms into the leg (McCall et al., 1979; Mooney 
and Robertson, 1976). A number of studies have looked at pain referral patterns which 
result from stimulating somatic structures with a range of stimuli (e.g. mechanical and 
chemical) (Feinstein et al., 1954; Fukui et al., 1997; Hockaday and Whitty, 1967; Inman 
and Saunders, 1944; Jung et al., 2007; Kellgren 1939; Laplante et al., 2012; Mooney and 
Robertson, 1976; O’Neill et al., 2002; Ohnmeiss et al., 1997). Whilst the distribution 
patterns have shown substantial variability between subjects and between studies, a 
consistent finding is that without exception the deep, non-neural tissues in the lumbar 
spine refer pain into the leg, which is felt as deep and often not well localised. 
 
Some studies show pain referring as far as the foot (Inman and Saunders, 1944; 
Kellgren, 1939; Mooney and Robertson, 1976; Ohnmeiss et al., 1997; O’Neil et al., 
2002) to calf without foot (Bernard and Kirkaldy-Willis, 1987; Feinstein et al., 1954; 
Jung et al., 2007) and distal referral to the thigh only (Fukui et al., 1997). Such 
differences might be related to the differences in methods of inducing or relieving pain 
and subjects used (symptomatic v asymptomatic). Such variation on methods include 
injections of noxious substances into the paraspinal muscles (Feinstein et al., 1954; 
Inman and Saunders, 1944; Kellgren, 1938), zygapophyseal joints (Kellgren, 1939; 
Mooney and Robertson, 1976), ligaments (Inman and Saunders, 1944; Kellgren, 1939), 
or scratching/ drilling the periosteum with a needle/wire (Inman and Saunders, 1944; 
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Kellgren, 1939). Both sclerotomal and non- segmental distributions have been found in 
different studies. Sclerotomes, like dermatomes and myotomes, reflect the embryonic 
formation of the musculoskeletal system. A sclerotome is the ventromedial portion of 
the somite that will give rise to the vertebrae and ribs, whereas the remainder of the 
somite is the dermomyotome, which later form the skin and muscular tissue (Palastanga 
and Soames, 2012). Inman and Saunders, (1944) found a sclerotome distribution of 
referred symptoms on 160 observations on 26 participants. However, spreading of saline 
outside of the stimulated structures could have occurred, resulting in irritation of the 
sensory nerves and a more segmental pattern of referral. In contrast, Feinstein et al., 
(1954) carefully controlled the amount of injected saline to avoid leakage and found that 
whilst a segmental distribution was found, it was neither dermatomal or sclerotomal in 
distribution. There were large areas of overlap between levels, suggesting that there is 
not a distinct referral pattern for each level. In agreement, using a more accurate method 
of fluoroscopy and arthrographic guidance of the needle, Mooney and Robertson, (1976) 
found a non-segmental distribution of symptoms. 
  
Later studies (Fukui et al., 1997; Jung et al., 2007; Laplante et al., 2012; Ohnmeiss et al., 
1997; O’Neill et al., 2002), were more robust in their methods, attempting to ensure that 
a clear diagnosis was made, that injections were accurately placed by using methods 
such as fluoroscopy, providing exact numbers of patients and fully reporting the results 
(see appendix 3 for further details of the studies). The exact location and distribution 
varied between these studies, and the patterns were predominantly neither dermatomal 
or sclerotomal in distribution, meaning that it would not be possible to identify 
symptomatic level from a pain distribution alone. 
    
To summarise, somatic structures within the spine are capable of referring pain into the 
leg, in a non-uniform distribution. Such variety in the location and distribution of 
symptoms means that it is not possible to diagnose the structure responsible or even if 
the structure responsible is somatic or neurogenic from distribution alone. Further 
assessment is required, and section 2.4 discusses the way in which sub-grouping 
individuals in to radicular, radiculopathy and somatic can be achieved. However, 
individuals with spinally referred leg pain may not only have a neurogenic or somatic 
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presentation to their pain, but may also have an abnormal processing of pain which 
predominates; central sensitisation (Schäfer et al., 2011; Smart et al., 2012) 
 
2.3 Central Sensitisation 
 
Individuals with chronic pain may develop a condition called central sensitisation (CS), 
a condition where pain messages are abnormally processed, resulting in excessive pain, 
which may become less localised to the site of original dysfunction. There are a number 
of mechanisms thought to be responsible for central sensitisation, including altered 
processing of sensory information in the brain, disturbance in the normal descending 
inhibitory pain systems with concurrent increase in facilitatory ascending pain 
mechanisms, wind up of spinal cord neurones from repetitive stimulation of the primary 
afferent nerve fibres and long lasting enhancement (potentiation) of synapses within the 
anterior cingulate cortex (Arendt Nielsen and Henriksson, 2007; Li et al., 1999; Nijs, et 
al., 2010; Yunus, 2007). These mechanisms result in a variety of symptoms for patients 
including widespread hyperalgesia (heightened response to mechanical and 
warmth/cold) and allodynia (a pain response to non-noxious stimuli). However, 
heightened sensitivity to other sensory stimuli such as light, sound and smell has also 
been reported (Nijs et al., 2010). 
 
CS has been reported in individuals with chronic LBP (Giesbrecht and Battie, 2005; 
Giesecke et al., 2004; Jensen et al., 2010; Schmidt-Wilcke et al., 2006), although there is 
limited evidence as to the proportion of individuals with chronic LBP who have this 
condition. Smart et al., (2012) found a prevalence of central sensitisation in 23% of 551 
patients with low back (+/- leg) pain. The presence of CS was based on the results of a 
Delphi study of the opinions of 103 clinical experts (Smart et al., 2010a). As such, it is 
clear that an absolute diagnosis of CS cannot be made, but the likely presence of the 
condition can be ascertained.   
 
With respect to the presence of leg pain, one study demonstrated that leg pain did not 
appear to increase the presence of central sensitisation and evidence of nerve root 
28 
 
irritation was often not associated with CS (Jensen et al., 2010). This suggests that 
neuropathic pain may not necessarily be more likely to lead to CS than somatic pain. 
This however, was in contrast to 0’Neill et al., (2007) who found that 12 patients with 
referred leg pain and a diagnosis of radiculopathy demonstrated significantly increased 
sensitivity to pressure algometry over tibialis anterior (but not infraspinatus) compared 
to 12 controls. However, this could be a segmental increase in pain which may not be 
related to central sensitisation. In addition, O’Neill’s (2007) study only used 12 patients 
compared to the 326 (111 who had confirmed nerve root irritation) in Jensen et al.’s 
(2010) study.  
 
Individuals with CS are considered to have higher levels of distress and depression 
(Apkarian et al., 2004; Arendt Nielsen and Henriksson, 2007), poorer general health-
related quality of life (Smart et al., 2012) and poorer prognosis than those without this 
condition (Giesecke et al., 2004; Jensen et al., 2010; Thomas, 1999). It is thought that 
individuals with CS may not gain benefit from manual based treatments, since the 
normal mechanism of pain relief through the pain gate or descending pain inhibition are 
disrupted in this condition (Nijs et al., 2010; Zusman, 2008).  
2.4 Clinical Identification of sub-groups of referred leg pain 
 
As discussed, the 2 main types of spinally referred leg pain can be classified as 
mechanical nociceptive pain (somatic referred pain) or neuropathic (radicular and 
radiculopathy). In addition the presence of CS may be the predominating pain 
mechanism in some individuals with referred leg pain. Some authors have attempted to 
identify these patients by measures to identify the pain mechanism rather than the 
structures at fault (Beith et al., 2011; Smart et al., 2010a; 2010b; 2011; 2012; Schäfer et 
al., 2009). 
 
Beith et al., (2011) utilised the painDETECT questionnaire to identify neural from non-
neural cases of back and leg pain. This screening tool has been validated for the use in 
individuals with low back pain (Freynhagen et al., 2006). However the tool does not aim 
to identify those with and without a neural compromise (i.e. loss of nerve conduction), 
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and therefore individuals with both radicular pain and a lumbar radiculopathy would be 
grouped together. Since radiculopathy indicates a worsening neurological state than 
radicular pain, as deterioration in nerve function is seen with radiculopathy (Bogduk, 
2009), this may be an important differentiation to make. In addition, the use of the pain 
DETECT in identifying neuropathic pain may be inaccurate in individuals with central 
sensitisation (Gauffin et al., 2013). Since CS is considered to be prevalent in individuals 
with chronic LBP (Jenson et al., 2010), it is possible that the use of this screening tool 
may not provide an accurate means of assessing neuropathic pain in these participants.  
 
Smart et al., (2010a; b; 2011; 2012), found that a collection of signs and symptoms 
indicating either nociceptive, peripheral neuropathic pain and CS was reliable and had 
discriminative validity in identifying these 3 separate pain mechanisms in individuals 
with low back +/- referred leg pain. Such factors include the specific descriptors of pain 
used, or the location of symptoms. For example, individuals whose pain was located in 
large areas outside normally recognised referral patterns, and whose pain was evoked on 
every movement were considered to have central sensitisation. However, this method 
did not aim to distinguish between individuals with neuropathic pain with or without 
neural compromise. In addition, since many participants did not have leg pain (283/464) 
(Smart et al., 2012), there may have been more cues to a nociceptive (but non-somatic) 
cause of their LBP, regardless of other factors.  
 
Schäfer et al., (2009) used a system to identify the cause of radicular pain, in addition to 
somatic pain and CS. The neuropathic pain questionnaire; the LANSS scale was used in 
association with other signs and symptoms to sub-group 40 individuals with back 
related leg pain. Good reliability of the system was found using 6 Physiotherapists 
(Κappa =0.71).  Schäfer et al., (2009) suggested that a value >12 indicated the presence 
of CS, rather than neuropathic pain. Whilst the authors of the scale (Bennett, 2001) 
proposed that a score > 12 suggests neuropathic pain, and that in their original study 
some of the patients used had central pain, there was no discussion about the use of the 
scale for CS alone. The authors also supported their classification system with additional 
components in addition to the LANSS scale. These consisted of a number of test 
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procedures to identify any neural compromise (neurological integrity testing), or suggest 
mechanosensitivity of the nerve root. However, it was not clear how therapists decided 
that the leg pain was a somatic referral. It appeared that this decision was made as a 
result of negative findings on the other tests. It was not clear if the therapist attempted to 
reproduce the referred leg pain symptoms by stressing the lumbosacral spine. It is 
possible that the leg pain may have been caused by other non-spinal structures such as 
the hip joint, or even possibly non-musculoskeletal structures.  
 
To be of relevance to the clinician, any sub-classification system should fit within 
current practice of identifying these types of patients. The remainder of this chapter 
provides support for a clinical assessment to identify the different sub-groups of 
individuals with spinally referred leg pain.  
 
2.4.1. Identifying individuals with Radiculopathy 
 
Neurological Integrity Tests 
Clinicians have attempted to identify lumbosacral radiculopathy for many years using 
neurological integrity tests consisting of sensory testing of the lower limbs (light touch), 
isometric muscle testing and reflex testing. These tests have been advocated to show not 
only that a lumbosacral radiculopathy exists, but to identify the level of the nerve root 
compromise (Bono and Garfin, 2004; De Luigi and Fitzpatrick, 2011; Petty, 2011a).  
Clinicians must complete a full neurological integrity test for any individual who has 
either neurological symptoms or has spinally referred leg pain, not only to identify the 
presence of a nerve root involvement, but importantly to rule out serious spinal 
pathology such as cauda equina dysfunction (Bono and Garfin, 2004; Humphreys and 
Eck, 1999; Petty, 2011a; Refshauge and Gass, 2004). 
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Dermatomes 
Sensory testing of the lower limb, normally using cotton wool, is commonly the first 
stage of testing for neurological compromise, since it is often thought that the large 
diameter sensory fibres are the first to show changes after a neuropathic incident 
(Freynhagen et al., 2008; Greening and Lynn, 1998). This is supported by animal studies 
on the lumbar spine which have shown that deterioration of the large diameter afferents 
and increase in the small sensory nerve fibres results after ligation of the nerve roots and 
DRG (Chatani et al., 1995; Kawakami et al., 1994). Reduction or absence of sensation is 
mapped out further to attempt to identify a pattern of sensory loss (Petty, 2011a; 
Refshauge and Gass, 2004). The distribution of altered sensation that appears to be 
related to loss of conduction of the nerve root is described as dermatomal (Foerster, 
1933; Greenberg, 2003; Keegan and Garrett, 1948; Lee et al., 2008; McLachlan, 1990).   
 
Historically dermatomal charts were devised from a number of different methods of 
establishing the sensory distribution of each nerve root (Foerster, 1933; Head and 
Canpbell, 1900; Keegan and Garrett, 1948; Sherrington, 1894), and resulting in charts 
(see figs 2.3 and 2.4) which were not consistent between studies (see appendix 4). One 
criticism of older papers such as Head and Campbell, (1900) and Foerster, (1933) is that 
the methods were not always accurately detailed. However, repetition with methods 
used previously could not be done today due to ethical considerations3.  Later studies 
which attempted to study dermatomes by looking at the sensation in the skin of 
individuals with diagnosed herniated intervertebral discs also received criticism, since 
there is variability in how and where the nerve root is compromised, resulting in marked 
variability in dermatomal charts between individuals with seemingly the same nerve 
root involvement.  
  
 
 
                                                 
3 it was not clear what benefit to patients sectioning nerve roots above and below one nerve root level 
would give, and indeed today it is well known that sectioning of nerve roots in individuals can result in 
irreversible pain states and considerable loss of function. 
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Fig 2.3 Head and Campbell’s dermatome map  Fig 2.4 Foerster’s dermatome map  
 (both from Lee et al., 2008. An evidence based approach to human dermatomes. Clinical 
Anatomy 21:363-373, with permission from John Wiley and Sons) 
 
Nitta et al., (1993) also found much variability in distribution after nerve root block in 
individuals with a diagnosed herniated intervertebral disc. It is possible however that 
spread of anaesthetic may have resulted in more than one nerve root being anaesthetised. 
More recently, Lee et al., (2008) amalgamated a number of dermatomal charts to try to 
establish a more accurate chart (fig 2.5). There are no autonomous zones drawn due to 
overlap between levels, the exception being the midline, where there is minimal overlap. 
The blank areas represent considerable variation and overlap, such that no consistency 
regarding level could be drawn. Such variability makes being accurate about the nerve 
root level difficult based on dermatomal pattern alone, however simply identifying if a 
sensory loss has occurred in the leg for the lumbosacral nerve roots may be appropriate. 
Absence or reduction of sensation in the posterior leg/foot or anterior lower leg/foot in 
the absence of the presence of evidence of a more peripheral nerve lesion (e.g. sensory 
loss post leg trauma, or pathologies of the peripheral nervous system e.g. diabetes), 
would support a diagnosis of lumbosacral radiculopathy.  
The validity of dermatomal testing will be examined alongside the other neurological 
tests. Prior to this an overview of myotomal and reflex testing will be presented. 
33 
 
 
 
Fig 2.5 Lee et al.’s (2008) dermatomal chart. An evidence based approach to human 
dermatomes. Clinical Anatomy 21:363-373, with permission from John Wiley and Sons) 
 
Myotomes 
Myotomes represent the motor supply from a single nerve root. Weakened groups of 
muscles supplied by a single nerve root are considered to be indicative of a 
radiculopathy (Refshauge and Gass, 2004; Petty, 2011a).  Table 2.1 shows commonly 
used myotomes, but as with dermatomal charts it is known that there is considerable 
overlap in such myotomes. Early work by Sherrington, (1892) demonstrated by 
electrically stimulating the nerve roots in monkeys, cats, dogs and frogs that a number of 
nerve roots contributed to a number of muscles. How these directly relate to humans is 
not clear, as in animals the lumbar levels do not quite correspond to the same levels in 
humans (e.g. dogs have 7 lumbar vertebrae and 3 sacral vertebrae). Young et al., (1983) 
and Tsao et al., (2003) investigated the anatomical pattern of innervation of muscles by 
the lumbosacral nerve roots in patients with radiculopathy (identified either surgically or 
radiologically). Motor and sensory nerve conduction studies were performed by Tsao et 
al., (2003) but only EMG by Young et al. (1983). The findings suggested that L5 
preferentially innervated extensor hallucis longus and tibialis anterior (Tsao et al., 2003; 
Young et al., 1983) and peroneus longus (Tsao et al., 2003) and for S1gastrocnemius 
(Tsao et al., 2003; Young et al., 1983) and hamstrings (Tsao et al., 2003). It must be 
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noted that 16 % of patients were incorrectly identified by the EMG findings compared to 
surgical findings (Young et al., 1983), which may lessen the strength of findings.  
 
Nerve Root Level Muscle Test 
L1/2/L3 Iliopsoas 
L2/L3/L4 Quadriceps 
L4/L5 Tibialis Anterior 
L5/S1 Extensor Hallucis Longus 
L5/S1 Peronei 
L5/S1/S2 Gastrocnemius/gluteals/hamstrings 
 
Table 2.1 Myotomes (Modified from Butler, 2000, Drake et al., 2005 and Iversen et 
al., 2013) 
Myotomes and dermatome testing make up 2 of the 3 tests used clinically to identify a 
nerve root dysfunction; the third is reflex testing which will be discussed below, 
followed by a critical look at the use of these tests in clinical practice. 
 
Reflex Testing 
In the lower limb, the most common tendon reflexes that are tested are the patella reflex 
and the ankle jerk reflex. These are considered to test the L3 or L4 nerve root and S1or 
S2 nerve roots respectively (Jönsson and Strömqvist, 1996; Butler, 1991; Petty, 2011a). 
This stretch reflex is thought to be decreased or absent in the presence of a dysfunction 
of the peripheral nerve pathways (either afferent or efferent), and increased in the 
presence of a central nervous system dysfunction. However one study has demonstrated 
a reduction in reflexes following injection of hypertonic saline into the zygapophyseal 
joints (Mooney and Robertson, 1976), and thus the presence of a reduced reflex alone 
may not best reflect a nerve root dysfunction. There is some debate in the literature 
about the value of reflexes in the diagnosis of nerve root compression, and this 
alongside the validity of the other 2 tests discussed will be considered in the section 
below. 
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Validity of Neurological Integrity Testing 
The majority of literature on this topic suggests that the tests described are not 
sufficiently accurate to diagnose a nerve root compression (van der Windt et al., 2011; 
Iversen et al., 2013). However, these systematic reviews have attempted to cluster a 
series of heterogeneous studies with varying robustness of methodology. In addition, 
most of the studies included in these reviews have not attempted to incorporate the 
amalgamation of both physical and subjective findings into the final decision making of 
the clinician; a factor thought to improve the accuracy of neurological testing (Mercer 
and Smith, 2007). In this study (Mercer and Smith, 2007), 5 extended scope 
physiotherapy practitioners examined 123 patients who were subsequently referred for 
MRI scans over a 9 month period.  The results showed a sensitivity of 100%, specificity 
of 98%, and accuracy of 100% for a disc prolapse at the L3/4 level, a sensitivity of  
89%, specificity 96% and accuracy of 94% for L4/5, and  sensitivity 93%, specificity 
85%, accuracy 89% for L5/S1. This study demonstrated that for experienced, highly 
trained physiotherapists, a full clinical examination including neurological integrity was 
an excellent indicator of intervertebral disc herniation. However, these were all patients 
referred to specialist clinics with a higher likelihood of nerve root involvement and may 
not reflect the population attending a standard Physiotherapy clinic. In addition all 
Physiotherapists were highly trained and used to seeing patients of this nature on a daily 
basis in their practice.  
 
Such high sensitivity and specificity values have not been found in most other studies 
(Iversen et al., 2013; Lauder et al., 2000; van der Windt et al., 2011).  Lauder et al., 
(2000) found sensitivity/specificity of myotomal testing to be 69/53% respectively, 
reflex testing sensitivity around 50% and specificity to be around 90%, and sensory 
testing 50% sensitive and 62% specific. If the findings were combined, specificity 
improved to 99% and the positive predictive value was 75%. Another interesting finding 
from Lauder et al.’s (2000) study was that 90% of individuals with a diagnosis of 
lumbosacral radiculopathy had one positive neurological integrity finding. However, the 
gold standard used was electrodiagnosis which has been reported to only have a 
diagnostic accuracy of 54% (van Damme et al., 1979), which reduces the conviction of 
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the results. Van der Windt et al.’s 2011 systematic review demonstrated poor validity 
for the tests with sensitivity of muscle weakness as a finding from 0.27 to 0.62 and 
specificity from 0.47 to 0.93.  Reflex testing ranged from 0.14 to 0.89 for sensitivity and 
0.6 to 0.93 for specificity, whilst sensation testing ranged from 0.14 to 0.61 and 0.6 to 
0.93 (sensitivity and specificity respectively).  
 
Such wide variation and generally overall poor validity do not support the use of these 
tests, however there were many limitations of both the systematic review (van der Windt 
et al., 2011) and original studies which question the credibility of this result. Firstly, the 
methodology of each study was so variable both in the gold standard used to identify the 
specific level (mainly MRI or surgery; surgery may be more valid), and in establishing 
if the gold standard was testing nerve root compression or disc herniation. Other 
important heterogeneous factors were the way in which tests were performed; some 
studies omitting details, others detailing techniques which are not normally used in 
practice. Examples include isotonic muscle testing rather than isometric (Kerr et al., 
1988),  range of movement compared to the other side as a measure of strength 
(Vucetic, 1996), and only testing one or two muscles for weakness. Perhaps most 
variance occurred in the sensory tests in that some tested pain, others tested light touch 
on both legs at the same time (potentially confusing the CNS with bilateral sensory 
input), and others looked at distribution of pins and needles or tingling. All of these 
factors make the conclusions of van der Windt et al., (2011) less convincing. Whilst 
there are limitations in the studies that were included in the van der Windt et al., (2011) 
study, a more recent study (Iversen et al., 2013), supports the conclusions made by van 
der Windt et al., (2011).  
 
One hundred and sixteen patients were assessed by both a Physiotherapist and a medical 
practitioner and results compared to findings on MRI or CT scan (Iversen et al., 2013). 
Both the consideration of each individual test and allowing for the clinicians’ overall 
diagnosis of level at fault did not provide sufficient evidence for the clinical value of 
these tests (likelihood ratios for clinicians’ diagnosis 1.74 (+ve) and 0.73 for L5 and 
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1.29 (+ve) and 0.61 for S14). However, the decision by the clinicians was based on a 
very directed examination and consideration of findings which are not all well supported 
in the literature. For example to diagnose an L4 radiculopathy  the sensory loss within 
the L4 dermatome could be either a loss to light touch or pin prick, but it is unclear if a 
loss in both sensory modalities was needed to be considered positive. In addition 
weakness of ankle dorsiflexion was considered to be indicative of a motor loss of L4, 
which according to Young et al., (1983) best represents L5. In addition, a positive SLR 
alone was considered to be indicative of a radiculopathy, which has questionable 
validity for specific nerve root levels. Such clinical decision making may not best reflect 
current clinical practice, and may have resulted in an inaccurate diagnosis of nerve root 
involvement.   
 
In support of the use of neurological integrity tests for assessing the presence of a 
radiculopathy, Takahashi et al., (1999) found a statistically significant greater nerve root 
pressure (59.8 (+/- 50.3) mmHg compared to 15 (+/- 5.3) mm Hg) in individuals with 
diagnosed disc herniation from MRI and positive neurological integrity, compared to  
those with negative neurological integrity. Whilst some changes to the nerve root 
pressure may have been induced by measuring pressure after a laminotomy, these 
changes would have been representative of all participants. The importance of this study 
is that all individuals were diagnosed with disc herniation from an MRI scan, yet not all 
had positive neurological integrity tests. It is possible therefore that the poor sensitivity 
values found in the aforementioned studies could reflect the differences in individuals 
with a visually identified herniated disc, i.e. not all individuals with herniated discs have 
sufficient neurological compromise to cause changes to neurological integrity, whilst 
others do. Hence, further studies are required to support these findings.  
 
To summarise, the literature is generally not supportive for a single test for identification 
of nerve root level, but is more supportive of the combined use of the tests and the 
clinical presentation of the patients. Despite many papers suggesting poor validity 
                                                 
4 Positive likelihood ratio considered to influence post-test probability and suggest robust clinical decision 
>5.0 and negative likelihood ratio <0.2 (Jaeschke et al., 1994) 
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measures for these tests, these remain the advised tests of choice for assessment of 
neurological integrity in clinical practice (Bono and Garfin, 2004; Humphreys and Eck, 
1999; Petty, 2011a; Refshauge and Gass, 2004). In addition, the limitations of many of 
these studies may mean that the findings are not conclusive. The positive findings of 
clinical judgement alongside these tests from Mercer and Smith (2007), and improved 
diagnostic accuracy found by combination of tests by Lauder et al. (2000) suggests that 
there may still be justification for the use of these tests in clinical practice.  Moreover, 
the lack of alternative tests for the diagnosis of nerve root involvement means that these 
tests continue to be routinely used in practice.  
 
Straight Leg Raise Test for diagnosis of radiculopathy 
The straight leg raise test has also been proposed as a test which accurately detects the 
presence of a radiculopathy (Kobayashi et al., 2003). The leg is lifted with the individual 
in supine and the knee extended. The test is known to influence the lumbosacral nerve 
roots; causing excursion and strain to occur (Gilbert et al., 2007 a and b, Goddard and 
Reid, 1965). The principle behind the positive test for radiculopathy is that the nerve 
root becomes pulled against the herniated disc leading to greater amounts of pain or 
neurological deficit (Rabin et al., 2007).  
 
Indeed, Kobayashi et al., (2003) found a restriction in movement of the nerve root 
adjacent to the disc herniation during the SLR in 12 individuals with lumbosacral disc 
herniation, which significantly increased after removal of the disc herniation. In 
addition, blood flow measured using a laser Doppler flow meter, was markedly 
decreased at the angle that the individuals had complained of pain during the SLR and 
significantly increased after discectomy. The restriction and subsequent improvement in 
nerve root excursion during the SLR was supported by another study by the same 
authors 7 years later in a larger cohort of 32 participants (Kobayashi et al., 2010). 
However, despite this compelling evidence in support of SLR for radiculopathy, studies 
have not convincingly supported the use of SLR for diagnosing radiculopathy.  
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Predominantly sensitivity is good to excellent (Lauder et al., 2002; Poiraudeau et al., 
2001; Rabin et al., 2007), but specificity varies from poor to good (Lauder, 2002; 
Poiraudeau et al., 2001; Vroomen, 2002). Some of the differences in the results of the 
studies may be related to the way in which the SLR test was performed, some 
specifically look for referral of pain below the knee (Rabin et al., 2007) whereas others 
lacked clarity in the description (Vroomen et al., 2002). It must be noted that the SLR is 
a neurodynamic test which aims to assess dysfunction in any of the neurological 
structures from the nerve root down to the continuation into the sciatic nerve and its 
distal connections (Butler, 1991; Butler, 2000; Shacklock, 2005a). Hence, its lack of 
specificity for radiculopathy is logical, since the test cannot identify lumbar disc 
herniations alone. Individuals with radicular pain and radiculopathy would be expected 
to have a positive SLR; therefore the test lacks the ability to discriminate between the 2 
conditions. However, as explained in the section below, it is critical in differentiating 
between radicular and somatic referred pain. 
 
In summary, the decision of sub-grouping individuals into radiculopathy should be 
decided based upon the clinical picture (e.g. history of the condition, location of 
symptoms into the leg which are aggravated by spinal movements) and the presence of 
positive neurological integrity tests. The use of the SLR will be discussed in greater 
detail in the section below, and further in chapter 3.  
 
2.4.2. Identifying individuals with Radicular pain 
 
Nerves that are sensitised will be painful when they are moved (Hall and Elvey, 2004; 
Walsh and Hall, 2009b). One way of testing lumbosacral nerve root sensitivity is with 
the use of neurodynamic tests, including SLR or slump tests (chapter 3 includes a 
discussion of the clinical use of the SLR and slump tests). These neurodynamic tests 
represent the ability of the nervous system to cope with movements which cause them to 
slide through their interfacing tissues, and at times become compressed or lengthened as 
a result (Boyd et al., 2005; Shacklock, 1995; Shacklock, 2005a). Nerves not only adapt 
to large changes in nerve bed length mechanically but also physiologically, because 
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throughout such movements they must continue to function (Butler, 2000; Shacklock, 
2005a). In cases where the nerve becomes sensitised to movement, this suggests a 
degree of compromise in its ability to cope either mechanically or physiologically (Boyd 
et al., 2005; Gallant, 1998).  
 
The SLR and slump tests are two neurodynamic tests which influence the lumbosacral 
nerve roots, lumbosacral plexus and continuations into the sciatic nerve and its 
divisions. The slump test additionally stresses the more proximal portions of the 
neuraxis by causing further excursion of the spinal cord and brain stem (Butler, 2000; 
Shacklock, 2005a). One study has shown substantial agreement between SLR and slump 
tests (κ =0.69) and good reliability of both tests in individuals with spinally referred leg 
pain (r = 0.64) (Walsh and Hall, 2009c).  
 
Beith et al., (2011) found a statistically significant reduction in range of SLR in patients 
with neuropathic back and leg pain compared to those with nociceptive back and leg 
pain.  An important aspect of neurodynamic testing to determine the presence of a 
mechanosensitive nerve is structural differentiation, since SLR alone moves many 
structures such as the lumbar spine, hip, knee and ankle joints and the surrounding 
myofascial structures.  Structural differentiation consists of movements of the joints 
furthest away from the area of symptoms, such that a change in symptoms is unlikely to 
be attributable to the local non-neural structures, since they will not have been moved. 
An example would be a reproduction of symptoms in the buttock during SLR, which 
increase with the addition of ankle dorsiflexion. Since the proximal structures have not 
been moved, the increase in buttock symptoms is more likely to be due to changes in the 
nerve since dorsiflexion increases the strain in the tibial nerve (Alshami et al., 2007;  
Boyd et al., 2013; Coppieters et al., 2006) and sciatic nerve (Boyd et al., 2005; 2013; 
Coppieters et al., 2006). 
 
It can therefore be concluded that SLR or slump test would identify pain referred from a 
nerve root dysfunction. In addition, it has been demonstrated that sensitised nerves do 
not just display sensitivity to movement, but also to touch, and this sensitivity is 
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commonly felt often along the course of the nerve trunk (Asbury and Fields, 1984; 
Walsh and Hall, 2009c). In the case of lower lumbar spinal nerve roots or DRG, the 
tenderness to palpation is likely to be felt along the course of the sciatic nerve (Dyck, 
1987; Walsh and Hall, 2009c). This may be due to neurogenic inflammation mediated 
by the nervi nervorum (Hall and Elvey, 2004). The nerve trunk acts as a sensitised 
nociceptor, producing pain on even minor mechanical stimuli (Devor and Rappaport, 
1990).  As a result of this, palpation along the nerve trunk has been advocated (Schäfer 
et al., 2009, 2011; Walsh and Hall, 2009c). The validity of palpation as compared to 
slump tests or SLR was high (sensitivity 0.83, specificity 0.73) if 2 or more palpation 
sites were positive (Walsh and Hall, 2009c). Whilst a limitation of Walsh and Hall, 
(2009c) is around the issue of SLR and slump test as a gold standard for nerve 
dysfunction in this study, the aim was to see if the 2 tests related to each other in the 
presence of leg pain. 
 
To summarise, the presence of radicular pain may be identified by a positive SLR or 
slump test and the presence of 2 or more tender points on nerve palpation at the sciatic 
(at the buttock), tibial (behind the knee) and common peroneal (around the fibular head) 
nerves. However, since the sensitivity and specificity of nerve palpation as compared to 
the SLR or slump test was not 100%, it is possible that a negative nerve palpation test 
could be found in the presence of a positive SLR or slump test and vice versa. Since 
there is a stronger body of evidence for the use of neurodynamic tests in identifying 
neuropathic pain (see chapter 3) than nerve palpation alone, a final decision on sub-
group should be made on the findings of the SLR or slump test.  
 
Neurological integrity tests are required to distinguish between radicular pain and 
radiculopathy. Individuals with negative neurological integrity, neurodynamic tests or 
nerve palpation may be considered to have somatic referred leg pain, however further 
examination is required to ensure that the pain is neuromusculoskeletal in origin and 
related to the spine, not other local structures such as the hip joint. 
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2.4.3. Identifying individuals with Somatic Referred leg pain 
 
Somatic referred leg pain may arise from dysfunction of a number of different structures 
(muscles, joint structures, ligaments etc). For the purposes of the present study, the 
precise location of the source of somatic referred leg pain is not the critical concern. The 
main focus is on whether there is a neural or non-neural cause of spinally referred leg 
pain. The location of leg pain cannot be used to identify neural versus non-neural 
structures. Individuals with solely a somatic referred leg pain have no neurological signs 
and symptoms (Bogduk, 2009; Fukui et al., 1997; O’Neill et al., 2002), therefore, 
neurological integrity tests, which assess changes to nerve conduction (light touch, 
reflex testing and muscle strength), will be normal.  Furthermore, neurodynamic tests 
using structural differentiation (Coppieters et al., 2005; Nee et al., 2012a) would also be 
negative, since the nerve is not irritated in these individuals (Bogduk, 2009; Fukui et al., 
1997; O’Neill et al., 2002). In addition to negative findings in the tests described, 
individuals with somatic referred pain can be identified by reproducing their pain with 
movements which load the local soft tissues around the lumbar spine such as active 
range of movement (AROM) and passive accessory intervertebral movements 
(PAIVMS) of the lumbar spine, or manual testing of the muscles around the spine 
(Petty, 2011a; Refshauge and Gass, 2004).  
 
Patients with pain emanating from their somatic spinal structures have pain on 
movements of their spine because the spinal structures are sensitised either chemically 
or mechanically. In addition, exclusion of pain from peripheral joints is essential to 
support the diagnosis. Hence, somatic referred pain may be identified if an individual 
has their symptoms reproduced by at least one physical test procedure of a spinal non-
neural structure (and have negative neurological integrity and neurodynamic tests).  
 
The proportion of patients who have somatic referred leg pain is thought to be higher 
than the other 2 sub- groups identified for this thesis (Beith et al., 2011). Fifty six 
percent of 343 patients referred for Physiotherapy for their low back and referred leg 
pain in the South East region of the UK were identified as having somatic referred pain. 
A similar finding was found by Smart et al., (2012). Fifty five percent of individuals 
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with back (+/- leg) pain in the UK and Ireland were thought to have a nociceptive cause 
for their pain.  
 
In addition to identifying appropriate sub-grouping of individuals with spinally referred 
leg pain, it is important to ascertain if individuals have CS. The way in which CS may 
be identified is described in the section below. 
2.4.4. Determining Central Sensitisation Clinically  
 
There is no definitive diagnosis for CS, however a collection of symptoms and signs 
(pain for longer than 6 months (O'Neill et al., 2007), widespread areas of pain (Jensen et 
al., 2010; Smart et al., 2010a), hypersensitivity to warmth or cold (Berglund et al., 
2002), and hypersensitivity to touch (Jensen et al., 2010; O'Neill et al., 2007; Smart et 
al., 2010a), may give an indication of such a condition.  
 
Fibromyalgia is a condition in which CS is considered to be an important characteristic 
(Arendt Nielsen and Henriksson, 2007; Meeus and Nijs, 2007; Nijs et al., 2010; Yunus, 
2007; Woolf, 2011). The use of tender point assessment has been used to diagnose 
fibromyalgia (Woolf, 2011; Jensen et al., 2010), since one of the key findings of CS is 
widespread mechanical hyperalgesia. It has been postulated that CS may be prevalent in 
some individuals with low back pain (O’Neill et al., 2007; Nijs et al., 2010; Schmidt-
Wilcke et al., 2006), and found that a lowering of pressure pain thresholds occurs in 
individuals with chronic low back pain (Giesecke et al., 2004; Laursen et al., 2005; 
O’Neill et al., 2007). Jensen et al., (2010) assessed the presence and use of the same 
tender point assessment that is used to diagnose fibromyalgia in individuals with chronic 
low back pain.  Three hundred and twenty six patients (111 with diagnosed 
radiculopathy) filled in a common mental disorders questionnaire which incorporated 
aspects of distress, anxiety and depression before a tender point assessment was 
completed (see appendix 27). The presence of greater than 8 tender points was 
associated with widespread pain (odds ratio 3.67). In addition patients with greater than 
8 tender points had a longer duration of low back pain, and had positive associations 
with greater distress. Interestingly there was no association with the presence of nerve 
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root pathology and tender points; indeed there was a negative association between these 
two variables.  
 
It has been found that individuals with chronic low back pain have worse pain after 
exercise (Hoffman et al., 2005), a finding also present in individuals with chronic 
fatigue syndrome (another condition where CS has been demonstrated) (Whiteside et al., 
2004). This is in contrast to an improvement in pain in asymptomatic individuals and is 
thought to be related to the abolition of descending inhibitory pathways found in CS. 
However Meeus et al., (2010) found that whilst PPT decreased in individuals with 
chronic fatigue syndrome after submaximal exercise on a static bike, it increased in both 
asymptomatic individuals and patients with chronic low back pain. Therefore, this 
method may not be useful in identifying CS in individual with chronic LBP. Thermal 
hyperalgesia and wind up of spinal cord neurones from repetitive stimulation of the 
primary afferent nerve fibres, have also been found to be prevalent in individuals with 
CS (Desmeules et al., 2003; Li et al., 1999; Staud and Price, 2001). However the 
protocol for testing thermal pain thresholds and wind up requires the use of expensive 
time consuming quantitative sensory testing equipment, which are not practical for 
physiotherapists to use during a standardised assessment. Testing of painful points can 
be done using a hand held algometer, which is cost effective and time efficient. In 
addition, there is no evidence that thermal hyperalgesia is any more valid for identifying 
CS than mechanical hyperalgesia. 
 
Therefore, if greater than 2 of the symptoms of CS are present as described above, and 
greater than 8 painful points are revealed on physical assessment, an individual may be 
identified as having a centrally sensitised pain mechanism. People with spinally referred 
leg pain and CS may present with increased levels of disability. In addition, it has been 
found that individuals with different causes of their leg pain may have different 
contributions from non-physical factors such as psychological and social influences 
(Smart et al., 2012). The next section discusses the relevance of such factors in 
prognosis in individuals with low back and referred leg pain, and explains the rationale 
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for the choice of disability and psychosocial questionnaires that are frequently used in 
clinical studies.  
 
2.5 The Impact of psychosocial characteristics on outcome of 
spinally referred leg pain  
 
Low back pain, like all forms of pain is a complex process, affected by both physical 
and psychosocial factors (Haggman et al., 2004; Hill and Fritz, 2011; Jensen et al., 
2010; Vlaeyen and Linton, 2000). Poorer prognosis has been associated with higher 
psychosocial factors such as fear avoidance (Vlaeyen and Linton, 2000; Wessels et al., 
2006; Woby et al., 2004), depression and anxiety (Bergbom et al., 2011; Haggman et al., 
2004;), kinesiophobia (Picavet et al., 2002; Thomas et al., 2010), and catastrophising 
(Bergbom et al., 2011; Picavet et al., 2002; Sullivan et al., 2005; Wessels et al., 2006). 
In addition high levels of disability are considered to be a poor prognostic indicator 
(Hayden et al., 2010; Heymans et al., 2010; Hill et al., 2011), and levels of disability 
have been demonstrated to relate well to psychosocial characteristics (Thomas et al., 
2010; van Wilgen et al., 2010; Waddell et al., 1993).  
 
It is therefore plausible that higher levels of disability and psychosocial factors could 
detrimentally affect the outcome of treatment intervention in individuals with spinally 
referred leg pain. It is therefore important to analyse any interactions in clinical studies 
assessing the effects of treatment interventions, since these factors could mask any 
positive effects that occur. It has been proposed that individuals with neuropathic causes 
of leg pain may have a poorer prognosis due to a number of factors, including 
psychosocial elements (Haugen et al., 2012; Hill et al., 2011; Kongsted et al., 2012). 
Assessing the differences between the 3 sub-groups in relation to psychosocial factors 
may add to the current body of evidence regarding specific psychosocial factors in sub-
groups of individuals with spinally referred leg pain. This section gives an overview of 
the potential implications of higher levels of disability and psychosocial factors, and 
provides justification for the use of such questionnaires in clinical studies. 
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2.5.1 Psychosocial Factors and Prognosis  
 
The prognosis for individuals with chronic low back pain is complex and affected by 
many variables (Hayden et al., 2010; Heymans et al., 2010). However, it is well 
recognised within the literature that high levels of a number of psychosocial factors can 
negatively affect prognosis (Bergbom et al., 2011; Haggman et al., 2004, Picavet et al., 
2002; Sullivan et al., 2005; Vlaeyen and Linton, 2000; Wessels et al., 2006; Woby et al., 
2004) and that these factors are high in individuals with spinally referred leg pain (Hill 
et al., 2011), particularly neuropathic leg pain (Haugen et al., 2012; Kongsted et al., 
2012). Poorer prognosis has been linked to increased levels of certain psychosocial 
characteristics in individuals with chronic LBP. Chronic LBP varies in its definition, but 
most texts consider it to be LBP that has been present for between 3 to 6 months in 
duration (Freburger et al., 2009; Giesecke et al., 2004). The most common 
characteristics involving abnormal beliefs about the pain or about movement or work 
(Bergbom et al., 2011; Picavet et al., 2002; Sullivan et al., 2005; Thomas et al., 2010; 
Vlaeyen and Linton, 2000; Wessels et al., 2006; Woby et al., 2004) or high levels of 
depression, stress or anxiety (Bergbom et al., 2011; Haggman et al., 2004; Hill and Fritz, 
2011). Appendix 5 details some of the studies which have looked into prognostic factors 
and the presence of psychosocial factors in low back pain. Chronicity and even 
development of LBP have been closely linked to pain catastrophising and kinesiophobia 
(Picavet et al., 2002), whilst recurrence and chronicity have also been linked with fear 
avoidance beliefs and depression (Burton et al., 2004).  These psychosocial factors are 
defined and detailed in section 2.5.3. Burton et al., (2004) also found that the presence 
of leg pain was a factor associated with recurrence.  
 
One study demonstrated that leg pain with neurological signs had poorer prognosis 
when associated with higher levels of kinesiophobia (Haugen et al., 2012), but Kongsted 
et al., (2013) showed that despite an increase in psychosocial factors in individuals with 
referred leg pain and neurological signs (Kongsted et al., 2012; ), prognosis was not 
affected (Kongsted et al., 2013). However, Kongsted et al., (2013) did not reveal what, 
if any intervention participants may have been having in the one year time frame that 
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participants were involved in the study, which could have resulted in heterogeneous 
factors explaining the results.  
 
In contrast to Kongsted et al., (2013), Jensen et al., (2010) found that predictors of 
poorer prognosis were higher levels of fear avoidance, worrying and health anxiety, 
although these were no worse compared to individuals with low back and leg pain 
without neurological signs. These results appear to contradict Haugen et al., (2012) 
since Jensen et al., (2010) found no difference between the prognostic indicators for 
neurological versus non-neurological referred leg pain. However, Haugen et al., (2012), 
only looked at individuals who they considered to have a nerve root irritation resulting 
from a disc herniation, hence it is not known what differences in prognostic factors 
would have been found if individuals with and without neurogenic leg pain had been 
compared.  
 
Limitations of all three studies were the way in which they concluded that patients had 
neurological cause for their leg pain. Kongsted et al., (2013) included participants with 
either a positive SLR (less than 60°) or any one positive neurological integrity test. 
Haugen et al., (2012) included individuals with pain or symptoms below the knee and a 
positive disc herniation on MRI or CT scan. Jensen et al., (2010) classified individuals 
with radiculopathy from positive MRI findings plus a positive SLR and loss of sensation 
or reflex. Jensen et al., (2010) attempted to improve the accuracy of the classification, 
by only permitting individuals into the group with a positive MRI scan, but this may 
have negated those with an inflammatory (but not visible compressive neuropathy) 
cause of radicular pain. This may have explained the lack of difference between the 2 
groups. Similarly Haugen et al.’s (2012) classification did not include a neurological 
examination and hence individuals may not have had a neurological cause of leg pain 
despite the positive MRI or CT scan, since it is known that MRI scans often show 
pathological findings even in asymptomatic patients (Boden et al., 1990; Falconer et al., 
1948; Rydevik et al., 1991; van Rijn et al., 2006).  Likewise, Kongsted et al., (2013) 
may have grouped individuals with the radicular or radiculopathy together by allowing 
SLR to be the one positive test which categorised individuals in this way.  
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Whilst it is unclear if there is a difference in prognostic factors specifically between 
individuals with radiculopathy or radicular pain, Walsh and Hall, (2009a) found a 
greater level of disability and fear avoidance in a group of individuals with radicular 
pain than those with radiculopathy, somatic pain or greater neuropathic signs and 
symptoms5. However, of interest, all sub-groups had borderline abnormalities for 
anxiety and moderately high fear avoidance, suggesting the presence of leg pain alone, 
regardless of the cause, may result in high levels of certain psychological sub-straits. 
Schäfer et al., (2011), using the same sub-grouping system, found a significantly greater 
level of anxiety in the individuals with CS, compared to the radicular and radiculopathy 
groups. Interestingly, there was no significant difference between the somatic referred 
leg pain group and the centrally sensitised group.  In addition, no significant effect of 
any of the psychosocial factors (fear avoidance beliefs, anxiety and depression) was 
found on improvement in outcome of a neurodynamic treatment between the 4 sub-
groups. Hence, despite the suggestion that prognosis may be poorer in individuals with 
neurogenic causes of leg pain, and that higher levels of psychological factors are a cause 
for this worse prognosis, there is limited evidence that has demonstrated this for 
individuals with referred leg pain.  
 
Low numbers of participants in each group (minimum of 7 and maximum of 15, Walsh 
and Hall, 2009a; minimum of 9, maximum of 29, Schäfer et al., 2011), and the method 
of sub-grouping which were discussed in section 2.4 mean that further investigation of 
these psychosocial factors in individuals with referred leg pain are essential to ascertain 
their significance.  
2.5.2 Association of disability and psychosocial factors 
 
Whilst LBP has been recorded throughout history (Allan and Waddell, 1989), the 
associated disability has only been recorded in relatively more recent times (Waddell, 
1987). This has been suggested to reflect a sociological phenomenon, related to the 
progression in medicine (Waddell et al., 1993).  Whilst pain is linked to disability, it has 
                                                 
5 the classification system used was that of Schäfer et al., (2009), details can be found in chapter 2.4 
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been demonstrated that this relationship is weak (Slater et al., 1991; Waddell et al., 
1993).  However, Grotle et al., (2004) found that pain was associated with disability, 
measured by the Oswestry disability Index (ODI). This difference in findings compared 
to those of Waddell et al., (1993) and Slater et al., (1991) may be because questions 
about pain are integrated into the ODI. Regardless of the exact relationship between pain 
and disability, there is a growing body of evidence which links high levels of disability 
with high levels of psychological factors. Fear avoidance factors have been linked 
closely with higher levels of disability (Crombez et al., 1999; Grotle et al., 2004; 
Waddell et al., 1993). Waddell et al., (1993) found that higher levels of fear avoidance 
beliefs about work correlated highly with higher levels of disability, but not pain. Fear 
avoidance beliefs about physical activity were significantly associated with high scores 
on the ODI (Grotle et al., 2004) in individuals with both acute and chronic low back 
pain.  Crombez et al., (1999) found that fear avoidance beliefs were strongly correlated 
with disability in individuals with chronic low back pain.   
 
Pain catastrophising and kinesiophobia have also been found to be important predictors 
of disability in patients with neuropathic pain (French et al., 2007; Sullivan et al., 2005) 
and chronic low back pain (Crombez et al., 1999; Picavet et al., 2002). In addition, pain 
related fear was found to be a strong predictor of chronic disability, 1 year after the first 
incidence of low back pain (Klenerman et al., 1995). Depression has been demonstrated 
to be linked with disability (Epping-Jordan et al., 1998). However, in a systematic 
review emotional distress (including anxiety, depression and stress) did not seem to be a 
predictor in chronic disability (Truchon and Fillion, 2000), although its presence may 
impact on disability through a vicious circle of distress, leading to inactivity and 
disability, which further induces emotional distress (Gatchel and Gardea, 1999). This is 
supported by Crombez et al., (1999) (not included in Truchon and Fillion’s 2000 
systematic review) who found anxiety be less predictive of disability than fear 
avoidance or kinesiophobia. However in contrast, Wand et al., (2010) found that 
depression made a significant contribution to the prediction of disability as measured 
with the Roland and Morris disability questionnaire, whilst Grotle et al., (2004) found 
that distress was strongly related to disability in individuals with chronic LBP. 
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Since the factors discussed appear to be related to outcome in individuals with low back 
and spinally referred leg pain, these factors should be incorporated into clinical studies 
to assess if they have an impact on the effect of any treatment. A number of scales exist, 
and the following section describes and critiques each scale. 
 
2.5.3 Choice of Disability and Psychological Questionnaires 
 
A wide array of questionnaires for measuring a plethora of different psychological traits 
and identifying levels of disability can be found in the literature. As discussed in the 
previous section, the most pertinent psychosocial factors which have been related to 
poor outcome in individuals with low back and spinally referred leg pain have been 
emotional distress (Burton et al., 2004, Jensen et al., 2010; Kongsted et al., 2012; 2013; 
Schäfer et al., 2011; Smart et al., 2012), fear avoidance beliefs (Burton et al., 2004; 
Jensen et al., 2010; Kongsted et al., 2012, 2013; Schäfer et al., 2011; Walsh and Hall, 
2009a; Woby et al., 2004) catastrophising (Picavet et al., 2002; Woby et al., 2004) and 
kinesiophobia (Haugen et al., 2012; Picavet et al., 2002). Even within these specific 
traits, a number of possible measurement tools are available in the literature. The choice 
of specific questionnaires should be based on the appropriateness of their use for the 
cohort in question, and acceptable validity and reliability. Each of the questionnaires is 
discussed below. 
 
Oswestry Disability Scale (Appendix 6) 
This is a self- reporting questionnaire which has been designed to assess the functional 
impairments of individuals with low back pain (Fairbank et al., 1980). It consists of 10 
items covering levels of pain, personal care, and various functional activities such as 
lifting and social life. The total score is turned into a percentage score of sections 
completed. This allows for individuals to miss sections that may not be applicable (for 
example questions related to sex life, found to be omitted in 24% of cases by Fisher and 
Johnson, (1997)). The classification system of severity recommended by the original 
authors (Fairbank et al., 1980) is as follows: 
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0-20% minimal disability 
20-40% moderate disability 
40-60% severe disability 
60-80% crippled6 
80-100% bed bound 
 
Fisher and Johnson, (1997) assessed the content validity of the ODI in 190 patients 
undergoing rehabilitation for LBP. Specific tests were performed to assess the validity 
of 3 of the sub-sections of the ODI: sitting, lifting and walking (time of sitting was 
measured with a stop watch, walking distance was calculated until they needed to stop, 
and individuals were asked to hold greater amounts of weight by adding bags of flour to 
a carrier bag). There was significant correlation with the distance walked and specific 
section on walking (section 4), with high sensitivity and specificity calculated for this 
section (sensitivity 76%, specificity 96%). Statistical correlation was also found for 
sitting duration and section 5 of the ODI (sitting) with sensitivity and specificity 72 and 
69% respectively. Lifting was better correlated with the weight lifted than the time of 
holding the weight, with sensitivity and specificity being 81% and 52% respectively. 
However, such low specificity could be linked to the fact that individuals may not lift in 
the way that they were tested in the study; a static hold of flour in a carrier bag may be 
easier to sustain than lifting a child from the floor for example. ODI has been found to 
correlate highly with other outcome measures for individuals with LBP (Roland Morris 
disability questionnaire (Stratford et al., 1994), and McGill Pain Questionnaire 
(Beurskens et al., 1995), but less well with measures of pain or physical examination 
(Beurskens et al., 1995). Internal consistency (a measure of how each construct within a 
questionnaire correlates with the other constructs) of the ODI is good, with Cronbach’s 
α from 0.76 (Fisher and Johnson, 1997) to 0.87 (Kopec et al., 1996). 
 
Repeatability of the ODI has been found to be excellent with ICC of 0.88 (Joshi et al., 
2013) to 0.91(Kopec et al., 1996). 
                                                 
6 Unfortunately a revised classification system using a more appropriate term appears not to have been 
considered. 
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Fear Avoidance Beliefs Questionnaire (FABQ) (Appendix 7) 
 
Fear of pain, and the attempt to avoid pain is an innate response in human beings 
(Waddell et al., 1993). However, it has been demonstrated that fear avoidance 
behaviours may impact on the level of disability in individuals with low back pain 
(Waddell et al., 1993; Walsh and Hall, 2009a).The FABQ was developed by Waddell et 
al. in 1993. It consists of 2 scales; the first related to fear avoidance beliefs about 
physical activity, and the second to fear avoidance beliefs about work. A score of 0 to 6 
is used with 0 denoting completely disagree and 6 completely agree. There are 5 items 
in the first scale and 11 for the second scale. The total score is added after removing one 
item on the first sub-scale (physical activity) and 4 items on the second subscale (work). 
A higher score suggests higher fear avoidance beliefs, however a guide to what 
constitutes a more abnormal or concerning score has not been suggested by the authors 
(Waddell et al. 1993). Crombez et al., (1999) suggested that a physical activity score of 
greater than 15 may be used as a cut off score, and Fritz and George, (2002) have 
suggested a score of greater than 34 for the work scale, but both acknowledge that 
further work is required to demonstrate the validity of such scores. 
 
The 2 sub-scales (physical activity and work) have been found to significantly correlate 
with each other (Crombez et al., 1999). This study also demonstrated excellent internal 
consistency for work (Cronbach’s α =0.84), but lower consistency for physical activity 
(0.57), this was accounted for by the lower number of items included in the scale (after 
removal of instructed items; 4, compared to 7 for work). However, Jacob et al., (2001), 
found a higher internal consistency of 0.7 for physical activity and Grotle et al., (2006) 
found higher values for both scales; 0.90 and 0.79 for work and physical activity 
respectively. It must be noted that in both studies the questionnaire was translated into 
other languages (Hebrew in the former and Norwegian in the latter), is it not known 
therefore if these higher values are reflective of differences in language or culture, and 
so it may be that the internal consistency found by Crombez et al., (1999) is more 
relevant to participants completing the FABQ in English. Crombez et al., (1999) also 
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demonstrated construct validity as assessed against the Tampa scale of kinesiophobia 
(TSK). 
 
The FABQ has been shown to have good to excellent repeatability (Grotle et al., 2006; 
Waddell et al., 1993). Waddell et al., (1993) found an average kappa value of 0.74, and 
Pearson’s correlation of 0.95 and 0.88 (for work and physical sub-scales accordingly). 
Grotle et al., (2006) found a slightly lower re-test repeatability using the Norwegian 
version of 0.82 and 0.66 (for work and physical sub-scales).  These studies support the 
use of this tool as a robust measure of fear avoidance.   
 
Tampa Scale of Kinesiophobia (TSK) (Appendix 8) 
 
Kinesiophobia is a condition where an individual develops an excessive and 
incapacitating fear of movement, which is beyond that which would be expected in 
“normal” painful situations (Kori et al., 1990;  Lundberg et al., 2004), and is related to 
fear of re-injury. It shares some similarities with the physical activity sub-scale of the 
FABQ. 
  
This questionnaire was initially developed by Kori et al., (1990). It consists of 17 items, 
scored using a 4 point Likert scale of 1= strongly disagree to 4= strongly agree. Items 
4,8,12 and 16 require their score to be reversed because of the positive nature of the 
statement. A high score indicates a high level of kinesiophobia (French et al., 2007), 
although no specific score has been suggested as indicative of abnormality. The internal 
consistency of the Tampa scale is high (Cronbach’s α =0.68, Crombez et al., (1999), 
0.81, Lundberg et al., (2004), 0.84, French et al., (2007)). Construct validity has been 
demonstrated against the fear avoidance beliefs questionnaire (Crombez et al., 1999; 
French et al., 2007). In addition a high correlation exists between the Tampa scale and 
pain catastrophising and depression (French et al., 2007).   
Retest reliability of the Tampa scale has been found to be excellent (ICC, 0.91, 
Pearson’s correlation coefficient, 0.91, Lundberg et al., (2004)), however this was for 
the Swedish translation of the scale. 
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Pain Catastrophizing Scale (PCS) (Appendix 9) 
 
Catastrophising is defined as “an exaggerated negative mental set brought to bear during 
actual or anticipated painful experience” (Sullivan et al., 2001 pg 53). This 13 item scale 
was originally developed by Sullivan et al., (1995). A 5 point score exists for the degree 
to which the individual has feelings and thoughts about each statement, ranging from 0 
(not at all) to 4 (all of the time). The scale has been demonstrated to have high internal 
consistency (Cronbach’s α =0.87) by the developers of the PCS (Sullivan et al., 1995), 
but further supported by Osman et al. (1997) (α =0.93). Three subscale scores are 
produced by the PCS which assess rumination, magnification and helplessness. Its 
association with disability has been found in a number of studies (Picavet et al., 2002; 
Sullivan et al., 1998), with rumination being more greatly associated with disability 
(Sullivan et al., 1998). In addition, pain catastrophising has been demonstrated to be 
associated with intensity of pain and pain-related outcomes in individuals with 
neuropathic pain (Haythornthwaite and Benrud-Larson, 2000; Sullivan et al., 2005).  
 
A clinically relevant level of catastrophising is a total score of >30 (Sullivan et al., 
1995). Hence, whilst it might be useful to separate the scale into its 3 sub-sections, 
overall a score is required which determines whether an individual is catastrophising. In 
order to establish which, if any of the factors of pain catastrophising may have an impact 
on outcomes, both a total score and separate scores are important.  
 
Concurrent validity has been demonstrated against Negative Thoughts in Response to 
Pain Questionnaire and anxiety symptoms on the Mood and Anxiety Symptom 
Questionnaire (Osman et al., 1997).  
 
Retest reliability has been found to be 0.7 when re-administered after 8 to 12 weeks 
(Sullivan et al., 1995). 
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Short form -Depression Anxiety and Stress Scale (DASS 21) (Appendix 10) 
Emotional distress has been related to disability in chronic low back pain (Jensen et al., 
2010). Such distress has been separated into 3 sub-straits of distress: depression, stress 
and anxiety (Lovibond and Lovibond, 1995). The original DASS questionnaire scale is a 
42 item scale which aims to assess the degree of depression, anxiety and stress 
(Lovibond and Lovibond, 1995). However, a short form (DASS 21) has also been 
developed (Lovibond and Lovibond, 1995). The DASS 21 has 7 items for each of the 3 
sub-scales, and a 4 point likert scale, from “0 did not apply to me at all, to 3 applied to 
me very much, or most of the time”. Scores above 20, 14 and 25 on the depression, 
anxiety and stress subscales respectively are indicative of severe levels (original DASS). 
Lovibond and Lovibond, (1995) suggest halving the values for each sub-scale to gain 
the same levels for DASS 21, which was supported by Henry and Crawford, (2005). 
Hence scores above 10, 7 and 12.5 would be indicative of severity for depression, 
anxiety and stress respectively.  
 
Internal consistency of both DASS and DASS 21 has been found to be high (DASS 
anxiety α = 0.89, depression α= 0.96 and stress α=0.94, DASS 21 anxiety α=0.81, 
depression α=0.92 and stress=0.88) (Clara et al., 2001). Similar internal consistencies 
for DASS 21 were found by Henry and Crawford, (2005) (0.88 depression, 0.82 stress 
and 0.9 anxiety). Both Antony et al. (1998) and Clara et al., (2001) found that the 
DASS-21performed comparably to the DASS scale.  
Wood et al., (2010) found that the DASS-21 sub scales have significant associations 
with a number of other validated outcome measures. These included the affective 
distress and interference sub-scales of the Multidimensional Pain Inventory, social 
functioning, general health, mental health, and vitality sub-scales of the SF-36, and for 
separate sub-scales between the depression scale and the role limitations-emotional 
subscale of the SF-36.  
 
The scale is used both in individuals showing signs of depression and anxiety disorders 
(Clara et al., 2001), but also in a number of musculoskeletal condition such as 
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Rheumatoid Arthritis (Covic et al., 2012) and low back pain (Haggman et al., 2004; 
Parkitny et al., 2012). 
Overall DASS has been shown to have high retest reliability of 0.99 (Akin and Cetin, 
2007). 
 
2.5.4 Summary 
 
The importance of levels of disability and psychological influences on the prognosis of 
low back pain with particular reference to spinally referred leg pain has been presented. 
Different levels of disability or psychological factors could influence the effects of 
treatment modalities, therefore should be taken into account during analysis. In addition, 
some studies have suggested that individuals with neurogenic leg pain have greater 
levels of disability and presence of psychosocial factors than those with a somatic cause 
of leg pain, although this varies between studies, therefore further research is required to 
support or refute such assertions.  
2.6 Chapter Conclusion 
To summarise, this chapter has discussed the presentation of disorders resulting in 
spinally referred leg pain. It has supported the use of a pragmatic sub-grouping system 
for the identification of 3 main groups; radiculopathy, radicular pain and somatic 
referred leg pain. The influence of CS, and how this can be assessed using inexpensive 
time efficient equipment has been discussed. Finally, it has considered the effects of 
disability and psychological influences on the prognosis of spinally referred leg pain. A 
critical discourse around the use of the SLR test is pivotal to justify its use as an 
assessment and treatment tool. The next chapter provides a historical overview of the 
use of neurodynamic tests, and specifically the SLR test, and a critical evaluation of the 
use of the test as an assessment and treatment tool. 
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Chapter 3 Neurodynamic Assessment 
 
The aim of this chapter is to provide evidence of the robustness of neurodynamic tests in 
clinical practice and establish the principles of using these tests to identify individuals 
with neuropathic pain. For the most part, this chapter includes a discussion of the 
literature which has looked at the SLR or slump test, but where necessary and 
appropriate, other neurodynamic literature is also reviewed.   
3.1 Concept of neurodynamic tests 
The concept of moving the nervous system to produce a change in an individual’s 
symptoms is not new. There is some documentary evidence that the use of SLR for 
diagnosing LBP was used as far back as 2800 BC by Imhotep who was chief minister to 
Zoser, the first King of the Third Dynasty (Beasley, 1982). However, Lasègue is often 
credited as being the first author to document the use of the SLR (Lasègue, 1864). The 
assessment of nerves in the upper limb was also given credence historically; tests for the 
median, ulnar and radial nerves were documented in the 1920s and 1950s (Bragard, 
1929; Von Lanz and Wachsmuth, 1959). 
 
In the Physiotherapy literature, Maitland described the use of SLR and slump tests in the 
1970s (Maitland, 1973). Elvey introduced the brachial plexus tension test in 1979, and 
Butler wrote the book “Mobilisation of the nervous system” which became a popular 
text for Physiotherapists introduced to this seemingly new concept (Butler, 1991). 
However, prior to that time, studies had already been published which demonstrated 
movement of the nervous system during movements of the spine and leg. Authors such 
as O’Connell, (1946), Breig and Marions, (1962) and Goddard and Reid, (1965) had 
analysed excursion of the brain, spinal cord, lumbosacral nerve roots and sciatic nerve 
with movements of the trunk, head and leg. Later, studies looked at changes to the upper 
limb nerves during upper limb movements (Wright et al., 1996; Zoech et al., 1991). The 
focus of these pioneering studies was to assess the biomechanics of the nervous tissue, 
namely strain and nerve excursion as the nerve bed was lengthened. 
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 The principle behind nerve testing in this concept is that as a series of joint movements 
occur, the nerve bed lengthens and the nerves are subjected to a number of 
biomechanical changes such as uncoiling, nerve excursion, strain and compression. 
These classic studies found that as the cervical spine and trunk were flexed, strain 
increased, and the spinal cord moved within the spinal column (Breig, 1960; O'Connell, 
1946; Reid, 1960; Smith, 1956). Later studies focussed on tension changes within 
nerves as the nerve bed was lengthened (Kleinrensink et al., 2000; Kleinrensink et al., 
1995a; Lewis et al., 1998). At this time many of the tests used were referred to as neural 
tension tests (Butler, 1989; Hall et al., 1998), and the dysfunction for which patients 
were seeking treatment was known as adverse mechanical tension.  
 
As the 1990s progressed, the science behind the physiological changes involved with 
nerve dysfunction was developing rapidly, and research was published relating to 
changes to the peripheral and central nervous systems (e.g. Devor and Rappaport, 1990; 
Tal and Eliav, 1996). It became clear that pain and symptoms produced on movement of 
the nerves was not necessarily indicative of a biomechanical dysfunction. A more 
integrated approach, which combined both the mechanical aspects of nerve movement 
and nerve physiology, was developed.  The physiological changes that occur after a 
compression neuropathy or chemical irritation to the nerve root have been discussed in 
chapter 2. The term neurodynamics was introduced by Shacklock, (1995) to try to marry 
the two important aspects of nerve assessment. 
 
Shacklock, (2005a, pg 2) defines neurodynamics as “the clinical application of 
mechanics and the physiology of the nervous system as they relate to each other and are 
integrated with musculoskeletal function”. Such tests are designed to assess if 
movement of the nerve within the nerve bed, by applying a series of joint movements 
together which lengthen the nerve bed, produce the patient’s symptoms.  Such altered 
tolerance to the application of these tests has been termed neural mechanosensitivity 
(Hall and Elvey, 2004).  
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3.2 Normal nerve mechanics 
 
Nerves must move considerable amounts in order to cope with the large amounts of 
physiological movement which occur in the trunk and limbs during every day activities. 
They do so by a number of biomechanical and anatomical mechanisms, which help to 
protect them during the course of one’s lifetime. The peripheral nerves are continuous 
with the central nervous system due to the unique arrangement of the nerve sheaths, 
with the epineurium being continuous with the duramater (Butler, 1991; Rydevik et al., 
1984). Its continuity is also apparent in chemical and electrical terms, since the same 
neurotransmitters occur throughout the system, and electrical messages are conveyed 
through the peripheral nerves, spinal cord and to the brain (Butler, 1991). 
 
The presence of the connective tissue sheaths gives the nerves considerable 
biomechanical advantage during normal movement, since the sheaths are predominantly 
made up of connective tissues which are viscoelastic (Grewal et al., 1996; Millesi et al., 
1995; Sunderland and Bradley, 1949; Topp and Boyd, 2006). The peripheral nerves 
have a more highly developed network of connective tissue sheaths (see fig 3.1)  than 
the nerve roots and central nervous system, possibly due to the fact that there is less 
protection within the limbs for the nerves, and considerably more peripheral movement 
overall than within the trunk. In addition, within the spinal canal, the presence of 
cerebrospinal fluid together with the dura, pia and arachnoid mater may provide 
mechanical protection to these nervous tissues (Rydevik et al., 1984).  
 
During normal activities, the nerves are placed under stress, which may be perpendicular 
or in parallel to the nerve resulting in transverse or longitudinal stress. The nervous 
system deals with such stresses via a number of biomechanical mechanisms. Firstly, the 
nerve trunk takes an undulating course through its nerve bed (Millesi, 1986; Millesi et 
al., 1995; Sunderland, 1989a; Topp and Boyd, 2006). These undulations also occur 
within the epineurium and within the nerve fascicles themselves. During limb 
movements, the undulations straighten out, hence the nerve’s initial adaptation to 
movement does not involve any elongation of the nerve trunk. As further limb 
movements occur, the nerve will begin to elongate. Strain is the biomechanical term 
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used to describe nerve lengthening and is the change in length of the nerve divided by 
the original length; it is usually described as a percentage (Karduna, 2012; Topp and 
Boyd, 2006). Nerves which run on the flexor aspect of the joint will generally have 
smaller changes to make during limb extension, than nerves which run on the extensor 
aspect of the joint, where greater ranges of flexion (compared to extension) require a 
greater adaptation (Sunderland and Bradley, 1949; Sunderland, 1989a).  Most large 
peripheral nerve trunks run on the flexor aspect of limbs, but the ulnar nerve in the 
upper limb and sciatic nerve in the lower limb run on the extensor aspects.  
 
 
 
Fig 3.1 Structure of peripheral nerve (Reproduced from Topp and Boyd, 2012 
Journal of Hand Therapy 25:142–52.with permission from Elsevier Limited) 
 
Most nerve movement and nerve strain occurs around the moving joint (Dilley et al., 
2003; Boyd et al., 2005; Phillips et al., 2004). It had been thought that the sciatic nerve 
contained a greater number of fascicles as it passed over the hip joint to protect it from 
the greater amounts of longitudinal stress imposed on it during hip flexion (Sunderland 
and Bradley, 1949; Sunderland, 1989a). An increase in fascicles results in greater 
connective tissue surrounding the nerve fascicles, and may result in greater cushioning 
effects (beneficial for sitting down on the sciatic nerve as it passes around the ischial 
tuberosity), but also provides greater compliance for the nerve as the hip flexes. 
However, Phillips et al., (2004) found a greater number of fascicles in the non-joint 
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region of the sciatic nerve compared to the joint region in rats. Such differences may be 
due to a number of factors; Phillips et al. (2004), used rats, whereas Sunderland and 
Bradley (1949) used human cadavers, which may give more credence to Sunderland and 
Bradley’s results. However, technology had advanced considerably since 1949, and 
Sunderland and Bradley’s method of counting numbers of fascicles by enlarging the 
specimens on a micro projector and drawing out the sections, was undoubtedly less 
accurate than Phillips et al., (2004) who used digital micrographic images, and Adobe 
Photoshop to ascertain numbers of fascicles.  
 
Despite this disagreement in fascicle numbers, Phillips et al., (2004) found that the 
compliance of the nerve was greater around the moving joint, than in non-joint areas. 
Such increases in compliance in the absence of increased fascicle numbers may be 
explained by changes to the diameter of collagen fibrils, with thinner fibrils thought to 
have greater compliance than thicker fibrils (Ottani et al., 2001). Indeed Mason and 
Phillips (2011) found that joint regions of the median nerve had a greater proportion of 
smaller diameter collagen fibrils than the non-joint regions in rats. Interestingly, this was 
not the case for the sciatic nerve, although this study confirmed the findings of Phillips 
et al., (2004) that there was greater compliance at the joint region compared to the non-
joint regions. Hence, it is not known what causes the greater compliance of the sciatic 
nerve around the hip joint at present.   
 
One way in which nerves around the moving joint are protected is by a mechanism 
known as convergence. The nervous tissue distal and proximal to the moving joint is 
pulled towards the moving joint, resulting in less overall strain of the nerve at the 
moving joint (Shacklock, 2005a). The initial movement of the nerve will be around the 
moving joint, and then progresses to the nerve further away from the joint (Dilley et al., 
2003; Wright et al., 1996). Such accommodation from convergence is dependent on the 
position of the other joints. For example, if the knee is extended and ankle dorsiflexed 
and the hip then flexed (a SLR procedure), convergence distal to the hip will be 
restricted, since knee extension and dorsiflexion will have resulted in a distal pull on the 
sciatic and tibial nerves (Boyd et al., 2013; Coppieters et al., 2006).   
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Once undulations have been straightened out, and further increases in tensile stress 
occur, the nerve will continue to lengthen in vitro until it reaches the peak of its stress 
strain curve and failure occurs (Millesi, 1986; Millesi et al., 1995). It has been 
established that nerves exhibit a non- linear stress-strain relationship in both animal and 
cadaveric studies (Kwan et al., 1992; Sunderland and Bradley, 1949; Sunderland and 
Bradley, 1961a; Zoech et al., 1991), although the specific figures vary between animal 
and human studies. The animal studies suggest that there is a long toe region, where 
strain increases rapidly without an increase in stress until about 20% strain (Kwan et al., 
1992), however a study using fresh cadaveric median nerve suggested a much shorter 
toe region, where stress increased proportionately with strain at less than 2.5 % strain 
(Zoech et al., 1991). These large differences in range may be explained by a number of 
factors. Firstly, the different methods of fixation; for example the way in which the 
nerve is clamped may give rise to slippage. Secondly, excision of the nerve removes a 
structure called the paraneurium, which is thought to add friction in vivo (Millesi et al., 
1995). Finally, greater increases in strain values will be found if the nerve is allowed to 
contract ex-vivo, which may occur if the nerve is placed under strain at the start of the 
experiment. These factors and purely the fact that animals have very different functional 
needs than humans reflect some of the issues with utilising animal studies to extrapolate 
to humans. A smaller toe region would expose the nerve to greater stress during 
movements than a larger toe region.  
 
The connective tissue properties of nerve means that the nerves can tolerate forces of 
between 7.3 to 22.3kg of force for the median nerve, 6.5 to 15.5kg for the ulnar nerve, 
and 20.6 to 33.6kg for the tibial nerve (Sunderland and Bradley, 1961a). This equates to 
strain values of 7-30% for median nerve, 9-26% for ulnar nerve and 8-32% for tibial 
nerve. Forces above these levels will lead to rupturing of the nerve. The perineurium is 
generally accepted as the strongest connective tissue (Kwan et al., 1992; Rydevik et al., 
1990), although the epineurium has been found to be the last tissue to rupture in one 
study (Haftek, 1970).  In comparison, nerve roots fail at much lower loads (Sunderland 
and Bradley, 1961b), anterior roots were found to fail at between 0.2 to 2.2kg and 
posterior roots at between 0.5 to 3.3kg. Falconer et al., (1948) found slightly higher 
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(4.6kg) tensile forces were required for failure of the S1 nerve root. However, 
Sunderland and Bradley looked at 32 cadaveric nerve roots in total, whereas Falconer et 
al., (1948) only investigated 3 cadavers. The structural differences and simple parallel 
arrangement of the nerve roots in comparison to the peripheral nerves, helps to explain 
such differences. In peripheral nerves, the perineurium is considered to be the strongest 
structure, and as such will give the nerve greater tensile strength. In addition the 
funicular plexus arrangement of the nerve fibres gives the nerve both tensile strength 
and protection from compressive forces. However, in vivo it is unlikely that such levels 
would ensue unless a sudden stretch occurred where normal protective mechanisms such 
as muscle contraction of the antagonist muscle were overcome. However even slow, 
controlled stretch well below levels thought to rupture the nerve may be detrimental to 
nerve function (Driscoll et al., 2002; Jou et al., 2000; Kwan et al., 1992; Lundborg and 
Rydevik, 1973; Wall et al., 1992).  
 
Deterioration in circulation has been found at around 8% strain (Driscoll et al., 2002; 
Jou et al., 2000; Kwan et al., 1992). Deterioration in nerve conduction has been found in 
rabbits at 6% strain held for longer than 20 minutes, or 12% held for 10 minutes or 
longer (Kwan et al., 1992; Wall et al., 1992). How these figures relate to humans during 
normal movements is difficult to gauge. In addition two other characteristics of nervous 
tissue is the presence of stress relaxation and creep (Millesi et al., 1995, Wall et al., 
1991) both resulting in a reduction in stress at sustained loads, hence prolonged postures 
which cause altered strain on the nerves may have less of a detrimental effect on the 
tissue (Topp and Boyd, 2006).  
 
A number of studies have looked at amounts of nerve strain that occur during normal 
movements (Fleming et al., 2003; Wright et al., 1996; Wright et al., 2001; Zoech et al., 
1991) and during neurodynamic tests (Boyd et al., 2013; Byl et al., 2002; Coppieters et 
al., 2006; Gilbert et al., 2007 a and b; Goddard and Reid, 1965; Smith et al., 1993). 
However, the levels found vary considerably (from <1% Gilbert et al., 2007b to 26% 
Fleming et al., 2003) depending on the nerve examined, methods used to assess strain, 
the exact location of the area of nerve studied, the exact combination of joint movement 
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and the order in which they were performed. The findings most pertinent to the overall 
focus of this thesis (Chapter 1, pg7) are those for excursion and strain during the slump 
and SLR.  
3.2.1 Biomechanics of Slump and SLR Tests  
 
A number of studies have assessed the biomechanics of a number of neural structures 
during movements which make up components of the slump test (O’Connell 1946; 
Smith 1956; Reid 1960; Breig 1960) and SLR (Boyd et al., 2013; Breig and Marions, 
1963; Breig and Troup, 1979; Coppieters et al., 2006; Fleming et al., 2003; Gilbert et al., 
2007a; Gilbert et al., 2007b; Goddard and Reid, 1965; O’Connell, 1946; Smith et al., 
1993). 
 
The slump test consists of cervical and trunk flexion, hip flexion, knee extension and 
then ankle dorsiflexion or plantar flexion with inversion to stress tibial or common 
peroneal nerves respectively (Butler, 2000; Shacklock, 2005a).  Studies that have 
examined changes to spinal cord and meninges support the use of the cervical and trunk 
flexion components of the slump test as they show marked nervous system excursion 
and strain (Breig, 1960: O’Connell, 1946; Reid, 1960; Smith, 1956). From a position of 
spinal and cervical extension to spinal and cervical flexion, the spinal canal has to 
lengthen by 50-90 mms (Breig, 1960; Louis, 1981), and the spinal cord has to 
accommodate for such changes. Generally during trunk or cervical flexion, the spinal 
cord accommodates first by uncoiling and then elongation (Breig, 1960; Breig and 
Marions, 1963; Breig, 1978). However, when the trunk extends, the diameter of the 
spinal cord increases through wrinkling or bunching of the nerves (Breig 1960; Breig 
and Marions, 1963; Breig, 1978).  
 
Comparisons between studies need to be considered in terms of the exact location of 
where the nerves were examined, and the sequence of movements that ensued (details of 
studies can be found in appendix 11). The overall amounts of excursion vary due to the 
marked differences in methods in measuring the excursion. Some consistent findings 
however are as follows. Firstly, the direction of movement of the nerves that lie on the 
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lengthening side of the region is towards the moving joint. When the cervical spine is 
flexed, nervous tissue below the head moves in a cephalad direction (Breig and Marions, 
1963; O’Connell, 1946). An exception to this was a study by Smith (1956) who found 
that the spinal cord above C4 moved in a caudad direction, but below this level the cord 
moved cephalad. This was further supported in a much later study using MRI scanning 
(Yuan et al., 1998). This may be due to the presence of tension points where the nerves 
in this region have limited movement compared to local tissues, and hence the cord 
above is relatively pulled towards this point during cervical flexion (Butler, 1991). 
Indeed Yuan et al., (1998) found that the mid-cervical region had minimal displacement 
during cervical flexion.  
 
Another consistent finding is that larger amounts of excursion occur closest to the 
moving region (Breig and Marions, 1963; O’Connell, 1946; Reid, 1960), hence with 
head and neck flexion greater excursion has been found at T1 (6.8 mm, Reid, 1960) 
compared to the cauda equina (1-2mm, Breig and Marions, 1963). When the head and 
trunk are flexed together, some studies have demonstrated less excursion in different 
parts of the neuraxis compared to cervical flexion alone (Reid, 1960) whilst others have 
found greater excursion (Breig, 1960). This may be because Breig (1960) measured 
nerve excursion in overall sections (cervical, thoracic and lumbar) whereas Reid (1960) 
looked at nerve excursion between vertebral segments. Only one study attempted to 
assess strain during trunk movements. Smith (1956) found up to 24% strain at the level 
of C6 during trunk and cervical flexion in 4 monkeys. However, although monkeys 
share certain characteristics with humans, their gait varies between biped and 
quadruped, and their functional activities vary significantly from humans. Another 
limitation of both the animal and cadaveric studies is that both excursion and strain are 
likely to be more when surrounding bone and connective tissue are dissected out 
(Gilbert et al., 2007a), and when protective muscle contraction mechanisms are not at 
work (Hall et al., 1998; van der Heide et al., 2001) as they should be in vivo. 
 
The results of the studies at this point are summarised for clarity and to link this with the 
purpose of this section, which is to evaluate the evidence in support of the use of 
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neurodynamic tests. The critical aspect of neurodynamic testing is that the movements 
of the trunk and limbs must lengthen the nerve bed of the nerve being examined, so that 
the nerve undergoes a change in its resting position, this may consist of sliding through 
the tissues, elongation (and therefore increase in tension), and possible compression as it 
passes through surrounding interfaces (Butler, 1991; Butler, 2000; Shacklock, 2005a). 
The studies that have been discussed indicate that both excursion and strain occur when 
individuals are placed in trunk and cervical flexion. The strain values which have been 
described are of importance as it has been shown that lengthening nerve tissue beyond 
8% may have detrimental effects on function (Driscoll et al., 2002; Jou et al., 2000; 
Lundborg and Rydevik, 1973). The high levels of strain of up to 26% shown by Smith 
(1956) during cervical and trunk flexion may indicate that prolonged or repeated 
cervical and trunk flexion could predispose the cervical cord to pathology. When 
considering the static postures that humans tend to hold themselves in however, without 
neuropathic signs and symptoms, some degree of adaptation must occur which protects 
the nervous system from such pathology.  In vivo, human nervous tissue has enormous 
potential to adapt, and this is seen commonly in conditions such as slow growing 
intrathecal spinal tumours, where symptoms do not develop until the tumour has grown 
dramatically in size (Mercer, 2010). However, with respect to the slump test, increasing 
strain on tissue which is already mechanosensitive is most likely to reproduce 
symptoms, and as such the use of these movements during the slump test give these tests 
face validity.  
 
Whilst the studies above have considered movements of the spinal cord, many 
individuals seen in out-patient physiotherapy departments present with disorders of the 
nerve root. As described in chapter 2, nerve root disorders may be classified as 
radiculopathy (or nerve root compression) and radicular pain (nerve root irritation). 
Slump and SLR tests are purported to affect the nerve root as well as the spinal cord, 
and the studies presented below demonstrate this to be the case. 
 
Studies looking at the effects of trunk movements on the nerve root suggest that there is 
increased tension placed upon them during flexion (Breig, 1960; Breig and Marions, 
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1963), and small amounts of nerve root excursion. Breig and Marions (1963, page 1154) 
concluded that their findings “establish without doubt” that the lumbosacral nerve roots 
are stretched during cervical flexion. However the method of assessing tension was to 
wrap a fine thread around the nerve root attached to a spring balance with 20g of force 
applied. With this weight it was possible to lift the nerve root away from the lumbar 
canal. With cervical flexion it became more difficult to lift the nerve root from the 
lumbar canal, indicating increased tension. One to 2 mm of cephalad movement of the 
nerve roots in the cauda equina were found using observational methods. However, 
because of a lack of robust methodology, these studies provide only an indication of 
what might be occurring. 
 
Movements of the nerve roots during SLR have received more attention probably as this 
test, sometimes known as Lasègue’s test, was originally devised to diagnose lumbar 
radiculopathy (Deville et al., 2000; Goddard and Reid, 1965; Smith et al., 1993). Studies 
have demonstrated that excursion and strain occurs from L4 and below, and that 
excursion is in a caudal direction during SLR (Gilbert et al., 2007 a; Gilbert et al., 2007 
b; Goddard and Reid, 1965; Smith et al., 1993). However, ranges of nerve root 
excursion varied from as much as 5mm at S1 in cadavers from younger age groups 
(Goddard and Reid, 1965) to as little as 0.48mm at L5 in more aged cadavers (Gilbert et 
al., 2007a). Such wide variations in ranges of nerve root excursion may be explained in 
part by the marked differences in methodology. For example many of the cadavers in 
Goddard and Reid’s (1965) study were in rigor mortis and forcible breaking of the rigor 
was required in order to move the leg. It is possible that such strong forces could have 
had an impact on the normal mechanics of the nerve roots. In addition an anterior 
dissection method was used by Goddard and Reid (1965) which may have disrupted the 
perineal connective tissues (Peretti et al., 1989; Spencer and Dalton, 1995).   
 
Gilbert et al., (2007a) used a novel fluoroscope method of assessing nerve root 
excursion, and the data was analysed using Matlab which gave a 3d co-ordinate system 
referenced to a screw implanted into the sacral base. The anterior dissection method 
criticised above in Goddard and Reid’s (1965) study was also used, but attention was 
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given to avoiding transection of the foraminal ligaments. Such transection may increase 
the amount of caudal movement of the nerve roots during SLR since these ligaments 
connect the nerve root sleeves to the foramen. In Smith et al.’s (1993) study a posterior 
approach was taken, which would have resulted in transection of such ligaments and 
may have resulted in artificially larger excursion values (1.4 mm, 2.1.mm and 2.5mm 
for L4, 5 and S1 respectively; see appendix 11 for details). Whilst Gilbert et al., (2007a) 
argue that their smaller values (0.53, 0.48 and 0.51 mm for L4, 5 and S1) are related to 
both the robust measuring methods and careful dissection, the age of the cadavers pre-
mortem may also explain these smaller excursion values (aged between 72-88). Both 
Smith et al., (1993) and Goddard and Reid (1965) had younger aged cadavers; Smith et 
al., (1993) aged from 55- 77, and Goddard and Reid from less than 35- over 75 years. 
Indeed Goddard and Reid (1965) found 0 mm of movement at L4, 0-1.5 mm at L5 
(greatest in the intervertebral foramen), and between 0 and 2 mm at S1 in cadavers over 
75 years.  
 
One final explanation for the large differences found by Gilbert et al., (2007a) was that 
the pelvis was fixated in order to have a stable base for the fluoroscopy marker. During 
SLR a degree of pelvic tilting is likely to occur, and such control of the pelvis may have 
produced less nerve excursion because the trunk was not allowed to reverse its lordosis 
and flex. Hence it appears that whilst some of the limitations of the Smith et al., (1993) 
and Goddard and Reid (1965) studies may have caused inflation in excursion values, the 
results of Gilbert et al., (2007a) are limited as a result of the advanced age of the 
cadavers at death, and the restriction of the movement of the pelvis. 
 
 With regards to strain values, Smith et al., (1993) found that strain was exerted on the 
nerve roots during SLR in the region of 3.2, 2.7 and 3.4% for L4, 5 and S1 respectively, 
whereas Gilbert et al., (2007a) found negligible strain in the nerve roots. 
 
During SLR, it has been proposed that additional movements can be added to further 
stress the nerve roots (Butler, 1991; 2000; Shacklock, 2005a). Ankle dorsiflexion, hip 
medial rotation and hip adduction are frequently used as further components of the SLR  
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when symptoms are not reproduced from a straightforward SLR. Gilbert et al., (2007b) 
found that the addition of the dorsiflexion significantly reduced the amount of caudal 
excursion of the nerve roots and increased the strain up to 1.89% at S1.  Whilst the 
increase in strain was not statistically significant compared to no dorsiflexion, the effect 
size was moderate to large with dorsiflexion, indicating a tendency to greater strain in 
this group. Hip medial rotation was found to cause between 2-10mm of excursion 
towards the greater sciatic foramen of the S2 and S3 nerve roots in 4 cadavers (Breig 
and Troup, 1979), whilst hip adduction resulted in a 3mm excursion in 1 cadaver. The 
gross methods of assessment and limited number of cadavers does restrict the 
extrapolation of this study, however it does demonstrate that such movements can cause 
changes to the nerve root, which may explain any changes to patient’s symptoms with 
these manoeuvres. A further study (Sugiura et al., 1979) found an increase in pressure  
around the nerve root with the addition of adduction to a SLR in 5 fresh cadavers 
(measured by the insertion of a water filled rubber tube inserted between the nerve root 
and disc). 
 
 To summarise, the studies (Goddard and Reid, 1965; Smith et al., 1993; Gilbert et al., 
2007a;b) exploring nerve root excursion and strain during SLR indicate a small to 
moderate caudad movement of the nerve roots from L4 to S1, and that low levels of 
strain occur with increased hip flexion. In addition there is limited work which also 
supports the use of further manoeuvres such as dorsiflexion and medial rotation and 
adduction to add further proximal load to the nerve roots. These studies support the use 
of SLR to mechanically load the lower lumbar nerve roots, but SLR is also used to load 
the nervous tissue as it continues into the sciatic nerve (Boyd et al., 2013; Coppieters et 
al., 2006; Fleming et al., 2003; Gilbert et al., 2007 a; b; Goddard and Reid, 1965).  
 
Ranges of sciatic nerve excursion during SLR vary from 28mm (Coppieters et al., 2006) 
to around 4mm (Goddard and Reid, 1965), but because of the differences in location of 
the nerve studied, combinations of movements and methods of assessment, these values 
cannot easily or sensibly be compared. It is most pertinent to consider trends and the 
first of these is that regardless of differences in methods, the direction of excursion of 
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the nerve (on the lengthening aspect of the joint) towards the moving joint was 
consistent in all excursion studies (Boyd et al., 2013, Coppieters et al., 2006; Goddard 
and Reid, 1965). Most nerve excursion occurs closest to the moving joint (Boyd et al., 
2013; Coppieters et al., 2006; Goddard and Reid, 1965). In Coppieters et al., (2006) 
9.5mm of distal tibial nerve excursion was found around the ankle during dorsiflexion, 
compared to 3.1mm at the knee and 0mm of sciatic nerve just distal to greater 
trochanter. The reverse was seen when hip flexion was added first; 28 mm sciatic nerve, 
12.2mm tibial nerve knee, 6.4mm tibial nerve ankle. Details of the other studies can be 
found in appendix 11, but the above trends remain the same regardless of study. 
 
 An important aspect of some of these studies is the fact that some used embalmed 
cadavers (Boyd et al., 2013, Coppieters et al., 2006), whereas Goddard and Reid (1965) 
used fresh cadavers. Kleinrensink et al., (1995b) found a close relationship in tensile 
force data between embalmed and unembalmed cadavers during various components of 
the upper limb tension tests. However, there were marked differences in magnitude of 
tensile force during the tests. For example during the upper limb neurodynamic tests for 
the median nerve, tensile forces measured at the median nerve in the axilla were 32.44 N 
in embalmed cadavers and 19.99N in unembalmed cadavers. Such marked differences in 
magnitude suggest that the mechanical properties of the tissues have been significantly 
altered by the embalming process, although the positive correlation between the 2 types 
of cadavers suggests that the behaviour towards applied stress shows similarities. What 
is clear is that the absolute values found in biomechanical studies using embalmed 
cadavers should not be extrapolated directly to in vivo situations, but general trends such 
as increases or decreases in excursion may be relevant.  
 
In addition to nerve excursion, some studies have also investigated nerve strain during 
the SLR. Fleming et al., (2003) found that the sciatic nerve posterior to the hip joint 
underwent elongation of 26% when the hip was flexed to 45° and the knee extended.  
These values (Fleming et al., 2003) are substantially higher than those found by 
Coppieters et al. (2006) and Boyd et al., (2013). During hip flexion with the ankle 
dorsiflexed, strain measured by 2 linear displacement transducers fixed into the sciatic 
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nerve was 6.61% (Coppieters et al., 2006). However the exact location of the 
transducers was not clear, which could have implications because most excursion and 
strain occur close the moving joint (Boyd et al., 2005; Phillips et al., 2004). Boyd et al., 
(2013) found a maximum of 8% increase in strain at the sciatic nerve measured 5cms 
below the ischial tuberosity during SLR regardless of whether dorsiflexion was added 
prior to hip flexion or subsequently. It has been suggested that the application of 
different sequences of movements during neurodynamic tests, may increase the strain 
within different aspects of the nerve. This study raises questions as to the relevance of 
adding sequences of movements in different orders with respect to strain. Both 
Coppieters et al., (2006) and Boyd et al., (2013) used embalmed cadavers and as such 
the magnitude of strain may not be the same as unembalmed cadavers, or more 
importantly in vivo. In addition, Fleming et al. (2003) measured closer to the moving 
joint, which may partly explain the greater strain found compared to Coppieters et al 
(2006) and Boyd et al. (2013).  
 
These studies suggest that SLR produces both sciatic nerve excursion and strain, but the 
levels that occur vary between studies due to differing methodologies. More studies are 
required to establish the actual amounts of movement during SLR, and importantly these 
are required in vivo on human participants where possible.  
 
To summarise, nerve excursion and strain occur during flexion of the cervical spine and 
trunk and during SLR. The amounts of these vary depending on the methods used, but 
tend to show that an increase occurs with increasing applications of movements which 
lengthen the nerve bed. It may be that pre-loading the nerve with movements which 
lengthen the nerve bed distal and/or proximal to the site of the nerve reduce nerve 
excursion, but increase strain (Gilbert et al., 2007b). The direction of nerve movement 
of nerves on the elongation side of the moving joint is always towards the moving joint, 
except in circumstances where tension points within the spine exist. Such results 
indicate that the slump and SLR tests substantially influence the nervous system which 
supports their use in clinical practice. 
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3.2.2 Other biomechanical considerations with neurodynamic tests: 
concept of sliders and tensioners 
 
One aspect of neurodynamic assessment and treatment is to consider the effect of 
excursion and strain depending on the combination of movements that are applied. 
Some authors have specifically named these techniques sliders and tensioners due to the 
application of components of limb movement which will predominantly tension or slide 
the nerve within the nerve bed (Coppieters and Butler, 2008; Coppieters et al., 2009; 
Shacklock, 2005a). With regards to tensioners, a series of movements of the joints are 
applied which all aim to lengthen the nerve bed (Shacklock, 2005a). For example for 
SLR, the foot is dorsiflexed, knee extended and hip flexed to exert most tension on the 
sciatic nerve and it’s tibial nerve component (Boyd et al., 2009). With slider techniques 
joints at one end of the limb are positioned so that lengthening of the nerve bed occurs, 
whilst the joints at the other end are positioned so that the nerve bed is shortened (e.g. 
for SLR with tibial nerve bias, the hip could be flexed, and knee extended whilst the 
ankle is plantar flexed). Slider techniques are considered to be less provocative as they 
are thought to generate less tension and induce most movement (Shacklock, 2005a). 
Recent studies have verified this theory in the upper limb using cadavers (Coppieters 
and Alshami, 2007; Coppieters and Butler, 2008) and in vivo using diagnostic B mode 
ultrasound in both upper and lower limbs (Coppieters et al., 2009; Ellis et al., 2012 ). 
Appendix 12 gives the detail of each study.   
 
Coppieters and Alshami (2007) and Coppieters and Butler (2008) showed similar 
findings for median nerve excursion and strain during upper limb neurodynamic test 
with a median nerve bias (ULNT1). Fig 3.2 shows the 6 sequences chosen in these two 
studies for median nerve.     
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Fig 3.2 Sequence of movements in Coppieters and Alshami, (2007) and Coppieters 
and Butler, (2008) (From Coppieters and Butler, 2008 Manual Therapy 13:213-221 
with permission from Elsevier limited) 
 
The sliding technique (b) produced greater amounts of excursion of the median nerve 
measured proximal to the wrist by the use of a vernier caliper, than all other positions 
(12.4 mm) (p=0.0002, Coppieters and Alshami, 2007). No statistical testing was 
performed by Coppieters and Butler (2008) possibly due to the use of only 2 cadavers. 
Strain was greatest in the tensioner position (4% Coppieters and Alshami, 2007, 6.4% 
Coppieters and Butler, 2008). Of interest, excursion of the median nerve measured 
proximal to the elbow was greatest during the tensioner movement (a) (13.7mm 
Coppieters and Alshami, 2007, 16.5mm Coppieters and Butler, 2008), than the slider or 
other joint positions. This seemingly paradoxical finding is explained by the mechanical 
events that occur during these movements. The measurement was proximal to the elbow, 
and during elbow extension the nerve would move distally (Coppieters et al., 2009). The 
addition of wrist extension would result in a further distal movement at the proximal 
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elbow, therefore resulting in greater, not less excursion in this location. Proximal to the 
wrist however, elbow extension would result in a proximal movement, but wrist 
extension would result in a distal movement; the cumulative effect resulting in an 
overall reduction in nerve excursion. Hence, the effect with regards to nerve excursion 
during a tensioner manoeuvre, is very much dependent on the exact location of 
measurement in relation to joint movements. Importantly, proximal to the elbow an 
increase in peak strain was still found during the tensioner manoeuvre compared to the 
slider. Even at the highest peak strain (6.8%), this was below the levels that most animal 
studies have found to be harmful in terms of circulation, nerve conduction or structural 
changes (Driscoll et al. 2002; Jou et al., 2000; Kwan et al., 1992; Lundborg and 
Rydevik, 1973). However, since participants were cadavers, these values may not 
accurately portray figures found in vivo, although Boyd et al. (2005) found no 
significant differences in either strain or nerve excursion between live and fresh 
euthanized rats during the SLR test. If this similarity between fresh cadavers and living 
tissue exists in humans, a more important consideration may be the use of embalmed 
cadavers used in the aforementioned studies.  
 
As mentioned in section 3.2.1, although a close relationship between the biomechanical 
behaviours of median nerves in unembalmed and embalmed cadavers has been found 
(Kleinrensink et al., 1995b), actual figures for tensile forces were markedly different, 
with considerably greater tensile forces in embalmed compared to fresh cadavers. This 
may suggest that embalmed tissue is stiffer, which may result in less overall nerve 
strain. This may mean that strain values measured in embalmed tissue is less than in 
unembalmed tissue. 
 
In support of Coppieters and Alshami (2007) and Coppieters and Butler (2008), 
Coppieters et al. (2009) found a decrease in median nerve excursion during a tensioner 
technique compared to a slider technique in vivo utilising ultrasound imaging in 15 
asymptomatic participants. The sequence of movements of ULNT1 were similar but 
incorporated cervical contralateral and ipsilateral lateral flexion (CLLF/ ILLF) of the 
cervical spine, with a neutral wrist position.  A mean of 10.2 mm of nerve excursion was 
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found at the proximal elbow during the slider compared to 3.3 mm of excursion during 
CLLF with the elbow extended. Whilst this may seem to contradict Coppieters et al.s’ 
earlier studies since greater excursion was found at the proximal elbow during the slider 
technique, this is explained by the same biomechanical principles as for the other 
studies. CLLF moved the median nerve proximally and elbow extension moved the 
nerve distally in all participants (Coppieters et al., 2009), hence the 2 movements 
together resulted in a cumulative effect of an overall reduction in nerve excursion. 
Interestingly, the combined effect of both CLLF and elbow extension resulted in a 
difference in participants in overall direction of movement. The nerve moved distally in 
10, and proximally in 5 participants, demonstrating the difference in compliance in 
different areas of the nerve between individuals. 
 
The only study to date which has demonstrated this effect in vivo for the lower limb is 
by Ellis et al., (2012). Utilising ultrasound to provide images of the sciatic nerve in the 
posterior thigh during slump test, greater nerve excursion was found during the slider 
manoeuvre (slump test, with knee extension and cervical extension) than the tensioner 
position (slump test with knee extension and cervical flexion). However, the difference 
in excursion between the 2 positions, although reaching statistical significance was 
around 0.6mm only just above the smallest detectable difference of the technique 
(0.55mm, calculated from standard error of measurement (SEM) 0.2mm in Ellis et al., 
2012), indicating that some of the change could be attributed to measurement error of 
the technique.  Such small differences in values between participants can be explained 
by the control of knee extension to only minus 20°, in full slump position, hence small 
mean excursion values (mean 3.2mm for slider movement) were found at the sciatic 
nerve. Such small amounts of excursion make it difficult to demonstrate sufficient 
changes between movements, whereas in the Coppieters et al., studies above, the mean 
excursion value for the slider techniques were all over 10mm. 
 
These studies together demonstrate the effect of a combination of joint manoeuvres on 
strain and excursion of the nervous system during these neurodynamic tests. The 
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considerations of producing more or less excursion and greater or lesser strain during 
these tests will be discussed in the next chapter with regards to neurodynamic treatment. 
 
Showing biomechanical changes of the nerve with the application of joint movements is 
only part of the picture, because other tissues also move in response to such 
manoeuvres. It is therefore essential that the test can discriminate between neural and 
non- neural structures, and this next section provides evidence that done correctly, these 
tests have such discriminative ability. 
 
3.3 Structural Differentiation between neural and non-neural 
structures. 
 
The crucial aspect of being able to discriminate between non-neural and neural 
structures during a neurodynamic test forms the basis of structural differentiation. 
Movements are added or taken away at a joint most distant to the site of symptoms. A 
change in symptoms implies neural structures are the source of symptoms, since local 
structures around the area of symptoms have not been influenced (Boyd et al., 2009; 
Butler, 1991; 2000; Coppieters et al., 2006; Shacklock, 2005a). However, it has been 
suggested that due to the continuation of the body’s fascial systems (Barker and Briggs, 
1999; Gajdosik et al., 1985), movements of joints distant from the site of injury could 
increase symptoms in the presence of a myofascial injury. This would result in a falsely 
positive neurodynamic test. However, there is a small but growing body of evidence that 
suggests the influence of these fascial systems do not invalidate these neurodynamic 
tests (Coppieters et al., 2005; 2006).   
 
One way of ascertaining if fascial systems are influenced by neurodynamic tests is to 
assess the effects of structural differentiation manoeuvres during a neurodynamic test on 
relevant fascial tissue. Coppieters et al., (2006) found that the addition of hip flexion 
significantly increased the strain in the tibial, medial and lateral plantar nerves, but not 
the plantar fascia in cadavers. These results suggested that local soft tissue was not 
influenced by more proximal movements during SLR. In support of these findings, 
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Coppieters et al., (2005) found that a localised muscle pain was not influenced by the 
addition of structural differentiation in 25 asymptomatic participants.  Muscle pain was 
induced by injecting hypertonic saline into either tibialis anterior or soleus muscles. 
SLR or slump tests were performed with the ankle maintained in a plantar grade position 
with the use of an ankle foot orthosis. Symptoms either remained the same, or reduced 
during the two tests. These results suggest that myofascial structures which have 
theorised connections to both soleus and gastrocnemius did not induce an increase in 
tension sufficient to change symptoms. It must be noted however that injection of saline 
into the muscle, whilst producing local pain, does not reflect the changes to muscle that 
occur during trauma. It may be that in such cases where there is inflammation or 
fibrosis, movement of fascial structures may influence the muscle tissue to a greater 
level.  
 
Further investigation into the effects of structural differentiation during SLR or slump 
tests have shown changes to both final range of motion of the test (Boland and Adams, 
2000; Boyd et al., 2009; 2012; Fidel et al., 1996), activation of muscles which are 
positioned to counter the movement (e.g. hamstrings muscle during SLR) (Boyd et al., 
2009; Hall et al., 1998), and changes to symptoms (Boyd et al., 2012). Restriction in 
range of hip motion during SLR was found with the addition of dorsiflexion compared 
to a 30 degree plantar flexed foot position, with a greater restriction if SLR was taken to 
maximally tolerated symptoms (P2) compared to first onset of symptoms (P1), (5.5° P1, 
10.1° P2) (Boyd et al., 2009).  
 
A slightly greater restriction in range between the 2 foot positions (around 7.8°; mean of 
left and right legs) was found in a later study at P1 (Boyd et al., 2012). Slightly higher 
differences still were found by Boland and Adams (2000). A mean difference between 
SLR with and without dorsiflexion of 9° was found when tested to P1. Male 
asymptomatic participants were found to have a similar mean difference between SLR 
with and without dorsiflexion (9.5°) to Boland and Adams (2000), but a much larger 
mean difference in females (15.2°) (Herrington et al., 2008). Boyd et al., (2012) found a 
moderate significant correlation between gender and overall range of motion of SLR.  
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The larger differences found by Herrington et al., (2008) compared to the other studies 
described could be attributed to the lack of standardisation of the ankle range of motion 
since a neutral starting position was estimated to be around 10° plantar flexion, but this 
was held by the Physiotherapist, and not maintained by the use of a splint. Despite this, 
intra rater reliability was excellent (ICC =0.93) with a standard error of measurement of 
2.8°, although it was not clear if this was for both ankle positions or just one of them. 
Regardless of the actual figures, a trend can be seen demonstrating a reduction in range 
of motion with the addition of dorsiflexion.  
 
Similar trends in reductions in final range of movement have been found during the 
slump test (Fidel et al., 1996; Herrington et al., 2008). Herrington et al., (2008) found a 
slightly smaller mean difference in end range knee extension between cervical extension 
and flexion (6.6°, 5.4° for males and females respectively) compared to Fidel et al., 
(1996) (P1 8.1°, P2 7.3°).  The differences may be explained because Fidel et al., (1996) 
used an AFO to stabilise the ankle. 
 
Overall, such findings suggest that as the nerve bed becomes further lengthened by the 
addition of the structural differentiation manoeuvres, symptoms increase earlier in range 
limiting range of motion. However, in addition to joint movement decreases, another 
restriction to final range of motion may be due to an increase in activation of the local 
muscles, theorised to become activated in order to limit further ranges of motion, and 
protect the neural structures (Hall et al., 1998; Boyd et al., 2009).  
 
Abnormal muscle activity during SLR has been found in the posterior thigh muscles and 
erector spinae in some individuals with restrictions in forwards bending and 
contralateral SLR (Goeken et al., 1994). Goeken et al., (1994) found that earlier and 
greater activation was seen particularly in semimembranosis during SLR in individuals 
with “abnormal defence reactions”. Such individuals tended to have reduced ipsilateral 
SLR compared to those with normal defence reactions (median of 38°, compared to 
68°). Such defence reactions have been considered an important clinical aspect of 
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physiological responses during neurodynamic testing, however it is not clear if this 
protective response is related to protection of nervous tissue or other soft tissues.  
 
With respect to structural differentiation, Hall et al., (1998) found that increase in 
muscle activity in hamstrings occurred earlier during SLR with the addition of 
dorsiflexion in both asymptomatic participants and those with radiculopathy. Results 
regarding muscle activation were less clear by Boyd et al., (2009). There was a wide 
variability in EMG activity during SLR, but noticeably significantly higher levels in 
soleus and tibialis anterior at P1 between dorsiflexion and 30° plantar flexion. The 
authors suggested this was due to a protective response in the distal muscles to prevent 
further nerve lengthening from the far ends of the nerve bed, but if this theory is correct, 
it would be more logical for the hip extensors to have increased their activation between 
conditions in order to limit hip flexion. As there was no significant difference between 
conditions for the hip extensors, the effect of structural differentiation on protective 
muscle activity during SLR is not well supported from this study, however participants 
were asymptomatic; it is possible that symptomatic individuals may demonstrate more 
abnormal muscle activation patterns as found by Goeken et al., (1994).  
 
With regards to the slump test, Lew and Briggs (1997) found no change in the EMG 
activity of hamstrings in slump test between cervical flexion and extension; but a 
marked difference in pain response between the 2 positions (much greater in cervical 
flexion). The conclusion from the study was that this supported the use of 
neurodynamics, since an increase in activity would have been suggestive of a change to 
the myofascial structures. Since there was no increase in activity, this suggested that the 
change in pain response was a result of the neural tissues.  This conclusion seems at 
odds with the theory about protective muscle activation during neurodynamic tests. The 
hip and knee were maintained in the full test position and then cervical flexion and 
extension were added; it may be that any protective activity would be more likely to be 
from the trunk muscles in an attempt to limit the cervical flexion.  
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Overall, structural differentiation appears to be an important aspect of neurodynamic 
testing. It increases strain in the neural tissues whilst not producing strain in the local 
soft tissues, it does not appear to increase pain from a local soft tissue source, and it 
restricts final ROM during neurodynamic tests. However, it is not clear what role 
muscle activation has in terms of protection of the neural tissues, and at this stage does 
not help to support the use of structural differentiation. The limitation of most of the 
studies discussed above is that participants have been asymptomatic. Indeed, it has been 
found that in individuals with severe polyneuropathy due to type II diabetes, 
mechanosensitivity during SLR is diminished, and the effect of structural differentiation 
limited (Boyd et al., 2010). This highlights the need for appropriate exclusion criteria in 
studies assessing the effects of SLR, and in sub-grouping individuals using SLR as one 
of the criteria.  
 
3.4 Repeatability of neurodynamic tests 
 
Good to excellent repeatability of SLR has been found in both symptomatic (Boland and 
Adams, 2000; Strender et al., 1997) and asymptomatic populations (Boland and Adams, 
2000; Chow et al. 1994; Herrington et al. 2008). Boland et al., (2000) found intraclass 
coefficients (ICC) of 0.89 and 0.86 for SLR with and without dorsiflexion respectively 
for inter therapist reliability. However, standard error of measurements (SEM) were 
relatively high, (5.62° and 6.81° with and without dorsiflexion respectively), indicating 
that measures greater than this would be required to be convinced of change attributed to 
the technique. As mentioned previously, Herrington et al., (2008) found intra therapist 
reliability to have an ICC of 0.93 and SEM of 2.5°, but it is expected that intra therapist 
reliability is superior to inter therapist and Boland and Adams’ (2000) participants were 
both asymptomatic and symptomatic. 
 
Overall these studies suggest that there is good to excellent reliability when using SLR.  
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3.5 Conclusion 
 
This section has presented supportive evidence for the use of SLR and slump tests in 
clinical practice and for research purposes. Both tests have been demonstrated to induce 
nerve excursion and strain. In addition the use of structural differentiation seems to be 
able to discriminate between neural and non-neural structures. Together these studies 
provide justification that the SLR and slump tests have appropriate validity. The 
repeatability of the tests has been demonstrated to be high. However, whilst the 
evidence to date supports the use of these neurodynamic tests, more research is needed 
in vivo and in symptomatic groups.  
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Chapter 4 Neurodynamic treatment 
The principles behind neurodynamic assessment have been discussed in chapter 3, and 
the treatment of such conditions must be chosen appropriately. The focus of this thesis 
was to analyse the effects of a 3 x 1 minute SLR treatment in individuals with different 
causes of referred leg pain and therefore this chapter is pivotal to the rationale for the 
thesis.  Neurodynamic treatment as described by Shacklock (2005a), can be classified 
into two basic forms; movements of the limb plus or minus the trunk resulting in an 
overall longitudinal movement of the nerve within its nerve bed, and an indirect form of 
treatment often called an interface technique where tissues around the nerve are 
mobilised (Shacklock, 2005a). 
 
Whilst this thesis specifically relates to the effects of a SLR treatment, there is limited 
literature which has analysed the effects of SLR treatment, therefore in this chapter, 
other neurodynamic treatment literature is presented. In this chapter the rationale 
underpinning the different forms of neurodynamic treatment techniques is described, 
and the literature on the effects and effectiveness of these techniques is critically 
appraised.  
 
4.1 Types of Neurodynamic Treatment 
There are broadly two types of neurodynamic treatment; longitudinal (direct) or 
interface (indirect) techniques. As described in chapter 4, nerves move in response to 
changes in the nerve bed which in turn is influenced by joint movements. Whilst nerves 
moving within the nerve bed do not simply move in a longitudinal fashion (there is also 
movement transversely and superficially or deep (Dilley et al., 2003; Greening et al., 
2001; Hough et al., 2000), this is the direction of most movement. Longitudinal 
neurodynamic treatments consist of applying a series of joint movements resulting in 
(mainly) longitudinal excursion through the nerve bed, before repeatedly moving one (or 
more) joints, resulting in a proximal and distal movement of the nerve (or vice versa). 
These series of movements may aim to produce more excursion, with minimal or no 
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increase in strain (a slider technique), or potentially less movement, with greater strain 
(a tensioner technique). The biomechanical changes that occur during these techniques 
have been discussed in chapter 3. 
 
Another common form of neurodynamic treatment is interface treatment. A number of 
authors have advocated the use of techniques which move the structures surrounding the 
nerve, rather than moving the nerve itself (Butler, 2000; Nee and Butler, 2006; 
Shacklock, 2005a). The theoretical basis for these techniques include mobilising 
adhesive tissues around the nerve which may have resulted from some sort of traumatic 
event and may directly influence the nerve (Sunderland, 1989b), and to reduce the 
forces which interfacing structures may have on sensitive neural tissues (Nee and Butler, 
2006). Examples of interface techniques include mobilising the fibular head to affect the 
peroneal nerve (Butler, 1991), mobilising the carpal bones to influence the median nerve 
in the carpal tunnel (Tal-Akabi and Rushton, 2000), and lateral glides to the cervical 
spine to influence the nerve roots within the intervertebral foramina (Hall et al., 1998; 
Nee et al., 2013).  
 
An advantage of these techniques is that if the nerve is compromised by an external 
structure, and becomes mechanically sensitive as a consequence, then moving the 
surrounding tissues may reduce the compression or inflammatory effects on the nerve. 
However, a disadvantage is that in some conditions there may not be one specific 
interface that is causing the problem, and locating the problematic interface may be 
difficult as palpation anywhere along the length of a mechanosensitive nerve may 
reproduce the patient’s symptoms (Schäfer et al., 2009; Walsh and Hall, 2009c). In 
addition, it may not be possible to analyse whether the improvement in any symptoms is 
due to the underlying change to the nerve, or the effect of mobilising the structure itself. 
 
4.2 Longitudinal movement (direct) treatment 
As discussed in chapter 3, movements of the joints can be applied to produce excursion 
with little or no increase in strain (sliders) or to produce increases in strain (tensioners) 
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(Coppieters and Alshami, 2007; Coppieters and Butler, 2008, Coppieters et al., 2009; 
Ellis et al., 2012). The rationale for the choice of each is not clear, but more recently it 
has been suggested that sliders may be more appropriate for most neuropathic pain 
conditions as a larger excursion, with minimal strain may aid resolution of oedema 
(Schmid et al.,2012), improve blood and axoplasmic flow and settle down the 
inflammatory environment of the nerve (Coppieters and Butler, 2008; Nee and Butler, 
2006). In addition, it has been suggested that tensioner techniques may be detrimental to 
the nerve because of the larger increases in strain (compared to sliders), and that 
stretching nerve fibres may cause an increase in ectopic discharge of inflamed nerves 
(Dilley et al., 2005). However, more recent studies have demonstrated beneficial effects 
of tensioner techniques in both animal (Bertolini et al., 2009; Santos et al., 2012) and in 
vivo studies (Adel et al., 2011; Bialosky et al., 2009; Cleland et al., 2006; Kavlak et al., 
2011; Nagrale et al., 2012).  The supportive and negative evidence for the use of 
longitudinal treatments is presented in the next section.  
4.2.1 Proposed mechanism of effects of longitudinal treatments  
 
Regardless of the pathophysiology of the underlying nerve dysfunction, the main aims 
of treatment are to restore normal nerve gliding and neurophysiology to the nerve and 
surrounding tissues, with the result of decreasing pain and increasing function. A 
number of neurodynamic treatment effects have been proposed, but most are theoretical 
and are yet to be proven (Nee and Butler, 2006).   
 
Axoplasmic flow, intraneural circulation and decreased inflammatory responses 
 
Postulated longitudinal treatment effects include improving axoplasmic flow and 
intraneural circulation. Both of these effects are thought to occur due to the build-up and 
release of intraneural pressure that occur during an oscillatory longitudinal 
neurodynamic treatment technique (Coppieters and Butler, 2008; Nee and Butler, 2006); 
the so called milking effect. In addition, such alterations in pressures may lead to 
dispersal of intraneural oedema, which may be particularly beneficial since 
inflammatory exudate is acidic, and may enhance peripheral nerve sensitivity (Steen et 
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al., 1996).  The presence of oedema within the endoneurium is particularly detrimental 
since the perineurial barrier prevents the leakage of fluid out of endoneurium 
(Lundborg, 1988; Lundborg and Dahlin, 1992). The oedema can contribute to the 
compressive effects on the nerve fibres, resulting in greater pathology and pain 
(Olmarker and Rydevik, 1989; Rydevik et al., 1984). The resulting intraneural fibrosis 
(Sunderland 1989b) may cause changes to the normal viscoelastic elements of the nerve, 
with increased activation of nervi nervorum endings and greater mechanosensitivity 
(Bove and Light, 1997; Nee and Butler, 2006). In addition, the inflammatory soup 
contains many substances which enhance peripheral nerve sensitivity, such as 
macrophages which release cytokines and other pro-inflammatory mediators. Another 
proposed side effect of nerve inflammation is ectopic discharging of afferent nerves. 
Dispersal of these inflammatory exudates could theoretically reduce the occurrences of 
such discharges (Coppieters and Butler, 2008). The removal of oedema and underlying 
inflammatory soup may therefore be an important response to neurodynamic treatment.  
 
There is some preliminary evidence that longitudinal nerve mobilisation techniques may 
be effective in reducing oedema. Brown et al., (2011) found that ankle mobilisation was 
effective in the dispersal of injected intraneural dye in the tibial nerve of 6 unembalmed 
cadavers. The increase in spread of dye was significantly greater than on the control side 
(p<0.02). The conclusion of the study was that that ankle mobilisation would help to 
disperse oedema. However, the fluid was injected just beneath the epineurium, and 
hence it is not known how much entered the endoneurium (where the intraneural 
oedema would be situated), and how fluid specifically located around the axons would 
disperse. Since oedema becomes more organised after a period of time (Underwood, 
2009), it is unclear how this more viscous fluid would disperse.  It is also unknown what 
alterations in fluid dispersal would occur in vivo compared to cadavers. Despite all of 
these factors, the study does demonstrate that movement of a peripheral joint has the 
ability to disperse fluid intraneurally; perhaps the added benefit of elevating the limb (as 
in SLR) would further enhance this effect simply by the effect of gravity.  
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Further support for a reduction in oedema was offered by Schmid et al., (2012), who 
found a reduction in the signal intensity of MRI images of the median nerve at the wrist 
in individuals with carpal tunnel syndrome post longitudinal nerve mobilisation. 
Increase in signal on MRI T2 weighted scans reflects increases in fluid content 
(Kleindienst et al., 1996), and hence reduction in signal represents a decrease in oedema 
(Cudlip et al., 2002).  Nerve tendon gliding exercises, and a slider technique for the 
median nerve (fig 3.2) were given to 10 patients to perform 10 times per day for 1 week, 
and the wrist was scanned prior to and after 1 week of intervention.  A comparison 
group (N=10) received a night splint for 1 week. Both groups showed significant 
differences in signal intensity of the median nerve at the radio-ulnar level, but neither 
group showed any changes either at the pisiform or hook of hamate level, indicating that 
improvements occurred more proximal to the site on injury. Increase in swelling in CTS 
patients proximal to the site of compression has been demonstrated previously 
(Nakamichi and Tachibana, 2000), and therefore significant changes here may reflect 
the improvement in oedema in the most affected area. Whilst both night splinting and 
neural mobilisations were found equally to improve oedema, the particular relevance to 
the present study is that previously, opponents of longitudinal mobilisations have 
suggested that it is detrimental in nerve compression injuries due to potentially 
increasing oedema or nerve sensitivity (Dilley et al., 2005). However, individuals with 
severe signs and symptoms of CTS were excluded from the study, and the follow up was 
very short (1 week), hence the longer term effects of nerve and tendon mobilisation on 
oedema are not currently known.  
 
Reducing oedema may be of value in restoring normal nerve mechanosensitivity, but 
affecting inflammatory and immune system cells could also be important as this may 
demonstrate an augmentation in healing, and an improvement in resting nerve sensitivity 
(Martins et al., 2011; Santos, 2012). The sciatic nerve in rats were either crushed for 30 
seconds (Martins et al., 2011), or were subjected to a chronic constriction injury (CCI) 
by the use of chromic gut suture around the nerve (Santos et al., 2012). A tensioner SLR 
technique with the addition of cervical flexion for the final minute of treatment (Santos 
et al., 2012) was applied for 10 minutes in rats with CCI and control rats. Significant 
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reduction in mechanical hyperalgesia (paw withdrawal) was found from the second day 
of treatment, compared to the rats who did not receive treatment. Thermal hyperalgesia 
significantly decreased from the 4th treatment. Both mechanical and thermal 
hyperalgesia remained constant for the duration of the study (10 sessions; 20 days).  
 
Santos et al., (2012) also explored the effects of the SLR treatment on glial cells and 
nerve growth factor (NGF). Glial cells in the spinal cord, have been demonstrated to 
become activated after nerve injury (DeLeo and Yezierski, 2001; Garrison et al., 1991), 
resulting in the production and release of an array of pro inflammatory mediators such 
as pro-inflammatory cytokines, prostaglandins and neurotropic factors. NGF is produced 
by a form of glial cell called an astrocyte, and has been associated with development of 
hyperalgesia after sciatic nerve constriction (Herzberg et al., 1997). NGF was 
demonstrated to increase after CCI, but was normalised in rats after neural mobilisation 
in the DRG. Glial cell changes were assessed by analysing the presence of a protein 
called glial fibrillary acidic protein (GFAP), which demonstrated a marked increase in 
the CCI rats, which was normalised in the mobilisation group in both the DRG and 
spinal cord.  
 
Similar findings of improvements in mechanical hyperalgesia and changes to glial cell 
activation were found by Martins et al., (2011) after ankle joint mobilisation in sciatic 
nerve crushed animals. However, improvements in cold hyperalgesia were only 
observed at day 3, with changes equivocal to the crushed rats without ankle mobilisation 
thereafter (up to 35 days). Interestingly, mechanical hyperalgesia returned to almost 
normal after 35 days in both crushed and crushed mobilised groups, but cold 
hyperalgesia continued to increase up to 35 days, suggesting a continued 
hypersensitivity of the small diameter afferent nerves. This was not seen in the Santos et 
al., (2012) paper; neither mechanical nor thermal thresholds recovered in the CCI rats 
without mobilisation (up to day 34 post injury), but both improved (up to 34 days) in the 
nerve mobilisation group.  Disagreement in these thermal results could be attributed to 2 
differences in methodology. Firstly the neural mobilisation in the Santos et al., (2012) 
study did not start until 14 days after the CCI was imposed, whereas rats in Martins et 
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al., (2011) began ankle mobilisations 24 hours after crush injury. This may suggest that 
it is beneficial not to perform mobilisation techniques on acute inflammatory conditions, 
which supports most recommendations for management in the inflammatory stages of 
healing; POLICE (protection, optimal loading, ice, compression and elevation) 
(Bleakley et al., 2012). Secondly, Martins et al., (2011) used an ankle joint mobilisation, 
which although has an effect on the sciatic nerve via its tibial nerve connections (Boyd 
et al., 2013; Coppieters et al., 2006), would exert less mechanical load on the nervous 
tissue than a tensioner mobilisation, used by Santos et al., (2012). It may be that an 
overloading effect, considered to be a positive influence on other soft tissues during the 
proliferation and regenerative stages of healing, may be beneficial. It is unknown which, 
if any, of these theories could explain the differences in thermal changes found between 
the two studies, however, in clinical practice care is taken to avoid overload during 
inflammatory phases, and load is applied to tissue bearing in mind the patient’s 
symptoms, and underlying severity and irritability (something that is not possible to take 
into account in either of these studies). 
 
Overall, the results of these 2 studies (Martins et al., 2011; Santos et al., 2012) are 
important in the understanding of the potential effects that nerve mobilisation may have 
on nerve inflammation. Improvements in oedema and inflammation are potentially 
important effects of nerve mobilisation and another proposed effect of longitudinal 
oscillatory movements may be to directly mobilise intra or extra funicular fibrosis once 
it is formed (Hall et al., 1998). Other postulated mechanical effects include, restoring 
nerve and fascicular gliding (Walsh, 2005), and mobilising the viscoelastic connective 
tissue elements of the nerve.  
 
Mechanical Effects 
At present there is little supportive literature to demonstrate any changes to the length of 
the connective tissue of the nerve after neural mobilisation techniques. Some degree of 
extrapolation may be taken from literature looking at the effects of mobilisation on other 
soft tissue structures, since the fundamental structure of the nerve sheaths is similar to 
other connective tissue within the body, such as ligaments. As mentioned in chapter 4, 
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the nerves possess similar stress strain curves to other soft tissues due to the viscoelastic 
nature of the tissue, and also exhibit stress relaxation, or creep (Millesi et al., 1995; Wall 
et al., 1991). Lengthening of soft tissue is thought to occur due to creep and hysteresis 
(Lee and Evans, 1994, McGill and Brown, 1992; Threlkeld, 1992). Hysteresis is the 
change in length that occurs simultaneously with energy loss into the tissue due to 
cyclical loading (Soderberg, 1997; Flanaghan, 2013). Both of these effects may enable 
tissue to increase in length, however this is only a temporary change (Lee and Evans, 
1994; McGill and Brown, 1992; Threlkeld, 1992). It has been suggested that for 
permanent length changes to occur, that the tissue should be taken to the point of failure 
(Threlkeld, 1992), however this would not be warranted in nervous tissue due to the 
deleterious effects of neurogenic inflammation, potentially compounding an already 
inflamed nerve.  
 
McGill and Brown (1992) demonstrated a temporary (20 minutes) increase in forward 
spinal flexion in asymptomatic individuals after 20 minutes of sustained forward 
flexion. However, neural mobilisation techniques are generally not held for periods of 
time. Lee and Evans (1992) found an increase in segmental posteroanterior displacement 
of the vertebral segments of 28 young, asymptomatic participants, after both sustained 
and oscillatory mobilisations. This study demonstrated a creep and hysteresis effect of 
spinal manual therapy. The majority of creep occurred within the first 30 seconds, 
although additional gains in displacement were made after this time (up to 2 minutes). 
Only 3 cycles of the oscillatory load were applied, with greatest effects between the first 
and second loads.  
 
The studies discussed above, suggest that manual therapy techniques are capable of 
increasing motion around a vertebral segment, however, it is unknown if the same 
effects occur to nerve during neural mobilisation techniques. One way of establishing 
biomechanical changes to the nerve after neurodynamic treatment in vivo, is through the 
measurement of nerve excursion analysed from ultrasound images (Dilley et al., 2001; 
Ellis et al., 2012, see chapter 5). Whilst excursion is not a direct measure of elongation, 
it has a close relationship to it. Excursion relates to length changes in that during the 
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first 2 phases of the stress-strain curve, the tissue initially uncrimps, then moves 
(excursion ) before entering the third phase where lengthening (and less excursion) of 
the tissue occurs (Fig 4.1). Hence changes to tissue length may first demonstrate a 
greater amount of excursion before lengthening begins.  
 
 
Fig 4.1 Stress Strain Curve 
 
Descending Inhibitory Pathways 
Inhibition of pain utilising pain gate mechanisms or descending pain inhibitory 
mechanisms may also have a role in explaining the beneficial effects of neurodynamic 
treatments (Katavich, 1999). It appears that the descending inhibitory pain mechanism 
previously demonstrated in joint mobilisation studies (Sluka et al., 2006, Sluka and 
Wright, 2001), may also be responsible for positive outcomes of nerve mobilisation 
techniques (Bertolini et al., 2009; Martins et al., 2011; Santos et al., 2012). In these 
studies, improvements in pain were demonstrated in rats post nerve injury after nerve 
mobilisation techniques. Martins et al. (2011) and Santos et al. (2012) have been 
discussed above (page 86) in consideration of changes to glial cell activation and 
neurotrophic factors. Previous joint studies have suggested a predominantly supraspinal 
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noradrenergic or serotonergic pain relieving system post joint mobilisation (Sluka and 
Wright, 2001; Sluka et al., 2006; Skyba et al., 2003). Some studies suggest that short 
term mobilisation effects are more likely produced via the noradrenergic systems, and 
therefore influence more mechanical hyperalgesia (Vincenzino et al., 1996; Wright, 
1995). Martins et al., (2011) found only a change to mechanical rather than thermal pain 
thresholds after ankle joint mobilisation, which could suggest a more noradrenergic pain 
relieving mechanism. Prolonged changes to both thermal and mechanical thresholds 
were found by Santos et al., (2012), which may suggest that a tensioner mobilisation 
affects both descending inhibitory systems, or it may be that the long duration of 
treatment (10 minutes) imposed by Santos et al., (2012), may have had an additional 
effect on the serotonergic systems, a proposed effect of longer duration treatments such 
as acupuncture (Takeshige, 1992).  
 
Bertolini et al., (2009) only looked at changes to mechanical hyperalgesia, but found an 
improvement in both a sustained stretched SLR group and a tensioner SLR treatment 
group after CCI of the sciatic nerve in rats compared to a sham treatment group. 
Mechanical thresholds (paw withdrawal) significantly improved immediately and 24 
hours after the fifth and final treatment (5 consecutive daily treatments, starting on day 3 
post injury), compared to immediately post CCI in both stretch and tensioner groups. 
However, 24 hours post final treatment, the tensioner group (but not the SLR stretch 
group) had reduced hyperalgesia that was not significant to pre- CCI levels, indicating 
that levels were returning to pre-injury status. This suggests that whilst sustained stretch 
improves hyperalgesia, some degree of hyperalgesia remains (8 days post injury), 
whereas the tensioner technique normalised hyperalgesia within this time frame. 
However, despite results being presented which demonstrated statistical significance 
within groups, no results were presented for between analyses, which may suggest that 
no differences were found between the groups, and this may limit the conclusions drawn 
from the study.   
 
Activation of the dorsal and ventral periaqueductal gray areas within the mid brain have 
been suggested as being responsible for non-opioid descending inhibitory events post 
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manual therapy (Wright, 1995). Such changes will induce a systemic pain relieving 
effect, rather than a localised or segmental effect which may occur with pain gate 
response (Schmid et al., 2008; Wright, 1995). At present however, there is insufficient 
evidence that the non-opioid descending inhibitory mechanism is the sole mechanism 
responsible for such changes (Schmid et al., 2008). Relating the hypoalgesic effects 
found in the studies discussed to the glial cell activation changes found by Santos et al., 
(2012) and Martins et al., (2011), suggests an interesting link between descending pain 
mechanisms and altered neuro- inflammatory mechanisms. 
 
 It has been suggested that the descending release of noradrenaline and serotonin inhibit 
the release of glutamate from the Aδ and C afferent nerve endings (Yoshimura and 
Furue, 2006). Since chronic glial cell activation has been found to result in a decrease in 
glutamate uptake (Milligan and Watkins, 2009), a combination of both decreased glial 
cell activation, and descending inhibition of release of glutamate may result in an overall 
decrease in glutamate in the dorsal horn, with resulting decreased excitatory synaptic 
transmission (Milligan and Watkins, 2009), and reduction in pain. 
 
The literature discussed above demonstrates a positive change after longitudinal nerve 
treatments, however there has been some suggestion that such techniques may cause an 
increase in sensory nerve firing, and could increase the pain felt by individuals with 
neuropathic pain (Dilley et al., 2005, Jaberzadeh et al., 2005). One study which supports 
such assertions was done in rats whose nerves were inflamed experimentally by 
exposing the nerves to a substance called complete Freunds adjuvant (CFA) (Dilley et 
al., 2005). It was found that a small percentage of C and A fibres ectopically fired when 
they were stretched. The authors suggest that in situations where patients have signs of 
neural inflammation, lengthening the nerve bed should be avoided, as this may 
contribute to wind up within the central nervous system and therefore central pain.  It 
must be noted, however that only 1.8% of C fibres and 1.3% of A fibres ectopically 
fired when stretched after exposure to CFA. A slightly larger proportion of rats with 
CFA applied directly to the axons within the perineurium (by sectioning the perineurium 
first), showed spontaneous firing (6.5% C and 8.8 % A fibres). Such sectioning of the 
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perineurium could have effects on the normal function of the nerve and so does not best 
represent a neuropathy in humans.  In addition, the axon was directly stretched using 
forceps; this clearly does not reflect the situation in vivo, where the axons are protected 
by the connective tissue coverings. These connective tissues limit the imposed tensile 
forces direct to the axons during longitudinal movements of the nerve (Butler, 2000; 
Grewal et al., 1996).  
 
Taken in conjunction with the animal studies discussed above (Bertolini et al., 2009, 
Martins et al., 2011, Santos et al., 2012), it appears that the mechanism of increased 
firing after stretching the axon does not occur in the same way when a compression or 
crush neuropathy is applied to the whole nerve structure, and a longitudinal nerve 
treatment applied. In addition, Bialosky et al., (2009) has demonstrated a reduction in 
temporal summation post neural mobilisation in individuals with carpal tunnel 
syndrome, suggesting a dampening down of nerve sensitivity after treatment (this study 
will be discussed further in the next section). The combination of clinical and animal 
studies overall, reflect that longitudinal nerve mobilisation in compression neuropathy 
and crush injury do not increase afferent firing. However, regardless of the results of 
these studies, individuals with neuropathic pain present in a variety of ways. In 
individuals with severe and irritable symptoms, tensioner techniques, or indeed any 
extreme movement of the affected area, could aggravate symptoms, and therefore these 
techniques would not be appropriate.  
 
Whilst there is evidence that pain may be improved by nerve treatment techniques, 
patients with neuropathic pain commonly have sensory changes including anaesthesia of 
an area (Bogduk, 2009; Greening and Lynn, 1998). There has been some suggestion that 
longitudinal nerve treatments could diminish nerve conduction even further, if strain 
values reach those levels sufficient to decrease blood supply to the nerve, in an already 
compromised region (Boyd et al., 2005; Humphreys et al., 1998). 
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Nerve conduction 
The suggestion that nerve conduction could be affected by nerve mobilisation could be 
considered to be a positive or negative aspect of neurodynamic treatment. If blood 
circulation improves post nerve treatment then theoretically, conduction could improve. 
However, since strain levels during neurodynamic positions have been found to vary 
between studies (1% up to 26% (Fleming et al., 2003; Gilbert et al., 2007b), and strain 
greater than 8% could cause changes to circulation, nerve conduction and inflammation 
and oedema (Driscoll et al., 2002; Kwan et al., 1992; Lundborg and Rydevik, 1973), it is 
difficult to predict how nerve conduction could be affected during these treatment 
techniques.  
 
Humphreys et al., (1998) found that tibial nerve F wave latency7 deteriorated after SLR  
to 50° in 10 asymptomatic participants. A mean difference of 1ms was found before and 
during the SLR position, which are below levels considered to be clinically significant 
(2ms Humphreys et al., 1998). In addition, it has been found that normal side to side 
differences are around 3.5ms for tibial nerve F wave latency (Alavian-Ghavanini and 
Haghpanah, 2000). Since Humphreys et al., (1998) initially measured the latency in both 
legs, compared to a single leg such small differences are unlikely to be attributed to the 
SLR position itself. In contrast to this study, Ha et al., (2012) found an improvement in 
motor nerve conduction velocity (NCV) of the median nerve after sustaining the median 
nerve upper limb neurodynamic test. Results were significantly different to pre- 
measures and to a group who received a home regime of the same neural mobilisation 
exercises. However, motor NCV may not be an accurate measure of change after minor 
nerve dysfunction, since sensory changes may be the initial finding in minor nerve 
dysfunction (Greening and Lynn, 1998). In addition, mean differences were only in the 
region of 2m/s. It has been demonstrated that variation in motor NCV may be around 
6% within subjects (Galloway et al., 2011).  The mean pre-readings for the neural 
mobilisation groups were 58.71m/s, hence a 6% difference would be 3.5mm. This 
suggests that the 2mm change found by Ha et al., (2012) could be attributed to normal 
                                                 
7 F wave latency is a measure of motor nerve conduction; it measures the action potential of the smaller 
number of fibres which propagate towards the dorsal horn, causing a firing of the cells at the anterior horn 
and returning efferent action potential. 
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variation in readings, although the variation may be more relevant to individual 
differences in readings. Nevertheless, such small differences in motor NCV may not be 
relevant despite the statistical differences found. 
 
A more sensitive method of detecting early changes in minor peripheral nerve 
dysfunction may be the use of vibrametry (Dellon, 1981; Greening and Lynn, 1998; 
Goldberg and Lindblom, 1979). No significant changes to vibration thresholds (VT) 
were found in a group of 30 asymptomatic individuals after a SLR tensioner treatment 
(Ridehalgh et al., 2005), indicating that in individuals without neuropathy there are no 
detrimental changes to the large diameter afferent nerves. However, in rats with nerve 
injury, it has been found that greater levels of strain are reached during the SLR (mean 
22.6% with ankle dorsiflexion), than in uninjured animals (mean 9.7% with 
dorsiflexion) (Boyd et al., 2005). However, this was 7 days after the crush injury had 
been induced; 21 days later, there was no significant difference in strain between 
uninjured and injured animals during the SLR, suggesting that changes to the connective 
tissue behaviour was short term. Hence if a similar restoration of mechanical 
characteristics occurs after 3 weeks, it is possible that techniques which lengthen the 
nerve bed may not have deleterious effects. As with all animal nerve compression 
studies, rats with induced nerve crush injury, may not reflect the normal pathogenesis 
that occur in humans with nerve compression or irritation.  
 
In support of longitudinal neurodynamic techniques, Kavlak et al., (2011) found an 
improvement in light touch and 2 point discrimination in the foot supplied by the tibial 
nerve in individuals with tarsal tunnel syndrome after slump tensioner treatments added 
to a usual practice exercise regime. However, mean or median differences were very 
small. Indeed, the median difference between pre and post readings of light touch, 
despite reaching significant difference was zero. In addition, a series of T tests or non-
parametric equivalent tests were performed on the data, rather than analysis of variance 
or equivalent, making the statistical results less convincing. However, regardless of 
whether positive changes were found post mobilisation, the study demonstrated that 
there was no deterioration in these sensory measures. This indicates that sensory 
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conduction may not be detrimentally affected by these types of neural mobilisation in 
individuals with compression neuropathy.  
 
4.3 Effectiveness of longitudinal neurodynamic treatment 
There has been an increase in longitudinal neurodynamic treatment research over the 
past decade, with most showing positive responses to treatment (Adel, 2011; Beneciuk 
et al., 2009; Bialosky et al., 2009; Cleland et al., 2006; De-La-Llave-Rincon et al., 2012; 
Kavlak et al., 2011; Nagrale et al., 2012, Nee et al., 2012b; Sarkari and Multani, 2007; 
Schäfer et al., 2011; Schmid et al., 2012), although some have found less positive effects 
(Heebner and Roddey, 2008; Scrimshaw and Maher, 2001) (see appendix 13 for 
summary of studies) . Some of the studies looking at effectiveness of longitudinal 
neurodynamic treatment have looked at the addition of neurodynamic treatment to 
standardised exercise programme (Heebner and Roddey, 2008; Scrimshaw and Maher, 
2001), or combination of exercise and hands on treatment or provision of orthotics or 
other modalities such as ice (Adel, 2011; Cleland et al., 2006; Kavlak et al., 2011; 
Kornberg and Lew, 1989; Nagrale et al., 2012; Sarkari and Multani, 2007).  In these 
studies, the comparative group were given the physiotherapy programme without the 
addition of the neurodynamic treatment.  
 
Other studies have focussed on the effectiveness of the neurodynamic treatment 
compared to a control or sham treatment (Beneciuk et al., 2009; Bialosky et al., 2009; 
Nee et al., 2012b, Schmid et al., 2012; Tal Akabi and Rushton, 2000). In the former 
case, the usefulness of the addition of neurodynamic treatment portrays a more realistic 
presentation of how neurodynamic treatment is used in clinical practice, but does not 
give an indication of how effective the treatment is in isolation. The difficulty with this 
scenario is that cumulative effects of a treatment may give a false improvement in 
outcome measures since more treatment is being provided, and where this is applied by 
the Physiotherapist may create a stronger placebo effect. Conversely, results could be 
falsely worsened because of the additional treatment on top of an often overloaded 
programme. Results from these studies have been varied. Using a similar physiotherapy 
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programme in individuals with spinally referred leg pain (without signs of neurological 
compromise) 3 studies have found significant improvements in the neurodynamic 
treatment group compared to the physiotherapy programme alone on a range of outcome 
measures (Adel, 2011; Cleland et al., 2006; Nagrale et al., 2012). Slump tensioner 
(Cleland et al., 2006; Nagrale et al., 2012) and SLR (Adel, 2011) were sustained for 
differing periods of time. Such sustained techniques in individuals with neuropathic 
symptoms have been thought to be potentially detrimental (Boyd et al., 2005; Dilley et 
al., 2005) due to levels of strain reached, changes to intraneural circulation and 
potentially ectopic firing of small diameter nerves. However, these techniques in two of 
these studies demonstrated not only significant improvements, but changes to a number 
of outcome measures which were greater than the minimal clinically important 
difference (MCID) (Cleland et al., 2006; Nagrale et al., 2012). Unfortunately whilst 
Adel (2011) found significant changes in a number of outcome measures, the data 
provided did not permit any analysis of MCID, in addition a series of multiple T tests 
were performed which increases the risk of a type I error, or in other words may have 
meant that the null hypothesis was falsely rejected. However, even if this error did 
occur, individuals in both groups all had improvements in a number of relevant outcome 
measures, suggesting that the addition of a strong SLR tensioner did not aggravate the 
individuals involved in the study, which diminishes the suggestion that these techniques 
may be harmful.  
 
Using physiotherapy management techniques plus neurodynamic techniques  has also 
resulted in positive findings in other studies in individuals with spinally referred leg pain 
(Sarkari and Multani, 2007), hamstring strains with postulated sciatic nerve involvement 
(Kornberg and Lew, 1989), and tarsal tunnel syndrome (Kavlak et al., 2011). Kornberg 
and Lew (1989) concluded that the addition of slump stretching to standard 
physiotherapy care resulted in significant reduction in missed games of Australian Rules 
football. However, neither a standardised physiotherapy management programme, nor a 
standardised slump treatment prescription was utilised; physiotherapists were free to 
decide on the most appropriate treatment for the patients. This sort of pragmatic trial 
may be useful when considering that Physiotherapists should apply techniques based on 
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a thorough assessment of the patients, but the lack of any standardisation of treatment 
makes it difficult to account for improvement in the main outcome measure solely on 
the addition of the slump technique.  
 
Sarkari and Multani, (2007) also had a number of limitations which made the 
statistically significant greater improvement in hip ROM and VAS scores after SLR 
treatment compared to physiotherapy management alone, less conclusive. The detail of 
the physiotherapy programme was scant, there was no detail of how the range of motion 
of the hip was measured, and no p values were presented. Likewise, whilst Kavlak et al., 
(2011) found improvements in an array of outcome measures in participants with tarsal 
tunnel syndrome after a slump tensioner, numbers of limitations made the results less 
convincing. Details of numbers of exercises performed, or how many times per day 
participants repeated them were omitted from the method. One of the outcome measures 
used was range of motion of the subtalar joint and this was measured with a universal 
goniometer. Reliability has not been found to be consistently high in patients with 
neurological disorders; ICC for inversion has been found to be only 0.53, whilst that for 
eversion was 0.65 (Elveru et al., 1988). It is unknown what the smallest detectable 
difference for such measurements would be, but mean differences found were around 6° 
in the study group, it is not possible to say whether these values could be related to error 
or a real difference in range of motion. Significant improvements were found in Tinel’s 
sign and 2 point discrimination in 2 out of 3 sites after neurodynamic treatment, but not 
in the usual physiotherapy management alone. However, mean differences for 2 point 
discrimination were small (around 0.3), unlikely to be clinically meaningful. Measuring 
Tinel’s sign may not be accurate as the measure could vary depending on the amount of 
force applied by the examiner.  
 
Taken together the results of the latter 3 studies (Kavlak et al., 2011; Kornberg and 
Lew,1989 and Sarkari and Multani, 2007), do not provide strong evidence of the 
effectiveness of neurodynamic treatment as part of a package of care. In addition, 2 
studies have suggested that the addition of a neurodynamic treatment to a standardised 
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physiotherapy management programme does not improve outcome (Heebner and 
Roddey, 2008), and may even have a negative effect (Scrimshaw and Maher, 2001).  
 
Participants with CTS (Heebner and Roddey, 2008) did not improve any more than the 
standard care alone, and the carpal tunnel specific questionnaire was marginally (0.7), 
but significantly better (p=0.016) in the standard care group. However, a number of 
limitations of the study may account for some of these findings. A total of 31 patients 
were lost during the course of the 6 month study, resulting in only 14 participants in the 
standard care group and 15 in the standard care plus neural mobilisation group, which 
was below the minimum required (21 in each group) from the power calculation. 
Compliance appeared to be worse in the neurodynamic group than the standard care 
alone (p=0.01), which could also, in part account for the result. One other consideration 
which may account for the difference in these results compared to other studies that 
have been discussed, is the fact that participants were instructed to do the exercises at 
home and were not offered any treatment by the Physiotherapist. Their technique was 
not reassessed even at the one month follow up and hence progression or regression of 
exercises at home may not have been properly carried out, and it is possible that some 
participants may have not been performing exercises optimally. 
 
 In agreement with Heebner and Roddey (2008), Scrimshaw and Maher (2001) found 
that the addition of neurodynamic exercises (SLR) to standard care post spinal surgery 
did not improve outcomes compared to standard care alone. Indeed in further analysis of 
between group differences for improvement, overall there was a slightly worse outcome 
than the standard care group. However, such analysis was not supported by the 
statistical findings and a suggestion that individuals were worse in the SLR group 
cannot be concluded from the results of this study. Overall the conclusion as to the 
effectiveness of a longitudinal neurodynamic treatment in conjunction with standard 
physiotherapy management is equivocal.  
 
Stand-alone neurodynamic treatments have been applied in a number of studies 
(Beneciuk et al., 2009; Bialosky et al., 2009; De-La-Llave-Rincon et al., 2012; Schmid 
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et al., 2012; Tal Akabi and Rushton, 2000), with a predominance of positive findings. 
All of these studies however, have been conducted using upper limb neurodynamic test 
1 (median nerve bias) as the neurodynamic treatment on asymptomatic individuals 
(Benecuik et al., 2009) or individuals with CTS (Bialosky et al., 2009; De-La-Llave-
Rincon et al., 2012; Schmid et al., 2012; Tal Akabi and Rushton, 2000). One study 
assessed the effect of a slider SLR technique on different groups of individuals with 
spinally referred leg pain (Schäfer et al., 2011), and is discussed further below (page 
102).  
 
Benecuik et al., (2009) and Bialosky et al., (2009) demonstrated a significant 
improvement in temporal summation after an ULNT1 tensioner technique in 
asymptomatic participants and individuals with CTS respectively. Temporal summation 
is considered to be an important phenomenon in the contribution to central sensitisation, 
where tonic C fibre activity leads to wind up at the dorsal horn (Rygh et al., 2005), and 
has been found to increase in conditions where central sensitisation predominates (Staud 
et al., 2007). However, Benecuik et al., (2009) only found this to be of significance 
immediately after the initial treatment, not at the end of the 9th Rx session nor one week 
subsequently. The authors suggest that this may be due to a ceiling effect which 
occurred because the participants were asymptomatic.  
 
Some support of this is offered by the results of Bialsoky et al., (2009) since the 
participants with CTS had significant improvements in temporal summation compared 
to the sham group after 3 weeks of treatment. Unlike Benecuik et al., (2009), where 
additional improvements in other outcome measures occurred compared to the sham 
treatment (VAS and ROM of elbow during the ULNT), Bialsoky et al. (2009) found no 
other significant differences in an array of other outcome measures (see appendix 13 for 
details) between the sham and tensioner technique, although significant improvements 
from baseline were found in both groups. This suggests that apart from a change in 
temporal summation, no other benefits were specifically seen from the tensioner 
technique. However, it must be noted that the sham treatment given, whilst limiting the 
amount of strain through the median nerve, would have resulted in nerve excursion at 
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the wrist during the wrist and finger extension (Dilley et al., 2003, Hough et al., 2007; 
Ugbolue et al., 2004), hence it could be considered to be a neural treatment of sorts.  
 
Improvements in outcomes in individuals with CTS were found in another 3 studies 
(De-La-Llave-Rincon et al., 2012; Schmid et al., 2012; Tal Akabi and Rushton, 2000) 
after neurodynamic treatment. However, despite significant improvement after the 
neurodynamic treatment compared to the control group, a carpal bone mobilisation also 
improved outcomes similarly in participants (Tal Akabi and Rushton, 2000). Such 
carpal bone mobilisation could be considered a neural interface technique, and may 
suggest therefore that in entrapment neuropathies, both direct and non-direct forms of 
nerve treatment can be equally effective. Caution should be taken when extrapolating 
this data due to the small numbers of participants in each group (7 in each group). 
 
Schmid et al., (2012) also did not find a difference between a night splint group and a 
slider neurodynamic treatment group, although both demonstrated significant 
differences from baseline in MRI signal (indication reduced oedema) and functional 
outcome measures from one week of treatment. Whilst this study demonstrates that 
neurodynamic treatment is not superior to rest, it does provide evidence of no harm in 
patients with nerve entrapment. It had been suggested that these sorts of techniques 
could increase oedema in the CT (Brahme et al., 1997), and this study counters that 
argument.  
 
De-La-Llave-Rincon et al., (2012) found that whilst significant improvements in 
pressure pain threshold (PPT) were observed at C5-C6 after ULNT slide technique in 
participants with CTS, no other sites, including the carpal tunnel showed significant 
improvement compared to baseline. Improvements were found in numeric pain rating 
scale (NPRS) after treatment, but a lack of comparative group or treatment, means that 
the changes could be attributed to natural progression or placebo effect alone. 
Cumulatively, there is some limited evidence that longitudinal neurodynamic treatments 
may be beneficial, and stronger evidence that they do not cause harm in individuals with 
nerve entrapment syndromes.  
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This is further supported by Nee et al., (2012b), who specifically investigated harmful 
and adverse effects, in addition to beneficial effects of neurodynamic treatment (both 
sliders and tensioners) in individuals with non-traumatic nerve related neck and arm 
pain. A significant improvement (specific p value not reported) in global rating of 
change scale (GROC) was found in the experimental group (who also had cervical 
interface treatment and general cervical and shoulder mobilisation exercises; see 
appendix 13) compared to the control group (advised to stay active). Three out of 38 
participants in the experimental group, and 4 out of 18 in the control group reported a 
worsening in the GROC scale, demonstrating that deterioration in condition was no 
worse than a control group. In addition, adverse effects, whilst reported in 16 out of 38 
participants in the experimental group, were found to last for less than 24 hours, did not 
require additional treatment, and did not result in a worse outcome at the end of the trial 
compared to those who did not complain of any adverse changes.  
 
One study, found a better outcome in individuals in a specific sub-group of individuals 
with low back and leg pain (Schäfer et al., 2011). Four sub-groups were identified by 
Schäfer et al., (2011): 1. Neuropathic sensitised (NS) (i.e. >12 on LANSS scale), 2. 
Denervation (D) (+ve neuro integrity), 3. Peripheral nerve sensitised (PNS) (<12 
LANSS scale and +ve SLR, nerve palpation and lumbar flexion), 4. Musculoskeletal 
(M) (somatic). The results suggested that patients who were grouped within the PNS 
group, had significantly better outcomes (Roland Morris disability scale and global 
perceived rating scale) than all other groups, but not NPRS, which was not significantly 
different between the PNS and the NS group. Two treatment techniques were applied 
over a 2 week period (5 x weekly); the first technique was a lateral flexion technique 
designed to open the intervertebral foramen (interface technique, 5 x 60 secs), and the 
second a hip and knee mobilisation technique in side lying (slider technique, 5 x 30 
secs). The use of two different types of neurodynamic treatment techniques used 
together means that any effects of treatment cannot be attributed to any one technique, 
making it difficult to rationalise the use of individual treatment techniques. 
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Other limitations of the study affect the strength of the results; one clear issue being that 
the group in which most positive effects were seen only had 9 participants. Recruitment 
of participants with specific criteria can be unpredictable and within the time period of 
the study, such small numbers in this important group was unavoidable. However, such 
small number of individuals does affect the extrapolation into clinical practice; that 
being that in participants classified in a PNS group a neurodynamic intervention is more 
likely to be effective. Perhaps more importantly since the definition of neuropathic pain 
has been updated (Cruccu et al., 2010) all three sub groups who had neurological cause 
for their leg pain could have positive responses to this scale (NS, denervation and 
PNSG). This has quite major implications for the study’s outcomes as the comparisons 
between groups may not be discriminatory. 
 
One difficulty of interpreting the effectiveness of such neurodynamic techniques 
described in the above studies is the lack of consistency of treatment dose and timings of 
measurement of outcomes (see appendix 13 for details). Whilst literature has been 
published analysing optimal treatment dose for joint mobilisations, no such work has 
been established for nerve treatment. In addition the joint mobilisation studies have been 
performed on asymptomatic participants (Krouwel et al., 2010; Pentelka et al., 2012; 
Willett et al., 2010) or in rats (Sluka and Wright 2001), and therefore extrapolation of 
these studies is even more difficult in justifying neurodynamic treatment doses. Three 
times 30 seconds treatment dose was advocated for many years as a starting point by 
Maitland (1973), with some support from biomechanical studies such as Lee and Evans, 
where 30 seconds provided the greatest proportion of a creep effect. However Sluka and 
Wright (2001) found that longer treatment durations (>6 mins) were required to 
demonstrate a hypoalgesic effect in rats. Until more published literature is provided on 
optimal treatment doses, clinicians establish the best dose based on reassessing outcome 
asterisks between and after chosen repetition and durations, however the starting dose 
may be less clear. 
 
The timings of assessment of outcome measures may also have an impact on the 
considered effectiveness of the treatment intervention. Measuring immediately after 
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treatment may produce different effects than if measured 10 minutes, a few hours or 
even days later. Benecuik et al., (2009) found a significant difference in temporal 
summation immediately after treatment, but not after other time frames. However, it is 
not clear what the immediate effects are after one neurodynamic treatment in most of the 
studies described. Whilst long term outcome is of great importance in establishing 
overall effectiveness of such treatments, it is helpful to establish immediate changes 
since subsequent measures can be affected by other extraneous variables.     
4.4 Summary and Conclusions 
There is a growing body of literature which supports the use of neurodynamic 
treatments. Research has demonstrated support for a number of physiological and 
mechanical changes which may account for improvement after neurodynamic treatments 
found in some studies. Such changes include the reduction in inflammation, oedema and 
pain behaviours.  The use of longitudinal treatment techniques has been controversial, 
with numbers of authors suggesting potential detrimental changes in individuals with 
nerve dysfunction (Boyd et al., 2005; Dilley et al., 2005). However as this chapter has 
demonstrated, there is little evidence to support such assertions, but there still remains a 
need for robust research looking into the effectiveness of such longitudinal 
neurodynamic techniques, using outcome measures which reflect both mechanical and 
neurophysiological mechanisms. In addition, preliminary work looking at a standardised 
neurodynamic treatment dose with immediate measurement of outcomes is essential to 
determine any early changes to outcome. 
 
The following chapter assesses the methods that may be useful in analysing both 
mechanical and neurophysiological effects of a neurodynamic SLR treatment. 
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Chapter 5 Measurement of nerve excursion, pain and 
nerve conduction. 
 
There are a number of ways in which an intervention like SLR can be assessed to 
evaluate its effectiveness. Analysing how the nerve moves before and after treatment 
may give an insight into differences in the way in which the nerve behaves 
mechanically. However, measurements of nerve excursion alone, would not explain any 
neurophysiological changes. Since most individuals with painful conditions visit the 
Physiotherapist for relief of their pain, a measure of pain is commonly used in studies 
looking at the effectiveness of a treatment modality. In addition, because individuals 
with neuropathic pain often have changes to nerve conduction, measures to assess any 
changes to their nerve conduction is of importance to not only determine effectiveness, 
but to ensure that the treatments are not detrimental to nerve function. This chapter aims 
to assess and critically evaluate appropriate methods of assessing nerve excursion, pain 
and conduction.  
5.1 Measuring nerve deformation in vivo 
 
As presented in chapter 1, the overall focus of the thesis was to explore the difference in 
responses of individuals with spinally referred leg pain to a 3 x 1 minute SLR tensioner 
treatment. Such neurodynamic techniques aim to move the nerve through its interfaces 
resulting in mechanical and neurophysiological changes (Coppieters and Butler, 2008; 
Nee and Butler, 2006). Such mechanical changes could manifest themselves as a change 
to nerve excursion during SLR. Historically, methods of assessing nerve excursion have 
included cadaveric research (e.g., Boyd et al., 2013; Breig et al., 1960; 1963; Coppieters 
et al., 2006; Goddard and Reid, 1965), during surgery (Fleming et al., 2003), or animal 
studies (Boyd et al., 2005; Kwan et al., 1992; Millesi et al., 1995). Recently, real-time 
ultrasound imaging (USI)  has been utilised to measure nerve motion (Coppieters et al., 
2009; Dilley et al., 2001; Dilley et al., 2003; Ellis et al., 2008; Erel et al., 2003; 
Greening et al., 2005; Hough et al., 2000). This technology has made great advances in 
researchers’ ability to comment on not only what happens to nerves during normal 
movements in asymptomatic individuals, but also in pathological situations such as 
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carpal tunnel syndrome, non –specific arm pain and whiplash (Erel et al., 2003; 
Greening et al., 2005; Hough et al., 2000).  
5.1.1 History of musculoskeletal ultrasound 
 
The first recorded use of USI in medical fields was in the early 1940s when a 
neurologist Karl Dussik, used the technology to investigate brain tumours (Ylinen et al., 
2005). Subsequently in the 1950’s it was developed for the use of pelvic and breast 
tissues (Shampo and Kyle, 1997) utilising both brightness (B) and amplitude (A) modes. 
It was with the development of antenatal scanning in the 1960s that ultrasound 
technology exploded onto the medical diagnostic scene (Ylinen et al., 2005). 
 
Adipose tissue, tendon, cartilage and bone characteristics were reported using USI in the 
late 1950’s (Dussik et al., 1958); the first reported use of USI for musculoskeletal 
structures. With the increasing advances in technology, its use in musculoskeletal 
diagnostics has rapidly developed (Jacobson and van Holsbeeck, 1998). USI is also used 
in rehabilitation by assessing changes to muscle during exercise and functional activities 
(Whittaker and Stokes, 2011). In addition, measuring tissue motion is possible with the 
use of Doppler (Anderson and McDicken, 1999; Hough et al., 2000; Hough et al., 2007) 
and computer assisted techniques which detect motion of a section of tissue and track its 
relative change in position through a sequence of moving images (Dilley et al., 2001; 
(Korstanje et al., 2009; Korstanje et al., 2010; Varghese et al., 2000). One of the 
common types of computer-assisted analysis is frame-by-frame cross correlation. 
 
5.1.2 Theoretical basis of ultrasound 
 
Ultrasonic sound waves are produced by a transducer which contains a piezoelectric 
crystal; this crystal vibrates and produces high frequency sound waves (ultrasound). 
These longitudinal waves are capable of travelling through solids, liquids and gases and 
are therefore ideal for use within the body (Pope, 1999). Different tissues have their own 
opposition to sound waves; this is known as acoustic impedance (Pope, 1999). Such 
acoustic impedance is a consequence of 2 factors, the speed of the propagated sound 
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wave, and the density of the measured tissue. For example, bone has high acoustic 
impedance whereas air has relatively low impedance. The sound waves travel through 
the tissues until they reach a soft tissue interface which has different acoustic 
impedance; at this point reflection or transmission occurs (Whittaker and Stokes, 2011). 
Where a good acoustic match occurs, the sound waves will be transmitted and little 
reflection will occur. If there is a large mismatch then the sound waves are strongly 
reflected. The transducer detects the reflected sound waves and converts them into 
electrical current and produces an image (Jacobson and van Holsbeeck, 1998). Hence, in 
situations where there is a large acoustic mismatch, a bright image is produced 
(hyperechoic), and when there is a good acoustic match a dark image results 
(hypoechoic or anechoic). Examples of this are soft tissue- bone interface (hyperechoic) 
and soft tissue-soft tissue interface (hypoechoic) (Jacobson and van Holsbeeck, 1998; 
Pope, 1999). 
 
The depth of penetration of the ultrasound wave is dependent on the frequency of the 
transducer; higher frequencies penetrating more superficially than lower frequencies. 
However, there is a compromise, with lower frequencies which penetrate more deeply 
having poorer resolution than the more superficially penetrating ones. There are 2 types 
of resolution to consider; lateral and axial resolution. Lateral resolution is the ability of 
the beam to detect 2 objects side by side, with better resolution being able to detect the 2 
objects which are closer together (Pope, 1999). Higher frequencies and narrow beam 
widths enhance lateral resolution. Axial resolution detects the position of the 2 objects 
along the axis of the ultrasound beam, so is often termed depth resolution. Shorter pulse 
durations result in improved axial resolution, and since there are the same numbers of 
cycles in a single pulse, short wavelengths and hence higher frequencies give a superior 
axial resolution (Pope, 1999).  
 
A number of modes of ultrasound exist which are used for a variety of different usages. 
B mode or brightness ultrasound provides a real time 2 dimensional grey scale image 
and is commonly used in USI to diagnose lesions within a variety of soft tissues, but 
also in both rehabilitative USI and tissue motion analysis. More recently 3 and 4 
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dimensional versions of the B mode image are being utilised with increasing popularity, 
particularly for foetal scanning (Messing et al., 2007). M mode or motion mode is a 
modification of the B mode image. Changes in depth of the tissue can be calculated 
using a single beam tracked over time. It has been used successfully in measuring the 
valves in the heart (Pope, 1999). Doppler ultrasound scans were originally devised in the 
1950s in Japan where they were used to assess blood flow in the peripheral vessels, eye 
ball movements and heart movements (Sigel, 1998). Recent advances have provided an 
array of different modes of Doppler,  including colour, spectral and power Doppler, 
which all work on the Doppler shift principle (see below) which was originally used in 
radar.  
 
5.1.3 Safety of Ultrasound Imaging 
Ultrasound is considered to be a safe method of imaging structures of the body. In fact 
there have been no reported cases of safety breaches since the 1950s (Szabo, 2004). Two 
bioeffects of ultrasound are mechanical effects and thermal heating. Thermal heating is 
related to absorption of the energy produced by the movement of molecules subject to 
insonation. The loss of energy (attenuation) into the tissues, and therefore potential to 
heat tissues is greatest in higher frequency modes (Duck, 2008). The power of the 
ultrasound machine may determine the extent of the heating effect, since some of the 
heating effects are directly related to the heating effect of the transducer itself (Duck, 
2008). However the power and intensities of modern ultrasound machines mean that 
rises in temperature of more than 2° are extremely rare (Duck, 2008). In addition, 
heating of a large mass of tissue is prevented because the rise in temperature is broadly 
limited to within the constraints of the ultrasound beam, and depth of penetration in 
higher frequency prevents heating of more deeply located tissues. Another important 
factor in the consideration of heating tissues is the length of time that the transducer is 
stationary. Greater amounts of heating occur with longer scanning durations. Generally, 
in most scanning contexts, the transducer is only held in one position for seconds, and 
the risk therefore is further limited. 
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Another bioeffect of ultrasound is acoustic cavitation. Gas bubbles within fluid undergo 
marked changes when placed within an ultrasound beam, with expansion and 
contraction of the bubble during decreased and increased pressure components of the 
sonic wave (Duck, 2008). The bubble may become unstable when it contracts and result 
in collapse. However, the likelihood of acoustic cavitation occurring is extremely 
unlikely in most situations because there is an absence of free bubbles, and the pressures 
and frequencies used in modern day machines are low (Duck, 2008). Indeed according 
to the American Institute of Ultrasound in medicine, “there is no basis in present 
knowledge to suggest an adverse nonthermal bioeffect from current diagnostic 
instruments not exceeding the US FDA output limits” (Fowlkes et al., 2008 p 510). 
Greater risks occur in areas within the body where there are stabilised gas bodies, such 
as the lung or abdomen, and particularly where gas filled contrast agents are injected 
into the blood stream. These will not be considered further as they are not relevant to 
this thesis.   
 
5.1.3.1 Best Practice to minimise adverse effects of diagnostic ultrasound 
 
Guidelines for safe practice of diagnostic ultrasound have been published, and a 
principle is used which is the ALARA principle (Fowlkes, 2008), which means that the 
output used should be as low as reasonable achievable.  Two indices exist which help 
the operator to consider the likely thermal and non-thermal bioeffects. It has been 
recommended that the thermal indices (TI) be as low as possible, particularly in at-risk 
groups such as foetal or intracranial scanning, where absorption of ultrasound is high, 
and temperature increases have been demonstrated (Fowlkes et al., 2008). There is 
guidance as to the length of time that scanning should continue where TI are set and 
cannot be changed. According to the British Medical Ultrasound Society (BMUS) 
Safety guidelines (2009), TI of between 1 to 1.5 should be used for no longer than 120 
minutes, and as with all outputs, should aim to be in contact with the individual for as 
short a time as possible. The mechanical index (MI) relates to the potential for 
ultrasound to cause a non-thermal bioeffect. However, since the risk is so low in 
sonographic evaluation of most diagnostic applications (as discussed above), this may 
be less relevant (Fowlkes, 2008). 
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The Titan ultrasound machine (SonoSite Ltd, Hitchin, UK) which was used in both the 
repeatability and clinical studies in this thesis, has a TI of <1 and a maximum MI of 1. 
The transducer was held in position over the posterior thigh for 3 seconds, for each 
component of knee extension during the modified SLR movement sequence (a total of 3 
components).This falls well below the TI guidance by the BMUS (2009). The nerve and 
surrounding tissue that were scanned in these studies, do not fit within the guidelines for 
at-risk structures during ultrasound imaging with regards to non-thermal effects.  
 
All scans performed in the studies for this thesis were performed by the researcher who 
is an experienced Physiotherapist, and successfully completed an ultrasound module on 
the Medical Imaging MSc at the University of Leeds in 2006. Many hours of practice 
were required to enhance the researcher’s technique of USI the sciatic nerve in the 
posterior thigh prior to data collection. 
 
5.1.4 Measuring nerve motion with ultrasound 
 
Soft tissue motion has been measured with USI for some time. As the resolution of 
ultrasound transducers developed, the ability to scan peripheral nerves became more 
common place (Walker et al., 2004). The sciatic nerve has been successfully identified 
in the posterior thigh (Ellis et al., 2008; Graif et al., 1991) and the popliteal fossa (Ellis 
et al., 2008). It is described as being a homogenous tubular echogenic structure when 
scanned longitudinally and a round echogenic structure with interspersed echoes when 
scanned in its transverse view (Graif et al., 1991).  
 
An array of techniques have been developed to measure soft tissue excursion. These 
include Doppler (Hough et al., 2000, Hough et al., 2007), elastography (Lalitha et al., 
2011) and frame-by-frame cross correlation or speckle tracking (Coppieters et al., 2009; 
Dilley et al., 2001; Dilley et al., 2003; Ellis et al., 2008; Ellis et al., 2012).  
 
111 
 
 Doppler 
Doppler has predominantly been used in medical imaging to analyse the flow of blood 
through vessels pre and post-natally and to detect abnormalities in heart valves and 
blood vessels (Yagel et al., 2010). This technique utilises the Doppler Effect, where 
there is an apparent change in frequency when movement occurs between a source and 
observer (Pope, 1999). This change in frequency is dependent on a number of factors 
including the angle between the probe and the moving tissue, the speed of the moving 
tissue, and the frequency of the wave emitted from the ultrasound machine (Hough et 
al., 2000). Hough et al. (2000) developed a new method in order to use this technology 
to analyse nerve motion. One problem with the use of Doppler to analyse movement is 
that if the probe is held perpendicular to the nerve, the resulting Doppler shift and 
therefore velocity would be equal to zero. This is because the Doppler shift equation is : 
 
 =2vcos 
     c 
(where  = doppler shift,  = frequency of the source, v= relative velocity,  = angle of 
the ultrasound beam in relation to the moving structure and c = velocity of ultrasound 
waves in the body). 
 
Hence if  = 90°, cosine of 90 is zero. In order to limit this scenario from happening, 
Hough et al. (2007) added a beam steering angle of 15°, which reduced the angle 
between the nerve and the beam to between 45 and 60°. 
 
This method was utilised to analyse median nerve motion at the wrist in 37 
asymptomatic participants and 19 individuals with carpal tunnel syndrome (CTS) 
(Hough et al., 2007). Repeatability of the technique was performed on 5 participants 
over 3 occasions. Intraclass correlation coefficients (ICC) ranged from 0.58- 1 with a 
standard error of measurement (SEM) of between 0.012 and 0.49 mm depending on the 
position of the elbow, and if nerve or nerve/tendon ratio was analysed. The SEM of 
nerve movement was 0.32 mm with the elbow flexed and 0.49 mm with the elbow 
extended, which are small when compared to the mean longitudinal nerve movement 
found (4.2- 15.8 mm in the CTS group and 5.2 to 17.4 mm in the control group).  
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One issue with the use of this technology is the fact that velocity of the moving tissue 
needs to be sufficiently high enough in order for the Doppler shift to be accurately 
calculated. Very low velocities would result in negligible values for the Doppler shift. 
High velocity movement may be less appropriate in situations where symptomatic 
individuals are being moved into potentially pain provocative positions. Slower 
movements of the limb mean that the position can be stopped early in range if symptoms 
prevent further movement.  
 
Elastography 
One method that has shown great potential in estimating tissue strain is elastography. 
This method is based on the premise that applying a force to a tissue results in a 
returning force which enables one to ascertain the resulting stiffness of the underlying 
tissue. This method has been utilised by applying pressure to tissue with an ultrasound 
probe and analysing the echo signals obtained before and after the compression is 
applied using frame-by-frame cross correlation methods described below (Varghese et 
al., 2000). This method has been used successfully in detecting tumours, as they are 
harder than other soft tissue (Krouskop et al., 1987) and as such the strain exerted by the 
underlying tissue and detected by cross correlation is higher than in normal tissue. More 
recently elastography has been used to help to diagnose soft tissue lesions such as 
tendinopathy (Drakanoni et al., 2009; Lalitha et al., 2011). 
 
This technique appears to be a robust method of analysing axial tissue strain in response 
to a compressive load (Varghese et al., 2000). Promisingly, longitudinal excursion and 
strain of tendon has been accurately measured using elastography on dissected porcine 
flexor tendons (Chernak and Thelan, 2012). However this very new technique has not 
been assessed in vivo on nervous tissue, although it has great potential for nerve 
deformation studies in the future.  
 
Frame-by-frame -cross correlation method 
In studies looking at changes in muscle, excursion has been calculated by comparing the 
movement in relation to other structures because of the heterogeneous nature of 
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muscular structures.  For example, Fukunaga et al., (1996) were able to calculate 
longitudinal motion of tibialis anterior by identifying and comparing the muscular tissue 
with the musculotendinous junction. However, as explained earlier, nerve in its 
longitudinal section is broadly a homogenous tubular echogenic structure, and as a result 
there are no distinctive points along the nerve with which to compare movement. Hence, 
another method is required to assess longitudinal excursion of the nerve during 
movement of the limbs. 
 
 The cross correlation method is a form of “speckle tracking” which utilises the speckled 
grey pattern, which is interference of echo signals from within the tissue (Anderson and 
McDicken, 1999). This speckle is relatively consistent between frames of images, and as 
such can be followed as the tissue moves (Anderson and McDicken, 1999). Various 
software has been developed to analyse the amount of movement using this 
mathematical method. Once the moving image is saved, a series of regions of interest 
(ROI) are selected on the image. These ROI can vary in shape and size, and are selected 
by the researcher. Each ROI contains a portion of the image and has a unique number of 
grey scale pixels. There are advantages and disadvantages of different sizes of ROI. A 
large ROI will contain a less equivocal, but still distinctive pattern, but may not be able 
to follow the nerve so well if there is a large deformation during the movement. A small 
ROI might have a more indistinct pattern, but is better able to continue to track with 
larger nerve deformation (Korstanje et al., 2010). Some authors have recommended 
particular sizes of the ROI, for example to measure carotid artery wall motion, a ROI of 
3.2 X 2.5 mm² was found to be optimal (Golemati et al., 2003). To the present author’s 
knowledge, no specific recommendations have been made as to the specific size of a 
ROI for measuring nerve motion. Dilley et al., (2001) used ROI between 500 X 30 
pixels to cover most of the median nerve, or multiple ROI of ~ 80 X 30 pixels where the 
nerve was obliquely orientated. However, no attempt was made to assess the accuracy of 
different sizes of ROI. Ellis et al. (2008) used the same software programme as Dilley et 
al., (2001) to establish the reliability of the technique in measuring sciatic nerve motion, 
however the authors did not comment on the best size of ROI to use. However, 
Korstanje et al., (2010) used software which allowed the use of multiple concurrent 
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ROI, and used the ROI size with the best match, demonstrated by the highest correlation 
(see below). Such software is not routinely available, and therefore it is pertinent to use 
a number of ROI of varying shapes and sizes.  
 
The cross-correlation procedure works by the software recognising the region by its grey 
scale; each pixel is assigned a specific number based on its brightness (or echogenicity), 
from 0 (black) to 256 (white). For each successive frame, the programme identifies this 
same area and calculates the amount that the region has moved by offsetting the co-
ordinates of the ROI along the horizontal image plane, and shifting them one pixel at a 
time; the pixel shift (Dilley et al., 2001). A correlation coefficient is calculated for each 
pixel shift. The pixel shift that has the highest correlation coefficient is identified as the 
“true” value. Dilley et al., (2001) noticed that comparisons of sequential frames resulted 
in an underestimation of movement, and therefore recommended that analysis is 
performed on every other frame, however this is dependent on the speed of movement in 
relation to the frame rate (Korstanje et al., 2010). The output of the analysis produces 
the vertical and horizontal movement, and the overall horizontal movement from these 
two values, in addition it provides this for each ROI and an average for all of the ROI. A 
useful aspect of the programme is that it is possible to observe the movement of each 
area for each successive frame and ensure that all areas appear to be following the nerve 
appropriately.  
 
Dilley et al., (2001) found that the method of frame- by- frame cross correlation was 
accurate in assessing nerve excursion in a number of string and avian phantoms (n= 
unknown) and control subject (n=1), and repeatable in 10 control participants.  The 
string and avian sciatic nerve phantoms were fixed within a water bath and the bath 
moved a set distance by a chart recorder, whilst simultaneously collecting series of 
ultrasound images. The control participants placed their forearm in a water bath and the 
transducer was moved a known distance over the forearm whilst the median nerve was 
imaged. 
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For repeatability, the median nerve was imaged longitudinally 6-12 cms proximal to the 
wrist crease during extension of the wrist in 3 participants, and during index finger 
extension in 7 participants. The movements were performed between 3-4 times, and for 
wrist extension one subject returned 5 days later for a repeat of the procedure. 
Movements performed at very low velocities of < 0.25mm/sec were not accurately 
estimated.  
 
Error measurements were found to be less than 10% of the overall excursion. With 
regards to repeatability, the average median nerve movement between the two trials on 2 
separate days in one subject varied less than 10% during passive wrist extension. The 
authors considered that variability was low as standard deviations varied between 0.2-
0.4 mm for within session readings for wrist extension, and between 0.16 and 0.67 mm 
during the passive index finger extension. Average nerve excursion for wrist extension 
was between 2.85 and 3.74 mm and for index finger extension was between 1.38 and 
4.48 mm.  
 
The technique described by Dilley et al. (2001) has enriched the field of nerve motion 
research. A number of studies have used this method to assess changes to nerve motion 
in groups of individuals (Dilley et al., 2003; Dilley et al., 2008; Erel et al., 2003), and to 
assess how different types of neurodynamic exercises can influence the amount of nerve 
motion (Coppieters et al., 2009; Ellis et al., 2012). However, there are limitations of the 
original study which must be taken into account. Firstly, the numbers of phantoms used 
was not disclosed making the use of statistical methods impossible. Limited numbers 
were used for the repeatability study and more robust reliability statistics such as ICC or 
SEM were not used, which would have given more critical values to estimate the errors 
of measurements that may occur using this technique. 
 
More detail was given by Coppieters et al., (2009) who found excellent reliability of the 
technique for assessing median nerve excursion at the proximal humerus (ICC 0.96, 
SEM 0.66mm, smallest detectable differences (SDD) 1.84mm). However, some lower 
limb nerves, such as the sciatic nerve, are deeper, and the image may have poorer 
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resolution. Ellis et al., (2008) assessed the reliability of measuring sciatic nerve motion 
in the back of the thigh and behind the knee using the same frame-by-frame cross-
correlation method as Dilley et al., (2001) devised. The sciatic nerve was imaged with 
participants in sitting with the knee flexed to 50°, whilst participants extended their 
cervical spine and their ankles were passively dorsiflexed.  
 
Mean longitudinal nerve excursion of 3.47 mm was seen at the posterior thigh with an 
ICC of 0.75 and SEM of 0.79 mm, indicating good reliability and relatively low error 
measures. Longitudinal movement of the nerve behind the knee could only be recorded 
in 3 participants because the nerve moved beyond the field of view and therefore could 
not be further analysed. Whilst the study helps to support the technique for analysing 
sciatic nerve excursion in the posterior thigh, the movements of the nerve were small 
because the moving joint was distant from the site of imaging. If the knee or hip had 
been moved, greater amounts of sciatic nerve excursion at the posterior thigh would be 
expected since the nerve will follow the moving joint. This may explain why Ellis et al., 
(2008) found scanning behind the knee, (closer to the moving ankle) more difficult, and 
means further work is required to establish repeatability of the technique when nerves 
closer to the site of movement are analysed. 
  
Transverse plane nerve movement 
Whilst longitudinal nerve excursion has been successfully analysed by the Doppler and 
frame-by-frame cross correlation methods, transverse plane movement (i.e. superficial 
and deep, and lateral/medial) has had limited attention. Most studies have measured 
longitudinal movements, and where measurements of transverse plane motion have been 
used, no reference to reliability or error measures have been cited (Erel et al., 2003). 
However, more recently (Boyd et al., 2012)  used a method which has been shown to be 
reliable for transverse plane tibial nerve excursion at the knee.  
 
The method consists of importing the transverse image sequence into image J and 
manually outlining the border. The most central pixel (centroid) of the nerve can be 
identified by the software, and movement is calculated by comparing the centroid value 
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in last frame to that in the first frame. Boyd et al., (2012) found the reliability of the 
technique to be high for the tibial nerve behind the knee (ICC (SEM) 0.97 (0.42mm), 
0.98 (0.47mm) for med/lat and sup/deep respectively) during ankle dorsiflexion. 
However, the tibial nerve is more superficial than some other lower limb nerves such as 
the sciatic nerve, and since resolution may be poorer it is not known if the technique is 
robust for all nerves.  
 
5.1.5 Summary  
 
This section has reviewed the use of USI to analyse nerve excursion. At the current 
time, frame-by-frame cross correlation appears to be the most robust method of 
assessing nerve excursion in vivo. Transverse plan nerve motion however has only 
recently been investigated, using a potentially reliable technique. 
 
Analysing nerve excursion before and after a neurodynamic treatment reveals one aspect 
of a treatment effect, but since studies have suggested potential changes to pain and 
nerve conduction (chapter 4), appropriate methods of measuring these 2 outcomes are 
necessary. The following two sections will evaluate methods of assessing pain and nerve 
conduction. 
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5.2 Methods of assessing nerve conduction 
  
5.2.1 Introduction 
 
Patients with neuropathy are commonly diagnosed by electrodiagnostic tests, such as 
sensory and motor nerve latency and nerve conduction velocity tests. However, these 
tests may be inconclusive in conditions where a number of nerve fibres continue to 
function, and thus propagate an action potential (Greening and Lynn, 1998). This has 
been demonstrated in both clinical studies (Atroshi et al., 2003; Finsen and Russworm, 
2001) and in animal studies. Yoshizawa et al. (1995) found that nerve conduction 
velocity did not alter until 6 months after a silicone tube was inserted around the 7th 
lumbar nerve root in dogs despite marked changes to the large diameter afferent nerves 
after just 3 months.  In a clinical study, Finsen and Russworm (2001) found that 14 out 
of 63 patients with successful outcome post-decompressive surgery for carpal tunnel 
syndrome had negative electrodiagnostic tests prior to the surgery. Atroshi et al., (2003) 
found that nerve conduction studies had low positive predictive values for individuals 
with carpal tunnel syndrome.  
 
Due to such poor ability to detect the presence of alteration in nerve conduction in 
individuals with confirmed neuropathy, such tests are unlikely to be useful in showing 
changes in individuals with neuropathic low back pain. Quantitative sensory testing 
(QST) protocols for diagnosis of neuropathic pain have been supported by a number of 
authors (Felix and Widertröm-Noga, 2009; Rolke et al., 2006). The battery of tests 
which are used in the overall protocol are extensive (7 tests measuring 13 parameters), 
and take around 30 minutes to test (Rolke et al., 2006). In addition, the equipment which 
is required to fully investigate all parameters is expensive, and not widely available. In 
addition, QST protocol aims to test if individuals are suffering from neuropathic pain, 
rather than testing solely for nerve conduction, although some of the individual tests also 
assess conduction. 
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Vibration threshold testing (VTT) is one of the measures used in the QST protocol. It 
has been proposed as a measure for identifying individuals with common entrapment 
neuropathies such as carpal tunnel syndrome and work related upper limb disorders 
(Greening and Lynn, 1998; Greening et al., 2003; Tucker et al., 2007) and is a measure 
of the large diameter afferent nerves, the A beta fibres. It consists of applying a 
vibrating probe to the surface of the skin and the individual being tested informing the 
tester when they feel the sensation of vibration. It has been used in a number of 
conditions such as work related upper limb disorders (Greening and Lynn, 1998), carpal 
tunnel syndrome (Dellon, 1981; Lundborg, 2004), diabetes (Goldberg and Lindblom, 
1979), compartment syndromes (Phillips et al., 1987), and to assess changes in nerve 
conduction after neurodynamic mobilisation (Ridehalgh et al., 2005). It is considered to 
be a useful tool in the early diagnosis of a neuropathic condition, as it assesses the 
function of the large diameter afferent fibres (Aβ) which are postulated to be the first 
fibres to show dysfunction after neural compromise (Dahlin et al., 1989; Fink and 
Cairns, 1982). In addition, most animal studies that have assessed changes to the nerve 
root and dorsal root ganglion post trauma have found greatest changes to the large 
diameter afferent nerves, and greatest pain behaviours to mechanical stimuli rather than 
thermal stimuli (Hou et al., 2003; Kawakami et al., 1996; Obata et al., 2002; Omarker 
and Myers, 1993). Further, individuals with radicular leg pain were found to have a 
disruption in the large diameter fibres (as tested with VT) but not the small diameter 
fibres (Freynhagen et al., 2008). 
 
The use of a test to assess the function of the nerves after a neurodynamic intervention is 
useful for a number of reasons. Firstly, patients with neuropathic pain may already have 
deterioration in nerve function. It has been suggested that neurodynamic treatment may 
improve axoplasmic flow, blood flow and thus encourage dispersal of oedema 
(Coppieters and Butler, 2008; Nee and Butler, 2006). Such improvements could 
theoretically reduce the compression on the nerve and help to restore normal function, 
and VTT may help to capture this change. 
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In contrast, if strain over 8% is imposed on the nerve and the vessels which supply the 
nerve during the neurodynamic treatment technique, deterioration in blood flow may 
occur (Driscoll et al., 2002; Lundborg and Rydevik, 1973). If strain exceeds 12% then 
nerve conduction may deteriorate (Kwan et al., 1992). It is difficult to assess if such 
strain values occur during a technique like the SLR as strain of the sciatic nerve during 
the SLR has been found to vary between 6 and 26% (Boyd et al., 2013; Coppieters et al., 
2006; Fleming et al., 2003). However, there may be an increase in strain values when 
the nerve is injured (Boyd et al., 2005).  
 
An elevation of VT suggests deterioration in nerve function of the Aβ fibres, and such 
rapid changes if they occurred after a neurodynamic mobilisation, would likely to be 
caused by a reduction in circulation (Ochs et al., 2000). It is unlikely that structural 
changes or increased oedema would occur immediately after the technique. In a study 
looking at the effects of a longitudinal SLR treatment using repeated ankle dorsiflexion 
(3 x 60 secs) with the leg in SLR , no changes were found to VT in both control 
participants and participants who ran greater than 20 miles per week (Ridehalgh et al., 
2005). Runners are considered more at risk of injury to the peroneal nerve due to 
repeated movements of the foot and ankle, and the high incidence of ankle sprains in 
this group of individuals (Fabre et al., 1998; McCrory et al., 2002; Pahor and 
Toppenberg, 1996). The study results (Ridehalgh et al., 2005) suggested that even in 
more at-risk groups, SLR assessment and treatment is not detrimental to nerve function. 
However, only 10 runners and 20 control participants were recruited to the study, 
therefore it is possible that such low numbers may have resulted in the non-significant 
changes. In addition, none of the participants were currently complaining of symptoms, 
and therefore it is not known if individuals with symptomatic neuropathy would behave 
in the same way.  
 
As with all outcome measures, the analysis of the robustness of the technique is crucial 
in order to ensure that any change is attributed to the intervention and not because of 
variability in measurements between testing sessions. This chapter will assess the 
validity, repeatability and factors which may compromise VTT.  
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5.2.2 Validity of Vibration threshold testing 
 
The validity of the technique has been considered in older observational studies (Dellon 
et al., 1980; Phillips et al., 1987), and in combination with other sensory tests for 
diagnosis of neuopathic pain (Rolke et al., 2005; 2006). VTT was found to be 
diminished in 9 out of 11 patients with suspected compartment syndrome (Phillips et al., 
1987). On testing the pressure within the compartments, 9 out of 11 patients had an 
elevated pressure, and all of these patients had elevated VT. A further study in 12 
healthy participants subjected to an experimental increase of up to 35-40 mm Hg in their 
lower leg by the means of an inflated pneumatic antishock garment had elevations in VT 
(Phillips et al., 1987). Participants also complained of numbness and change to sensation 
in the distribution of the deep peroneal nerve which matched the VT loss. The results of 
this study suggest that in situations where nerve function was altered by marked 
compression, VT was not only sensitive (i.e identified correctly all nerve dysfunctions), 
but also specific, since 2 out of the 11 patients with suspected compartment syndrome 
who did not have elevated pressures were found to have normal VT. The small sample 
sizes, and lack of statistical methods do limit the extrapolation of the results, but show a 
clear link between an elevation in VT and deterioration in nerve function. 
 
 In agreement, Dellon et al., (1980) looked at the use of  VT to diagnose nerve 
dysfunction in people with different causes of nerve injury including 56 patients with 
direct nerve injuries (e.g. nerve divisions and neuromas) and 61 with compression 
injuries (e.g. crush, CTS). Following on from VT, additional tests were performed to 
analyse the construct validity of VTT. Surgical exploration was performed on the acute 
nerve injuries (n =47). In all cases where VT was elevated, there was evidence of nerve 
injury. In addition, VT was found to closely follow the stage of injury in 3 burns 
patients. One, who had normal VT on admission, subsequently developed marked 
swelling and inflammation and deterioration in VT. After escharotomy VT returned to 
normal. Whilst these studies are more observational and therefore not conclusive in 
terms of validity, they suggest that VTT is a clear indicator of deterioration in nerve 
function. 
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Construct validity of VTT was examined in 78 individuals with diabetes (Valk et al., 
2000), by comparing the VT with sensory dimensions on the Diabetes symptom 
checklist-Type 2 (DSC-2). Examples included tingling or strange sensations in the hands 
and legs. The authors concluded that the use of VTT was valid for the assessment of 
sensory changes in individuals with diabetes. However Pearson’s correlation, whilst 
statistically significant (0.02 and 0.04 for foot and hand respectively), was only 0.3 and 
0.26. An r value of 0.3 represents only a moderate correlation (Cohen, 1992), and 0.26 
suggests a weak to moderate correlation.  
 
A higher correlation (r=0.447) was found by comparing composite nerve conduction 
tests to VTT in 247 individuals with diabetes (Burns et al., 2002). One potential issue 
with this study is that the nerve conduction studies themselves may not be accurate in 
individuals with early stages of neuropathy caused by diabetes, since the intact axons 
may continue to propagate the signal as discussed above.  
 
Whilst this raises some questions over the absolute validity of VTT, a plethora of studies 
have demonstrated elevations in VT in discrete groups of individuals with neuropathy 
including carpal tunnel syndrome (Borg and Lindblom, 1986; Winn and Putz Anderson, 
1990), work related arm pain (Greening and Lynn, 1998, Greening et al., 2003), 
compartment syndromes (Dellon et al., 1980), diabetes (Martina et al., 1998; van 
Deursen et al., 2001), and polyneuropathies from a number of causes (Martina et al., 
1998). These indicate that elevations in VT are an indicator of conduction changes that 
occur due to dysfunction of the nervous system.   
 
There are a number of considerations when using VTT, which must be taken into 
account to ensure repeatable, accurate testing, these will be discussed below. 
5.2.3 Methods of testing vibration thresholds 
 
There are a number of approaches used for testing VTs. The mode that appears to be 
most commonly used is the method of limits (Greening and Lynn, 1998; Greening et al., 
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2003; Hilz et al., 1998; Martina et al., 1998; Ridehalgh et al., 2005). This method 
consists of the subject informing the tester when they first feel the onset of a sensation 
of vibration as the stimulus is gradually increased, called vibration perception (VP), and 
then to let them know when the sensation disappears as the stimulus is first increased 
above VP, and then gradually decreased (vibration disappearance (VD)). Generally three 
measures of each are taken, and a mean of the 6 readings taken to give a value of 
vibration threshold (VT). One of the issues with such a method is that there is a reaction 
time consideration, as the stimulus continues to rise whilst the subject becomes aware of 
the sensation of vibration (Yarnitsky, 1997). The idea of using both perception and 
disappearance is that there will be a delay in true perception and also in disappearance, 
so using a mean of the two, aims to cancel out the reaction time component (Hilz et al., 
1998).  
 
Another method for testing VT, called the method of levels which excludes reaction 
time, delivers a pre-set stimulus and the subject is asked to inform the tester if they can 
feel vibration or not. If not, the stimulus is doubled until a yes is given, before reducing 
the stimulus by half until the participants says they can’t feel it anymore. This continues 
to be raised and decreased until the step between yes and no is within a predetermined 
range. The mean of the last yes and no is taken as the VT (Yarnitsky, 1997). The 
advantage of this method is that it excludes the issue of reaction time, although it can 
take considerably longer to test. In addition, this method of using discrete sensory 
stimulus increments appears to be more commonly used for thermal thresholds 
(Yarnitsky, 1997). Only one paper describing the method of levels for VTT was 
identified in this review (Hagander et al., 2000), and this may restrict comparisons 
between studies. The specific method of attaining VT is important when assessing 
studies because direct comparison between vibration thresholds cannot be made, as ones 
using method of limits, even with a mean of VP and VD, are likely to be higher than 
those using method of levels (Yarnitsky, 1997). 
 
Whilst the method of limits is used more commonly, it has been suggested that simply 
taking VP is as accurate as taking the mean of both VP and VD to produce VT 
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(Goldberg and Lindblom, 1979; Hilz et al., 1998). Goldberg and Lindblom (1979) found 
that VPT correlated well with VT, and better than VDT in 110 healthy male volunteers. 
However this was established by assessing the correlation between VDT and VT, and 
VPT and VDT; i.e. no figures were given for VPT and VT. In addition, only male 
participants were used, and as it has been shown that VT differ between men and 
women (Halonen, 1986; Hilz et al., 1998), it is unclear from this study alone if this trend 
would be the same in women. 
  
Hilz et al., (1998) found that all three measurements (VT, VPT and VDT) were closely 
correlated in a study of 530 healthy participants with a large variation in age range (3-79 
years). This was apparent regardless of age or gender, suggesting that any of the three 
measurements would be acceptable.  
 
Whilst the method of limits is likely to yield most accurate and comparable results to 
other studies, other factors may affect VTT.  
5.2.4 Factors affecting vibration thresholds 
 
There are many factors which may influence VT including gender, age, site tested, 
medication, temperature, and intake of substances such as caffeine or alcohol; these will 
be discussed in turn. 
 
Gender and age 
 
As mentioned, some studies have demonstrated a difference between men and women, 
but this is not consistent between studies. Hilz et al., (1998) found a difference in VT 
measured at the 2nd metacarpal and 1st metatarsal between men and women, but only in 
ages above 50 years. Halonen et al., (1986) also demonstrated that with increasing age, 
men’s VT deteriorated more than women’s in a study on 202 participants tested at the 
dorsum of the 1st metatarsal, although the age where this occurred was not specified. A 
limitation of this study was that it was not clear if participants had been asked to refrain 
from medication or caffeine, which could influence VTs (Gregg, 1952). 
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 In contrast, Martina et al., (1998) only found a difference between men and women in 
one site; the medial malleolus whereas the other sites (index finger, ulnar styloid and 
great toe) did not show a difference between gender, even with increasing age. The 
method of testing VT was different in this study, in that a Rydel-Seiffer tuning fork was 
used, however this study also compared the tuning fork to a vibrameter and reported that 
the two correlated well (Spearman Ranks correlation coefficient 0.46 index finger and 
0.65 big toe in asymptomatic group, and 0.46 and 0.71 respectively in a polyneuropathy 
group).  
 
Although these studies together do not conclusively support the difference between men 
and women in all sites tested, most have demonstrated that VT deteriorates with age. 
These studies combined suggest such changes start at about the age of 40 years, but 
whilst they continue to deteriorate with age, they are still useful measures as long as age 
related corrections are applied (Hilz et al., 1998).  
 
Choice of test site 
 
A variety of testing sites are used in the literature, but most testing is performed on the 
hand or foot (Greening and Lynn, 1998; Hagander et al., 2000; Halonen, 1986; Hilz et 
al.,1998; Martina et al., 1998; Phillips et al., 1987; Ridehalgh et al., 2005). Higher VT 
have been demonstrated in the feet than the hands (Hilz et al., 1998; Martina et 
al.,1998), with the difference being more apparent with age (Goldberg and Lindblom, 
1979). Such elevations may be due to either a difference in the number of 
mechanoreceptors between the two areas, or because the neural pathways are longer in 
the lower limb than arm, and therefore action potentials have further to travel (Hilz et 
al., 1998).  
 
Differences in VT have been found between bony sites and soft tissue sites (Hagander et 
al., 2000). VTs were tested on the pulp, dorsum and middle phalanx of the index finger 
and dorsum of proximal phalanx and nail of the great toe. At the index finger the pulp 
had lower VTs than the nail, but no differences were found in the great toe. In addition 
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the narrowest percentile range was at the pulp followed by the phalanx and least at the 
nail in the index finger, suggesting that there is less variability in the readings at the 
pulp. No differences were found between sites at the great toe. Such differences between 
sites may be due to dampening of the vibration by soft tissue. However it has been 
found that even bony surfaces have differing dampening effects (Goldberg and 
Lindblom, 1979). The tibia was found to have greater dampening than the metatarsals, 
and the carpal bones had the least dampening of the three sites.  
 
Other Parameters 
 
Pressure exerted 
 Depending on the type of vibrameter used, it is possible to apply different amounts of 
pressure during vibration testing. Hagander et al. (2000) found that vibration thresholds 
were not statistically different between 3 different levels of pressure (30, 50 and 100g) 
in the foot.  However, VT was significantly lower measured at 30g in the hand. The 
Somedic vibrameter which has been used in a number of studies assessing changes to 
VT in individuals with neuropathy (Greening and Lynne, 1998; Greening et al., 2003) 
uses a standardised pressure of 650g. Hagander et al. (2000) suggested that pressures 
over 100g were considered uncomfortable in some participants, therefore the comfort of 
participants should be assessed when using this instrumentation for VT testing.  
 
Temperature 
Skin temperature may have an effect on VT. Halonen (1986) found that temperatures 
below 20° centigrade significantly elevated VTs in men (compared to men’s baseline 
measures), but not in women. Warming does not seem to affect VT (Hilz et al. 1998) in 
temperatures up to 34°. However, both of these measures were carried out under 
artificial conditions; the cooling was imposed by putting the hand into ice and then 
measuring the VT every 0.5° rise, and the warming study by heating with an infra-red 
lamp. It is not clear if systemic rather than localised heating or cooling would have the 
same effect.  
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Medication 
No significant changes to VT occurred 30, 60 and 90 minutes after ingestion of 
diazepam, but the spread of values increased considerably, suggesting that there was 
more variability in readings after diazepam (Meh and Denislic, 1995). At 90 minutes, 
this variability reduced to similar ranges as before ingestion. The authors recommend 
that ingestion of diazepam should be avoided prior to testing, but do not give a specific 
time frame for this, however their results suggest that taking diazepam greater than 1 ½ 
hours prior to testing may be acceptable. This part of the study was only conducted on 6 
normal individuals, which may explain the lack of significant data, and may warrant 
caution over time frames after which it is appropriate to test VTs.  
 
Both caffeine and aspirin were found to have an effect on VTs (Gregg, 1952). 
Participants were found to have a reduction in VT with caffeine intake, whereas aspirin 
tended to increase VT. Fifty three participants showed a marked reduction in VT 
(between 66-82% change from pre-ingestion) after taking caffeine, whereas aspirin 
elevated VT by around 70% in 70 participants. A placebo group was apparently used, 
although not all of the results were presented, and it did not appear that any statistical 
testing was performed between the placebo and intervention groups or between pre and 
post injection figures. Bearing these limitations in mind, the study suggests that there 
may be a trend for increases in VT post aspirin intake and decreases in VT post caffeine 
intake. The length of time that VT remained reduced after caffeine intake was not clear, 
as only data for 2 participants, who had taken a combination of both caffeine and 
aspirin, was presented. As caffeine and aspirin had opposite effects on VT the length of 
time shown (approximately 60 minutes) may not be reliable. VTs, after ingesting aspirin 
alone, remained elevated after 120 minutes. No studies have been found in the literature 
that have assessed the effects of non-steroidal inflammatory medication or paracetamol 
on VT, but based on the effects of aspirin it is possible that these types of medication 
may also have an effect on VT. 
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As there is a lack of robust information on length of time that VTs may be affected, it is 
pertinent to ask individuals to avoid caffeine or taking any pain medication for 24 hours 
prior to VT testing.  
 
Alcohol  
The effects of the use of alcohol are somewhat unclear due to the limited literature and 
different methodology used. It has been demonstrated that there is a strong correlation 
between individuals with high levels of alcohol intake and an elevation in VT (Melgaard 
et al., 1986). Whilst this suggests that alcohol may affect VT, these were individuals 
who had sought help for an alcohol addiction or had major signs of alcohol abuse. It is 
not clear if simply drinking alcohol prior to testing VTs would affect the results in some 
way. Another study (Sosenko et al., 1989) found that occasional use of alcohol did not 
affect VT, however it was not disclosed how this information was sought, nor how long 
prior to testing the participants had drank the alcohol. 
 
Whilst there is limited evidence as to the effects of alcohol on VTs, it may be pertinent 
for individuals to avoid alcohol for 24 hours prior to testing. 
5.2.5 Retest Reliability 
 
A number of studies have demonstrated that VT measurements are reliable. Hilz et al. 
(1998) found substantial short term repeatability in 530 asymptomatic individuals 
(Spearman 0.87<Rs<0.99). Unfortunately the time frame of this short term re-test was 
not specified. Longer term repeatability was correlated, but to a lesser degree 
(0.43<Rs<0.59). This reflects a moderate, but not substantial relationship. In addition, 
whilst this gives an idea of the relationship, it does not indicate the error within the data, 
and so the measures on the 2 occasions may correlate well against each other, but there 
may be a large variability in measurement (Bland and Altman, 1986). Such variability 
would impact on responsiveness of the measure to detect clinically meaningful change 
and may lead to either very large sample sizes being required or null hypotheses being 
incorrectly accepted.  
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Halonen (1986) found no significant difference between successive tests of VT 
measured at the great toe and tip and metacarpal bone of the index finger in 202 
participants (p>0.1) analysed with paired T tests. However, this is not the best way to 
ensure repeatability; it only indicates that they are not statistically different from each 
other, and provides no detail about measurement error (Bland and Altman, 1986). 
 
A more robust study, in terms of choice of statistical analysis looked at reliability in a 
small sample of asymptomatic participants, and a group of patients with spinal cord 
injury and neuropathic pain (Felix and Widerström-Noga, 2009). There were only 10 
participants in each group, but even with such low numbers the repeatability of 
measures is of relevance, poor agreement can still be ascertained in small sample sizes, 
and likewise for good agreement. Using the mean of 3 VPTs over 8 different sites in the 
upper limb, trunk and lower limb resulted in ICCs of 0.86 (95% CI 0.45-0.76) for the 
asymptomatic group and 0.9 (95% CI 0.84-0.94) for participants with spinal cord injury, 
showing substantial reliability. More credence could have been given to the study if 
additional methods such as Bland Altman and SEM had been undertaken, but such 
strong ICCs and small confidence intervals (especially for the spinal cord injury group) 
indicate that VTT is a reliable method  to use in patients with neuropathic pain. 
 
Slightly lower correlations (r=0.77) for repeatability of VTT were found for 78 
individuals with diabetes (Valk et al., 2000). Importantly SDD values were given, and 
found to be in the region of 9%, indicating that changes greater than 9% would be 
needed in future studies to ensure that the changes were attributed to a treatment effect. 
 
The studies discussed suggest that reliability of VTT is acceptable. However, the 
technique is operator dependent and therefore it is essential to assess researchers’ 
repeatability measurements prior to any intervention studies.  
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5.2.6 Summary  
 
VTT appears to be a robust method of assessing the function of large diameter afferent 
nerves. However, there are a number of factors that must be taken into consideration 
when testing this sensory modality; the most important being age of the subject, the 
choice of method of ascertaining the VT, and the effects of any medication and other 
stimulating substances. With regards to age, VT starts to deteriorate in men after the age 
of 40, therefore when participants in studies using VT as an outcome measure are over 
40 years of age, age adjustment methods are necessary.  The method of limits (mean of 
three vibratory perception and three vibratory disappearance) appears to be an accurate 
method for ascertaining VT.  
 
5.3 Pressure Pain Thresholds 
 
5.3.1 Introduction 
 
Individuals seeking treatment for painful conditions predominantly seek to relieve their 
pain. Therefore measurements which assess changes in pain perception are essential in 
order to assess for a treatment effect. There are many methods of assessing pain 
including the use of pain scales, and indirectly by measuring the function of small 
diameter pain fibres with responses to hot and cold (Lautenbacher et al., 2005). All of 
these measures have their advantages and disadvantages, but one disadvantage of using 
pain scales such as the numerical pain rating scale is in studies where participants all 
receive the same intervention, and cannot therefore be blinded to a treatment 
intervention. Here, participant bias may lead to inflated improvement in pain measures. 
Measuring the function of small diameter fibres requires time consuming and expensive 
equipment (see QST in 5.2.1), and may have limitations for research because of these 
reasons.  
 
An increasing number of studies assessing effectiveness of manual therapy techniques, 
have used a measure which evaluates the change in response to the first onset of pain 
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caused by the gradual build-up of pressure (De-La-Llave-Rincon et al., 2012; Krouwel 
et al., 2010; Moss et al., 2007; Sterling et al., 2000; Willett et al., 2010). Pressure pain 
thresholds (PPTs) have been shown to be repeatable (Antonaci et al., 1998; Persson et 
al., 2004; Sterling et al., 2000), but are subject to within subject variability (Rolke et al., 
2005). 
 
Of particular relevance to this thesis, patients with nerve pain have been found to have 
increased mechanosensitivity to both movement and palpation of the affected nerve 
trunk (Fidel et al., 1996; Schäfer et al., 2009; Sterling et al., 2000), and PPTs have been 
used to assess such tenderness to palpation. In addition, PPTs have been found to be 
affected by manual therapy both local and distant to the site of treatment, suggesting that 
there are both segmental and systemic inhibitory mechanisms at play (Krouwel et al., 
2010; Moss et al., 2007; Sluka et al., 2006; Willett et al., 2010). The following section 
evaluates the literature relating to testing PPTs with standardised algometers. 
5.3.2 Reliability and validity of measuring pressure pain thresholds 
 
The construct validity of the Wagner Force one algometer has been assessed by 
comparison to a force plate (Kinser et al., 2009). The algometer was placed in the centre 
of the force plate and the reading on the algometer was compared to the force plate 
output. Highly significant Pearson’s correlation (r=0.99) was found between force 
platform readings and the algometer. This demonstrates that this algometer accurately 
measured the pressure applied, but the authors’ claim that this demonstrates validity is 
not correct, since force plates are not used as a measure of pain. However, whilst the 
validity cannot be assumed from this study, it is well established that if you press on an 
area of the body hard enough, this will trigger polymodal nociceptive endings, and 
produce a sensation of pain (Dafny, 2000). Although, the amount of pressure that is 
required to produce such a response is variable between individuals, and subject to many 
factors. These will be discussed later in this section. 
 
A number of studies have looked at the repeatability of measuring PPTs and found that 
both inter and intra tester reliability is good to excellent (Antonaci et al., 1998; Persson 
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et al., 2004; Sterling et al., 2000; Vanderweeën et al., 1996; Walton et al., 2011). The 
earliest of these studies (Vanderweeën et al., 1996), measured the PPTs in 14 trigger 
points around the shoulder and spine, and found an ICC of between 0.64-0.96 (intra 
tester). This indicates substantial to excellent reliability (Fleiss, 1986); unfortunately no 
CI, SEM or SDD were given which limits the appreciation of the error size during such 
measurements. In addition, only one PPT for each site was tested, which is not normal 
practice, and it has been found that the first PPT is significantly different on the first 
reading to subsequent readings (Kosek et al., 1999; Persson et al., 2004). Higher ICC 
values were found by Antonaci et al. (1998) for intra tester reliability of 15 points over 
three consecutive sessions (ICC 0.85), and acceptable ICCs for inter tester reliability 
(ICC 0.75). Whilst SEM and CI were not provided, the authors worked out the intra and 
inter examiner variations which were 15% and 18% respectively. This suggests that 
variation of measurements between sessions and testers is relatively high. The gap 
between sessions however was only 2-3 minutes, and each point was tested 3 times in 
each session. Such large numbers of points and repetition could either increase the PPTs 
due to habituation of the stimulus (Kosek et al., 1999), or reduce them if the points 
became sensitive from successive testing. 
 
Persson et al., (2004) also found excellent intra tester reliability (ICC 0.7-0.94) within 
one session, of 7 points in the shoulder tested 4 times with 10 mins between each test. 
As with the previous studies, no SEM data was provided, but 95% CI varied between 
each test site and were as wide as 0.54-0.84, and as narrow as 0.82-0.95. The largest CI 
was a distal and lateral point in deltoid, which may have indicated the difficulty in 
maintaining the probe perpendicular to the tissue. This highlights the importance of 
establishing the best sites to test with pilot work prior to any intervention studies. 
  
Walton et al., (2011) assessed SEM and SDD in addition to reliability in individuals 
with and without neck pain. Three measurements of PPT were taken from the upper 
fibres of trapezius and tibialis anterior. Inter rater reliability was performed with only a 
5 minute gap between testing which may not have allowed for any sensitive areas to 
have recovered from the stimulus of the first tester’s assessment. Repeated measures 
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were taken with a 3-5 day gap between tests. Excellent intra (ICC 0.94-0.97) and 
substantial inter rater reliability (0.76-0.84) were found in the asymptomatic group, and 
were equally matched in the symptomatic group (0.96-0.97, intra and 0.81-0.9 inter 
rater). SEM and SDD were lower in the asymptomatic group than the symptomatic 
groups and at the trapezius site compared to the tibialis anterior site (asymptomatic 
trapezius SEM 18.2 kPa (7%), SDD 42.7 (17%), symptomatic trapezius SEM 20.5 
(8.6%), SDD 47.2 (19.8%), asymptomatic tibialis anterior SEM 37.4 (11.2%), SDD 86.3 
(26%), symptomatic tibialis anterior SEM 42.3 (10.5%), SDD 97.9 (24%)). Such 
relatively high error measurements must be taken into account when considering the 
effects of any treatment interventions. However, it is not known from this study if error 
measures would alter if PPT were tested in the same session, rather than between days. 
This would provide useful information for studies where immediate effects of treatment 
are being investigated.    
 
In conclusion, PPTs appear to be a reliable method of assessing pain perception in a 
variety of points around the body. The repeatability of any technique however, is in part 
related to the skill of the operator, and therefore the reliability of the technique used by 
any researcher should be assessed prior to intervention studies. 
 
5.3.3 Factors to consider when testing pressure pain thresholds 
 
Several factors may have an impact on PPT testing and include gender, site, age and 
number of repetitions. 
 
5.3.3.1 Gender 
 
Some studies have found lower PPTs in females than men (Chesterton et al., 2003; 
Manning and Fillingim, 2002; Sterling et al., 2000; Vanderweeën et al., 1996), although 
one study found no difference in PPTs between genders (Lautenbacher et al., 2005). 
Chesterton et al. (2003) tested the first dorsal interosseous muscle of the hand in 240 
participants, evenly divided between men and women. Women had PPTs of between 
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12.2 to 12.8 N (1.2 kg) (28% lower than men). This was a well-controlled study, with a 
large sample group which was suited to simply assess the difference in gender.  
 
Sterling et al. (2000) found in a study on 45 men and 50 women, that women had 
significantly lower PPTs (p=0.006) then men in all three upper limb nerves tested 
(radial, median and ulnar). An approximate (calculated from the published figures) 28% 
difference between men and women were found at the median nerve, with smaller 
differences (around 23%) for radial and ulnar nerves. These compare well to Chesterton 
et al.’s (2003) study findings, despite differences in units of measurement and sites 
tested. 
 
Vanderweeen et al., (1998) and Manning and Fillingim (2002) also found lower PPTs in 
women compared to men, but these were not consistent. In Manning and Fillingim’s 
(2002) study, differences were only found between genders in non-athletic individuals. 
One area of confusion in this paper was the definition of non- athlete population, who 
were individuals who participated in sports for more than 3 hours per week (the group 
varied between >3 and 15 hours). The number of hours of training that the competitive 
college athletes participated in was not divulged, meaning that the differences between 
groups for a number of factors including muscle bulk, cardiovascular fitness, circulating 
endorphins may not have been sufficiently different.  
 
Vanderweeen et al., (1996) found significantly lower PPTs in women in 6 out of 14 
points on acquisition of the first PPT, but re-testing the points 5 minutes later revealed 
only 2 of the points were significantly lower. This may suggest that repeated measures 
on women may even out the differences between men and women, however, Chesterton 
et al., (2003) found that the difference between men and women remained significant 
even after 6 measurements of the same points.  
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5.3.3.2 Site 
 
A difference in PPT has been found between types of tissue (nerve/muscle interface 
being lower than bone or muscle) (Kosek et al., 1999), and upper limb compared to 
lower limb (hand being lower than the foot) (Rolke et al., 2005).  Within the foot it was 
also found that the nail bed had highest PPTs followed by bone then muscle (Rolke et 
al., 2005).  
 
5.3.3.3 Age 
 
There does not appear to be a consensus in the literature about the effects of age on 
PPTs. Sterling et al., (2000) found age not to be a significant factor in PPTs performed 
over the upper limb nerves, whereas Lautenbacher et al., (2005) found that PPTs were 
significantly lower in an elderly group (63-88 years compared to a younger group (21-
35 years). The differences between the study results could be due to the differences in 
the upper age range; 88 years in Lautenbacher et al.’s (2005) study, but only 65 years in 
Sterling et al.’s (2000) study. Hence, age may have an impact on PPT, and as such age 
adjusted methods may be required in any analysis of studies using older participants.  
 
5.3.3.4 Body Mass Index 
 
Some authors have specifically excluded participants with a BMI of greater than 26 
kg/m2 (Krouwel et al., 2010) or 32 Kg/m2 (Letchuman et al., 2005). However, there is 
no justification for doing so in these studies and there appears to be no literature to the 
present researcher’s knowledge to support such exclusion. Participants with anorexia 
have been shown to have an elevation in PPTs compared to those within normal ranges 
of BMI (Raymond et al., 1999), suggesting that weight could alter PPTs, but these 
participants suffer from many other physical and psychological factors than simply 
reduction in BMI, and these factors may be more important than the weight alone.  BMI 
did not alter PPTs in 26 asymptomatic participants (Defrin et al., 2003). In agreement, a 
study on 87 individuals with non-specific LBP and 64 asymptomatic participants 
(Farasyn and Meeusen, 2005) found no difference in PPTs in participants with BMI 
below 26 kg/m2 compared to those over 26 kg/m2. Whilst exclusion of participants with 
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higher BMI may reduce the effects of extraneous variables to testing, to do so 
potentially reduces the extrapolation of study results to the wider public. In addition, 
some symptomatic groups, such as those with LBP, have a higher BMI than the general 
population, and therefore exclusion would result in a lack of a representative sample 
from that specific group (Farasyn and Meeusen, 2005).  
 
5.3.3.5 Number of Repetitions 
 
A consensus of repetitions per site does not seem to have been reached within the 
literature. Some authors have used just 1 repetition (Vanderweeen et al., 1996), 2 
repetitions (Chesterton et al., 2003), mean of 3 readings (Sterling et al., 2000), median 
of 3 readings (Lautenbacher et al., 2005), and 4 repetitions with a 10 minute gap 
between (Persson et al., 2004). Persson et al. (2004) found that the 1st PPT reading was 
significantly different from the others, and the 1st PPT compared to the 5th PPT was 
significantly higher in 3 different sites in the arm (Kosek et al., 1999). Further 
assessment is required to analyse the most repeatable method of assessing PPT, and 
should form part of the pilot work of studies using PPT as an outcome measure.  
 
5.3.4 Summary  
 
Measurements of PPT are repeatable and stable over time. Females tend to have lower 
PPTs than a similar matched group of males, and it may be that older individuals have 
lower PPTs. It is not known if BMI has an effect on PPT, although it has been 
postulated that individuals with BMI over 26 kg/m² have higher PPT. Nerve areas tend 
to have lower PPTs than muscle or bone and the first measure of PPT may be different 
from subsequent measures.  
 
5.4 Conclusion 
 
This chapter has discussed the use of measures which assess nerve biomechanics, nerve 
conduction and pain. Longitudinal nerve excursion can be reliably measured using off 
line analysis (frame-by-frame cross correlation) of B mode ultrasound images, but 
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further studies are required to assess whether this method is suitable for measuring 
sciatic nerve excursion in the posterior thigh with movements close to the moving joint. 
Methods to analyse transverse plane nerve excursion are still in their infancy.    
 
Since nerve conduction may be affected by increased nerve strain, which is thought to 
occur during neurodynamic tests like the SLR, nerve conduction is a useful measure to 
assess if such changes occur after neurodynamic treatments. VTT is repeatable and 
detects changes to the large diameter afferent nerves. This chapter has provided some 
considerations of factors which affect VT, which need to be taken into consideration in 
research using VTT as an outcome measure. 
 
Pain measures are important tools to analyse improvement in painful conditions after 
treatment. PPT appears to be repeatable, but is subject to variation due to certain factors. 
This chapter has presented the factors which influence the robustness of PPT testing, 
and these should be taken into account when this outcome measure is used in studies.  
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Chapter 6 Rationale and aims and objectives of the 
experimental work 
The five previous chapters have provided a rationale for the study and the choice of 
outcome measures that were chosen. Chapter 2 outlined the cause and sub-grouping of 
individuals with spinally referred leg pain. It also determined the main causes of these 
types of pain, and how individuals with each of the three types of leg pain could be 
identified clinically. It also discussed how the presence of central sensitisation could 
have detrimental effects of prognosis, and how disability and psychosocial factors can 
impact on prognosis in individuals with spinally referred leg pain. Hence identifying 
these characteristics is important when analysing the effects of treatment.  
 
Chapter 3 examined the use of neurodynamic testing in practice. It outlined some 
important biomechanical factors which are essential in interpreting the literature on 
nerve excursion, and provided supporting evidence for the validity of such tests. Chapter 
4 examined the literature which has supported the use of neurodynamic techniques as a 
treatment intervention. Whilst the literature is expanding in this area of Physiotherapy 
practice, there is still insufficient literature which has examined the immediate effects of 
nerve treatments on both mechanical and neurophysiological effects in symptomatic 
individuals. In addition, it also highlighted the concern that some authors have expressed 
in applying tensioner techniques in individuals with neuropathic pain, but demonstrated 
the lack of conclusive evidence to support such views, and even presented some 
literature which showed beneficial effects to pain and the potential for the reversal of 
central pain processes. 
 
Chapter 5 critiqued the potential outcome measures which could be used in a study 
looking at the effects of a neurodynamic treatment intervention and identified three main 
outcome measures which would be useful in a study of this sort; ultrasound imaging to 
measure nerve excursion, pressure pain thresholds to measure pain, and vibration 
thresholds to measure nerve conduction. These three measures would give both a 
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narrative for any changes that occurred to the mechanics of the nerve being moved and 
the neurophysiological changes.  
 
The main aim of the study was to determine what effects  a 3 x 1 minute SLR tensioner 
treatment had on pressure pain thresholds, vibration thresholds and sciatic nerve 
excursion between 3 different sub-groups of individuals with spinally referred leg pain 
(somatic, radicular and radiculopathy).  
The objectives underpinning this aim were to:- 
I. Determine the validity and repeatability of the frame-by-frame cross 
correlation method to analyse nerve motion 
II. Determine normative excursion data for the sciatic nerve during a 
modified side lying SLR test 
III. Determine the repeatability of the VT and PPT tests in individuals with 
spinally referred leg pain. 
IV. Determine the immediate effects of a SLR treatment dose on nerve 
excursion, PPT and VT. 
V. Analyse the differences in the 3 outcome measures between the 3 groups 
of individuals with referred leg pain. 
 
A second aim was to assess if the presence of central sensitisation, levels of disability 
and psychosocial factors were different between the three groups and interacted with the 
effect of treatment.  
The objectives underpinning this aim were:- 
VI. Determine any baseline differences between the sub-groups   
VII. Introduce each factor into the main statistical analysis as covariates to 
establish any interaction with the main analyses. 
 
A third aim was to assess how well the psychosocial factors and levels of disability were 
related to each other.  
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In order for these objectives to be achieved, initial studies which explored the validity 
and repeatability of the three outcome measures proposed were performed. In addition, 
since the data collected in the repeatability study for nerve excursion consisted of 
asymptomatic participants, the data were also analysed to gain information about 
normative nerve excursion. The clinical study explored the main aims of this thesis and 
consisted of two main parts. The initial part was the sub-grouping of individuals with 
spinally referred leg pain, which was done by Physiotherapists who volunteered to assist 
in the study. The second part was the data collection to assess the effects of the SLR 
mobilisation on pain (PPT), conduction (VTT) and nerve excursion (ultrasound 
imaging) in individuals with spinally referred leg pain. Fig 6.1 shows the flow chart of 
studies which form the next 2 chapters.  
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Fig 6.1 Flow chart of Studies  
 
 
 
 
Reliability/normative study of 
cross correlation method of 
speckle tracking of ultrasound 
images of sciatic nerve during 
SLR (Chapter 7) 
Reliability study of VTT 
and PPT in participants with 
referred leg (Chapter 7) 
Clinical Study (Chapter 
8) 
Part 1 Physiotherapist 
recruitment and sub 
grouping of participants 
Part 2 Laboratory study 
Validity study of cross 
correlation method of speckle 
tracking of ultrasound images 
of nerve (Chapter 7) 
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Chapter 7 Validity and Repeatability Studies 
 
The overall aim of the present study was to determine what effects a 3 x 1 minute SLR 
tensioner treatment had on pressure pain thresholds, vibration thresholds and sciatic 
nerve excursion between 3 different sub-groups of individuals with spinally referred leg 
pain. The outcome measures proposed for the clinical study were sciatic nerve excursion 
during the SLR measured using a frame-by frame cross correlation method of ultrasound 
images, VTs of areas of the foot and ankle supplied by the lumbosacral plexus and PPTs 
of the leg (tibial nerve behind the knee and gastrocnemius as it is supplied by the 
lumbosacral plexus), and contra lateral deltoid to assess if any improvements in pain are 
segmentally or systemically mediated. 
 
The validity of the ultrasound technique has been assessed, but in small numbers on 
avian or string (Dilley et al., 2001), and it was felt that this was not sufficient to support 
the use of the technique in this study. Good repeatability of all three measures had been 
found in previous studies, but all of the techniques are subject to operator skill, and 
therefore it was important to establish reliability for the researcher prior to the main data 
collection. 
 
Therefore three studies were performed: 
1. The validity of using a frame-by-frame cross correlation method of analysis of 
excursion on real time B mode ultrasound images of pig nerve. 
2. The repeatability of using this same cross correlation method of analysis of 
excursion of the sciatic nerve in the posterior thigh during the SLR. 
3. The repeatability of VT and PPT measurements in the areas described above.  
 
In addition, because asymptomatic participants were used in the ultrasound repeatability 
study and there is limited in vivo description of normative movement during the SLR, a 
separate section is given to the analysis and discussion of these data. 
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The objectives of the studies were as follows: 
 
1. To assess if frame-by-frame cross correlation technique was a valid measure of nerve 
excursion.  
2. To assess if frame-by-frame cross correlation technique was a reliable measure of sciatic 
nerve excursion during a modified SLR technique in side lying. 
3. To describe the trends in sciatic nerve excursion during a modified SLR test in 
asymptomatic participants. 
4. To assess if VTT of the lateral malleolus and 1st metatarsal was repeatable in individuals 
with spinally referred leg pain 
5. To assess if PPT at contralateral deltoid, ipsilateral tibial nerve and ipslateral 
gastrocnemius sites was repeatable in individuals with spinally referred leg pain. 
 
7.1 Ultrasound cross-correlation method 
 
7.1.1 Validity 
 
As mentioned in chapter 5, there is limited work on the accuracy of utilising the cross 
correlation method to measure nerve movement. Error measurements of <10% were 
found on avian nerve and string phantoms (Dilley et al., 2001), but it was not stated how 
many phantoms were used and in addition such phantoms may not best represent human 
nerve.  
 
The purpose of this study therefore was to analyse the use of frame by frame cross 
correlation on B mode ultrasound images of movements of pig sciatic nerve, and 
establish if the technique was robust for measuring excursion.  
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7.1.1.1 Method 
Materials 
Eight fresh porcine forelimbs were obtained and the neurovascular bundle was 
identified, before the nerves (musculocutaneous and median, n=16) were dissected 
free of surrounding tissues. Pig nerve was used as it is has a close relationship to 
human nerve (Wall et al., 1991). These were frozen and stored at -30°C until 
required. Nerves were thawed at room temperature for 4 hours before testing 
(Clavert et al., 2001). 
 
Each nerve was mounted in a water bath by fixing one end to a rigid stand; and the 
other end was passed around a pulley with a baseline weight of 0.49 N (50G) which 
was hung to the nerve. The ultrasound transducer was positioned immediately above 
the nerve in the water, and held in place by a clamp and stand. A plastic ruler was 
positioned underneath the nerve so that markings of the ruler were visible from 
outside the water bath (Fig 7.1). This allowed the magnification of the photographic 
image of the nerve to be determined. 
 
 
 
Fig 7.1 Lateral view of porcine nerve mounted in water bath  
 
Instruments 
Nerve displacements were tracked by both optical and ultrasonic methods. These 
two measurements were compared so as to establish the validity of using ultrasound 
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images to track nerve sliding. A camera mounted on a tripod, was positioned in front 
of the water bath so that the ultrasound probe, nerve and ruler were visible. The 
camera was placed as far away as possible (approximately 2 metres) with the zoom 
on to ensure a clear image, so that parallax was kept to a minimum. The exact 
distance was not required as the photographs were subsequently analysed by image J 
software which allowed conversion of mms to pixels by measuring the distance of 
10mm on the ruler and assigning this distance a set number of pixels.  
 
A FF Sonic UF-750XT (Fukuda Denshi) ultrasound machine with a 7.5 MHz linear 
array transducer, connected to an image grabber (Global lab image Data Translation, 
Bietigheim-Bissingen, Germany, with a 25 frames per second capture rate ) was used 
to scan the porcine nerve.  
 
Procedure 
A static photograph was taken of the baseline position. The stand that clamped the 
ultrasound transducer was then moved a short distance so that the transducer moved 
longitudinally over the nerve to mimic sliding of the tissue (the distance was not set, as 
the amount was calculated from the photographic images subsequently). The images 
were captured and saved with the image grabber onto an external hard drive.  A static 
photograph was taken of the new position of the probe over the nerve. 
 
Analysis 
The ultrasound images were saved in MPeg format and converted to bitmap images. 
Subsequently all images were analysed off line using frame-by-frame cross 
correlation which was developed by Dilley et al., (2001) using Matlab (Mathworks 
Inc, Natick, MA). For the chosen frame a cluster of three to five regions of interest 
(ROI) were selected along the nerve of slightly different shapes and sizes depending 
on the size of the nerve (Fig 7.2). The programme recognises the region by its grey 
scale; each pixel is assigned a specific number based on its brightness (or 
echogenicity), from 0 (black) to 256 (white). For each successive frame, the 
programme identifies this same area and calculates the amount that the region has 
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moved by offsetting the co-ordinates of the ROI along the horizontal image plane 
and shifting them one pixel at a time; the pixel shift (Dilley et al., 2001). A 
correlation coefficient is calculated for each pixel shift. The pixel shift that has the 
highest correlation coefficient is identified as the “true” value. Dilley et al., (2001) 
noticed that comparisons of sequential frames resulted in an underestimation of 
movement. Therefore, the researcher analysed a selection of different options; 
tracking sequential frames, every other frame and between every third frame. The 
best frame selection appeared to be on every other frame, and therefore this method 
was used for the analysis.  
 
The output from the programme produces the vertical and horizontal movement, and 
the overall horizontal movement from these two values, in addition it provides this 
for each ROI and an average for all of the ROI. A useful aspect of the programme is 
that it is possible to view an image clip showing how the programme is tracking the 
movement. This provides an element of quality assurance to ensure that all ROI 
appear to be following the nerve movement. At times, certain ROI did not follow the 
movement of the nerve and these were discounted from the analysis; in these cases 
the mean value was used unless there was substantial one sided outliers, when the 
median value was used. 
  
 
Fig 7.2 Regions of interest  
 
The cross correlation procedure described above was carried out tracking the 
position of the three to four ROI, before and after the probe was moved 
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longitudinally above the nerve.  
The photograph images were opened into image J, and the edges of the ultrasound 
probe were compared before and after the probe was moved. The pixels were 
converted to mms by measuring the length in pixels of a 10mm section of ruler in the 
photographs. 
 
Statistical Analysis 
The data were assessed for normality and then intraclass correlation coefficients (ICC 
2,1), confidence intervals, standard error of measurements (SEM) and a Bland Altman 
plot was drawn to see if the measures were in agreement (Bland and Altman, 1986). The 
results from the SPSS spread sheets can be found in appendix 29 and the attached CD. 
 
7.1.1.2 Results 
 
Table 7.1 shows the comparison between the amount of movement analysed by the 
photographic method and that by the cross correlation method on the ultrasound images. 
As can be seen, the distance that each nerve moved varied considerably between trials, 
but is similar between both the photographic and ultrasound methods for each nerve. 
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  Amount of movement (mms)   
Nerve Ultrasound Photograph 
1 11.12 10.92 
2 11.66 11.93 
3 10.05 10.00 
4 12.93 11.60 
5 12.66 12.05 
6 8.16 7.72 
7 12.80 12.37 
8 12.21 11.98 
9 15.09 15.92 
10 25.53 23.73 
11 9.41 13.28 
12 17.63 18.57 
13 16.17 15.41 
14 19.64 20.73 
15 18.39 22.79 
16 15.68 15.12 
Mean (SD) 14.32 (4.45) 14.63 (4.65) 
 
Table 7.1 Amount of movement (sliding of each nerve) measured by cross correlation method of 
ultrasound images and photographs. 
 
Statistical Analysis 
All data were normally distributed (Shapiro Wilk ultrasound p=0.31, photographs 
p=0.15), and therefore ICCs were calculated on the data. 
The ICC was 0.93 (C.I. 0.82-0.98) and SEM =1.19 mm. 
 
A Bland Altman plot was produced (fig 7.3) which showed a good spread around zero, 
indicating good agreement (Rankin and Stokes, 1998). Two of the measures lie outside 
the upper limit of agreement and represent outliers.  
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Fig 7.3 Bland Altman Plot of ultrasound v photographic sliding data 
 
7.1.1.3 Discussion 
 
The results indicate that the use of a cross correlation analysis of B mode ultrasound 
images of nerve motion is a valid method for assessing longitudinal nerve excursion.  
Dilley et al., (2001) suggested that the use of this method for assessing string and avian 
nerve phantoms was a valid measure of longitudinal excursion. Their results indicated 
that there was less than 10% error in the measurements. The results of the present study 
show an average error of 1.19 mm, which is an error of 8.5% when one considers the 
mean nerve movement to be 14mm. This is slightly lower than Dilley et al.’s (2001) 
study. The present study analysed 16 porcine nerves, which may be more appropriate to 
compare to human nerve since the size and characteristics of porcine nerve are more 
similar to human (Rydevik, 1991). Dilley et al. (2001) did not present the numbers of 
nerves or string that they analysed in that part of the study, nor did they attempt to 
perform any statistical analysis on the data. The present validity study suggests that the 
technique may be more accurate than Dilley et al., (2001) indicated.  
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The amount of sliding that occurred in nerves 11 and 15 were considerably less than the 
photographic data and as such deserves a comment. A blurred image was found for 
nerve 15. Such blurring may result in underestimation of the programme as it may reject 
movement from some frames, as the ROI does not match a region in these frames. In 
addition, looking at the photographs, the ultrasound transducer in these 2 nerves was at a 
slight angle to the nerve. Hence, both the tracking method and the method of analysing 
the movement of the probe from the photographs could be inaccurate. The clarity of the 
image is essential to ensure that the image analysis software is able to visualise the 
image sufficiently to recognise that same region throughout the entire period. It is vital 
therefore that the operator has sufficient skill to produce clear images. This element to 
scanning the sciatic nerve was assessed during the repeatability study. 
 
7.1.1.4 Conclusion 
 
The use of frame-by-frame cross correlation method using B module ultrasound images 
appears to be a valid method of analysing longitudinal nerve excursion. This method 
appears to measure longitudinal nerve movement with an error of 1.19 mm. This must 
be taken into account when assessing any change to nerve movement after longitudinal 
SLR treatment and also when comparing between the different sub groups of 
participants with referred leg pain. 
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7.1.2 Reliability of nerve motion using ultrasound 
Ensuring the technique is measuring what it should be measuring is an essential element 
when ensuring a robust outcome measure, but in addition, ensuring that the measure is 
repeatable enables the researcher to be sure that any changes to the outcome are due to 
the intervention, and not just due to fluctuations in readings between measurements.  
 
Excellent intra-rater reliability was found for measuring longitudinal movement of the 
sciatic nerve in the posterior thigh (Ellis et al., 2008); however this was done in a seated 
slump position and during ankle dorsiflexion and cervical extension only. In the clinical 
study (chapter 8), the nerve was scanned in the posterior thigh during knee extension, 
which was likely to produce larger levels of excursion than Ellis et al., (2008) for 2 
reasons. Firstly, nerves move most around the moving joint (Dilley et al., 2003; Phillips 
et al., 2004; Boyd et al.,2005), and the posterior thigh scanning location was much 
further from the ankle (Ellis et al., 2008) than the knee in the clinical study. Secondly, a 
greater range of joint movement occurs at the knee than at the ankle, hence the nerve has 
to adapt to greater amounts of joint range, and will do so by increasing excursion (as 
well as strain). 
 
Dilley et al. (2001) also found good intra-rater reliability for measurements of the 
median nerve in the forearm, although very small numbers (3 and 7) were examined 
meaning that statistical methods appropriate for assessing reliability were not performed 
(more details of this study can be found in chapter 5). The median nerve is more 
superficial than the sciatic nerve, and therefore the resolution of the image may be 
superior compared to the sciatic nerve, since ultrasound waves emitted from higher 
frequency transducers are absorbed faster, with increasing depth (Rizzatto, 1998). 
 
The ultrasound technique requires much practice to perfect (Beekman and Visser, 2004), 
and so it was important to establish that the researcher was sufficiently skilled in 
obtaining clear images, because the frame-by-frame cross correlation method is likely to 
be less reliable if poor images are used. 
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For these reasons it was essential to test the repeatability of the method planned for the 
clinical study with the same operator8.  
 
7.1.2.1. Method 
 
Participants and Recruitment 
Ethical approval was gained from the Faculty of Health and Social Sciences Research 
Ethics and Governance Committee at the University of Brighton (appendix 14). 
 
Eighteen asymptomatic participants (9 women, 9 men, mean age (SD) 28.9 (14.3), range 
19-68 years) were recruited for the study. All participants were required to read an 
information sheet and sign a consent form prior to participating (appendix 15). A list of 
exclusion criteria was assessed including any neuromusculoskeletal conditions, systemic 
disorders such as rheumatoid arthritis and pregnancy (appendix 15). 
 
Instruments 
A Titan ultrasound machine (SonoSite Ltd, Hitchin, UK) with a 5-10MHz linear array 
transducer connected to an image grabber (Global lab image with a 25f/s capture rate) 
was used to scan the sciatic nerve in the posterior thigh. 
 
A universal goniometer and an electrogoniometer (Biometrics ltd, dataLINK 
goniometer) were used to measure the position of the knee. 
 
A purpose made jig was used to enable the hip to be positioned in 30 and 60°of hip 
flexion, and the knee allowed to move from 90° through to 0° (see fig 7.4) 
 
Procedure 
The order of left or right leg to be tested was randomly chosen by participants asked to 
pick out a piece of paper from a bag which consisted of 20 pieces of paper, 10 with left 
                                                 
8 This reliability study was published in Manual Therapy in 2012 (see appendix 31) 
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written on, and 10 with right. Participants were asked to undress to shorts and a top 
before their height and weight were taken. Lumbar spine, hip, knee and ankle 
measurements were taken to ensure that there was no joint restriction which would 
prevent the participants from being placed in the SLR position. Neurological integrity 
tests of the lower limbs were performed and consisted of light touch (tested with cotton 
wool), reflexes of the knee and ankle, and isometric muscle testing of the lower limb 
myotomes. Any participants who had positive tests would have been excluded, but this 
was not the case in any of the 18 participants. 
 
The electrogoniometer was placed laterally over the knee joint by placing the upper end 
block in line with the greater trochanter and the lower end block in line with the lateral 
malleolus (Biometrics ltd dataLINK goniometer manual). The participants were then 
asked to lie supine whilst an ankle foot orthosis was placed on each foot and secured 
with bandages. 
 
The participants then lay down on the jig with the chosen leg upper most, and the hip 
joint positioned over the joint of the jig (resulting in the hip being positioned in 30°), the 
knee was straightened as far as possible and the electrogoniometer zeroed. One or two 
pillows were placed under the subject’s head to prevent cervical lateral flexion 
occurring, and this varied between participants depending on the width of their 
shoulders. The subject was then secured onto the jig with a series of straps around the 
pelvis and lower leg (fig 7.4). The knee angle was measured with the universal 
goniometer, and the electrogoniometer reading repeated before the knee was flexed to 
90° (measured by the electrogoniometer). The knee was held in this position by a peg 
placed anterior to the crease of the ankle, and then the position of knee flexion was 
measured with the universal goniometer. Whilst the knee position was held at 90°, it 
was noticed that small variations in the reading on the electrogoniometer occurred, and 
therefore the reading used for analysis was the reading shown immediately after the 
measurement with the Universal goniometer. The universal goniometer measurements 
were used to subsequently assess for agreement with the electrogoniometer. Universal 
goniometers have been demonstrated to have excellent intra tester reliability for 
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measurements of knee flexion and extension (ICC flexion 0.997 and 0.972 to 0.985 for 
extension, Brosseau et al., 2001), and accuracy as compared to measurements taken by 
X ray (r=0.97-0.98, Gogia et al., 1987).  
 
The sciatic nerve was then located in the posterior thigh in its transverse view with the 
ultrasound transducer. The nerve was located on a line between the ischial tuberosity 
and the greater trochanter (Karmakar et al., 2007) and 10 cms distal to the gluteal fold 
(Bruhn et al., 2008). The best image of the nerve in its transverse view was found by 
moving the transducer slightly up and down along the course of the nerve. The position 
of the transducer was then marked on the skin with a non-permanent marker. The 
transducer was then rotated and a longitudinal image acquired (Fig 7.5). The movement 
of the sciatic nerve was captured between 90 to 45° of knee extension, 45 to 20° and 20° 
to 0° using the image grabber to save the images to a portable hard drive. These ranges 
of movement were chosen after pilot work discovered that between 45 to 0° of knee 
extension, there was considerably more out of plane movement which meant that 
keeping the transducer above the nerve was difficult. Utilising smaller ranges of 
movement made it easier to follow the nerve and ensured that the best image was 
maintained within the field of view. Once these images had been captured, the 
transducer was removed, and the marks measured from the ischial tuberosity and the 
knee crease. 
 
The subject’s hip was then positioned in 60° of flexion with the jig, and the full 
procedure was repeated in the same way as described above. All ultrasound imaging was 
performed by the researcher, and the knee was extended, and images saved by a research 
assistant. 
 
Participants returned for an identical test procedure between 48 hours and one week 
later. 
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Fig 7.4 Subject positioned on purpose made jig. Scanning of sciatic nerve in posterior thigh. 
Images from Ridehalgh et al. (2013) Manual Therapy 17(6):572-6 with permission from 
Elsevier limited. 
 
Data Analysis 
All longitudinal images were saved onto a portable hard drive and analysed off line 
using frame-by-frame cross correlation which was developed by Dilley et al., (2001) 
using Matlab (Mathworks Inc, Natick, MA). For the chosen frame a cluster of three 
or four regions of interest (ROI) were selected along the nerve of slightly different 
shapes and sizes (Fig 7.5). The detailed description of the procedure can be found in 
7.1.1.  
 
 
 
Fig 7.5 Regions of Interest  
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The cross correlation procedure described above was carried out tracking the 
position of the 3 to 4 ROI during knee extension, depending on the size of the nerve 
(see Fig 7.5). The images were also tracked visually and the mean value was used 
unless there was substantial one sided outliers, when the median value was used.  
 
The total amount of movement measured during each hip position was used to 
compare between occasion 1 and occasion 2, hence for each subject there was an 
overall longitudinal movement calculated for hip at 30° moving the knee from 90 to 
0° of flexion, and an overall longitudinal movement with the hip at 60° and knee 
moving from 90 to 0°. 
 
Statistical Analysis 
Repeatability of longitudinal sciatic nerve motion was calculated using intraclass 
correlation coefficients (ICCs) (2,1), with subsequent analysis using SEM and 95% 
confidence intervals (Bland and Altman, 1986). SDD for the 2 hip positions was 
calculated using the equation 1.96 x√2 x SEM (Schuck and Zwingmann, 2003).   
 
Agreement between the universal goniometer knee measures and the electrogoniometer 
measures were compared using ICCs (2,1) with subsequent analysis using standard error 
of measurement and 95% confidence intervals (Bland and Altman, 1986).  All analyses 
were performed using SPSS version 18. The results from the SPSS spread sheets can be 
found in appendix 29 and attached CD). 
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7.1.2.2. Results 
 
Two participants were excluded as the image quality was too poor for the motion 
analysis software to track longitudinal movement of the nerve. In both of these 
participants a depth of 6.5 cms had been used to be able to view the sciatic nerve, and as 
such the resolution was not as clear as more shallow depths. 
 
Agreement between universal goniometer and electrogoniometer 
Table 7.2 shows the figures for each subject’s knee range of movement for both the 
universal (UG) and electrogoniometer (EG). 
 
Subject UG 0° EG 0° UG 90° EG 90° 
1 0 0 88 92 
2 2 0 93 90 
3 2 1 95 87 
4 2 1 105 83 
5 0 2 82 79 
6 3 5 84 86 
7 0 2 95 85 
8 3 7 98 88 
9 3 4 88 90 
10 6 5 91 89 
11 5 5 91 86 
12 2 4 91 89 
13 1 1 88 91 
14 1 3 86 84 
15 4 4 84 84 
16 5 1 92 88 
 
Table 7.2 universal v electrogoniometer measures at set up positions of zero and 90 degrees flexion 
 
The ICC for 0° was 0.51 (0.04 -0.8 C.I.) and SEM 1.39°. The ICC for 90° was 0.084 (-
0.42-0.54), SEM 4.57°. However, such low ICCs for knee flexed to 90° with relatively 
low standard error measures required further analysis, since small differences between 
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measures is known to affect the robustness of ICC (Hopkins, 2000). Coefficient of 
variation (CV) (Hopkins, 2000) was therefore used for the 90° of flexion data, but was  
not possible for the 0° position, as the calculation uses the mean of the differences of the 
2 measures to calculate the CV. Since the differences were zero in some cases, this 
inflated the CV values. CV for 90° of knee flexion were 5.04% for the Universal 
goniometer and 5.26% for the electrogoniometer (calculations for CV can be found in 
the attached CD), this indicated that the error measures for both goniometers were 
similar and low.  
 
Longitudinal Nerve Excursion 
 
Table 7.3 shows the amount of sliding for all participants with the hip in 30° of flexion 
and 60° of flexion. The total amount of movement is shown for the whole range of knee 
extension from 90 to 0° flexion. Mean (SD) movement at 30° hip flexion was 9.92mm 
(2.2) for test 1 and 10.06mm (2.5) for test 2. At 60° hip flexion mean (SD) for test 1 was 
12.44mm (4.42) and test 2 was 12.54 (3.97). 
 
It can be seen that there was a large amount of variability between participants in the 
amount of nerve motion occurring overall and between the two hip positions. Values 
between tests 1 and 2 showed relatively little variation for most participants, but 
participants 4, 13 and 16 had larger differences for one of the hip positions. 
 
 
 
 
 
 
 
 
 
 
159 
 
Subject no Gender position Test 1 Test 2 
1 F Hip 30 flexion 10.25 10.69 
   Hip 60 flexion 5.11 5.60 
2 M Hip 30 flexion 13.95 13.79 
   Hip 60 flexion 17.92 17.83 
3 M Hip 30 flexion 10.01 8.92 
   Hip 60 flexion 10.19 11.07 
4 M Hip 30 flexion 7.41 7.86 
   Hip 60 flexion 7.58 10.36 
5 M Hip 30 flexion 10.37 11.25 
   Hip 60 flexion 8.51 7.76 
6 F Hip 30 flexion 9.50 9.47 
   Hip 60 flexion 11.90 11.57 
7 F Hip 30 flexion 9.41 8.39 
   Hip 60 flexion 7.21 7.40 
8 F Hip 30 flexion 8.61 9.03 
   Hip 60 flexion 10.24 10.60 
9 F Hip 30 flexion 8.74 8.33 
   Hip 60 flexion 12.30 12.47 
10 F Hip 30 flexion 6.93 6.69 
   Hip 60 flexion 10.50 11.13 
11 M Hip 30 flexion 10.42 9.95 
   Hip 60 flexion 18.34 17.16 
12 F Hip 30 flexion 10.64 10.00 
   Hip 60 flexion 14.04 12.20 
13 M Hip 30 flexion 10.98 10.61 
   Hip 60 flexion 12.70 15.10 
14 M Hip 30 flexion 6.42 6.86 
   Hip 60 flexion 14.87 13.70 
15 M Hip 30 flexion 14.69 15.92 
   Hip 60 flexion 17.49 17.54 
16 M Hip 30 flexion 10.32 13.21 
   Hip 60 flexion 20.21 19.11 
 
Table 7.3 Amount of nerve movement (mm) at different ranges of hip movement between 90 and 0 
degrees of knee flexion. Participants 4,13 and 16 are highlighted as they had relatively large 
differences between test days. 
 
All data was normally distributed (Shapiro Wilk test for hip flexion 30° p=0.19 and 
p=0.28 for occasions 1 and 2 respectively, and for hip flexion 60° p= 0.78 and 0.62 for 
occasions 1 and 2 respectively).  
The ICC for 30° hip flexion was 0.92 (C.I. 0.79-0.97). The SEM was 0.69 mm, and 
SDD was 1.9 mm.  
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The ICC for  60° hip flexion was 0.96 (C.I. 0.89- 0.99). The SEM was 0.87mm, and 
SDD was 2.41mm. 
A Bland Altman plot was produced for each position of hip flexion to assess if any bias 
between the two readings occurred (figs 7.6 and 7.7). 
 
 
Fig 7.6  Bland Altman plot of sciatic nerve sliding (mm) with hip in 30 degrees flexion (knee 90 to 0 
degrees) for test 1 and test 2  
 
 
Fig 7.7  Bland Altman plot of sciatic nerve sliding (mm) with hip in 60 degrees flexion (knee 90 to 0 
degrees) for test 1 and test 2 
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Both plots show a good spread around zero which indicates good agreement (Rankin 
and Stokes, 1998). One of the data points lies outside the 95% limits of agreement in 
both plots. These two outliers represent two different participants, and the rationale for 
why this occurred is discussed below. 
7.1.2.3 Discussion 
These results suggest that the use of the cross-correlation method of analysis for 
measuring longitudinal sciatic nerve excursion using B mode ultrasound sciatic nerve 
images is a repeatable method. Very good to excellent ICCs values (Fleiss, 1986), and 
mean measurement errors < 10% were found for both the 30 and 60° hip flexion 
protocols. Two other studies have shown the cross correlation method to be reliable in 
assessing longitudinal nerve excursion (Dilley et al., 2001 and Ellis et al., 2008). Dilley 
et al., (2001) found that the average median nerve movement measured in the forearm 
between two trials on 2 separate days in one subject varied less than 10% during passive 
wrist extension. The authors also considered that variability was low for within session 
readings as standard deviations varied between 0.2-0.4 mm for wrist extension, and 
between 0.16 and 0.67 mm during the passive index finger extension. Average nerve 
excursion for wrist extension was between 2.85 and 3.74 mm and for index finger 
extension was between 1.38 and 4.48 mm. Since small numbers of participants were 
used (one for repeat measures on a separate day, and 3 for wrist extension group), no 
other statistical analysis was attempted and therefore it is not possible to compare the 
results of this study directly with Dilley et al., (2001).  
 
Ellis et al., (2008) found mean longitudinal sciatic nerve movement of 3.47 mm during a 
modified slump test in the posterior thigh with an ICC of 0.75 and SEM of 0.79 mm. 
The ICCs found in the present study are slightly higher than Ellis et al. (2008) (0.92 and 
0.96 for hip flexion of 30 and 60° respectively), but the SEMs are similar (0.69 and 
0.87). The mean amounts of movement are understandably different between the two 
studies since the movements imposed, and starting positions for each study contrast 
considerably; participants in Ellis et al.’s (2008) study being held in slump position 
whilst the head was extended and ankle dorsiflexed. The nerve was scanned in the 
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posterior thigh, and since most movement occurs closest to the moving joint (Dilley et 
al., 2003; Phillips et al., 2004; Boyd et al., 2005), small movements would have been 
expected at this location. What is promising about the present study is that despite larger 
excursion values, where it may be considered more technically difficult to follow the 
nerve movement, it appears that the technique is still repeatable. 
 
The SEMs found in this repeatability study were 0.69 and 0.87 mm and SDD 1.9mm 
and 2.41 mm for the two hip positions. This means that in the clinical study (chapter 8) 
any differences in measurements were required to be greater than 1.9mm (hip flexed to 
30°) and 2.41mm (with hip flexed to 60°) to be 95% certain that these differences are 
due to a real change and not due to error.  
 
 One potential problem with using the cross correlation method to analyse nerve motion 
is the speed at which the movement occurs (Dilley et al., 2001). Nerve movements 
recorded below 0.25mm/sec were too low to be accurately measured by Dilley et al., 
(2001).  Passive movements of the limb between each stage of knee extension were 
performed within 3 seconds. The smallest movement found between 90 to 0° of 
movement was 5.11mm (subject 1 at 60° hip flexion). Assuming that all of that time was 
taken (9 secs), then the lowest rate of movement would have been 0.57mm/sec. In 
reality much of the movement had finished within the first 2 secs, but even if this was 
not the case, the speed of nerve movement is likely to be well above those required to 
provide accurate data. 
 
Goniometry measurements. 
The results of the ICC for comparison between the electro and universal goniometers 
showed fair agreement for 0° (0.51) but poor agreement for 90° (0.084). The coefficient 
of variation was calculated since ICC may be inaccurate where the 2 compared 
measures are very similar. Both the electrogoniometer and universal goniometer shared 
similar error measures, suggesting that they were closely related.  However, there were 
problems with using the electrogoniometer during the study. At times, the angle that the 
electrogoniometer indicated as being the position to stop the movement, did not appear 
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correct compared to eyeballing, and so the movement was stopped, the 
electrogoniometer re-positioned, and the process was started again. This increased the 
time that the participant was required to stay in the lab, and also meant that the leg was 
moved an extra time. Whilst this was unlikely to significantly alter the amount of nerve 
excursion during the movement (since changes to viscoelastic tissues are likely to 
require sustained or repeated movements into resistance for over 30 seconds), minor 
changes in starting position could have occurred. Therefore, a pragmatic decision was 
made to use a universal goniometer in the clinical study. The SEM of the goniometer 
was 4.57° at 90° knee flexion. Total nerve excursion during this modified SLR is due to 
a combination of joint movement (hip, knee and ankle), and such small differences 
between individuals are unlikely to significantly alter if the knee was positioned in just 
over or just under  90° of flexion.  
 
Study Considerations and limitations 
There are some considerations about the technique which are worth noting. In two 
instances where the nerve was imaged at greater depths, poor resolution meant that the 
software programme was unable to track the moving image appropriately. However in 
some instances (3) even at depths of greater than 6 cms the programme was able to track 
the nerve movement. It may be that differences in soft tissue characteristics may be the 
cause of such difficulties. All 3 participants who were scanned at this depth were female 
(participants 1, 9 and 10), the remaining 4 females were scanned at depths of 5.5 cms, 
whereas only 2 males were scanned at 5.5 cm. This may suggest that the nerve is more 
deeply situated in females. Considerably longer periods of time were required to gain 
the best images in these participants and therefore increased estimates of time were 
taken into consideration for the clinical study. 
 
The frame-by-frame cross correlation procedure identifies areas of the nerve which 
match with subsequent frames based on the echogenicity of the pixels within each ROI. 
This method does not always result in correct tracking of the nerve. The advantage of 
the programme is the ability to visually track the moving image, and hence it was very 
clear when the programme did not best track the moving nerve. In these cases, repeated 
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selection of different sizes and location of the ROI were required in order to establish 
accurate nerve excursion.  
 
In 3 cases, differences between occasion 1 and occasion 2 were as high as 2.4mm. In 
these cases, the clarity of the image in occasion 1, particularly towards the end of range 
of knee extension was substantially poorer than occasion 2 on visual inspection, and 
resulted in a smaller tracked excursion in the software. The results of two of these cases 
can be seen as the outliers in the Bland Altman plots (figs 6.9 and 6.10). These cases 
highlight the importance of acquiring a clear image of the moving nerve throughout the 
whole target sequence.  
 
7.1.2.4. Conclusion 
The results of this study suggest that the method of frame-by-frame cross correlation for 
assessing longitudinal sciatic nerve motion is repeatable. The accuracy of the technique 
is dependent on obtaining a clear image throughout the whole movement, and observing 
that the tracking programme is following the moving nerve.  
 
 
7.1.3 Normative sciatic nerve excursion during a modified SLR 
test 
 
The data that were collected in the reliability study were utilised to assess the normative 
ranges of movement and any trends in normal nerve excursion during the modified side 
lying SLR test9. 
7.1.3.1 Methods 
 
The participants used, equipment and overall procedure was identical to the reliability 
study (section 7.1.2.1, page 152), except that on the second attendance transverse plane 
movement was also analysed.  
                                                 
9 This study was published in Manual Therapy in 2014 see appendix 31 
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Procedure for Transverse plane movements 
 
The sciatic nerve was located in the posterior thigh in its transverse view with the 
ultrasound transducer. The nerve was located on a line between the ischial tuberosity 
and the greater trochanter (Karmakar et al., 2007) and 10 cms distal to the gluteal fold 
(Bruhn et al., 2008). The best image of the nerve in its transverse view was found by 
moving the transducer slightly up and down along the course of the nerve. The knee was 
extended in 2 stages; 90 to approximately 45˚ of knee extension and 45 to approximately 
0˚. The transducer was then rotated and the longitudinal images captured in 3 stages (as 
described in 7.1.2.1). 
 
Analysis 
Initially the plan for the analysis of the transverse images was simply to describe the 
direction of movement, and therefore it was not appropriate to perform a repeatability 
study using this data. However, subsequent to the data collection (collected in 2011), 
Boyd et al., (2012) published a paper describing how to analyse the data using this 
technique (described below). Repeatability of the technique for the tibial nerve found by 
Boyd et al., (2012) was ICC (SEM) 0.97 (0.42mm), 0.98 (0.47mm) for med/lat and 
sup/deep respectively). 
 
The transverse images were imported into image J ( Rasband, W.S., Image J, U. S. 
National Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997-
2012), and a manual outline of the borders of the nerve was made. The most central 
pixel (centroid) of the nerve was then identified (Alshami et al., 2009; Boyd et al., 
2012). The amount of transverse plane movement (med/lat and sup/deep) was calculated 
by comparing the centroid value in the last frame to that in the first frame. Over or under 
estimation was reduced by measuring the amount of subcutaneous movement (using the 
same centroid method) and subtracting it from the nerve motion. This process was 
performed for both knee movements (90-45° and 45 to 0°), and added together to give 
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the overall medial/lateral and superficial movements for knee extension from 90 to 0° 
for the two hip positions.  
 
The description of the analysis of the longitudinal images has been discussed in section 
7.1.2.1. 
 
Data Analysis 
Descriptive statistics were used to detail the amounts and direction of nerve excursion 
during the modified SLR. The longitudinal excursion data were analysed for normality. 
A paired T test was performed to determine if there were any statistically significant 
differences in longitudinal nerve excursion between 30° and 60° of hip flexion. A 
Pearson’s correlation was performed to see if there was any relationship between 
participants’ height, age and longitudinal nerve excursion. All analyses were performed 
using SPSS version 20. Since repeatability of the transverse plane movements had not 
been established for the researcher, descriptive statistics only were employed for this 
data. 
 
 
7.1.3.2. Results 
 
Transverse Movements 
 
The nerve moved superficially in 14/16 participants during the SLR in both 30 and 60° 
of hip flexion (30° hip flexion (HF) mean 4mm (SD 2.2), 60° HF mean 3.6mm (SD 2.3). 
For the remaining 2 participants, one had no superficial movement with 30° HF, and one 
participant had 0.5mm of deep movement with 60°HF. Lateral movement was the most 
consistent sideways movement with 10 participants moving laterally during the SLR 
with 30°HF, and 9 with 60° HF. However between hip positions, this was not consistent, 
i.e. the nerve may have moved laterally in 30° HF, but medially in 60° HF and vice 
versa (see fig 7.8). There was marked variation in direction of movement between 
individuals. 
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Fig 7.8 Transverse plane sciatic nerve movements 
 
Longitudinal movements 
As explained in page 147, the longitudinal excursion data were normally distributed 
(30° HF Shapiro Wilk p=0.2, 60° HF Shapiro Wilk p=0.78). The direction of nerve 
excursion in all participants was distal. Table 7.4 shows the large variability between 
participants in the amount of overall nerve motion. In addition it can be seen that large 
variability existed between the two hip positions. Overall there was a trend for a greater 
amount of movement at 60° HF compared to 30° HF. 
The results of the paired T test found that mean nerve excursion was significantly 
greater when the hip was pre-positioned in 60° flexion (mean nerve excursion 30° HF= 
9.9mm, 60° HF =12.4mm, mean difference 2.53mm, p=0.02, 95% confidence interval 
(C.I.) 0.4-4.6, standard error of mean 0.99).  
The Pearson’s correlation test showed non-significant correlation between participants’ 
height and excursion in either hip position (r= 0.23 and 0.41, p= 0.4 and 0.12 for 30° HF 
and 60° HF respectively), or age and excursion (r=0.06 and -0.32, p= 0.83 and 0.23 
respectively). 
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 Nerve excursion (mm) Difference  
Subject no Hip 30° flexion Hip 60° flexion  
1 10.25 5.11 -5.14 
2 13.95 17.92 3.97 
3 10.01 10.19 0.18 
4 7.41 7.58 0.17 
5 10.37 8.51 -1.86 
6 9.5 11.9 2.4 
7 9.41 7.21 2.2 
8 8.61 10.24 1.63 
9 8.74 12.3 3.56 
10 6.93 10.5 3.57 
11 10.42 18.34 7.92 
12 10.64 14.04 3.4 
13 10.98 12.7 1.72 
14 6.42 14.87 8.45 
15 14.69 17.49 2.8 
16 10.32 20.21 9.89 
     
Mean (SD) 9.92 (2.20) 12.44 (4.42)  
 
Table 7.4 Longitudinal nerve excursion. Total amount of movement is shown for the whole range of 
knee extension from 90 to 0° flexion. The direction of movement in all participants was distal. Minus 
values indicate that there was less movement with 60° hip flexion  
 
 
7.1.3.3.Discussion  
 
The results of this study suggest that there is wide variation in longitudinal and 
transverse plane movement in asymptomatic individuals. Whilst transverse plane 
movement was measured, the technique was not considered to be accurate because of 
the changing shape and at times loss of outline of the nerve, and therefore the directions 
of movement, rather than the actual amounts of movement will be discussed further. A 
similar technique was used by Tagliafico et al. (2012) for measuring cross sectional area 
of the sciatic nerve in the mid-thigh. Relatively small measurement error (SDD= 13%) 
was found, however static images were obtained, and changes to the shape of the nerve 
during limb movements may increase measurement error. Boyd et al., (2012) found the 
technique to be repeatable during ankle dorsiflexion, but this was for measurements of 
the tibial nerve at the knee. The nerve here is more superficially located; hence the 
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resolution of the nerve may be enhanced compared to the sciatic nerve in the thigh. 
Indeed, in the present study, observation of the transverse plane images of nerves which 
were more superficially located (< 4 cms depth) appeared to better represent the 
transverse plane movements measured with the centroid method. 
 
Most nerves (14/16) moved superficially when the knee was extended. Boyd et al., 
(2012) found a consistent superficial movement of the tibial nerve measured at the 
popliteal fossa during ankle dorsiflexion with the limb positioned in SLR. Whilst the 
location of the nerve and movements imposed were different to the present study, the 
results together suggest that mostly nerves move superficially when the nerve bed is 
lengthened in asymptomatic participants. It is not clear why the sciatic nerve in the thigh 
should move more superficially, but could be related to relative position of the nerve to 
the posterior femur or knee joint, or muscular effects on the nerve as the hamstrings are 
lengthened.  
 
A greater proportion of nerves moved laterally, although medial movement occurred in 
some participants, suggesting that side to side movement during a modified side lying 
SLR test is variable. This may be related to the location of the sciatic nerve in the thigh 
compared to the tibial nerve at the knee. A more medially positioned tibial nerve 
compared to sciatic nerve would exert a  medial pull as the knee extended. In addition, if 
the sciatic nerve branches closer to the knee, there may be a stronger lateral pull from 
the division of the common peroneal nerve. Another possible reason could be due to 
differences in soft tissue characteristics within the thigh; the exact effects of these are 
unknown. Boyd et al., (2012) also found some variation in medial and lateral movement 
of the common peroneal nerve at the knee during ankle movements, but not the tibial 
nerve. This may further support the effect of a higher or lower branching common 
peroneal nerve, since the direction of pull might be influenced by the region that the 
nerve branches. Together with the present study’s data it suggests that individual 
variation in side to side movements of nerve occurs during a SLR manoeuvre. 
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The mean longitudinal nerve excursion found at 30° of hip flexion was 9.9mm, and at 
60° hip flexion was 12.4mm. A wide range of sciatic nerve excursion during SLR has 
been found in the literature, varying from 4 mm (Goddard and Reid, 1965) to 28mm 
(Coppieters et al., 2006). However such large ranges in variation are almost certainly 
due to participants used (cadavers), location of measurement of nerve excursion, and the 
order in which the joint movements occur. Likewise, Ellis et al., (2012) and Boyd et al., 
(2012) used the same frame-by-frame cross correlation method to measure sciatic nerve 
excursion (Ellis et al., 2012) during the slump test and tibial and common peroneal 
nerves (Boyd et al., 2012) during a modified SLR test. The differences in values found 
are not comparable to the present study since the location of nerve studied, combination 
of movements performed and nerves analysed (Boyd et al., 2012) are substantially 
different. Hence it is more appropriate to analyse comparable trends between studies. 
The sciatic nerve always moved towards the extending knee. This is consistent with a 
number of studies which have found that the direction of nerve movement is towards the 
direction of the moving joint in both upper (Erel et al., 2003) and lower limb studies 
(Boyd et al., 2012; 2013; Coppieters et al., 2006; Goddard and Reid, 1965).  
 
As mentioned, variability in longitudinal excursion between individuals is large. In the 
present study excursion ranged between 6.42mm to 14.69 mm with the hip flexed to 30° 
and from 5.11mm to 20.21mm at 60°. Such variability has also been found in previous 
studies. Goddard and Reid (1965) found that the sciatic nerve at the pelvis varied from 
4-7.5 mm during SLR. Whilst the range of movement was not given by Boyd et al. 
(2012), the relatively high standard deviation (e.g. in hip flexion, ankle dorsiflexion 
produced a mean excursion of 0.66mm, with a SD of 0.25mm) suggests a wide variation 
in range between individuals. It is not currently known why such large variations exist. 
This current study found no significant correlation between height or age and excursion. 
However, such a small sample size and skewed younger age group in this study may 
have impacted upon the robustness of such analyses and as such requires more attention 
in future larger scale studies. Whilst the region of the nerve analysed may have had a 
bearing on the amount of nerve excursion because the nerve is more compliant around 
the moving joint (Phillips et al. 2004), participants were measured in the same location, 
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and therefore the influence on distance from the joint is likely to have affected the 
variability between individuals. Nerves exhibit more stiffness behaviour where they 
branch (Millesi et al., 1995); it is possible that in some individuals where branching of 
the sciatic nerve into common peroneal and tibial nerves occurred more proximally, the 
nerve may have moved less than those whose nerve divided more distally. 
 
Looking at differences between nerve excursion between 30 and 60 °of hip flexion, it 
can be seen that in 8 out of 9 male participants, there was greater nerve excursion when 
the hip was flexed to 60° than when it was flexed to 30°. Only subject 5 had less 
excursion at 60° of hip flexion than at 30°. Five out of 7 female participants also had 
more sciatic nerve movement at 60° compared to 30° of hip flexion. Therefore overall 
(in 13 participants), there was a trend to see larger amount of nerve excursion with the 
hip more flexed. This was not expected, as with greater range of hip flexion, it was 
hypothesised that more strain and less excursion of the sciatic nerve would have 
occurred, since increasing the nerve bed length normally has this biomechanical effect 
(Boyd et al., 2012; Ellis et al., 2012; Gilbert et al., 2007b; Coppieters and Butler, 2008). 
However, these studies looked at increasing the length of the nerve bed by adding 
neurodynamic components more distally or proximally, rather than comparing nerve 
strain and excursion in two different positions of hip flexion. In support of the present 
study’s findings, Dilley et al. (2003) found that during contralateral cervical flexion, 
proximal excursion of the median nerve in the distal upper arm was greater at 90° 
(greater pre-loading) than 30° shoulder abduction. 
 
There are a few possible explanations for why this was found in the present study. 
Firstly, it is known that the first adaptation to movement is for the nerve above and 
below the moving joint to lessen their waved course by uncoiling (Millesi, 1986). Since 
the trunk and head were not fully flexed in the present study (as in the slump test), the 
nervous system was able to adapt by uncoiling proximally to the knee. With increasing 
range of hip flexion, the uncoiling may have fully occurred, and therefore movements of 
the knee resulted in a greater distal pull by the knee joint, and an increase in excursion. 
However, some individuals did not show this pattern of movement; for some, less 
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excursion occurred with the hip more flexed. This could reflect a difference in the 
resting slack of the nerve between individuals. If more uncoiling occurred with the hip 
flexed to 30°, then greater amounts of excursion would have been reached earlier, 
meaning that at 60° of hip flexion, the most adaptation to further movement would be by 
lengthening, and hence a reduction in nerve excursion would be seen compared to 30°. 
However, ultimately if the SLR had been performed in greater amounts of hip flexion, it 
is likely that a point would have been reached in all individuals, where less excursion 
would have been seen. Greater ranges of hip flexion were not analysed in this study 
since it was expected that many participants in the symptomatic study would be unable 
to be positioned in SLR with hip flexion greater than 60° due to pain.  
 
Limitations 
The limitations discussed on page 151 are relevant to the normative examination of the 
study’s data, but in addition some specific factors are pertinent to this section of the 
study. The SDD for the longitudinal nerve movements for 30 and 60° of hip flexion 
were 1.9mm and 2.4mm. Therefore, differences greater than these were needed to 
ensure a 95% chance that the differences in measurements were not due to measurement 
error. Since the considered differences in this current study were between the 2 hip 
positions, the higher of the 2 SDD measurements must be utilised. Looking at the 
individual differences between the 2 hip positions, 9 out of 16 participants had 
differences greater than 2.4mm, indicating that the differences were not attributable to 
error. However, differences in the remaining 5 participants were 2.4mm or less. This, 
together with the relatively small number of participants in this study means that caution 
should be taken before extrapolating to the greater population.   
 
Difficulty in the centroid technique used for transverse plane movements were found 
where the outline of the nerve was less clear, or where the nerve changed shape 
considerably between the first and last frame in the image sequence. In the first instance, 
informed estimates were made on the outline. In the latter case, it is possible that errors 
were made in calculating the amount of movement because the centroid would be in a 
different part of the nerve when the nerve shape changed considerably.  
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7.1.3.4. Conclusion 
Longitudinal sciatic nerve excursion during a modified SLR with knee extension in side 
lying in asymptomatic participants is variable in terms of actual amounts of nerve 
excursion. The direction of movement in all participants was distal, supporting previous 
data which has demonstrated that nerve excursion (for the nerve on the lengthened 
aspect of the joint) always moves in the direction of the moving joint. In some 
participants greater excursion occurred with the hip positioned in greater amount of 
flexion, suggesting differences in baseline coiling of the underlying nerves, and possibly 
differences between individuals in their underlying compliance. Transverse plane 
movement showed even greater variability, but it is not clear whether such variability is 
due to a true variation between individuals or due to measurement error. 
The next section details the repeatability studies for the other 2 outcome measures used 
in the present study; vibration and pressure pain thresholds10.  
 
 
7.2 Repeatability of Vibration and Pressure Pain Threshold Testing 
 
As discussed in chapter 5, vibration thresholds (VTs) give an indication of the 
conduction of the large diameter afferent fibres. Pressure pain thresholds (PPTs) are a 
semi-objective measure of an individual’s pain response. Both have been shown to be 
repeatable measures (Antonaci et al., 1998; Felix and Widerström-Noga, 2009; Halonen, 
1986; Hilz et al., 1998; Persson et al., 2004; Sterling et al., 2000; Vanderweeën et al., 
1996), but for the purposes of the present study, it was essential to demonstrate that the 
current researcher was able to use these pieces of equipment repeatably, and with as 
small amount of error as is possible in order to ensure that any changes that occurred in 
the clinical study were associated with the treatment technique and not measurement 
error. 
 
                                                 
10 These studies were presented at IFOMPT 2012 conference in Quebec, Canada (see appendix 32 for full 
details) 
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7.2.1. Method  
 
Participants and Recruitment 
Eleven participants (6 females, mean (SD) age 37.64 years (11.4) see table 7.5 for 
demographics) between the ages of 18 and 65 complaining of spinally referred leg pain 
were recruited through University of Brighton email, and posters displayed around the 
University Campus at Eastbourne. Participants were asked to refrain from taking 
caffeine, alcohol and any over the counter analgesics for 24 hours prior to testing as this 
may have influenced the PPT and VT measurements.  
 
Inclusion criteria were that their leg pain was due to referral of pain from their lumbar 
spine, had been present for at least three months, and that they were not currently 
undergoing any treatment for their pain. Exclusion criteria included any serious spinal 
pathology, systemic illness (such as cancer, diabetes or rheumatoid arthritis), any known 
neuropathy or were pregnant. 
All participants were asked to read an information sheet and sign a consent form if 
happy to proceed (appendix 16) 
Ethical approval was gained from the Faculty of Health and Social Sciences Research 
Ethics and Governance Committee at the University of Brighton (appendix 17). 
 
Equipment 
A Vibrameter (Somedic AB, Sweden) was used to assess the VT of each participant. 
The tissue displacement range was 0.1-400µm and frequency was set at 100Hz ( x2 
AC).  
 
The tracker freedom wireless algometer (J Tech Medical Salt Lake City, U.S.A.) was 
utilised to assess pressure pain thresholds. The algometer has a 1cm² metal tip which is 
applied perpendicular to the testing area, and a pacer which allows the rate of pressure to 
be controlled at 1kg/sec. The participants press a hand plate which freezes the value at 
the point of change of pressure to discomfort.   
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Procedure 
The area was screened for privacy and each participant was asked for details of their 
current referred leg pain problem (onset, previous episodes, previous treatment, pain 
levels and effect of movements on pain level and duration of pain) as well as for any 
previous history that may have limited them from participating in the study (as above).  
 
Participants were asked to wear shorts and a vest top. Height and weight of each 
participant was measured. Participants lay supine on a plinth and neurological integrity 
tests were performed by testing light touch sensation, reflex and muscle power of the 
lower limbs. In addition a number of tests were conducted to ensure that the leg pain 
was referred from the lumbar spine. These consisted of lumbar spine active movements, 
lumbosacral passive accessory intervertebral movements, and SLR or slump test. If the 
subject’s symptoms were not reproduced on these tests, they were excluded from the 
study as the symptoms may not have been referred from the lumbar spine. 
Participants then picked a piece of paper from a plastic bag which contained 10 pieces 
of paper with the letter V written on them and 10 with the letter P. If participants 
selected a letter V, then VTs were performed first and if they selected a letter P, PPTs 
were performed first. 
 
Vibration testing 
Participants were asked to lie prone on a plinth and a practice VT was obtained from the 
unaffected foot at the base of the plantar surface of the first metatarsal to familiarise 
each participant to the sensation. The probe was applied perpendicular to the body part 
and the weight of the probe rested fully on the participant. The vibration stimulus was 
increased until the participant first felt the stimulus and at this point the researcher was 
informed and the reading noted. The stimulus was elevated further, and then reduced 
again until the participant indicated to the researcher that they could no longer feel the 
stimulus. Once this was performed satisfactorily, the VT readings were taken from the 
affected base of the plantar surface of the first metatarsal. This process was repeated 
until three vibration perception (VPT) and three vibration disappearance values (VDT) 
were recorded. The participant was then asked to lie on their unaffected side and VT 
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readings taken from the lateral malleolus on their affected side. These sites represented a 
portion of the sensory supply of the lumbosacral plexus (Drake et al., 2005).  
 
Participants were asked to inform the researcher if the probe was uncomfortable as 
Hagander et al. (2000) found that pressures over 100g were uncomfortable. Although 
the resting probe is 650g, no participants complained of discomfort at either of the 
testing sites. 
 
 Pressure Pain Threshold Testing 
 
PPT Sites 
PPTs were taken from the middle portion of deltoid on the unaffected side (this site was 
chosen because in the clinical study a change to this measurement may reflect a 
systemic pain relieving effect), the tibial nerve behind the knee and central point of 
gastrocnemius on the affected side (supplied by the lumbosacral plexus, predominantly 
sural and/or posterior cutaneous nerve of the thigh (Palastanga et al., 2012). To ensure 
that the same part of gastrocnemius was taken for each subject, the distance from the 
knee crease to the heel was measured, and a point marked one third of this distance from 
the knee crease.  
 
PPT Procedure 
Participants were asked to lie in prone and a practice PPT was taken from the unaffected 
leg over the gastrocnemius belly to familiarise the participant to PPT. 
 
Participants were asked to lie on their affected side and the probe was applied 
perpendicular to middle portion of deltoid, and the pressure applied through the probe 
by the researcher at the rate indicated by the pacer. Participants were asked to push the 
hand plate when the sensation of pressure changed to one of discomfort. The participant 
was then asked to lie prone and the same procedure repeated for the tibial nerve behind 
the knee, before moving on to the gastrocnemius point. Two further readings were taken 
of each, giving a total of three for each site. 
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A break of 30 minutes between testing procedures then occurred, before the testing was 
repeated in the same way. This was to reflect the time between testing that would occur 
in the symptomatic study.  Participants were asked to remain in the human movement 
laboratory for this period of time. They were offered water or juice to drink, but not 
caffeine as this may have affected the VT measurements.  
 
Analysis 
VTs were assessed by taking the three readings of VPT, the three readings of VDT and 
then taking a mean value of the 6 values. This is called the ‘method of limits’ and 
enhances the reliability of the measures (Goldberg and Lindblom, 1979; Halonen, 1986). 
 
The PPTs were analysed by looking at the mean of all three readings for each site, the 
mean of the first and second reading and the mean of the second and third readings, as it 
has not been well established as to which method is most robust. 
 
Repeatability of both techniques was assessed by looking at ICCs (2, 1), confidence 
intervals and standard error of measurements using SPSS software version 18. Smallest 
detectable differences (SDD) were calculated using the equation SDD = 1.96 x √2 x 
SEM (Schuck and Zwingmann, 2003). The results from the SPSS spread sheets can be 
found in appendix 29 and attached CD. 
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7.2.2. Results 
 All participants recruited were included in the study. Table 7.5 gives a breakdown of 
their characteristics. 
 
Table 7.5 Demographic data for participants. Note participants 2, 4 and 10 have BMI over 26 kg/m2 
 
Vibration Thresholds 
The values for VTs for each subject for test 1 and test 2 are shown in table 7.6    
SUBJECT VT TEST1 LM VT TEST2 LM VT TEST1 IST MT VT TEST2 IST MT 
1 0.858 0.872 3.117 3.132 
2 0.603 0.525 3.533 3.662 
3 0.473 0.478 0.485 0.508 
4 0.487 0.433 0.428 0.395 
5 0.162 0.132 0.185 0.203 
6 0.302 0.303 0.377 0.49 
7 0.472 0.277 0.602 0.703 
8 0.393 0.427 0.397 0.54 
9 0.375 0.267 0.36 0.357 
10 0.422 0.448 0.64 0.588 
11 0.488 0.445 2.507 2.943 
Mean 0.458 0.419 1.148 1.229 
SD 0.175 0.190 1.250 1.312 
 
Table 7.6 VT readings (µm) (LM = lateral malleolus, 1ST MT=plantar surface of first metatarsal) 
Subject 
number Age Gender 
Height 
(m) 
Weight 
(kg) BMI 
Leg 
affected 
History of 
leg pain 
VT or PPT 
first 
1 59 F 1.6 64 25 R  55 years VT 
2 46 M 1.18 136 97.67 L  2 years   PPT 
3 25 M 1.81 61 18.62 R  4 years PPT 
4 54 F 1.64 87 32.35 L  20 years PPT 
5 34 F 1.6 62 24.22 L 1 year PPT 
6 42 M 1.71 67 22.91 L 20 years VT 
7 23 F 1.76 62 20.02 R 6 months VT 
8 32 M 1.88 85 24.05 R 4 years VT 
9 33 F 1.65 57 20.94 L 3 years VT 
10 34 F 1.74 81 26.75 R 5 years VT 
11 32 M 1.95 92 24.19 L 2 years   VT 
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Statistical analysis 
Normality plots were performed on the data and it was found that the data for the lateral 
malleolus were normally distributed (Shapiro Wilk p=0.33 and p=0.15 for test 1 and test 
2 respectively), but for the first metatarsal were not normally distributed (Shaprio Wilk  
p= 0.001 and 0.000 respectively). Therefore, all VT data were log transformed which 
successfully normalised the data, and ICCs performed on the transformed data. ICCs for 
VT for lateral malleolus were 0.89 (95% C.I. 0.66-0.97) and for the first metatarsal ICC 
was 0.99 (C.I. 0.96-1). Since the data was log transformed, the SEM were not in the 
same units of measurement and would not make sense in relation to the raw data. 
Unfortunately it was not possible to inverse log the SEM to revert them back into 
meaningful measurements, and therefore they were expressed as a SEM of the mean of 
the log transformed data, and expressed as a percentage. SEM of the mean were 9.1% 
for the lateral malleolus and 5.2% for the first metatarsal. SDD were calculated from the 
SEM, and also expressed as the mean of the transformed data and were found to be 
25.1% for the lateral malleolus site, and 14.4% for the first metatarsal site.  
Bland Altman plots were undertaken to assess for any bias occurring between test 1 and 
test 2 (figs 7.9 and 7.10). A good spread around zero was found for both plots indicating 
good agreement (Rankin and Stokes, 1998). However, for the first metatarsal, a general 
increase in scores was found on the second reading. One of the data points (subject 7) 
lies outside the 95% lower limit of agreement in fig 7.9, and one of the data points lie 
outside the upper limit of agreement in fig 7.10 (subject 11).  
 
180 
 
 
Fig 7.9. Bland Altman plot of vibration thresholds at the lateral malleolus for tests 1 and 2 
 
 
 
Fig 7.10. Bland Altman plot of vibration thresholds at the plantar surface of the 1st metatarsal for tests 
1 and 2 
 
 
Pressure Pain Thresholds 
Since there was debate in the literature of a best method to ascertain the most accurate 
PPT readings, the data was analysed using different methods. The mean of all 3 
readings, the mean of the mean of 1st and 2nd readings and the mean of 2nd and 3rd 
readings were all analysed and the values for each subject are shown in tables 7.7 to 7.9. 
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SUBJECT 
PPT DELT TEST 
1 M3 
PPT DELT TEST 
2 M3 
PPT DELT TEST 
1 M1+2 
PPT DELT TEST 
2 M1+2 
PPT DELT TEST 
1 M2+3 
PPT DELT 
TEST 2 M2+3 
1 2.97 3.77 2.8 3.55 3.05 4.05 
2 6.4 5.9 6.65 5.85 6.25 6.05 
3 3.93 3.5 3.9 3.4 3.6 3.45 
4 6.27 5.87 6.6 5.95 6.25 5.7 
5 5.63 5 5.75 4.55 5.6 5.35 
6 4.1 4.8 4.25 4.95 3.85 4.9 
7 2.5 2.27 2.7 2.15 2 2.2 
8 6.57 5.63 6.75 5.3 6.4 5.9 
9 2.43 3.37 2.45 2.95 2.5 3.6 
10 4.5 4.23 4.6 4.35 4.15 4.05 
11 4.37 5.53 4.55 5.35 4.25 5.9 
Mean 4.52 4.53 4.64 4.4 4.35 4.65 
SD 1.53 1.2 1.62 1.24 1.56 1.27 
 
Table 7.7 PPT readings (Kg) for deltoid. M3= mean of all three readings, M1+2= mean of 1st and 2nd 
readings, M2+3- mean of 2nd and 3rd readings for test 1 and test 2 
 
 
SUBJECT 
PPT TN TEST 1 
M3 
PPT TN TEST 2 
M3 
PPT TN TEST 1 
M1+2 
PPT TN TEST 2 
M1+2 
PPT TN TEST 1 
M2+3 
PPT TN TEST 2 
M2+3 
1 4.47 6.2 4.15 6.1 4.75 6.6 
2 4.53 5.33 4.5 5.15 3.8 5.6 
3 4.07 4.13 4.2 4.05 4 4.1 
4 2.73 3.8 2.25 3.55 3.3 4.15 
5 3.87 4.13 3.75 4.25 3.9 4.25 
6 3.43 3.8 3.4 3.65 3.6 4 
7 1.63 1.47 1.95 1.55 1.45 1.4 
8 7 5.3 7.9 5.1 5.85 5.5 
9 3 3.47 3.1 3.3 2.95 3.5 
10 5.47 4.73 6 5 4.6 4.4 
11 5.57 6.97 5.05 6.85 6.25 6.7 
Mean 4.16 4.48 4.2 4.41 4.04 4.56 
SD 1.5 1.48 1.69 1.45 1.33 1.5 
 
Table 7.8 PPT readings (Kg) for tibial nerve (TN) in the popliteal fossa. M3= mean of all three 
readings, M1+2= mean of 1st and 2nd readings, M2+3- mean of 2nd and 3rd readings for test 1 and test 2 
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SUBJECT 
PPT GAST TEST 
1 M3 
PPT GAST TEST 
2 M3 
PPT GAST TEST 
1 M1+2 
PPT GAST TEST 
2 M1+2 
PPT GAST TEST 
1 M2+3 
PPT GAST TEST 
2 M2+3 
1 5.87 5.53 6 5.8 5.3 5.1 
2 8.2 7.4 8.4 7.7 7.9 7.2 
3 4.33 4.23 4.35 4.1 4.15 4.35 
4 4.33 4.73 3.8 4.5 4.75 5.2 
5 3.57 4.07 3.8 4.2 3.2 4 
6 4.4 4.83 4.25 4.9 4.5 4.8 
7 1.57 1.57 1.55 1.7 1.35 1.7 
8 9.17 7.33 9 7.9 8.9 6.95 
9 3.17 3.7 3.25 3.5 2.9 3.9 
10 2.97 3.2 3.15 3.3 2.75 3.2 
11 5.83 6.8 5.8 6.7 5.45 6.7 
Mean 4.86 4.85 4.85 4.94 4.65 4.84 
SD 2.27 1.81 2.26 1.92 2.23 1.68 
 
Table 7.9 PPT readings (Kg) for gastrocnemius. M3= mean of all three readings, M1+2= mean of 1st 
and 2nd readings, M2+3- mean of 2nd and 3rd readings for test 1 and test 2 
 
Statistical analysis 
All data was normally distributed (Shapiro Wilk test all greater than 0.05), and therefore 
ICCs (2,1) were performed on the data. Table 7.10 shows the ICCs, confidence intervals 
and SEM for PPTs for each method used. 
 
Region  Mean Used ICC 95% C.I. SEM SDD 
Deltoid of all 3 0.87 0.61-0.96  0.52 1.44 
Deltoid of 1 and 2 0.84 0.54-0.96  0.57 1.58 
Deltoid of 2 and 3 0.85 0.55-0.96  0.54 1.50 
Tibial nerve of all 3 0.78 0.4-0.94  0.69 1.91 
Tibial nerve of 1 and 2 0.66 0.16-0.89  0.95 2.63 
Tibial nerve of 2 and 3 0.9 0.65-0.97  0.52 1.44 
Gastrocnemius of all 3 0.94 0.79-0.98  0.55 1.52 
Gastrocnemius of 1 and 2 0.96 0.88-0.99  0.43 1.19 
Gastrocnemius of 2 and 3 0.9 0.7-0.97  0.63 1.75 
 
Table 7.10 ICCs, C.I. and SEM for PPT readings 
 
Different methods were best suited for different sites. Since the overall best method 
(considering that only one method was suitable for all sites, rather than different 
183 
 
methods for different sites) appeared to be the mean of the 2nd and 3rd measure11. Bland 
Altman plots were plotted for this method (figs 7.11-7.13). The plot for deltoid (fig 
7.11) shows a spread around zero, with no outliers. However for the tibial nerve whilst 
there are no points outside of the limits of agreement, there is a general trend for greater 
scores on the second test than the first test. A similar trend is shown for PPT of 
gastrocnemius. 
 
 
Fig 7.11 Bland Altman plot of PPTs taken from deltoid using mean of  2nd and 3rd readings  for test 1 
and test 2 
 
 
Fig 7.12 Bland Altman plot of PPTs taken from tibial nerve using the mean of the 2nd and 3rd readings  
for test 1 and test 2 
                                                 
11 Despite the slightly higher error measures for gastrocnemius, the ICC and 95% CI were still considered 
sufficiently high 
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Fig 7.13 Bland Altman plot of PPTs taken from gastrocnemius using the mean of the 2nd and 3rd 
readings  for test 1 and test 2 
 
 
7.2.3 Discussion 
 
The results of this study show that vibration threshold testing and PPTs on participants 
with spinal referred posterior leg pain are repeatable within a 30 minute retest period. 
The rest of this section will be divided specifically into discussion of the VT results and 
PPT results.   
 
Vibration Threshold Testing 
ICCs for VT at the first metatarsal were 0.99 and at the lateral malleolus 0.89. These 
values are considered to show excellent agreement (Fleiss, 1986). The percentage SEM 
compared to the mean were 9.1% and 5.2%, for the lateral malleolus and first metatarsal 
respectively, and SDD was 25.1 and 14.4 % for the 2 sites respectively. Such percentage 
error would reveal an SEM of around 0.04µm and 0.06µm and SDD of 0.17µm and 
0.11µm for lateral malleolus and first metatarsal respectively. Therefore, relatively large 
changes (compared to the mean) would be required to show change (in 95% of cases) 
after an intervention to ensure that the difference is not related to error alone. 
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The findings of this study are supported by a number of studies (Felix and Widerström-
Noga, 2009; Halonen, 1986; Hilz et al., 1998). Felix and Widerström-Noga (2009) 
found ICC values to be 0.87 and 0.9 in 8 different sites in both asymptomatic and 
symptomatic (individuals with spinal cord injury) participants respectively. Hilz et al. 
(1998) found a high short term retest reliability in 530 asymptomatic individuals 
(Spearman 0.87<Rs<0.99) indicating a good to excellent relationship between tests. 
Slightly lower correlation re-test reliability values (r=0.77) were found for 78 
individuals with diabetes (Valk et al., 2000). Importantly SDD were found to be in the 
region of 9%, these are the same as those found for the lateral malleolus but higher than 
the first metatarsal.  
 
Taken together the strength of evidence suggests that VTT is repeatable for both 
measuring sites, but with relatively high error measures (25% and 14% for each site 
respectively). 
 
Pressure Pain Threshold 
Since there appeared to be no superior method of establishing PPT from the literature, it 
was decided to establish the reliability for three separate methods; taking the mean of all 
3 readings for each site, the mean of the first and second reading, and the mean of the 
second and third reading. The best ICC, SEM and SDD values for the deltoid site were 
established for the mean of 3 readings (ICC 0.87, SEM 0.52, SDD 1.44), for tibial nerve 
were the mean of the second and third (ICC 0.9, SEM 0.52, SDD 1.44), whilst for 
gastrocnemius it was the mean of the first and second readings (ICC 0.96, SEM 0.43, 
SDD 1.19). Such values indicate that agreement for deltoid was good, and excellent for 
the other two sites (Fleiss, 1986). However, using 3 different methods to assess PPT in 
each of the 3 sites, would not be feasible in the clinical study, and therefore a pragmatic 
decision was required. 
 
The ICC values for gastrocnemius were above 0.9 for all methods, although the lowest 
ICC and highest SEM values were for using the second and third readings. The deltoid 
site also showed similarities in all three measures, but the lowest ICC and highest error 
186 
 
were for the first and second readings. However, for tibialis anterior ICC dropped from 
0.9 for the mean of 2nd and 3rd to 0.78 for the mean of 3 readings, and further to 0.66 for 
the mean of the first and second readings. Therefore, the only acceptable measure for 
tibialis anterior site was the mean of the 2nd and 3rd readings. Since acceptable ICC and 
error measures were found for the other 2 sites using this method, the most acceptable 
method to carry over into the clinical study was the mean of the 2nd and 3rd readings. 
Persson et al., (2004) also recommended ignoring the first of four PPT reading in a 
study on 27 healthy female volunteers tested on deltoid and upper fibres of trapezius. 
This reading was found to be significantly lower than the other readings, with no other 
significant differences being found on subsequent measures.  
 
This study suggests that intra tester repeatability is good to excellent over deltoid, 
gastrocnemius and the tibial nerve behind the knee. High intra tester reliability of PPT 
testing has also been found by a number of authors (Antonaci et al., 1998; Persson et al., 
2004; Sterling et al., 2000; Vanderweeën et al., 1996). 
 
Vanderween et al., (1996) found that intra tester reliability of 14 different trigger point 
areas around the body ranged from ICC of 0.64-0.96, which represents moderate to 
excellent reliability (Fleiss, 1986), but did not indicate which sites showed moderate 
ICCs and which were excellent. In addition, no error or CI data was presented and so 
direct comparison between these results and the present study are limited. A similar 
spread of ICC values were found by Persson et al. (2004), (ICC 0.7-0.94), depending on 
whether each reading was compared with each other or a mean of 3. However, it was 
difficult to decipher which ICC corresponded to which comparison in measurements. In 
addition, the study participants were all female, and therefore the results cannot be 
compared precisely to the results of the present study. Almost identical intra tester ICC 
values to Persson et al.’s (2004) were found for PPT s around the head and shoulder 
region by Antonaci et al., (1998). The ICCs ranged from 0.75 to 0.91, the lowest being 
in masseter muscle, the highest over the greater occipital nerve.  
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The Bland Altman plots demonstrated that deltoid showed most even spread around 
zero, indicating good agreement between the first and second test (fig 7.11). Both tibial 
nerve and gastrocnemius plots, however showed a greater tendency for measures to be 
higher on the second test, indicating that in a repeated measures trial like the clinical 
study, any increases in PPT could be attributed to an adjustment in individual’s 
perception of PPT. However, taking the SDD into account when considering the effects 
of a rise in PPT post-intervention, would compensate for this effect.  
 
Choosing the method of taking the mean of the second and third measurements, the 
SDD of this study were 1.5, 1.44 and 1.75 kg respectively. When one considers the 
mean values for the PPTs obtained, these error measures are relatively high (33% for 
deltoid and tibial nerve and 37% gastrocnemius). Hence any differences in measures 
before and after the SLR intervention in the clinical study needed to be greater than 
these figures in order that a change could be attributed to a treatment effect and not 
error.  Compared to other studies, these values fall between those of Krouwel et al. 
(2010) and Willett et al. (2010) and Pentelka et al. (2012). Willett et al. (2010) found 
SDD values of 0.5 kg/cm² at the foot and 0.53 kg/cm² at the thigh, whilst Krouwel et al. 
(2010) also found low values for SDD (0.47 at a quadriceps site and 0.44 at a deltoid 
site). In contrast Pentelka et al. (2012) had higher SDD than the ones found in the 
present study (1.94 at deltoid, 2.55 in the lower leg and 2.53 in the foot). The reason for 
such wide variation in SDD is not clear. All participants in the 3 aforementioned studies 
used asymptomatic participants, but still showed marked variation in the SDD. 
Particpants in the present study had higher BMI readings and age than participants in 
Krouwel et al.’s (2010) study (mean age 26.43, BMI 22.54 Krouwel et al., 2010, 37.64 
years, BMI 30.61 current study). However, similar mean ages as the present study but 
lower BMI were found by both Willett et al., (2010) and Pentelka et al., (2012) (mean 
age 33.05, BMI 26.2 Willett et al., 2010, 37.63 years, BMI 23.9 Pentelka et al., 2012). 
This suggests that higher levels of error are not attributed to age or BMI. 
  
As indicated in chapter 5, the consideration of BMI has been taken into account by some 
when measuring PPTs (Letchuman et al., 2005). Three participants had BMI greater 
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than 26 kg/m² (participants 2, 4 and 10), and of these, 2 had greater than 32 kg/m² 
(participants 2 and 4). Such small numbers of participants meant that statistical analysis 
of changes in PPT related to BMI was not appropriate. Subject 2 had double the mean 
value of PPTs for gastrocnemius, and 33% higher mean values for deltoid, whilst PPT 
values for tibial nerve were about average. Subject 4 had elevated deltoid PPTs of 
around 33%, but lower than average PPTs for the tibial nerve and average values for 
gastrocnemius. Subject 10 had average PPTs for gastrocnemius, very slightly higher 
values for tibial nerve, and lower than average values for gastrocnemius. Whilst these 
results cannot be considered strong evidence to support a change in PPTs with 
increasing BMI, subject 2 had a BMI of 97.7 and markedly higher PPTs for the two 
areas which have large amounts of soft tissue covering them. Subject 4 was just over 
Letchuman et al.’s (2005) cut off point and had considerably high deltoid values, but 
average values for gastrocnemius.  The results in this study suggest that an elevation in 
BMI may cause an elevation in PPT especially in soft tissue sites. However, to exclude 
participants with BMI over 26 kg/m² in a spinally referred leg pain population, would 
possibly exclude too large a number of representative individuals. In studies where 
participants with increased amounts of BMI are included, BMI should be accounted for 
in the statistical analysis 
 
To summarise, this study suggests that the use of PPTs in the locations chosen for the 
clinical study are repeatable, but with relatively high error measurements in the region 
of 33-37%. Whilst each site’s repeatability was better for different methods of analysis, 
the mean of the 2nd and 3rd readings was acceptable for all 3 sites. Hence the mean of the 
second and third readings was chosen in the clinical study. BMI may increase PPT at 
sites where there is a greater amount of soft tissue, and should be taken into account in 
studies where BMI is not an exclusion criteria.  
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7.3 Chapter Conclusion  
 
This chapter has provided evidence to support the use of the 3 outcome measures in the 
clinical study. Validity of the frame-by-frame cross correlation method for measuring 
nerve excursion demonstrated high levels of accuracy as compared to photography. 
Repeatability of the method was demonstrated for measuring longitudinal sciatic nerve 
excursion during a modified SLR in side lying. The repeatability of the transverse plane 
motion was not assessed, since the method of analysis published by Boyd et al. (2012) 
was not available until after data collection had taken place. However, a descriptive 
analysis of the results using a method where the nerve outline was drawn and movement 
analysed showed marked variability between asymptomatic individuals. Less variability 
was demonstrated for longitudinal nerve excursion, although differences were found 
between individuals. Some individuals had more nerve excursion with greater amounts 
of hip flexion, indicating that pre-tensioning the nerve does not always result in less 
nerve excursion. However, it is thought that if the hip had been flexed more, a point 
would have been reached where reduced nerve excursion (and relatively greater strain) 
occurred in all participants. 
VTT and PPT demonstrated acceptable repeatability for all measures at all sites. 
However there was a tendency for greater VT after the first reading at the lateral 
malleolus, although the differences were small. PPT at the tibial nerve and 
gastrocnemius also demonstrated an increase on the repeat test, and relatively high SDD. 
Such error measures were required to be taken into account in the clinical study.  
 
The next chapter details the clinical study that was undertaken as the main study for this 
PhD thesis. 
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Chapter 8 Straight Leg Raise treatment for individuals 
with spinally referred leg pain: exploring characteristics 
that influence outcome. 
The overall aim of the present study was to determine what effects  a 3 x 1 minute SLR 
tensioner treatment had on pressure pain thresholds, vibration thresholds and sciatic 
nerve excursion between 3 different sub-groups of individuals with spinally referred leg 
pain. In order for this to be achieved, individuals were first assessed by clinicians to 
establish suitability for the study and to appropriately sub-group. In addition, since a 
secondary aim was to assess if the presence of central sensitisation was different 
between the 3 groups and interacted with the effect of treatment, clinicians assessed 
participants to determine the presence of central sensitisation. By doing so, the 
researcher was blinded to each participant’s status. Participants then attended a second 
appointment where the effects of a SLR treatment were analysed using ultrasound 
imaging of the sciatic nerve during a side-lying SLR test,  VTs to assess nerve 
conduction of the large diameter afferents, and PPT to assess changes to pain sensitivity. 
Data collection occurred from August 2012 to September 2013. 
8.1 Method  
 
Study Design 
 
The study was an experimental, repeated measures design. 
 
 
Sample Size Analysis 
 
A power analysis was performed from the reliability nerve excursion data and indicated 
that a sample of 75 was required (25 in each group).  This number was based on a 20% 
effect size with a power of 0.8 and α of 0.05. The calculation was performed in Minitab 
(One Way ANOVA), where the 20 % size of the effect was 1.98mm and standard 
deviation was 2.2, based on the mean and standard deviation data from the repeatability 
study (mean 9.92). 
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Participants 
 
Participants fulfilled the inclusion criteria of referred leg pain in the posterior thigh 
and/or lower leg (in the lumbosacral nerve root distribution) with or without low back 
pain and under the age of 70 years without other medical problems such as diabetes, 
rheumatoid arthritis or other systemic disorders (see appendix 18 for full list of 
exclusion criteria). In addition, participants whose condition was considered to be severe 
or irritable (see appendix 26) were also excluded, to avoid exacerbating their symptoms 
during the study. Participants were recruited from both within and outside of the NHS to 
optimise numbers of participants. 
 
NHS participant recruitment 
Participants were recruited from the Physiotherapy waiting lists of 3 NHS trusts within 
Sussex, but the exact recruitment process was dependent on the trust. Two of the trust 
sent out letters of invitation (see appendix 20), information sheets and consent forms to 
potentially suitable patients alongside the standard Physiotherapy appointment letters. 
One trust telephoned patients directly, and if they expressed an interest in participating, 
the information sheet and consent form was posted or emailed out to them. Interested 
participants returned the signed consent form directly to the researcher. The researcher 
then contacted the Physiotherapists at the relevant Trust, who contacted the participants 
to organise their first Physiotherapy appointment. 
 
Non-NHS participants Recruitment  
Participants with spinally referred leg pain, who were not currently undergoing 
treatment for their pain, were also recruited via email within the University of Brighton, 
newspaper adverts in local weekly newspapers, social networking sites (Facebook and 
twitter) and posters displayed in various local establishments. The researcher discussed 
the study directly with any interested individuals and sent an information sheet and 
consent form for their consideration. Participants then contacted the researcher if they 
were still interested in participating in the study. 
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Ethical approval and Research Governance 
Ethical approval was gained from both the University of Brighton Faculty of Health and 
Social Science Research Ethics and Governance Committee and NHS ethics (NRES), 
with research and development approval from each of the three trusts (see appendices 21 
to 25). Regardless of the recruitment process, all participants were given an information 
sheet to read (at least 24 hours prior to consenting) and signed a consent form prior to 
their initial assessment by the Physiotherapist (appendices 18 and 19). 
 
Initial Procedure: Part 1 Physiotherapy Assessment 
 
Physiotherapists and training. 
The Physiotherapists (6) who performed the examination procedures were experienced 
clinicians (band 6 or above), with at least 4 years clinical experience. One had a 
postgraduate manual therapy qualification, and 3 were close to completing their 
postgraduate manual therapy qualification. Prior to the commencement of the study, the 
researcher attended each of the trusts on 2 occasions to discuss the study with the 
Physiotherapists and to go through the sub-grouping procedure and assessment of 
central sensitisation. One Trust asked for a third visit, to ensure that all Physiotherapists 
were comfortable and competent with the procedure. The Physiotherapists who assessed 
the patients at the University were current postgraduate students on the MSc 
Neuromusculoskeletal Physiotherapy programme, with a minimum of 4 years clinical 
experience. Training was given to each of these therapists on a one to one basis. 
 
Patient Assessment and sub-grouping 
Participants were seen either in the Physiotherapy Department of one of the 3 NHS 
Trusts or in one of the practical teaching rooms in the School of Health Professions, 
University of Brighton. Screens or curtains were placed around the participant to ensure 
privacy during the assessment. A full subjective and physical examination of the patient 
was performed by the physiotherapist. The procedure was the same as if the patient was 
attending for a standard Physiotherapy assessment. However, if participants complained 
of more than 2 signs of central sensitisation (pain for longer than 6 months (O'Neill et 
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al., 2007), widespread areas of pain (Jensen et al., 2010), hypersensitivity to warmth or 
cold (Berglund et al., 2002), and hypersensitivity to touch (Jensen et al., 2010; O'Neill et 
al., 2007), an additional examination of painful points was also performed by the 
Physiotherapist (see appendix 27). The Wagner algometer was placed on each of the 
points, and the pressure increased up to 4kg/cm². If more than 8 of the points were 
painful, the participants were considered to be centrally sensitised.  
 
The physiotherapist who assessed the patient then allocated the participants into one of 
the 3 groups: radiculopathy, radicular pain or somatic referred pain, based on 
predetermined criteria (Appendix 26). The participant was placed in the radiculopathy 
group if they had positive neurological integrity tests (myotomal weakness, sensory loss 
in a dermatomal pattern, and reduced reflex). Participants were allocated to the radicular 
group if they had negative neurological integrity tests, but a positive SLR or slump test 
(indicated by reproduction of the participant’s symptoms that was aggravated or relieved 
by a structural differentiation manoeuvre (e.g. ankle dorsiflexion/ release of ankle 
dorsiflexion)) +/- tenderness on 2 regions of nerve palpation. Individuals with somatic 
referred pain were identified by a negative neurological integrity test, negative SLR or 
slump test, and leg pain reproduced through stressing spinal structures e.g. on active 
movements of the spine and spinal passive accessory intervertebral movements 
(PAIVMS).  
 
The therapist then informed the researcher whether the participant fulfilled all inclusion 
and exclusion criteria and asked if they were happy to proceed (written, informed 
consent had already previously been given), and gave the participant’s contact details to 
the researcher. A form with the individual’s main assessment details (appendix 28) was 
completed and coded by the physiotherapist who assessed the patient. The individual’s 
name and contact details were completed on a separate form with their personal code. 
The 2 sheets were not compared until after the laboratory part of the study and analysis 
of the data. In this way, the researcher was blinded to the sub-group allocation until after 
the analysis of each participant was completed.  
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Psychosocial and disability Questionnaires 
Participants were given 5 questionnaires by the Physiotherapist to complete between the 
initial assessment and the laboratory procedure. If patients had queries or difficulties in 
completing the form, they were given support by the researcher when attending the 
laboratory for the second part of the study. The questionnaires consisted of the Fear 
avoidance belief questionnaire (FABQ), Tampa scale of kinesiophobia, Oswestry 
disability index (ODI), Depression, anxiety and stress scale (DASS), and pain 
catastrophising scale (PCS) (see appendices 6-10, and chapter 2.5.3 for rationale and 
details).  
 
Part 2 Laboratory study 
 
Participants attended the laboratory normally within one week of the initial assessment. 
Occasionally individuals were not able to attend for up to one month after the initial 
appointment, and in this case, individuals were asked to notify the researcher if there 
had been any change in their symptoms over the course of that time frame. All NHS 
patients were seen in the laboratory within a week of the initial physiotherapy 
appointment to ensure no disruption to their physiotherapy management. Where 
physiotherapists felt that participants needed to be seen again for their follow up 
physiotherapy appointment within one week, participants were excluded from the study. 
All data was collected by the researcher with help from a research assistant. 
 
Instruments 
 
For nerve excursion measurements 
A Titan ultrasound machine (SonoSite Ltd, Hitchin, UK) with a 5-10MHz linear array 
transducer was used to scan the sciatic nerve in the posterior thigh. An image grabber 
(Global lab image with a 25f/s capture rate) was connected to the video output of the 
ultrasound in order to digitally save image sequences captured by the ultrasound. 
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A universal goniometer was used to measure the position of the knee during the 
modified SLR. 
A purpose made jig was used to enable the hip to be positioned in 30 and 60° of hip 
flexion, and the knee allowed to move from 90° through to 0° (see fig 7.4). 
 
For Pressure Pain Thresholds 
 
The tracker freedom wireless algometer (J Tech Medical Salt Lake City, U.S.A.) was 
utilised to assess PPTs. The algometer has a 1cm² metal tip which is applied 
perpendicular to the testing area, and a pacer which allows the rate of pressure to be 
controlled at 1kg/sec. Participants press a hand plate which freezes the value at the point 
of change of pressure to discomfort.  
 
 
For Vibration Thresholds 
A Vibrameter (Somedic AB, Sweden) was used to assess the VT of each participant. 
The tissue displacement range was 0.1-400µm and frequency was set at 100Hz ( x2 
AC). 
 
Procedure 
Participants were reminded of the full procedure and informed that the procedure would 
take around one and a half hours. They were asked if they had any questions about the 
study, and if they were happy to proceed. 
 
Baseline measures 
All participants had their height and weight measured for additional demographic data 
by the research assistant. 
 
Vibration threshold Measures 
Participants were asked to lie prone on a plinth and a practice VT was obtained from the 
unaffected side on the plantar surface of the base of the first metatarsal. The purpose of 
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this practice session was to familiarise each participant with the sensation. The 
vibrameter probe was placed perpendicular on the base of the first metatarsal so that the 
weight of the probe rested fully on the area. The vibration stimulus was slowly increased 
until the participant felt the onset of vibration. The stimulus was then increased before 
being reduced again until the participant could no longer feel the sensation. Once a 
consistent measure (within 10% of each measure) had been demonstrated, VT readings 
were taken from the affected side on the base of the plantar surface of the first 
metatarsal. Three vibration appearance values and 3 disappearance values were taken. 
The participant was then asked to lie on their unaffected side and VT readings were also 
taken from the lateral malleolus of the affected side. All VT measures were taken by the 
researcher, and notated by the research assistant. 
 
Pressure pain threshold Measures 
PPTs were taken from the middle portion of the deltoid muscle on the unaffected side, 
the tibial nerve behind the knee, and a central point of gastrocnemius on the affected 
side. To ensure that the same part of gastrocnemius was taken for each subject, the 
distance from the knee crease to the heel was measured, and a point marked one third of 
this distance from the knee crease.  
 
Participants were asked to lie prone and a practice PPT was taken from the unaffected 
leg over the gastrocnemius belly and tibial nerve to familiarise the participant to PPT. 
Participants were then asked to lie on their affected side and the probe was applied 
perpendicular to middle portion of deltoid and the pressure applied through the probe by 
the researcher at the rate indicated by the pacer (1kg/sec). Participants were asked to 
push the hand plate when the sensation of pressure changed to one of discomfort. The 
participant lay prone and the same procedure was repeated for the tibial nerve behind the 
knee, before moving on to the gastrocnemius point. Two further readings were taken 
from each site, giving a total of three for each site. The researcher performed all PPT 
measurements. 
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For each subject the order in which the PPT or VT was performed was randomly 
allocated by asking the participant to pick a piece of paper out of a bag that contained 
equal numbers of papers with either a V or P written on. If V was selected, then VT was 
performed first.  
 
Sciatic Nerve Excursion 
The participant lay supine on the plinth and an ankle foot orthosis was placed on each 
foot, so that the ankle joints and rear foot were positioned in neutral.  The participant lay 
on their unaffected side on the jig. The hip joint was positioned over the hinge of the jig 
so that the initial hip position was 30° of flexion and the hip was secured. The knee was 
passively fully extended and maintained in this position and the position marked by 
drawing a line on the jig posterior to the heel (in line with the AFO). The underneath leg 
was straightened and secured with straps, and the trunk was secured to the back plate of 
the jig to keep the lumbar spine in neutral flexion/extension (see fig 7.4). The head and 
neck were positioned in neutral flexion/side flexion. The knee was then flexed to 90° 
(measured by the Universal goniometer) and the position marked on the jig in pencil as 
described above. The knee was then extended to 45°, 20° and full extension and 
positions were marked on the jig again as described.  
 
The ultrasound transducer was placed on the mid-posterior thigh (see fig 7.4), and the 
sciatic nerve was identified approximately 10 cms distal to the gluteal fold (Bruhn et al., 
2008) on a line between the ischial tuberosity and the greater trochanter (Karmakar et 
al., 2007). The transducer was orientated in the transverse plane and an ultrasound 
image of the sciatic nerve was acquired in cross section. The knee was passively 
extended in two stages by the research assistant; 1) 90° to approximately 45° of knee 
extension, and 2) 45° to full extension.  
 
The transducer was then rotated into the sagittal plane and an ultrasound image of the 
sciatic nerve in longitudinal section was acquired. The knee was passively extended by 
the research assistant in three separate stages; 1) 90° to approximately 45° of knee 
extension, 2) 45° to approximately 20° and 3) 20° to full extension. In this way, both 
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transverse and longitudinal movements of the sciatic nerve were captured by the 
ultrasound during SLR and concurrently saved digitally as image sequences by the 
attached image grabber. If pain was produced before full knee extension was reached, 
the knee movement was stopped at this point. This same terminal range of knee 
extension was used post-intervention, to ensure that any nerve excursion changes were 
not due to differences in final range of motion. All ultrasound scans were taken by the 
researcher. 
 
The subject’s hip was then positioned in 60° of flexion, and the full procedure was 
repeated in the same way as described above.  
 
Treatment procedure 
The SLR treatment was undertaken by the researcher, whilst the research assistant timed 
each set of mobilisations. Participants lay supine on the plinth with their ankles 
maintained in the AFO on both sides and the affected knee extended. The affected hip 
was flexed to the point of a change to symptoms (onset or increase in resting 
symptoms), or if there was no change in symptoms, to the point where the researcher 
could not further increase range of hip flexion due to resistance (R2). If symptoms were 
still not reproduced, medial rotation and adduction were added until either symptoms 
occurred or resistance limited further movement. The knee was then flexed until 
symptoms subsided (if present) and the treatment consisted of the knee being extended 
to the point of symptom onset and off again repeatedly (a knee joint mobilisation in SLR 
position). If no symptoms were produced, the knee was flexed and extended in and out 
of end range resistance of the knee.  A grade III- to III+ mobilisation (large amplitude 
into tissue resistance (Petty, 2011b) was performed. The rationale for large amplitude 
grades of movement was to have the most effect on proprioceptive afferents which may 
help to reduce pain via the pain gate mechanism or descending inhibitory pain 
mechanisms (Schmid et al., 2008), and also it has been proposed that theoretically these 
techniques could improve a number of variables including blood flow, venous return 
and oedema (Schmid et al., 2012; Shacklock, 2005a).  In addition, mobilising soft tissue 
in resistance is thought to cause a temporary increase in length due to the effects of 
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creep and hysteresis (Lee and Evans, 1992), and creep characteristics have been 
demonstrated in peripheral nerve (Millesi et al., 1995; Wall et al. 1991). A treatment 
dose of 3 x 1 minute mobilisations were performed, with a 1 minute rest between 
mobilisations. The choice of treatment time has not been established to date for 
neurodynamic mobilisation. This choice was informed purely by routine clinical 
practice, and previously used by the researcher (Ridehalgh et al., 2005). 
 
Post Treatment Measures 
VT, PPT and nerve motion measures during the side lying SLR test were then repeated 
immediately after the treatment intervention as described above for baseline measures.  
 
Analysis 
Vibration threshold  
Three appearance and 3 disappearance values were taken, as described under procedure, 
and the mean of these measures taken to give the final VT reading. This follows the 
method of limits (Goldberg and Lindblom, 1979; Halonen, 1986) previously described 
in 7.2.1. Repeatability was found to be excellent (see section 7.2). 
 
Pressure pain threshold analysis 
Three PPT readings were taken from each site. The first reading was discarded and the 
mean of the second and third measures used for the final reading of each site. This 
method was found to enhance the reliability of PPT measures as discussed in section 
7.2. 
 
Image analysis 
The ultrasound images sequences of the nerve in cross-section were imported into Image 
J (Rasband, W.S., Image J, U. S. National Institutes of Health, Bethesda, Maryland, 
USA, http://imagej.nih.gov/ij/, 1997-2012), and the borders of the nerve were manually 
outlined. The programme allows identification of the location of the most central pixel 
(“centroid”) in the nerve (Alshami et al., 2009; Boyd et al., 2012). The location of the 
centroid from the first frame is then compared to the last frame of the image sequence to 
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calculate the amount of transverse plane motion. To prevent over- or under- estimation 
of movement, the amount of subcutaneous tissue movement was calculated and 
subtracted from the nerve motion using the frame-by-frame cross correlation programme 
described below (Dilley et al., 2001). This process was carried out for each of the two 
knee movements, and added together to produce the overall medial/lateral and 
superficial movements for knee extension from 90 to 0° for both hip positions.  In some 
cases, where the borders of the nerve were not clear, the centroid method appeared to be 
markedly inaccurate compared to visual inspection of the image sequence. In these 
cases, the analysis of the transverse plane movement was done by using the cross-
correlation technique described for the longitudinal images below. 
 
The ultrasound image sequences of the nerve in longitudinal section were imported into 
Matlab (Mathworks Inc, Natick, MA) and analysed using frame-by-frame cross 
correlation as developed by Dilley et al. (2007). The detailed description of the cross-
correlation procedure can be found in section 7.1, but in brief the procedure involved 
manual selection of three to four overlapping regions of interest within the nerve 
(Korstanje et al., 2010). These regions were subsequently automatically tracked 
throughout the image sequence, resulting in the calculation of longitudinal excursion of 
the nerve (see Fig 7.7). Excellent reliability of the technique was previously 
demonstrated (Ridehalgh et al., 2012, see appendix 31 and section 7.1). 
Total longitudinal nerve excursion was calculated by adding the data from the three 
steps of the knee extension protocol during each hip position. Hence, for each subject, 
total longitudinal nerve excursion was calculated for the hip at 30° moving the knee 
from 90 to 0° of flexion, and for the hip at 60° moving the knee from 90 to 0°. 
 
The scans were coded so that the researcher was blinded to participant and group 
allocation, and also to pre and post measures during the analysis process.  
 
Statistical Analysis 
The data was analysed to ensure normality using the Shapiro Wilk test. Baseline 
comparisons were made using Pearson’s correlation coefficients and Kendall’s tau, for 
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data which was not normally distributed. Baseline differences were analysed by one way 
ANOVA or for non-normally distributed data Kruskall Wallis, and for nominal data Chi 
square test was used.  Differences between the 3 outcome measures, and between the 3 
sub-groups were analysed using a 3 way mixed factorial ANOVA (time and site/hip 
position the within subject variables, and group the between subject variable) with 
subsequent covariate analysis to assess for any factors which influenced the outcomes. 
Pots hoc testing was performed using Sidak corrected post hoc tests, unless indicated 
otherwise, and contrasts where appropriate. To minimise the chance of a type I error for 
the covariate analysis, assumption of homogeneity of regression slopes was tested. To 
compare the normative longitudinal nerve excursion data to that of the symptomatic 
groups, a one way ANOVA was utilised with Gabriel post hoc testing. All p values were 
considered significant at p<0.05 level.  
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Fig 8.1 Flow chart of method 
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8.2 Results 
 
Baseline data 
A total of 117 participants contacted the researcher in response to letters of invitation or 
in response to advertisements, emails or displayed posters. Forty three of these 
participants were excluded due to existing conditions such as diabetes, central canal 
stenosis and rheumatoid arthritis, and others due to being over the age of 70. A further 6 
were excluded after the Physiotherapy assessment either because their leg pain was not 
spinally referred, or they had symptoms suggestive of other neurological disorders 
which required further investigation. One participant was excluded due to their 
symptoms resolving between the Physiotherapy assessment and laboratory appointment. 
The final number of participants for the study was 67; 13 of these were recruited from 
Physiotherapy waiting lists, and 54 were recruited from outside of the NHS. Table 8.1 
highlights the numbers in each group, and the demographic details of all participants. 
There were no baseline differences in any of the variables between groups except for 
age and pain below the knee. Post hoc testing of age using Gabriel’s pairwise test (Field, 
2013, pg 458) found no significant differences between the 3 sub-groups (see below). 
For pain below the knee, observing the mean values of the 3 groups, it can be seen that 
the significance lies with the somatic group, having a marked lower percentage of 
individuals with pain below the knee than radicular or radiculopathy groups. 
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  Diagnostic sub-groups  
 Total Somatic Radicular Radiculopathy p 
N 67 11 33 23  
Age (years) 52.9 (13.3) 57.5 (10.6) 48.5 (13.2) 57 (13.1) 0.027*ᵃ 
Gender (% female) 49.3 54.5 51.5 43.5 0.78ᵇ 
Pain below knee (%) 70.1 18.2 75.8 87 0.000ᵇ 
Pain duration (years) 2.7 (4.9) 3.1 (5.9) 3.1 (5.7) 2 (2.8) 0.422ᵃ 
NHS Patients (%) 19.4 25 21.2 13.04 0.58ᵇ 
BMI 27.1 (4.6) 25.4 (3.6) 27.2 (4.9) 27.8 (4.6) 0.36ᵃ 
Disability (ODI) 17.3 (10.1) 16.3 (7.9) 17.5 (8.1) 17.4 (13.5) 0.94ᵃ 
Fear avoidance physical 
activity (FABQP) 
10.4 (4.9) 11.6 (4.2) 10.3 (4.8) 10.2 (5.5) 0.79ᵃ 
Fear avoidance work 
(FABQW) 
9.2 (8.4) 5.7 (7.2) 9.2 (9) 10.8 (7.9) 0.26ᵃ 
Pain Catastrophising (PCS) 
Total  
8.7 (8.9) 5.8 (3.8) 9.2 (8.9) 9.4 (10.5) 0.5ᵃ 
PCS Rumination 1 (5) 1 (4) 1 (5) 2 (6) 0.5    
PCS Magnification 2 (3) 2 (2) 2 (3) 2 (2) 0.46    
PCS Helplessness 2 (3) 2 (2) 2 (5) 2 (4) 0.71   
Depression (DASS21) 1 (3) 1 (3) 1 (3) 1 (6) 0.72   
Anxiety (DASS21) 1 (3) 1 (2) 2 (3) 1 (3) 0.69   
Stress (DASS21) 4.8 (3.8) 3.9 (3.2) 5.3 (3.7) 4.5 (4.2) 0.54ᵃ 
Kinesiophobia (Tampa) 33 (10) 34 (10) 33 (10) 35 (11) 0.59   
 
Table 8.1 Baseline characteristics for the study participants 
ᵃOne Way ANOVA, data given is means and standard deviations   * post hoc testing revealed 
no sig diffs between groups (somatic v radicular p = 0.114, somatic v radiculopathy p = 0.999, 
radicular v radiculopathy p = 0.051). 
ᵇChi Square Test 
 Kruskall Wallis, data not normally distributed and data given is median and interquartile 
ranges 
Key: BMI body mass index, ODI Oswestry disability scale, DASS disability anxiety and stress 
scale. 
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8.2.1 Correlations within the data 
 
The data were explored to assess any significant relationships between the 3 outcome 
measures (PPT, VT and sciatic nerve excursion) and all other variables. The strong, 
significant correlations were found for the PPT and VT readings, but not the 
longitudinal nerve excursion and can be found in table 8.2. Details of all other 
significant, but weak correlations and non-significant correlations can be found in 
attached CD. 
 
Variables Type Correlation 
coefficient 
P value Confidence 
interval 
r² 
VTLM pre : age Pearsons 0.554  0.000 0.37-0.71 0.307 
VTLM post: age Pearsons 0.501 0.000 0.31-0.67 0.25 
VT1MT pre: age Pearsons 0.467 0.000 0.27-0.63 0.22 
VT1MT post: age Pearsons 0.446 0.001 0.22-0.63 0.199 
PPT deltoid pre: 
BMI 
Pearsons 0.403 0.003 0.14-0.63 0.16 
PPT gastrocnemius 
pre: BMI 
Pearsons 0.45 0.001 0.19-0.66 0.203 
PPT gastrocnemius 
post: BMI 
Pearsons 0.423 0.001 0.19-0.63 0.18 
 
Table 8.2 Correlations between outcome measures and other factors 
Key: VTLM vibration threshold from lateral malleolus, VT1MT vibration thresholds 1st 
metatarsal.  
 
Main Analyses 
 
Pressure Pain Thresholds 
Mean (SD) pre and post SLR treatment PPT readings and mean differences (SD) can be 
found in table 8.3. Very small differences in PPT can be seen for all sites and sub-
groups. It can also be seen that there are large standard deviations, suggesting marked 
variation in response to SLR treatment between individuals. Looking at the individual 
differences (attached CD), some individuals demonstrated an increase in PPT post 
treatment, and others a decrease in PPT. It has been suggested that this represents 
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responders and non- responders to treatment (Farrar et al., 2006), and to analyse this 
further a cumulative proportion of responders analysis was performed (Fig 8.2 to 8.4). 
 
Site Deltoid Tibial Nerve Gastrocnemius 
Group Pre Rx Post Rx Mean 
Diffs 
Pre Rx Post Rx Mean 
Diffs 
Pre  Rx Post Rx Mean 
Diffs 
Somatic 5.69 
(2.19) 
6.27 
(2.73) 
0.58 
(2.45) 
6.25 
(2.88) 
6.84 
(3.02) 
0.59 
(0.92) 
5.55 
(2.10) 
6.19 
(2.44) 
0.64 
(1.80) 
Radicular 4.59 
(2.33) 
4.4 
(2.08) 
-0.19 
(0.97) 
4.62 
(2.21) 
4.84 
(2.25) 
0.22 
(1.27) 
4.61 
(2.07) 
4.63 
(2.09) 
0.02 
(0.83) 
Radiculopathy 4.58 
(1.54) 
4.96 
(1.98) 
0.38 
(0.95) 
5.14 
(2.02) 
4.93 
(1.62) 
-0.21 
(1.26) 
5.02 
(1.78) 
4.78 
(1.94) 
-0.24 
(0.73) 
 
Table 8.3 Mean (SD) PPT for each site and for each sub-group of individuals with 
spinally referred leg pain. Key: Rx treatment 
 
 
 
 
 
Fig 8.2 Cumulative proportion of responders PPT at deltoid site for each group 
 
 
Figure (8.2) shows that a greater proportion of individuals with somatic referred pain, 
positively responded to the SLR treatment than the other 2 sub-groups. The proportion 
of individuals who responded in the radicular and radiculopathy groups is similar. More 
than 50% of individuals in all 3 groups had an increase in PPT after the SLR treatment. 
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Fig 8.3 Cumulative proportion of responders PPT at tibial nerve site for each group 
 
Fig 8.3 Demonstrates that a greater proportion of individuals (>80%) in the somatic 
group positively responded to the SLR treatment at the tibial nerve site. The other 2 
groups had a smaller proportion of individuals who responded compared to the somatic 
group, but still had more than 50% responding (increased PPT) post treatment. 
 
 
Fig 8.4 Cumulative proportion of responders PPT at gastrocnemius site for each 
group 
 
At the gastrocnemius site, both the radicular and somatic group had a larger proportion 
of responders than non-responders; with over 70% of individuals in the somatic group 
with increased PPT post treatment, and over 60% of individuals in the radicular group. 
However, only just over 30% of individuals with radiculopathy showed an increase in 
PPT.  
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Statistical Analysis 
All data were normally distributed (Shapiro Wilk p >0.05), apart from the tibial nerve 
pre-readings in the radicular group (p=0.009) suggesting that for all other data at the 
95% significance level, there is not enough evidence to reject the null hypothesis that 
the variable is normally distributed. Since only one out of the 18 readings reached 
statistical difference on the Shapiro Wilk test, and ANOVA is robust to alterations in 
normal distribution (Field, 2013 pg 444), no transformations were carried out, and the 3 
way mixed factorial ANOVA was carried out on the data (see appendix 30). 
 
Mauchly’s test of sphericity was not significant therefore sphericity was assumed. There 
was no main significant effect (p>0.05) of group (F (2, 64) =2.77, p=0.07).  There were 
no significant main effects of time or site, and no significant interaction effects for time 
v site, or time v group (appendix 30 and attached CD gives the full results of the 
statistical analysis), but a statistically significant interaction effect between site v time v 
group (F (4, 128) =2.47, p=0.048) was found. Planned contrasts revealed a statistical 
difference between deltoid and gastrocnemius, before and after treatment (p=0.022). Fig 
8.5 shows the mean difference (pre to post treatment) in PPT for all sites in the 3 groups. 
In the somatic group, both sites showed a similar mean increase in PPT after treatment, 
but in the radicular group there is a trend for a reduction in PPT post treatment in the 
deltoid site, but a slight mean increase in PPT post treatment at the gastrocnemius site. 
In the radiculopathy group, however, an opposite effect is seen, with a mean increase in 
PPT at the deltoid site, but a decrease at the gastrocnemius site.  
 
Controlling for the effects of body mass index, demonstrated a significant main effect of 
group (F (2, 64) =4.279, p=0.018). Sidak corrected post hoc tests showed significantly 
higher PPT readings for the somatic group compared to the radicular group (p=0.016). A 
significant main effect of site (F (2, 126) =3.96, p= 0.021) and a significant interaction 
effect between time v site v group was also found (F (4, 126) =2.634, p=0.037). Planned 
contrasts revealed that the difference for site alone was between the tibial nerve and 
gastrocnemius sites (F (1,63) = 6.17 p= 0.016), and the 3 way interaction (time v site v 
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group) lay between the tibial nerve and gastrocnemius site, before and after treatment (F 
(2, 63) =4.45, p=0.016).  
In addition, there was a significant interaction effect for BMI and site (F (2, 126) = 3.16, 
p=0.046). Planned contrasts revealed the difference lay between tibial nerve site and the 
gastrocnemius site (p=0.028).  
 
Tests for the assumption of homogeneity were significant for group and BMI (F (1, 63) 
= 5, p= 0.01), and for site v time v group and BMI (F (4, 126) = 2.72, p= 0.033), but not 
for site and BMI (F (2,126) =2.74, p=0.068). Therefore the main effect for group and 
interaction effect for site v time v group found in the covariate analysis cannot be 
accepted as the assumption of homogeneity is not tenable (Field, 2013 pg 499), however 
the interaction effect for site and BMI can be accepted. 
 
  
 
Fig 8.5 Mean differences PPT (Kg) (before and after Rx) at the 3 sites. 
  
Since no main effect for sub-group had been found, further analysis of pre-readings with 
the 3 groups’ data combined was performed to assess if there was a difference in 
baseline readings for each site related to BMI. A one way ANOVA for each site 
revealed no significant difference for BMI (over or under 26 kg/m²) for deltoid (F 
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(1,66)= 3.16, P=0.08) and the tibial nerve sites (F (1,66) =0.92, P=0.34), but a 
significantly higher PPT reading for individuals with BMI over 26 kg/m² at the 
gastrocnemius site (F (1,66) = 5, p=0.029). Figs 8.6 to 8.8 show the overall mean PPTs 
between the 2 BMI groups for all participants. It can be seen that all readings showed a 
higher trend for BMI over 26 kg/m².  
 
 
Fig 8.6 Mean PPT (Kg) readings pre Rx for all 3 groups combined at the deltoid site 
 
 
Fig 8.7 Mean PPT (Kg) readings pre Rx for all 3 groups combined at the tibial nerve 
site 
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Fig 8.8 Mean PPT (Kg) readings pre Rx for all 3 groups combined at the 
gastrocnemius site 
 
Controlling for pain below the knee resulted in a similar result to the PPT analysis alone, 
in that the only significance was an interaction effect between time, site and group (F (4, 
126)= 2.54, p=0.043), and planned contrasts showed a significance between deltoid and 
gastrocnemius sites, before and after treatment (p=0.033). Testing the assumption of 
homogeneity resulted in non- significant results between time, site, group and pain 
below the knee (F (4, 122) = 2.74, p= 0.117), therefore we can assume the relationship 
and accept these results. Fig 8.9 demonstrates that the response to treatment was 
different in individuals with pain above and below the knee. At the somatic site 
individuals with pain below the knee showed a mean decrease in PPT after treatment, 
but individuals with pain above the knee increased at both sites. In the radicular group, 
individuals with pain below the knee showed a mean decrease in PPT at the deltoid site, 
but an increase at the gastrocnemius site, whereas the mean PPT decreased at both sites 
in individuals with pain above the knee. Minimal mean differences were seen at either 
site for individuals with pain above the knee in the radiculopathy group, but an increase 
in PPT at deltoid and a decrease at gastrocnemius was noted.  
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Fig 8.9 Mean difference in PPT (Kg) readings in individuals with pain above and 
below the knee at the deltoid and gastrocnemius sites (note no confidence interval 
bars are included as only 2 participants in the somatic group had pain below the 
knee).   
 
However, caution must be taken when analysing these results since only 3 participants 
had pain that was above the knee in the radiculopathy group, and only 8 (out of 33) in 
the radicular group. Conversely only 2 (out of 11) participants in the somatic group had 
pain below the knee. 
 
Whilst gender was not statistically different between the groups, and no significant 
correlations had been found, it has been suggested that females have lower PPT than 
males, and so this was added as a covariate into the analysis. A main effect was found 
for group (F (2, 63) = 3.6, p= 0.033), with planned contrasts showing the significant 
difference was between somatic and radiculopathy groups. There were no main effects 
for time or site, but an interaction effect of time, group and site was found (F (4, 126) = 
2.59, P=0.04) with planned contrasts showing the significant difference between the 
deltoid and gastrocnemius sites. Testing for the assumption of homogeneity revealed a 
significant difference between gender and groups (F (3, 63) =5.84, p=0.001), and 
between time, group, site (F (6,126) = 2.25, P=0.043) therefore the assumption of 
homogeneity of regression slopes has been broken, and the results of the covariate 
analysis cannot be accepted.  
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As there were no significant differences between the groups, the data for the 3 groups 
were combined, and an additional analysis was performed to assess the effect of gender 
on baseline PPT readings. A one way ANOVA found a significantly greater PPT at the 
deltoid site (F (1,66) =15.74, p=0.000) and the gastrocnemius site (F (1,66)= 15.05, p 
=0.000) in men compared to women, but no significant difference at the tibial nerve site 
(F(1,66)= 3.11, p=0.08). Figs 8.10- 8.12 show the baseline PPT readings at all 3 sites. 
 
 
 
Fig 8.10 Mean PPT (Kg) readings for men and women from the deltoid site. 
 
 
Fig 8.11 Mean PPT (Kg) readings for men and women from the tibial nerve site.    
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Fig 8.12 Mean PPT (Kg) readings for men and women from the gastrocnemius site. 
 
 
No other covariate analyses were explored as there were no other strong correlations or 
baseline significant differences.  
 
Vibration Thresholds 
 
At the start of the data collection, the vibrameter was unexpectedly damaged and needed 
to be repaired, but participants were already booked into the laboratory, and as they 
were NHS patients who were unable to receive their next Physiotherapy appointment 
until after the laboratory session, the session could not be delayed. Two participants 
therefore had missing VT data, one from the somatic group, and the other from the 
radiculopathy group. In addition, 3 participants had VT readings which were too high to 
be recorded from the vibrameter for the 1st metatarsal site (one from each group), and an 
additional participant from the radicular group had VT readings too high from both sites. 
Therefore 9 participants in the somatic group had VT from both sites, and one from the 
lateral malleolus site only, 30 participants in the radicular group had VT readings from 
both sites, and one from the lateral malleolus site only, and 22 participants from the 
radiculopathy group had VT readings from both sites, and 1 from the lateral malleolus 
site only. In the case of the missing data due to elevated VT readings, all participants 
were male and 64 years of age or over (64-69).  
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Mean (SD) and mean differences (SD) can be found in table 8.4. From these differences 
it can be seen that there was a tendency for a decrease in VT to occur in both the 
radiculopathy and somatic groups after treatment, but a slight increase in VT in the 
radicular group. However the large standard deviations show the marked variability in 
the data. Fig 8.13 shows the mean differences (before and after) measures for each site 
in the 3 sub-groups, with 95% confidence intervals demonstrating the large variability in 
readings especially for the somatic and radiculopathy groups.  
 
 Lateral Malleolus 1st Metatarsal 
Group Pre Rx Post Rx Mean Diffs Pre Rx Post Rx Mean Diffs 
Somatic 2.27 (4.08) 1.75 (2.94) -0.52 (1.15) 3.26 (4.45) 3.10 (3.70) -0.16 (0.84) 
Radicular 0.68 (0.48) 0.75 (0.74) 0.07 (0.56) 2.00 (1.85) 2.36 (2.71) 0.36 (1.43) 
Radiculopathy 3.00 (4.43) 2.50 (3.26) -0.50 (1.61) 5.28 (5.98) 3.89 (4.30) -1.32 (3.28) 
 
Table 8.4 Mean Vibration threshold (VT) (µm) for each site and for each sub-group 
of individuals with spinally referred leg pain 
 
 
  
Fig 8.13 Mean VT measures (µm) before and after treatment at the lateral malleolus 
and first metatarsal sites. 
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Table 8.5 shows the numbers of individual in each group who had differences in 
measurements greater than the SDD (25.1% and 14.4 % lateral malleolus and 1st 
metatarsal respectively) found in chapter 7. 
 
 Lateral Malleolus 1st Metatarsal 
 VT ↑>SDD VT↓>SDD VT ↑>SDD VT↓>SDD 
Somatic 0/10 (0%) 3/10 (30%) 3/9 (33.3%) 2/9 (22.2%) 
Radicular 7/31 (22.6%) 6/31(19.4%) 8/30 (26.7%) 10/30 (33.3%) 
Radiculopathy 3/22 (13.6%) 6/22 (27.3%) 7/21 (31.8%) 10/21 (45.5%) 
 
Table 8.5 Numbers (percentage) of individuals with differences in VT greater than 
SDD in the three leg pain groups 
 
Statistical Analysis 
Normality  
All data were not normally distributed, (Shapiro Wilk test<0.05), and an outlier was 
found in the radicular group. After removal of the outlier, the data remained not 
normally distributed, and therefore a number of transformations were attempted. A box-
cox transformation (VTª)-1/a (where a=0.1) successfully normalised all but one of the 
readings (the post treatment measures for the radicular group at the lateral malleolus) 
(see appendix 30). Since ANOVA is robust to minor violations of normality, this 
transformation was considered successful.  
 
Mauchly’s test of sphericity was not relevant as there were only 2 levels of within 
subject variables, therefore sphericity is assumed (Field, 2013 pg 561). There was a 
main effect for group (F (2, 57) = 4.79, p= 0.012). Sidak corrected post hoc tests 
indicated significantly higher VT for the radiculopathy compared to radicular group 
(p=0.01). There was a main significant effect for site (F (1, 57) = 38.17, p=0.00), but no 
other significant within subject effects (see appendix 30 and attached CD). 
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As age was strongly correlated with vibration thresholds, this interaction was entered 
into the analysis. No significant differences were seen for any within or between 
subjects analyses, indicating that the differences found in the first analysis, were 
strongly related to age. However, further testing for the assumption of homogeneity of 
regression slopes revealed a significant difference for age and group, indicating that the 
assumption of homogeneity of the regression slope has been broken (F (3, 54) = 7.28, 
P=0.000). Therefore the results from the 3 way mixed factorial ANOVA without age 
entered as a covariate are accepted. 
 
Since pain below the knee was significantly different between groups at baseline, this 
was entered into the analysis to assess any interaction effect. There was a significant 
main effect for site (F (1, 56) =4.07, p=0.048), but no other main effects of within 
subject variables or any interaction effects (see appendix 30 and attached CD). A 
significant main effect was found for group (F (2,56) = 5.27, p=0.008). However testing 
the assumption of homogeneity found a significant difference between group and pain 
below the knee (F (3,56) = 4.7, p=0.005) and therefore the assumption is not tenable. 
Therefore, the significant group effect found after entering pain below knee as a 
covariate was not accepted.  
 
Since there were no other baseline differences between groups, no further covariate 
analyses were performed.  
 
 
Sciatic Nerve excursion during modified SLR test 
Of the 67 images sequences, 60 were of sufficient quality to track. Of the 7 that were 
not, 4 were in the radicular group and 3 in the radiculopathy group. Of these 5 were 
women, 3 had BMI over 26kg/m², and one had a BMI over 35kg/m², and 2 were men 
both with BMI over 36kg/m². Hence longitudinal sciatic nerve excursion data is given 
for 11 participants in the somatic group, 29 participants in the radicular group and 20 
participants in the radiculopathy group.  
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Longitudinal Nerve Excursion 
The mean values (SD) of the nerve excursion can be seen in table 8.6.  
Hip position Hip flexed to 30˚ Hip flexed to 60˚  
Group Pre Rx Post Rx Mean Diffs Pre Rx Post Rx Mean Diffs 
Somatic 10.26 (2.85) 10.08 (2.51) -0.17 (3.12) 8.18 (2.54) 8.86 (3.59) 0.68 (2.78) 
Radicular 8.85 (3.15) 9.07 (3.01) 0.22(2.83) 10.18 (3.36) 9.71 (3.1) -0.48 (2.31) 
Radiculopathy 9.44 (4.22) 8.7 (2.73) -0.75 (2.9) 9.73 (3.45) 9.57 (2.73) -0.16 (2.41) 
 
Table 8.6 Mean (SD) pre and post treatment and differences in longitudinal sciatic 
nerve excursion (mm) for the 3 sub-groups. 
 
The table demonstrates the very small mean differences that were found after treatment, 
although the direction (increased or decreased) plus amount of excursion was varied. 
The greatest mean difference found was for the radiculopathy group at 30° hip flexion, 
this represented a mean decrease of 8.2%. Fig 8.14 and 8.15 show the proportion of 
participants whose nerve excursion increased in the 3 groups with the hip flexed to 30° 
and 60° hip flexion. 
 
 
 
Fig 8.14  Proportion of individuals with increased sciatic nerve excursion after 
treatment with hip flexed to 30° 
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Fig 8.15 Proportion of individuals with increased sciatic nerve excursion after 
treatment with hip flexed to 60° 
 
It can be seen that the somatic group had a greater proportion of individuals whose 
nerve excursion increased after treatment in both hip positions. Both radicular and 
radiculopathy groups had similar proportion of individuals with increased nerve 
excursion at 60° hip flexion (around 50%), but a smaller proportion (40-45%) with the 
hip flexed to 30°. A small proportion of individuals had nerve excursion greater than 
50% in all 3 groups with the hip flexed to 30°, but a smaller proportion with the hip 
flexed to 60°. 
 
 
Statistical Analysis 
Normality  
All data were normally distributed (Shapiro Wilk p >0.05), apart from the pre-treatment 
readings at 30 ° hip flexion for the radicular group (p=0.047), and post treatment 
readings at 60° hip flexion in the radiculopathy group (p=0.027). Hence for all data 
apart from these 2 readings, at the 95% significance level there is not enough evidence 
to reject the null hypothesis that the variable is normally distributed. Since only 2 out of 
the 12 readings reached statistical difference on the Shapiro Wilk test and ANOVA is 
robust to alterations in normal distribution, no transformations were carried out, and the 
3 way mixed factorial ANOVA was carried out on the data. 
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There were no significant main effects for group (F (2, 57) = 0.014, p= 0.986 ), or 
within subject analyses (see appendix 30 and attached CD).  
 
There were no baseline differences for any measures except pain below the knee, and 
age. Covariate analysis was performed using age, and no significant main or interaction 
effects were found. 
 
Covariate analysis using pain below the knee resulted in a significant main effect for hip 
position (F (1, 56) =6.98, p=0.01), but no other main or interaction effects. The 
assumption of homogeneity was performed and there was no significant difference 
between the covariate and hip position (F (1, 58) = 0.00, p=0.998), therefore the 
assumption of homogeneity is established, and the result of the covariate analysis can be 
accepted.  
 
Since individuals with somatic referred leg pain alone did not show any signs of 
neurological compromise or mechanosensitivity, and it was of interest to see how the 2 
groups with neuropathic pain behaved, the data was combined for these 2 groups and 
analysed descriptively to assess how the factor of pain below the knee impacted the 
ultrasound readings. Two analyses were performed, the first to look at baseline mean 
values for each hip position in individuals with pain below and above the knee (Fig 
8.16), and the second to assess the mean difference scores (before and after treatment) in 
individuals with pain below and above the knee in the 2 neuropathic pain groups (Fig 
8.17). It can be seen in Fig 8.16 when the hip is flexed to 30°, that a similar mean sciatic 
nerve excursion is seen, regardless of whether pain is below or above the knee, but with 
the hip flexed to 60° individuals with pain below the knee had greater sciatic nerve 
excursion than those with pain above the knee. Fig 8.17 demonstrates that in individuals 
with pain below the knee in the 2 neuropathic groups, there was a trend for a reduction 
in nerve excursion after the SLR treatment at both hip positions. In individuals with pain 
above the knee, there was a tendency for an increase in nerve excursion with the hip 
flexed to 30°, but minimal mean differences with the hip flexed to 60°.  
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Fig 8.16 Mean (pre- treatment) longitudinal sciatic nerve excursion (mm) for 
individuals with pain below and above the knee at the 2 hip positions (radicular and 
radiculopathy groups). 
 
 
 
 
Fig 8.17 Difference (pre-post treatment) longitudinal sciatic nerve excursion (mm) for 
individuals with pain below and above the knee at the 2 hip positions (radicular and 
radiculopathy groups). 
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Comparison with asymptomatic data from chapter 7 
The mean pre-treatment measures for each group were compared to the mean excursion 
values obtained in the reliability study for asymptomatic participants. Figs 8.18 and 8.19 
show the mean values for each group. 
 
Fig 8.18 Longitudinal sciatic nerve excursion (mm) for all groups (pre-treatment 
readings for symptomatic groups) with the hip flexed to 30 degrees. 
 
 
 
Fig 8.19 Longitudinal sciatic nerve excursion (mm) for all groups (pre-treatment 
readings for symptomatic groups) with the hip flexed to 60 degrees. 
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One way ANOVA was performed for each hip position to assess to see if any 
differences arose between the asymptomatic and symptomatic groups. A statistically 
significant difference was found with the hip at 60° flexion (F (3, 75) = 3.7, p= 0.016). 
Gabriel corrected post hoc tests revealed a significantly greater amount of nerve 
excursion in the asymptomatic group compared to the somatic group (p=0.012).  Since 
there was a marked difference in age for the asymptomatic group compared to the 
symptomatic groups (mean asymptomatic group = 28.9 years), age adjustment with 
covariate analysis was performed. No statistical significance was found between groups 
(with 60° hip flexion) after age adjustment (F (3,71) = 1.28, p= 0.288), indicating that 
age predicted the outcome between groups. However, tests for the assumption of 
homogeneity were significant for age and group (F (3,71) =2.72, p=0.036), indicating 
that a violation has occurred, and therefore the analysis without adjustment for age is 
accepted.    
 
Transverse plane nerve excursion 
The method of analysis for transverse movements is also affected by image quality and 
therefore some images were not of sufficient quality for the methods to adequately 
analyse nerve excursion. Therefore data was missing for one participant from the 
somatic group, 8 from the radicular group, and 3 from the radiculopathy group, resulting 
in data from 10 somatic participants, 25 radicular participants and 20 radiculopathy 
participants. 
 
There was marked variability in the direction and total amount of nerve excursion 
between individuals. Figs 8.20 and 8.21 demonstrate the mean values before and after 
treatment for each group and each hip position. Note the large confidence intervals 
indicating the wide spread of excursion values between individuals, particularly in the 
somatic group.   
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Fig 8.20 Mean medial and lateral sciatic nerve excursion (mm) for the 3 groups at 30° 
hip flexion (left) and 60° hip flexion (right). Note –ve numbers indicate lateral 
movement, +ve numbers indicate medial movement  
 
  
 
Fig 8.21 Mean superficial and deep sciatic nerve excursion (mm) for the 3 groups at 
30° hip flexion (left) and 60° hip flexion (right). Note –ve numbers indicate deep 
movement, +ve numbers indicate superficial movement 
 
Before treatment at both hip positions, the somatic group showed a different pattern of 
nerve movement to the other 2 groups, with a tendency to move laterally during the 
SLR, whereas the other 2 groups predominantly moved medially. After treatment, with 
the hip at 30° the nerve excursion in the somatic group moved medially, and at 60° of 
flexion moved laterally but to a lesser degree. At 30° hip flexion, both radicular and 
radiculopathy groups tended to move less medially than prior to treatment. However, at 
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60° there was little difference in medial/lateral excursion after treatment compared to 
before.  
 
At 30° hip flexion, all groups showed a tendency for the nerve to move more 
superficially before and after treatment. The somatic and radicular group tended to have 
less superficial excursion after treatment, whereas the radiculopathy group had a 
tendency to have slightly greater superficial movement after treatment. With 60° hip 
flexion, sciatic nerve excursion was superficial in the somatic and radicular groups, but 
deep in the radiculopathy group. After treatment, the nerve moved less superficially in 
the somatic and radicular groups, and much deeper in the radiculopathy group. 
 
Presence of Central Sensitisation 
Only 2 participants were found to have central sensitisation using the method described 
in appendix 26. The baseline data for each of these participants is shown in table 8.7, 
and mean values for each of the outcome measures in table 8.8 
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Participant 1 2 
Sub-group 
Radiculopathy Radicular 
Age 
56 36 
Gender  
F F 
Pain below knee  
Yes Yes 
Pain duration (years) 
35 10 
NHS Patients  
No No 
BMI 
28.96 17.96 
Disability (ODI) 
58 26 
Fear avoidance physical 
activity (FABQP) 
12 15 
Fear avoidance work 
(FABQW) 
0 20 
Pain Catastrophising (PCS) 
Total  
14 35 
PCS Rumination 
6 16 
PCS Magnification 
0 8 
PCS Helplessness 
8 11 
Depression (DASS21) 
0 0 
Anxiety (DASS21) 
2 3 
Stress (DASS21) 
0 6 
Kinesiophobia (Tampa) 
30 44 
 
Table 8.7 Baseline data for the two participants with central sensitisation. 
 
From the table it can be seen that both participants had a long duration of symptoms, 
much greater than the average of the participants (2.7 years). Participant 1 had a greater 
BMI than the average, but participant 2 had a much lower BMI than average 
(27.1kg/m²). Both had a greater score for ODI than the mean score of the group (17.3). 
Participant 1 had higher scores than the average score for all psychosocial scores except 
for FABQ (work), PCS (magnification), depression and stress (for average scores please 
refer to table 7.1). Participant 2 had higher scores than the average values for all other 
psychosocial scores, except for depression.  
227 
 
Table 8.8 demonstrates the effects of the SLR treatment on the 3 outcome measures in 
the 2 participants with CS. It can be seen that these 2 participants had considerably 
lower PPTs than the mean of participants in each of the associated sub-groups (see table 
8.3 for details). 
Participant 1 2 
 Pre Rx Post Rx Difference Pre Rx Post Rx Difference 
 PPT (Kg) deltoid 2.2 2.45 0.25 2.73 2.83 0.1 
PPT (Kg) tibial Nerve 1.85 2.25 0.4 1.51 2.08 0.57 
PPT (Kg) 
gastrocnemius  
2.1 2.35 0.25 1.49 1.81 0.32 
VT(µm) lateral 
malleolus 
0.99 1.35 0.36 0.32 0.59 0.27 
VT 1ST (µm) 
metatarsal 
1.64 1.08 -0.56 0.86 1.33 0.47 
Long nerve exc H30° 7.73 9.02 1.29 10.45 11.12 0.67 
Long nerve exc H60° 7.29 9.34 2.05 16.05 11.73 -4.32 
M/L nerve exc H30° 2.36 -1.64 -0.72 3.37 5.81 2.44 
Sup/deep nerve exc 
H30° 
2.87 3.95 1.08 6.51 4.7 -1.8 
M/L nerve exc H60° -1.51 -7.15 -8.66 0.72 0.59 -0.13 
Sup/deep nerve exc 
H60° 
1.14 -0.35 -1.49 0.99 2.64 1.65 
 
Table 8.8 Outcome measures- before and after treatment, with differences for the two 
participants with central sensitisation. Note for medial and lateral movement, -ve 
means the nerve moved in a lateral direction, and for superficial and deep, -ve means 
nerve moved deeply. All nerve excursion measurements in mm. 
  
VT were also considerably lower in both of the participants than the mean of the 
participants in the respective sub-group (see table 8. 5). Participant 2 had a larger 
longitudinal excursion at 30° but smaller excursion at 60° than the group mean, whereas 
participant 1 had lower longitudinal excursion than the group mean in both hip positions 
(see table 8.6). With regards to transverse movement, participant 2 moved medially and 
superficially in both hip positions which matched the mean direction of movement for 
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the sub-group. Participant 1’s nerve moved medially and superficially with the hip at 
30° (matching the group mean directions), but then moved laterally and superficially at 
60°, in contrast to the group mean which demonstrated medial and deep movement.  
 
Psychosocial Factors 
Correlation analyses were done between psychosocial factors and disability to assess the 
relationship between them. The significant, strong correlations can be found in table 8.9. 
All other correlations were weak or not significant (see attached CD). In addition, since 
pain below the knee had been associated with higher psychosocial factors, or higher 
levels of disability, correlations were performed between pain below the knee and the 
ODI and psychosocial scales. No significant correlations were found between pain 
below the knee or any of the scales. 
 
Variables Type Correlation 
coefficient 
P value Confidence 
interval 
ODI and PCS (total) Pearsons 0.43 0.001 0.22-0.64 
ODI and PCS rumination Pearsons 0.41 0.001 0.16-0.6 
PCS (total) and rumination Spearmans 0.86 0.000 0.77-0.92 
PCS (total) and helplessness Spearmans 0.90 0.000 0.83-0.94 
PCS (total) and magnification Spearmans 0.73 0.000 0.57-0.83 
PCS (total) and tampa Spearmans 0.49 0.000 0.28-0.66 
PCS (total) and anxiety Spearmans 0.53 0.000 0.311-0.69 
Rumination and anxiety Spearmans 0.40 0.001 0.18-0.60 
Rumination and helplessness Spearmans 0.79 0.000 0.67-0.88 
Magnification and helplessness Spearmans 0.52 0.000 0.29-0.71 
Magnification and anxiety Spearmans 0.55 0.000 0.32-0.71 
Magnification and tampa Spearmans 0.44 0.000 0.21-0.62 
Magnification and stress Spearmans 0.43 0.000 0.19-0.61 
Magnification and depression Spearmans 0.40 0.001 0.15-0.62 
Helplessness and tampa Spearmans 0.47 0.000 0.27-0.65 
Depression and anxiety Spearmans 0.41 0.001 0.15-0.61 
Depression and stress Spearmans 0.48 0.000 0.24-0.67 
Anxiety and stress Spearmans 0.58 0.000 0.41-0.72 
Anxiety and tampa Spearmans 0.42 0.000 0.19-0.62 
 
Table 8.9 Correlation analyses of disability and psychosocial factors 
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8.3 Discussion 
 
The main aim of the study was to determine if a 3 x 1 minute SLR tensioner treatment 
had an immediate effect on pressure pain thresholds, vibration thresholds and sciatic 
nerve excursion in 3 different sub-groups of individuals with spinally referred leg pain. 
In addition, it aimed to assess if the presence of central sensitisation, disability and 
psychosocial factors were different between the 3 groups and interacted with the effect 
of treatment. A smaller aim was to assess how well the psychosocial factors and levels 
of disability were related to each other. The first and second aims will be discussed 
under each outcome measure in turn. A separate section will be given to the third aim, as 
it relates less directly to the 2 main aims.  
 
8.3.1 Pressure Pain Thresholds 
 
Overall Findings 
There was no main effect for group or time and site. A significant interaction effect was 
found for time, group and site (between deltoid and gastrocnemius). However, when 
adjusting for BMI, a significant difference was found between the tibial and 
gastrocnemius sites and BMI, and an interaction effect was found between group, before 
and after treatment and between sites. However the interaction effect could not be 
accepted because the assumption of homogeneity was not demonstrated. Therefore, 2 
main findings emerged. 
 
 The first finding was a significant interaction effect between group, time and between 
gastrocnemius and deltoid. Analysis of Fig 8.5 revealed that the radicular group showed 
a decrease in PPT at the deltoid site after treatment, but a slight increase at the 
gastrocnemius site, and the radiculopathy group showing a marked increase at the 
deltoid site, and a marked decrease at the gastrocnemius site. The cumulative responders 
analysis was performed because it has been suggested that the use of such analysis 
allows for a more comprehensive analysis of the response to treatment between groups 
(Farrar et al., 2006). Figs 8.2-8.4 demonstrate some interesting trends for each site and 
between the groups. For the deltoid sites, over 60% of participants in the somatic group 
230 
 
showed improvement in PPTs, whereas in the radicular and radiculopathy groups, this 
was just over 50%. At the tibial nerve site, over 80% of the somatic group showed 
improvement in PPTs, whereas in the radicular and radiculopathy groups, over 50% 
improved. However, for the gastrocnemius site over 70 % of somatic participants and 
over 60% of radicular participants showed improvement in PPT, but only around 30 % 
of participants in the radiculopathy group improved after treatment. It has been 
suggested that a change in PPT over 15% may be clinically significant (Moss et al., 
2007). It can also be seen in Figs 8.2 to 8.4  that at the deltoid site, over 40% of 
individuals in the somatic and radiculopathy groups showed an increase in PPT over 
15%, but only around 25% in the radicular group. This trend reversed at the tibial nerve 
site with around 35% of individuals in the radicular group having increases of over 20%, 
whereas in the somatic and radiculopathy groups this fell to around 20% of participants. 
At gastrocnemius, less than 10% of participants in the radiculopathy group improved 
over 15%, whereas 30% of participants in the radicular group and over 50% in the 
somatic group improved by over 15%.   
 
The different sites tested were used to determine if any beneficial effects were 
segmentally or systemically mediated. Improvements at the deltoid site would indicate a 
descending, systemic inhibitory effect, possibly activated from the dorsal periaqueductal 
gray matter (Moss et al., 2007; Schmid et al., 2008; Skyba et al., 2003; Sluka and 
Wright, 2001) since the area was distant from the site of treatment. Any improvements 
at the tibial nerve site could indicate a more segmental effect since the nerve was being 
directly influenced, or a systemic effect. Gastrocnemius site changes could also reflect 
segmental or systemically mediated pain inhibition. Whilst there was no main 
significant effect at this site there was a significant interaction effect between the deltoid 
and the gastrocnemius site between the radicular and radiculopathy groups, and this 
relates to the cumulative responders analysis. Greater proportions of individuals in the 
radicular group had a clinically relevant improvement in symptoms at the gastrocnemius 
site than in the radiculopathy group, but the opposite response was seen at the deltoid 
site. This may indicate that for individuals with radiculopathy, a SLR treatment may be 
less effective at improving the site of pain, but still has an effect on descending 
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inhibitory pathways. The literature does not specifically support this assertion since 
blockage of the descending inhibitory systems have been postulated to occur in 
individuals with CS and neuropathic pain (Zusman, 2008; Yunnus, 2007), whilst 
descending excitatory systems operating via the rostroventromedial medulla, have been 
considered to exacerbate pain (Fields, 2004). This may explain the smaller proportion of 
individuals with a positive response to treatment in the radiculopathy group. However, 
descending excitation and loss of descending inhibition, may have been expected to 
markedly increase PPT at tibial nerve and gastrocnemius sites; this was not seen (no 
individuals had PPT greater than SDD at the gastrocnemius site in the radiculopathy 
group- see below). Whilst more individuals responded positively at the gastrocnemius 
site in the radicular group compared to the radiculopathy group, only around 30% had 
clinically significant changes, therefore no overall claim can be made of effectiveness of 
treatment at this site in this group.  
 
It is also of importance when interpreting these results to examine the individual 
differences in comparison to the SDD found in the repeatability study in chapter 7.2. 
The SDD found for each site were 1.55 for deltoid, 1.44 at the tibial nerve and 1.75 for 
gastrocnemius. Since the interaction effect was at the deltoid and gastrocnemius sites, 
and between the radicular and radiculopathy groups only, the SDD will be considered 
for these sites and groups only. For the radicular group at the deltoid site, only 1 
participant had increased PPT above the SDD, and only 3 participants had reduced PPT 
above the SDD. For gastrocnemius site, no participants had changes to the PPT readings 
after treatment that were above SDD. In the radiculopathy group, no participants had a 
reduction in PPT greater than the SDD, and only 2 had increased PPT above the SDD at 
the deltoid site, and no participants had scores greater than the SDD at the 
gastrocnemius site. Therefore this suggests overall that there was no overall effect on 
PPT of the treatment in any of the 3 groups.  
 
This lack of improvement in PPT differs from research which has looked at changes in 
PPT after spinal mobilisations in asymptomatic participants (Krouwel et al., 2010; 
Pentelka et al., 2012; Willett et al., 2010), spinal mobilisation in symptomatic 
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participants (Moss et al., 2007; Sterling et al., 2001; Vincenzino et al., 1996), 
neurodynamic mobilisation in symptomatic participants (De Le LLave Rincon et al., 
2012; Silva et al., 2013), and after neurodynamic mobilisations in symptomatic patients 
with degenerative pain (Villafane et al., 2011; 2012). Only one study was found where 
no significant differences in PPT were found after mobilisations, but this was in 
asymptomatic participants (Soon et al., 2010). 
 
However, statistical significance alone does not determine the effectiveness of the 
treatment. Both SDD, and clinical significance must be taken into account when 
considering these studies. Moss et al. (2007) proposed that a change greater than 15% is 
suggestive of a clinically significant effect. De Le LLave Rincon et al., (2012) found a 
small significant improvement in PPT after a slider median nerve treatment measured at 
C5/6, but no other sites (including over nerve sites)  one week after treatment, but not 
immediately after treatment in individuals with carpal tunnel syndrome. However, the 
percentage difference at this site was only 13.5%. In addition, 30 minutes of soft tissue 
mobilisations were applied to the neck and arm prior to the slider treatment, therefore it 
is not known if the small findings were influenced more by the soft tissue treatment than 
the neurodynamic treatment.  
 
Using a median nerve slider technique to treat individuals with osteoarthritis of the 
thumb improved the immediate PPTs at the trapeziometatarsal joint (TMJ), but not other 
tested sites in the hand (Villafane et al., 2011). Whilst a radial nerve slider improved 
PPT immediately in all 3 tested sites in the hand (Villafene et al., 2012). The mean 
change at the TMJ was only 0.84 kg/cm² (Villafane et al., 2011), and whilst small, such 
a change was over 15%, making it clinically significant according to Moss et al., (2007). 
Whilst error measures were not revealed in this study, the authors’ 2012 study revealed 
the SEM as 3.07kg/cm², with resultant SDD of 8.51 kg/cm². Assuming that the error 
measure was as high for the 2011 study, it is unlikely that the differences found between 
measures could be considered to be due to the treatment alone. Greater mean changes to 
PPT (3.33 kg/cm²) were found in the 2012 study after a radial nerve slider technique, 
although it is unlikely that the individual differences after treatment were as high as the 
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required SDD of 8.51kg/cm². Such high error measures render the results of these 2 
studies inconclusive. 
 
More relevant to the present study, Silva et al., (2013) demonstrated a significant change 
in PPT in individuals with sciatica compared to control participants after a SLR 
mobilisation. However, only 15 participants were recruited to each group and these  
were further divided into 4 sub-groups who underwent different lengths of time of 
treatment, resulting in only 4 participants in 3 of the time groups, and 4 in the fourth. 
Whilst the crossover design improved the power of the study, such low participants 
overall make the extrapolation of the results less convincing. In addition, the statistical 
analysis could be questioned since separate between and within subject analyses were 
performed. Baseline differences between the groups were not accounted for, despite 
individuals in the sciatica group having significantly smaller mean baseline differences 
to the control group at 3 time points. Such limited and inappropriate statistical testing 
limits the findings of Silva et al., (2013). One final limitation is the lack of detail on the 
diagnosis, or even definition of sciatica. Not only is the term outdated, but the omission 
of how the diagnosis was made means that a potentially heterogeneous group of 
individuals were studied, making the extrapolation of these results untenable.   
 
Other joint mobilisation studies have also demonstrated statistically significant increases 
to PPT in symptomatic participants after knee joint mobilisations in individuals with 
Osteoarthritis (OA) of the knee (Moss et al., 2007), and cervical mobilisations in 
individuals with lower cervical spine pain (Sterling et al., 2001) and lateral 
epicondyalgia (Vincenzino et al., 1996). All studies showed mean increases in PPT over 
20% of baseline levels. However, all 3 studies analysed the data using percentage 
differences instead of the raw data. Bonate (2000) suggested that percentage change 
scores should be avoided because the score is a biased estimator of the population 
change. Bonate (2000) advocated that if such percentage change scores are used, they 
should be carefully assessed to ensure that they do not violate the assumptions of the 
statistical test being used. None of the above researchers described such analysis, 
although Moss et al., (2007) used the baseline scores as a covariate to minimise bias. 
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Hence the results of Sterling et al., (2001) and Vincenzino et al., (1996), may be 
questioned. Whilst Moss et al.’s (2007) results may be more robust, it is not clear 
whether the values were greater than error measures despite the authors performing a 
repeatability study, because the raw PPT values were not revealed.  
 
The limitations of the studies discussed above may suggest that the significant 
differences found in their studies either may have been incorrectly analysed, or 
irrelevant since values may have been less than error measures or clinical significance. 
This may suggest that the lack of statistical differences in PPT found in the present 
study is not at odds with other published research. Another reason for the lack of 
statistically significant differences in the present study may be related to duration of 
symptoms.  Duration of symptoms for individuals in the 3 groups was quite varied, and 
ranged from 3 months to 20 years. It is possible such long duration of the recent episode 
may have meant that one treatment session may not have been sufficient to have an 
effect, although in Moss et al.‘s (2007) study, 47% of individuals had complained of 
knee OA for greater than 5 years, demonstrating that this factor alone may not be 
sufficient to account for the lack of significant differences in PPT found in the present 
study.  
 
Further rationale for the non-significant findings in the present study may be related to 
only retesting immediately after treatment, which may have limited the body’s response 
to treatment. De Le LLave Rincon et al., (2012), only found significant changes to PPT 
one week after treatment, although the lack of a comparison group means that other 
variables could be responsible for the changes found after one week. Finally, the present 
study used a 3 x 1 minute treatment dose. There appears to be no clear optimal treatment 
dose, and this dose was chosen to reflect current clinical practice (this was decided not 
only on the researcher’s own practice, but also from discussions with colleagues and 
postgraduate students). Whilst Silva et al., (2013) did not look at the difference in 
outcome between their 3 treatment durations (3, 5 and 15 minutes), all doses produced 
statistically significant improvements compared to control groups and placebo. This 
indicated that 3 minutes may be an appropriate treatment dose, although this was done 
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over one set, rather than 3 sets. However, Pentelka et al. (2012) found that a 4th set of 
mobilisations (for either 30 or 60 seconds) resulted in a statistically significant elevation 
in PPT compared to 3 sets or less, however this was for spinal accessory mobilisations 
in asymptomatic individuals. In addition, Sluka and Wright (2001) found that 9 but not 
3 minutes of knee joint mobilisations lead to a hypoalgesic effect in rats after ankle joint 
irritation. More research is needed to establish the optimal neurodynamic treatment 
times in symptomatic individuals.   
 
Whilst there is no definitive explanation for the differences found between the present 
study and other studies showing statistical significance, the limitations discussed in the 
studies using symptomatic participants suggest that changes to PPT after manual 
techniques are not sufficiently proven, and more research is required to corroborate or 
refute such findings. Studies which have used asymptomatic participants may not reflect 
the changes that occur in symptomatic participants.  
 
Effect of BMI  
The second main finding from this analysis was the significant difference between PPT 
sites and BMI. Therefore, descriptive analysis was performed to look at baseline PPT 
values for individuals with BMI under 26 kg/m², and those over 26 kg/m² since this was 
the value that had been suggested as a cut off point for exclusion, as it may lead to a rise 
in PPT (Defrin et al., 2003; Krouwel et al., 2010). Whilst the mean PPTs were higher at 
all sites in individuals with BMI over 26 kg/m², statistically significant increases were 
only found at the gastrocnemius site.  The results at this site are explicable, since PPT 
tests the sensory receptors in both the superficial and deep tissue (Defrin et al., 2003), 
hence greater adipose tissue may cushion the tested site more than in individuals with 
less cushioning. These results were in contrast to the results for the deltoid and tibial 
nerve groups. The tibial nerve may be less influenced by BMI since there is little 
adipose tissue behind the knee. Whilst the deltoid site may be more prone to adipose 
tissue, changes to PPT were not demonstrated in this study, and the rationale for this is 
not clear. Men have been demonstrated to have less adipose tissue in their upper limbs 
than women (Durnin and Womersled, 1974), and there were greater numbers of men 
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than women (20:16) with BMI over 26 Kg/m².  Therefore if more women had presented 
with BMI over 26Kg/m², PPT may have been more greatly affected at the deltoid site. 
 
 Defrin et al. (2003) found no difference in PPT related to BMI . However the three sites 
chosen were the upper back, the hand and the foot, where less adipose tissue is situated. 
It may be that sites that have greater amounts of subcutaneous tissue may require 
additional pressure in individuals with greater BMI. However, more research is required 
to establish this trend. 
 
Effect of pain below knee and PPT 
Adjusting for pain below the knee did not change the main analysis. Only 2 individuals 
had pain below the knee in the somatic group, and each had opposite responses to it (i.e. 
one participant had greater PPT at both sites after treatment, and one had reduced PPT), 
therefore reporting of trends are inappropriate in this group. Some trends were seen for 
the radicular and radiculopathy groups. At the gastrocnemius site, individuals with pain 
below the knee showed a mean decrease in PPT, whereas minimal mean change was 
seen in individuals with pain above the knee. The radicular group showed a slightly 
different trend with a mean increase at deltoid site, but a mean increase at the 
gastrocnemius site.  The results of the radicular group are difficult to justify, as if a 
systemic effect had occurred, as shown by the deltoid site change, then it would be 
expected that an improvement in PPT would also be found at the gastrocnemius site. 
Therefore, it is possible that the trend here is due to measurement error. For the 
radiculopathy group, it is possible that a segmental effect was seen, since only the 
gastrocnemius site showed a change, and not the deltoid site. As the tibial nerve site was 
not found to be significant in contrast testing, this suggests that any change related to the 
effect of pain below the knee was not apparent at the tibial nerve site. The reason for this 
is difficult to explain, since a segmental effect would also have been expected to have 
shown changes to the tibial nerve, as well as to the skin over the gastrocnemius. This 
again may suggest that such changes were related to measurement error. Since the SDD 
found in this study at the gastrocnemius site was 1.75, and decreased PPT at this site in 
individuals with pain below the knee was around 0.25, it is highly likely that this is not a 
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genuine effect. In addition, only 3 participants in the radiculopathy group had pain 
above the knee, reducing the strength of the finding.  
 
Effects of gender 
The results for the main analysis, adjusting for gender, could not be accepted because of 
the loss of homogeneity. Further analysis of gender on PPT was performed, to assess if 
baseline differences in PPT postulated to occur between men and women (Chesterton et 
al., 2003; Manning and Fillingim, 2002; Sterling et al., 2000; Vanderweeën et al., 1996), 
also occurred in individuals with spinally referred leg pain. Statistically higher PPTs 
were found in men compared to women at both deltoid and gastrocnemius sites, and a 
trend was seen at the tibial nerve site, which did not reach statistical significance. These 
higher PPT at deltoid and gastrocnemius nerve sites are in agreement with a number of 
authors (Chesterton et al., 2003; Manning and Fillingim, 2002; Sterling et al., 2000; 
Vanderweeën et al., 1996). Overall the current study suggests that in individuals with 
spinally referred leg pain, the trend for men to have higher PPT than women is retained.  
 
8.3.2 Vibration Thresholds 
There were no significant differences found before and after treatment between groups. 
However, there was a significant difference for VT readings between groups, with the 
radiculopathy group showing higher VT readings than the radicular group. However, 
age is known to increase VT readings, and individuals in the somatic and radiculopathy 
groups had a greater mean age than the radicular group (table 8.1).Whilst this did not 
reach statistical significance with post hoc testing, a strong significant correlation was 
seen between the VT readings and age, and therefore age was entered as a covariate into 
the analysis. The significant difference between groups found without age adjustment, 
was accepted because the assumption of homogeneity for the age adjusted analysis had 
been breached.   
 
The findings of a significant difference between the radicular and radiculopathy group 
with regards to VT may be explained by the pathological processes occurring. Generally 
most animal and human studies have demonstrated greater losses to nerve conduction 
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with greater nerve insult, be this at the nerve root level (Hou et al. 2003; Omarker and 
Myers, 1998; Pedowitz et al, 1992; Rydevik et al., 1991; Takahashi et al., 2003) or in 
other compression neuropathies like carpal tunnel syndrome (Atroshi et al., 2003; 
Finsen and Russworm, 2001). Since individuals in the radiculopathy group were 
identified as having an objective conduction loss on manual examination, the findings of 
greater elevations in VT in this group compared to the radicular groups may not be 
unexpected. However, it was not significantly different from the somatic group, who did 
not display any signs of neuropathy on examination.  
 
This could be explained by 2 factors, the first because of small numbers in the somatic 
group, leading to a type II error. However, whilst VT at both sites was higher in the 
radiculopathy group than the somatic group, the difference was not as large as between 
the radicular and radiculopathy group; therefore the results may be genuine. Another 
second factor could be related to age.  
 
As explained, the results of the analysis with age adjustment could not be accepted 
because of the breach of homogeneity. Whilst this may seem appropriate from a 
statistical perspective, a pragmatic approach must be taken when determining the 
results, because age is such an important factor when considering VT readings, 
particularly in men over the age of 40 (Goldberg and Lindblom, 1979; Halonen et al., 
1986; Hilz et al., 1998). In the radiculopathy group 50% of participants were men over 
the age of 40 (one of whom had such high VT readings that the vibrameter reached its 
maximum reading without the participant reporting vibration at the 1st metatarsal site). 
In the radicular group, men over the age of 40 represented 35% of individuals, and in the 
somatic group represented 40%.  Therefore, the lack of statistical significance between 
the neuropathic and somatic groups could be related to the high proportion of men over 
40 in the somatic group as well as the small numbers in this group. Overall, it is not 
possible to conclusively state that individuals with radiculopathy in this study had 
higher VT, because of a skew in the data with greater age.  
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There was also a main significant effect between sites, with VT being higher at the 1st 
metatarsal than the lateral malleolus in all 3 groups. In some individuals the measure 
was so high at this site that the reading was too high to be captured by the vibrameter. 
More distal sites are known to have an increase in VT than proximal sites possibly 
because of the distance with which the stimulus has to travel (Hiltz et al., 1998), but also 
in this case possibly because the plantar surface of the foot bears the weight of the body, 
and may therefore be less sensitive to the stimuli. In some individuals, hard callus on the 
base of the 1st metatarsal made the stimulus difficult to feel, in these cases the probe was 
moved around to attempt to test the skin in a region where less hard skin occurred. 
There was no significant difference between groups at this site, suggesting that this 
increase in not related to pathology of the lumbosacral nerve roots.  
 
Effect of Treatment 
 
No significant differences were found in VT for any of the groups before and after 
treatment. Whilst a trend was seen, which suggested that individuals in the 
radiculopathy and somatic groups decreased VT after treatment, and those in the 
radicular group increased VT, these were mean differences, and individual variation 
meant that there were no significant differences overall.  
 
Hence no beneficial effects of a 3 x 1 minute treatment can be claimed, but also of 
importance, no detrimental effects can be claimed, even in individuals with altered 
neurological integrity. It has been suggested that applying tensioner techniques in 
individuals with neuropathy may be detrimental to nerve function (Dilley et al., 2005, 
Boyd et al., 2005). The results of this study do not support such conclusions. Whilst it 
could be argued that the risk of accepting the results of the study may be due to the 
sample size and a type II error, it is important to consider the large variation in the effect 
of SLR treatment on VT between individuals, some showing decreases and others 
increases in VT post treatment, which may have washed out the effect of the treatment. 
In addition, the change in VT values related to the SDD, showed that in the somatic and 
radicular groups there was little difference in the proportion of individuals whose VT 
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increased after treatment above the SDD, and those who decreased. In the radiculopathy 
group, a much greater proportion of individuals showed a decrease in VT after 
treatment, than an increase above the SDD at both sites (see table 8.6). This indicates 
that if greater numbers had been recruited, either no effect would have been found, or it 
is possible that a significant improvement may have been found in the radiculopathy 
group. Also of importance the repeatability study (chapter 7) noted a trend for higher 
VT on the second reading compared to the first, therefore small elevation in VT could 
be related to this trend in the absence of a true deterioration in nerve conduction.    
 
To the author’s knowledge, only one study has looked at the effects of a neural 
mobilisation on VT (Ridehalgh et al., 2005). The findings of this study revealed no 
significant differences in asymptomatic participants, and a sub-group of participants 
who were runners. Runners have been considered to be more at risk of neuropathy due 
to incidence of injuries such as ankle inversion sprains and compartment syndrome 
(Leach and Purnell, 1989; Fabre et al., 1998; McCrory et al., 2002). Whilst the study did 
not show any significant changes after treatment, it did show a trend for a rise in VT to 
occur after treatment, with a possible risk of a type II error due to small numbers of 
participants. Nee et al., (2012) analysed the occurrence of adverse effects in individuals 
treated with upper quadrant neural treatments. A risk ratio was calculated to assess 
whether any adverse effects reported during the study resulted in a poorer outcome at 
follow up.  Adverse effects included unpleasant sensation during the treatments, such as 
aggravation of neck or arm pain, arm weakness and nausea. It was found that there was 
no difference in improvement between those who reported an adverse event and those 
who did not. Whilst this study did not analyse changes to nerve conduction, it does 
suggest that adverse effects from neural mobilisation are short lived and not harmful.  
 
The results of the present study suggest that even in participants with objective signs of 
neuropathy, no detrimental changes to VT, and therefore nerve conduction were found. 
This is an important clinical finding as it reduces the concern that such techniques are 
detrimental to nerve function.  
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Sciatic Nerve Excursion 
Longitudinal Excursion 
The results of the study found no significant difference after treatment between groups, 
in either of the 2 hip positions that the SLR was performed.  An analysis of the 
proportion of individuals with increased excursion after treatment (Figs 8.14 and 8.15) 
showed that at 30° hip flexion, over 55% of individuals in the somatic group increased, 
but less than 50 % of the other 2 groups increased. A slight difference was seen at 60° 
hip flexion, with over 60% of individuals in the somatic group showing an increase, 
around 50% in the radiculopathy group, and less than 50% in the radicular group. 
However such differences between groups were not significant. It is possible that the use 
of a 3 x 1 minute treatment dose is not sufficient to cause biomechanical changes to the 
nerve in some individuals, however literature which has examined the effects of 
mobilisations on other soft tissues have found a creep effect to occur between 30 and 60 
seconds (Bandy and Irion, 1994; Bandy et al., 1997; Lee and Evans, 1994), and optimal 
changes to tissue length between the 1st and 2nd repetition (Lee and Evans, 1994). 
Therefore, there may be other explanations for why such differences were found 
between individuals. The theories are complex and speculative, and are presented below. 
 
It is known that most nerve excursion and nerve strain occurs close to the moving joint 
(Boyd et al., 2013, Coppieters et al., 2006).  In the present study, the knee was extended 
and flexed in the SLR position, and therefore the greatest effect may have occurred at 
the nerve around the knee joint. For some individuals by doing this, a reduction in nerve 
excursion occurred. This may be explained by the predominant biomechanical change 
(i.e. lengthening through creep and hysteresis) occurring at the knee, resulting in greater 
compliance, and therefore less reliance on convergence occurring from the proximal 
segments. An explanation for an increase in nerve excursion seen may be the location of 
where the nerve divided. It is known that where nerves divide, they exhibit greater 
stiffness (Millesi, 1995). Hence, the effect of the mobilisation may be greater at these 
points of division, resulting in greater nerve excursion in the posterior thigh in those 
whose nerve divided closer to the scanned region. In addition nerves which had 
generally less compliance throughout, may have had a point of limited movement at the 
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posterior thigh, where nerve excursion occurred just proximal and distal to it. This point 
of restriction, may have incurred a greater mobilisation effect.  
 
An explanation for minimal change in excursion seen in some participants could be 
related to baseline compliance of the proximal nervous tissues. It is possible in an 
individual who had greater compliance of nervous tissue from above the knee (i.e. at the 
hip, lumbosacral plexus, or nerve root level), that as the knee was mobilised, most of the 
effects of extending the knee were unfolding of undulations from the more proximal 
areas. In such cases, there may be minimal changes to nerve excursion, because a point 
has not been reached where sufficient levels of strain are reached, resulting in a smaller 
biomechanical effect on the tissue due to creep or hysteresis. In individuals who have 
less compliance (either due to hypermobility, or because there is a restriction at the 
nerve root for example), then applying the SLR treatment may have caused more of a 
potential lengthening effect (either at the knee, or possibly at the point of restriction) due 
to creep and hysteresis. Less excursion at the posterior thigh may then be seen after 
treatment, because the greater compliance from the proximal regions, or around the knee 
allows more nerve borrowing from these regions during knee extension.  
 
Whilst there are minimal data which can directly support or refute these hypotheses, it is 
known that nerves take an undulating course through the nerve bed, and start to 
straighten out as the first adaptation of limb movement (Millesi, 1986; Millesi et al., 
1995; Sunderland, 1989a). Convergence, where nerves proximal and distal to the site of 
joint movement move towards the moving joint, has been demonstrated in numerous 
studies (Boyd et al., 2013, Breig and Marions, 1963; Coppieters et al., 2006; O’Connell, 
1946).  Dilley et al., (2007) found that excursion of the ulnar nerve in the forearm was 
minimal during shoulder abduction, even with the elbow flexed, when it would be 
expected that excursion would increase as a result of increasing the length of the nerve 
bed. The authors suggest that compliance at the shoulder and around the elbow 
accounted for such lack of change to nerve excursion in the forearm. Taken together 
they help to add some credence to the theoretical concept proposed above. In addition, 
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considering the results of individuals with pain below the knee may add further credence 
to the consideration of effects at the nerve root.  
 
Covariate analysis using pain below the knee resulted in a significant main effect for hip 
position and pain below the knee.  Comparing the baseline readings of individuals with 
pain below the knee and pain above the knee, there was a tendency for individuals with 
pain below the knee to have greater nerve movement with the hip flexed at 60° than 
with the hip flexed to 30°. It has been postulated that the incidence of pain below the 
knee is more prominent in individuals with neuropathic referred leg pain than somatic 
referred leg pain (Beith et al., 2011; Freynhagen et al., 2008). Indeed, in the present 
study, only 2 (out of 11) participants had pain that was below the knee in the somatic 
group, with 25 out of 33 in the radicular group, and 20 out of 23 in the radiculopathy 
group. It may be that pain below the knee suggests greater disruption to the nerve root, 
particularly the lower lumbosacral roots (Murphy et al., 2009), since most individuals in 
the radiculopathy groups had pain below the knee, and all had objective signs of 
neurological loss. It is possible that greater compression or irritation of the nerve root 
results in greater restriction to movement at this location. Marked restriction of L5 and 
S1 nerve roots (mean 0.5mm and 0.3mm L5 and S1 respectively) was found during 
SLR, which markedly improved after discectomy (3.8mm at L5 and 4.1mm at S1) in 
individuals with lumbosacral disc herniation (Kobayashi et al., 2003). The data was 
collected before and after the micro discectomy, suggesting that symptoms were severe 
enough in these individuals to warrant surgery, and hence represents findings of a more 
affected group. In addition, nerve excursion has been demonstrated to be reduced in 
another nerve entrapment disorder, carpal tunnel syndrome (Hough et al., 2007; 
Korstanje et al., 2012).  
 
If the nerve root has less ability to move, this may reduce the ability of these proximal 
nerve segments to accommodate to movement of the nervous tract lower down. 
Therefore, with more hip flexion, as the knee is extended and more accommodation of 
the nervous tissue is required, greater amounts of nerve excursion would be seen at the 
posterior thigh. This may explain the findings of the current study, where individuals 
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with pain below the knee had greater amounts of nerve excursion with the hip flexed to 
60°, than at 30°.  In addition, differences before and after the treatment may also be 
influenced by greater changes at the nerve root. In individuals in the radicular and 
radiculopathy groups, mean nerve excursion decreased after treatment in those with pain 
below the knee, but increased or showed minimal change in the individuals with pain 
above the knee. This may suggest that in individuals with pain below the knee, the nerve 
root was more influenced than in individuals with pain above the knee (and possibly 
where the nerve root was better able to move) because a greater mobilisation effect at 
the nerve root may have occurred during the SLR treatment. This mobilisation effect 
could have occurred due to creep or hysteresis, leading to greater compliance at the 
nerve root, or helped to reduce or disperse oedema (Brown et al., 2011; Schmid et al., 
2013). In this case, the reduced amount of nerve excursion seen after treatment at the 
posterior thigh can be explained by the ability of the more proximal tissues to 
accommodate to the SLR movement. 
   
As mentioned, all of these theories are speculative, and in addition the results should be 
taken into consideration with the smallest detectable differences found from the 
repeatability study (chapter 7). More individuals had differences after treatment greater 
than the SDD with the hip flexed to 30° (6/11 in the somatic group, 14/29 radicular and 
10/20 radiculopathy). For all 3 groups combined, this resulted in 50% of individuals 
with sufficient change to have a genuine treatment effect. This reduced to 25% when the 
hip was flexed to 60°.  This was related to the fact that the SDD was greater when the 
hip was flexed to 60° (2.4mm compared to 1.9mm with hip flexed to 30°).  Overall this 
suggests that the effects of mobilisation at 30° may be accepted more readily than those 
at 60°, and more research is required to investigate this further.   
 
Effect of age on longitudinal nerve excursion 
No significant correlation with age was found for either of the hip positions, which may 
suggest that there is no change to nerve excursion during neurodynamic testing with 
increasing age. This was a surprising finding, since the sciatic nerve shows dramatic 
changes to its structure during the aging process, with greater amounts of adipose and 
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fatty tissue, and general loss of myelinated fibres (Sladjana et al., 2008). Such increases 
in adipose tissue, and the general effects of ageing on connective tissue characteristics 
(Osakabe et al., 2001) might suggest less extensibility, and therefore differences may 
have been expected between the older and younger participants. This was not the case, 
but may be related to the fact that age was not found to be statistically different on post 
hoc testing between the groups, SLR was not taken to the extremes of the individual’s 
range of movement, and was measured at the posterior thigh, rather than the knee.  
 
Poorly tracked images 
The images of 7 participants were of poor quality, meaning that the cross-correlation 
software could not adequately track the images. As mentioned in chapter 7, the software 
relies on a clear image of the nerve in order that it can match the grey scale pattern in 
each of the ROI to the next ROI. One explanation for the poor images in 6 of the 
participants was the high BMI found in these individuals. The propagated ultrasound 
wave had to pass through greater amounts of adipose tissue, which may have attenuated 
the ultrasound beam more, and also may mean that the nerve is more deeply situated.  
For the final participant, it is not clear why a poor image was obtained, although her age 
(58 years) may have resulted in a poorer image due to the larger amount of adipose 
tissue found within the nerve of older individuals (Osakabe et al., 2001). 
 
Normative v symptomatic 
Significantly less sciatic nerve excursion was found with the hip flexed to 60° between 
the somatic group in this study and the asymptomatic groups in the normative study in 
this thesis. This was not expected, since it was considered that participants with somatic 
pain have no nerve involvement, and therefore nerve excursion during the SLR test 
would have been similar to a group of asymptomatic individuals. However, with age 
adjustment, this became non-significant, but since the assumption of homogeneity was 
broken, this result could not be accepted. The marked difference in age between the 
somatic group and asymptomatic group (mean age 57.5 years somatic and 28.9 years 
asymptomatic) however, indicates that age may have impacted upon the significant 
finding between these 2 groups. Whilst age was not considered to be of significance in 
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the clinical study, this may be because of similar ages within the 3 groups. It is of 
interest to note that the other 2 groups also had less nerve excursion at 60° compared to 
the asymptomatic group, but this did not reach significance.  
 
Boyd et al., (2012) found a reduction in mean tibial nerve excursion in both a neutral 
SLR position and hip flexed to the point of discomfort, during ankle dorsiflexion, in 
individuals with diabetes than asymptomatic individuals. However, the mean age of the 
asymptomatic group were markedly less than the group with diabetes (40 years 
compared to 57 years), hence changes to nerve excursion could have been attributed to 
age. The small numbers of participants recruited by Boyd et al., (2012) (5 in each 
group), also diminishes the conclusions of their study.  
  
Transverse plane movement 
Medial/lateral excursion 
No statistical analysis was performed on this data due to lack of evidence for reliability, 
and difficulty found when analysing the nerves in this plane. Before treatment at both 
hip positions, the somatic group had a tendency to move laterally during the SLR, 
whereas the other 2 groups predominantly moved medially. It is not clear why this 
might have happened. In the normative study in chapter 7, whilst marked variations 
were found in individuals in the amount of medial and lateral movement, the majority of 
individuals moved more laterally with the hip flexed to 30°.  This may suggest that the 
somatic group moved similarly to individuals without spinally referred leg pain. Medial 
sciatic nerve movement may have occurred in the 2 neuropathic pain groups because 
this would be the shortest pathway that the nerve could follow. There was  greater 
variation in the asymptomatic group at 60° of hip flexion, whereas variation was high in 
both hip positions in the clinical study. After treatment, with the hip at 30°, the nerve 
excursion in the somatic group moved medially, and at 60° of flexion moved laterally 
but to a lesser degree. At 30° hip flexion, both radicular and radiculopathy groups 
tended to move less medially than prior to treatment, possibly indicating that the nerve 
was moving similarly to asymptomatic participants. However, at 60° there was little 
difference in medial/lateral excursion after treatment compared to before. This suggests 
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that there are changes to the medial and lateral nerve movements after treatment at 30°, 
but with the hip flexed further, where greater nerve bed length changes would occur, no 
consistent response is seen. Linking these findings with the longitudinal data, at 30 ° hip 
flexion, the ROM tended to decrease after treatment, and therefore the nerve was not 
pulled medially to the same extent as prior to treatment. At 60°, such variation between 
individuals before treatment, makes the understanding of changes afterwards more 
complex, and at this time not feasible.    
 
The increased variability in medial/lateral nerve movement in individuals with 
neuropathy has also been found by Boyd et al. (2012), but at the common peroneal site, 
not the tibial nerve site during ankle dorsiflexion. In addition, despite the ROM of hip 
flexion being similar to the final hip position used in this study, individuals with and 
without diabetes showed a more consistent medial pattern of movement at the tibial 
nerve site. However, the tibial nerve at the ankle sits medial to the medial malleolus, and 
the direction of pull therefore from the posterior knee to the ankle must be in a medial 
direction, in order for the nerve to continue its course. Since the sciatic nerve may divide 
anywhere between the ischial tuberosity and the posterior aspect of the knee, its 
direction of pull towards the middle of the knee may vary during knee extension as its 
position in the upper leg is less predictable. In addition, the position of the nerve in 
relation to medial or lateral hamstrings may also affect the medial or lateral excursion 
(see fig 8.22 below). However, another reason for such difference could be attributed to 
error of the measurements. Whilst Tagliafico et al., (2012) found smaller measurement 
error for cross sectional area of the sciatic compared to tibial nerve; this was for static, 
rather than moving images. The marked change in shape of the outline of the sciatic 
nerve during the SLR makes this method of analysis challenging. Whilst Boyd et al., 
(2012) found the technique to be reliable at the tibial nerve, only small amounts of 
longitudinal nerve excursion movement occurred as the ankle was dorsiflexed (mean 
0.6mm). Such small movements are likely to have less of an effect on the changing 
shape of the nerve, and may explain the high reliability found in their study (ICC= 
0.97). More research is required to assess the repeatability of transverse plane movement 
at the posterior thigh site.    
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Superficial/deep excursion 
At 30° hip flexion all groups showed a tendency for the nerve to move more 
superficially before and after treatment. Somatic and radicular groups tended to have 
less superficial excursion after treatment, whereas the radiculopathy group had a greater 
tendency to have slightly greater superficial movement after treatment. This concurs 
with the findings in the asymptomatic participants, where the majority of participants 
showed a superficial movement during the SLR test. In addition, Boyd et al. (2012) also 
found a consistent pattern of superficial movement of the tibial nerve during ankle 
dorsiflexion in individuals with and without diabetes. However at 60° hip flexion, 
sciatic nerve excursion was superficial in the somatic and radicular groups prior to 
treatment, but deep for the radiculopathy group. Hence the somatic and radicular group 
behaved like the asymptomatic participants, but not the radiculopathy group. 
 
 It is possible that the individuals in the radiculopathy group, with greater nerve root 
dysfunction may have more protective muscle contraction of the hamstrings during the 
SLR test (Boyd et al., 2009). Since the sciatic nerve sits between semimembranosus and 
the short head of biceps, it is possible that if the muscles contracted, they could limit the 
amount of superficial movement (see fig 8.22). In addition, Boyd et al., (2009) found 
that if the ankle was dorsiflexed prior to SLR that semitendinosus contracted greater 
than biceps femoris. Whilst semimembranosus and short head of biceps femoris were 
not analysed, it is possible that they may show similar activation patterns as their 
medially and laterally placed counterparts. Since the ankle was placed and held in 
plantargrade in the present study, this may support the effect of muscle activation on this 
direction of nerve movement. In addition, Goeken et al., (1993) suggest that 
semimembranosus is the first hamstring muscle to become activated during the SLR. It 
is possible that a greater force was exerted anteriorly to the nerve resulting in a deep 
movement. 
 
 After treatment, the somatic and radicular groups moved less superficially but the 
radiculopathy group moved even deeper. This may suggest that muscle activation did 
not improve after treatment. However, this is speculative and further research analysing 
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muscle activation during the SLR, whilst scanning the sciatic nerve would be needed to 
substantiate this. 
 
Fig 8.22 Cross section through the mid-thigh (adapted from Bickels and Malawar, 
2009) 
 
Central sensitisation 
The presence of CS occurred in only 2 participants. The proportion of individuals with 
CS in people with spinally referred leg pain is not clear within the literature, however it 
is considered to be prevalent in individuals with chronic low back pain (Giesbrecht and 
Battie, 2005; Giesecke et al., 2004; Jensen et al., 2010; Schmidt-Wilcke et al., 2006; 
Smart et al., 2012). The small numbers found in this study perhaps suggests that CS may 
not be so prevalent in this group of individuals, but may also reflect a lack of 
willingness of individuals with CS to participate in the study. It is not known how many 
individuals saw the recruitment posters or emails, or were sent the information sheets 
and decided not to participate in the study.  
 
Another consideration is the method of ascertaining the presence of CS used in this 
study. No validated method of testing CS has been developed, therefore presence was 
assessed by subjective and physical factors which suggested a heightened nociceptive 
system. Such factors included subjective reporting of widespread allodynia, 
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hyperalgesia, and the presence of painful regions when tested with an algometer, which 
are commonly used to support a diagnosis of fibromyalgia. These points were used by 
Jensen et al. (2010) and found to be heightened in individuals with chronic LBP.  
 
The results of the 2 individuals with CS can be seen in section 8.2. Since such small 
numbers meant that no statistical analysis was appropriate, only descriptive analyses 
was performed. The relevance of some of the measures is not possible to comment on 
with such low numbers, however some points of interest will be briefly discussed. Both 
individuals had a long duration of symptoms, and had a higher ODI score than the mean 
of each of their respective group allocations (radicular and radiculopathy). Both 
participants had higher psychosocial scores than the group means for most scales. 
However, both participants scored zero for depression, and anxiety levels were also low 
in both participants.  This finding may suggest that depression and anxiety sub-traits are 
not inextricably linked with greater levels of pain. In addition, they indicate that in these 
2 individuals they are not linked to higher levels of disability, which has been postulated 
in individuals with LBP (Wand et al., 2010).  Both PPT and VT were lower than the 
group mean for each individual. A lower PPT was expected because these individuals 
had had pain on tender point assessment, which was an important indicator of CS in this 
study. Lowered VT levels may indicate a heightened sensitivity to the vibration 
stimulus, although this may have been expected to be reported as pain, since such 
heightened responses to non-nociceptive stimuli are considered to be a feature of 
individuals with CS. Neither individual reported the stimulus as painful.  
 
Pain below the knee 
The proportion of participants with pain below the knee varied markedly between the 3 
groups, with both the radicular and radiculopathy groups having a much greater 
proportion of individuals with pain below the knee (76% and 87% respectively) than the 
somatic group (18%). Schafer et al. (2011) found no significant difference in the 
presence of pain below the knee between 4 sub-groups of individual with spinally 
referred leg pain. It is not clear why the 2 studies found such different presentations of 
pain below the knee. Despite the differences in the way that the patients were sub-
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grouped (see chapter 2), individuals with neuropathic pain had a similar proportion of 
pain below the knee to the somatic sub-group in Schafer et al’s (2011). However, it is 
possible that the small numbers of individuals with somatic referred pain in the present 
study, could have led to a false representation of location of referred leg pain in a larger 
population. 
  
It has been postulated that people with pain below the knee have a poorer prognosis than 
those with pain above the knee (Hill et al., 2011). This was not demonstrated in the 
current study, since minimal changes to PPT occurred in any of the 3 groups and 
individuals in the radiculopathy group showed a decrease in VT, although this trend did 
not reach statistical significance. However, the difference in this study compared to Hill 
et al. (2011) is that the present study only assessed the immediate effects of one 
treatment, rather than a longitudinal observation of outcomes after 6 months. In 
addition, the individuals in Hill et al.’s (2011) study were not all treated in the same 
way, some receiving advice only, whereas other received medication or a course of 
physiotherapy. In agreement with the present study, Kongsted et al., (2013) found that 
the location of symptoms did not affect prognosis in individuals with spinally referred 
leg pain.   
 
 Greater levels of disability (Kongsted et al., 2012), depression and anxiety (Hill et al., 
(2011) have been found in individuals with pain below the knee. The current study does 
not concur with these findings, since there was no correlation between pain below the 
knee and higher levels of psychosocial or disability factors.  
 
Psychosocial Factors 
There were no significant differences in the psychosocial factors or level of disability 
between the 3 groups. This is in contrast to Walsh and Hall (2009a) who found higher 
disability and fear avoidance for individuals in a peripheral nerve sensitisation group 
(similar classification to the radicular group in the present study) than the denervated 
group (radiculopathy in the present study) and individuals with central sensitisation. 
However, the somatic group did not differ significantly from the peripheral nerve 
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sensitisation group, which is similar to the present study’s findings. Schafer et al., 
(2009) using the same sub-classification system as Walsh and Hall (2009a), only found 
a difference in anxiety in individuals with central sensitisation, and not between the 
other groups. Since only 2 participants in the present study were classified as having CS, 
it is not possible to fully compare the findings with Schafer et al., (2011), but of interest 
anxiety was low in both of the participants with CS found in the present study.  
Since no differences were found in the baseline scores between the 3 sub-groups, further 
analysis was not carried out into the effects of psychosocial factors on the outcome of 
treatment.  
 
The correlation of certain psychosocial scales to each other have been described in the 
literature. In the present study, strong correlations were found between sub-scales of the 
same questionnaire (e.g. different elements of the pain catastrophising scale, and 
between depression, anxiety and stress on the DASS scale). More interestingly, pain 
catastrophising (and all of its sub-scales) was found to correlate moderately with anxiety 
and kinesiophobia, and anxiety was found to correlate moderately with kinesiophobia.  
French et al. (2007) also found that pain catastrophising correlated with kinesiophobia, 
and Osman et al. (1997) found concurrent validity of the PCS as measured against 
anxiety.  
 
Fear avoidance beliefs (FAB) about work or physical activity did not show significant 
strong correlations with any of the other scales. This may be surprising, since fear about 
physical activity would be expected to correlate with fear of movement (kinesiophobia), 
however the correlation of these 2 subscales in the present study were only 0.35, 
suggesting a weak correlation (Taylor et al., 1990). This is in contrast to Crombez et al. 
(1999) who found that the FABQ correlated strongly to the Tampa scale (r= 0.57 and 
0.56 (physical activity and work respectively), in 35 individuals with chronic LBP. It is 
not clear why such differences were found compared to Crombez et al.’s (1999) study. 
The main difference between the 2 sub-scales is that FABQ asks questions which are 
mainly related to fear of movement due to pain, whereas the Tampa scale suggest more 
fear of causing more harm rather than more pain. With regards to median scores, 
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individuals with spinally referred leg pain had slightly higher Tampa scores than the 
FABQ physical activity scores (33/64 Tampa compared to 10.4/24 FABQ). It is possible 
therefore that individuals with spinally referred leg pain were more fearful of causing 
greater harm than pain. However, more research is required to establish if this trend is 
replicated in a larger cohort, and with comparison to individuals with LBP only.  
 
8.4 Summary of the Findings 
 
 Pressure pain thresholds, vibration thresholds and sciatic nerve excursion during 
the SLR test were not significantly different between the 3 sub-groups of 
individuals with spinally referred leg pain after a 3 x 1 minute SLR treatment.  
 
 Such findings may relate to the fact that individuals with these symptoms had a 
long history of the current problem, were only given one treatment session 
lasting for 3 minutes in total, and were only assessed immediately after 
treatment. 
 
 VTT found no difference between groups, and in individuals with radiculopathy 
(where an objective sign of conduction loss was found), there was a mean trend 
for an improvement in VT after treatment. Whilst this did not reach statistical 
significance, it suggests that even in individuals with conduction loss, further 
losses to nerve conduction are not seen after a neural mobilisation. This is a key 
finding which may influence clinical practice, where tensioner techniques have 
previously been considered as a more aggressive form of treatment.   
 
 Changes to sciatic nerve excursion in the posterior thigh after a 3 x 1minute SLR 
mobilisation were variable. This may be due to individual differences in 
biomechanical compliance of the nerve along its length, and possibly restriction 
of the nerve root. However, the limited ability to view the nerve root, and the 
fact that it is only possible to measure one nerve site at one time, means that this 
is speculative at the current time.   
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 A greater proportion of individuals with pain referred below the knee were found 
in the radicular and radiculopathy groups, particularly in the radiculopathy 
group. This may suggest that location of symptoms may help to identify the 
mechanism of pain. However, since only 11 participants were recruited to the 
somatic group, more research is required to verify these findings.  
 
 Disability and psychological characteristics were not found to be significantly 
different between the 3 sub-groups in this study.  
8.5 Limitations of the study 
Sub-grouping 
 
At present there are limited methods of sub-grouping individuals with spinally referred 
leg pain. Quantitative sensory testing would differentiate between neuropathic and non-
neuropathic pain, but is costly and time consuming. Pain questionnaires such as 
painDETECT and the LANSS scale do not distinguish between neuropathic pain with 
and without conduction loss. This study aimed to use a pragmatic sub-grouping system 
which is currently used in clinical practice. As such, the relevance of these findings may 
be more readily applied to clinical practice, since clinicians already use the sub-
grouping system. However, the use of neurological integrity tests has been debated, with 
often poor validity for the identification of specific levels. In addition, recently, 
deterioration in small calibre sensory fibres has been found in entrapment neuropathies 
(Rehm et al., 2008), and these may have not been identified by light touch assessment. It 
is possible therefore that some individuals were not correctly identified, and some of the 
individuals sub-grouped as having radicular pain may have had a radiculopathy. Since 
no differences were found between these 2 sub-groups, it may be that these 2 groups do 
not behave differently to a SLR treatment, and may be considered as one group. 
 
Sample Size 
The sample size calculation suggested that 25 participants were required in each group. 
Sixty seven participants were recruited overall, and only 11 participants were allocated 
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to the somatic group. Whilst the main risk of low numbers is a type II error, the results 
overall suggest that an increase in numbers may not have altered the findings. This is 
due to the fact that for all 3 outcome measures, many individuals showed an increase in 
the measure, whilst large proportions of individuals decreased. Such a wash out effect 
has been considered to be related to responders and non-responders in individuals, and 
in some cases the rationale for the introduction of clinical prediction rules (Tseng et al., 
2006). The use of psychosocial factors aimed, in part, to identify if such factors resulted 
in differences in the response to treatment. As these factors did not differ significantly 
between the sub-groups, it indicates that any change in the outcome measures were 
unlikely to be related to the psychosocial factors or disability. Therefore more research 
is needed to find out why some individuals responded to treatment more than others.  
 
Location of ultrasound imaging 
Whilst ultrasound imaging offers exciting opportunities to assess in vivo nerve 
excursion, there are limitations to this technique in the current study. The most useful 
area to have scanned would have been at the level of the nerve root, since individuals in 
the 2 neuropathic pain groups had pain referring from the nerve root. Any changes to 
nerve excursion or differences in nerve excursion prior to treatment between the groups 
may have been better analysed at this level. Unfortunately, ultrasound cannot penetrate 
through bone, and therefore obtaining a clear longitudinal view of the nerve roots in the 
lumbosacral region would be extremely challenging. The sciatic nerve can be easily 
visualised in the posterior thigh, and has been used to demonstrate nerve mechanics 
during slump test (Ellis et al., 2012). As it extends from the lumbosacral nerve roots via 
the lumbosacral plexus, any effects of the nerve treatment may be seen along the course 
of the nerve. Hence extrapolation for what may have been happening at the nerve root 
was attempted in the present study, utilising supportive research which has investigated 
normal mechanics of nervous tissue. Future possibilities to corroborate such assertions 
may be possible with dynamic MRI.    
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Transverse plane measurements 
New methods of analysing transverse plane nerve excursion emerged after the data 
collection for the reliability study. Since these measures had only ever been planned to 
be descriptively analysed, it was decided to use the new method of analysis that had 
been shown to be reliable by Boyd et al. (2012), but to continue to describe, rather than 
statically analyse the data. Ideally, if there had been more time, this method of analysis 
would have been more thoroughly investigated. It is not known therefore, if the large 
variability in readings is due to measurement error, or is indeed a true finding in both 
asymptomatic and symptomatic groups.  
 
Maintaining same final position of leg post treatment 
Whilst greater changes to nerve excursion would have been seen if the final SLR 
position had been allowed to change post treatment, this would have led to an inability 
to explain whether such changes were simply due to alteration in the nerve bed length, 
due to a greater joint range of motion (either due to changes to pain or muscle/joint 
increased range), or changes to the nervous tissue itself. Since it is known that overall 
nerve movement is a consequence of a complex series of events, including undulation, 
excursion and strain, regional alterations in overall excursion occur without altering the 
overall joint range of motion.  
 
Age of participants 
The mean age of participants in this study was 52.9 years. This reflected the problems 
with recruitment that were not anticipated at the start of the study. Since the majority of 
participants were not recruited from the NHS, many individuals who responded to the 
adverts in the local newspapers or radio were retired. This also reflects the local 
geographical area to where the study was located, where there is a large proportion of 
retired individuals (23% compared to 10% in the London borough of Wandsworth 
(Royal Geographical society, n.d.). Age adjustments were made to the final analysis, but 
the higher mean age may affect the extrapolation of the results.  
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In addition FABQ for work was more difficult for participants to apply when they were 
not currently working. Participants were asked to consider their activities of daily living 
as work, but the responses may be different from individuals in paid employment.   
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Chapter 9 Summary, Contribution to knowledge and 
suggestions for future work 
 
9.1 Overall Summary of findings 
 
The overall aim of this thesis was to determine what effects a 3 x 1 minute SLR 
tensioner treatment had on pressure pain thresholds, vibration thresholds and sciatic 
nerve excursion between 3 different sub-groups of individuals with spinally referred leg 
pain. Three outcome measures were identified which gave an indication of the impact of 
the treatment on pain, nerve conduction and sciatic nerve excursion. Prior to the start of 
the clinical study, validity of the nerve excursion measurement and repeatability of the 
outcome measures were undertaken, to ensure that the measures were acceptable. In 
addition, since the participants in the nerve excursion repeatability study were 
asymptomatic, normative movement was ascertained during the SLR.  
 
The method of analysing nerve excursion with frame-by-frame cross correlation was 
found to be valid. The findings of the 3 repeatability studies suggested that all 3 
outcome measures were highly repeatable. Error measures were identified for each 
outcome, and these were considered in light of the clinical study. Transverse plane 
(medial/lateral, and superficial and deep) nerve movement was captured, initially to 
simply describe trends, but as new methods of analysis emerged during the course of the 
PhD journey, it was decided to try to measure this movement. However, this occurred 
subsequent to the reliability study data collection, and therefore no repeatability 
measures were available for analysis. Some difficulties in the use of this method were 
found, particularly where the nerve changed shape considerably during the SLR, or 
where the outline of the nerve was less clear. 
   
Normative findings in the nerve excursion study produced new literature on in vivo 
sciatic nerve excursion, and supported some of the work done in the upper limb. These 
findings were that some individuals showed an increase in longitudinal nerve excursion 
with greater range of hip flexion, whilst others showed a decrease. Since greater strain is 
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known to occur with combinations of joint movements which result in greater 
lengthening of the nerve bed (a tensioner manoeuvre), it was considered that knee 
extension performed with the hip more flexed would result in less nerve excursion 
measured at the posterior thigh. It was postulated that where (counterintuitively) greater 
nerve excursion occurred with knee extension at 60° hip flexion compared to 
30°occurred, this could be explained by the participants having higher resting levels of 
nerve compliance. At 30 ° hip flexion, the accommodation to joint movement would 
mainly be through nerve undulation, but as the hip was flexed further into range, the 
undulations were taken out, resulting in greater nerve strain and nerve excursion from 
the observed, posterior thigh region. Transverse plane movement was more variable, but 
in general the nerve moved superficially and medially during knee extension. 
 
Overall there were no significant differences between the sub-groups, before and after 
the 3 x 1 minute treatment for any of the 3 outcome measures. In addition, for the PPT, 
few individuals showed changes after treatment which were above the SDD calculated 
from the repeatability study. Whilst the proportion of individuals who showed a 
clinically significant change was different between the 3 groups, such small changes 
after treatment in comparison to SDD, mean that some of the observed differences could 
be attributed to error. With regards to VT, whilst no significant improvements were 
found, an important finding of this study was that no significant deterioration was found 
even in participants with conduction loss. Indeed, in these participants a trend for a 
reduction in VT (suggesting an improvement in conduction) was found, with larger 
proportions of individuals showing a decrease in VT of levels greater than the SDD, 
than those showing an increase. These findings suggest that a SLR tensioner applied to 
the point of onset of symptoms for 3 x for 1 minute duration in non-severe and non-
irritable individuals with radiculopathy, is not harmful.  
 
There were two main considerations for longitudinal nerve excursion in this study. 
Firstly, that nerve excursion increased in the posterior thigh after treatment in some 
individuals, but decreased in others. It was postulated that individuals who moved less 
after treatment at the measured site may have had less compliance from the proximal or 
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distal structures, either due to predisposed stiffer connective tissue, or due to a 
restriction in compliance proximally due to changes at the nerve root for example. 
Therefore, the SLR technique may have caused a greater change in the length of the 
tissue which then allowed adaptive change to occur through creep and hysteresis. Such 
altered compliance may then have allowed greater adaptation from the previously 
restricted structures, resulting in less excursion closer to the moving joint (the knee). 
This was further supported by the fact that individuals with pain below the knee showed 
a decrease in excursion, and the majority of these individuals were in the radicular or 
radiculopathy groups. 
 
The second consideration was that in individuals with pain below the knee, greater nerve 
excursion was seen with the hip flexed to 60° than 30°. This again may suggest changes 
to nerve mechanics proximally, since an inability to accommodate to the movement of 
the knee due to a restriction more proximally (e.g. at the nerve root), would result in 
greater excursion as the sciatic nerve in the posterior thigh is pulled towards the moving 
knee joint.  
 
Transverse plane movement in the somatic group was similar to asymptomatic 
individuals with a superficial and lateral excursion during the SLR. In the neuropathic 
pain groups, the nerve moved medially, and in the radiculopathy group there was a 
tendency for the nerve to move more deeply. These differences may reflect the attempt 
to shorten the nerve path during SLR in the neuropathic pain group, and also the 
possible contribution of protective muscular responses in the thigh to SLR.  
 
The prevalence of central sensitisation in individuals with spinally referred leg pain is 
not known, although it has been postulated to be high. This study did not support such a 
high proportion since only 2 participants were identified, however 2 main factors could 
account for this. Firstly, individuals with CS may have greater amounts of pain, higher 
disability levels and greater levels of psychosocial attributes.  Such factors may have 
meant that people with CS were less likely to volunteer for a study where they had to 
tolerate being moved around, or be given questionnaires assessing their levels of 
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psychosocial distress. In addition, no validated measures of CS have been developed; 
therefore this study used the presence of recognised signs and symptoms of CS, and the 
presence of widespread hyperalgesia to pressure. It is possible that this method did not 
adequately identify the presence of CS. The 2 individuals in this study had higher levels 
of disability than the cohort average, and many of the psychosocial factors. However, 
since only 2 participants were identified with CS, no further conclusion can be drawn. 
  
The presence of pain below the knee was highest in the radiculopathy group, but was 
also high in the radicular group. This may suggest that pain below the knee is a good 
indicator of neuropathic spinally referred leg pain. However, the somatic sub-group 
consisted of only 11 participants, and therefore further research is required to 
substantiate this.  
 
9.2 Original Contribution to Knowledge 
There has been a growth in neurodynamic research in the last 5 years, which have 
increased the body of knowledge about the effects and effectiveness of such treatments. 
At the start of this PhD thesis in 2005, relatively little research had been published on 
lower limb neurodynamic treatments. The opportunity to find out more about what 
happened after such a treatment was exciting and pioneering at that time. However, even 
with the recent increasing body of knowledge, there remain gaps regarding the basic 
underlying effects of such treatment in symptomatic groups. 
 
Recent research has demonstrated that these treatments may be effective in combination 
with other physiotherapeutic modalities, and animal studies have uncovered some 
physiological rationale for improvements. This study aimed to assess the effects of a 
single dose of neurodynamic treatment between sub-groups of individuals with spinally 
referred leg pain, and establish differences between the 3 groups on pressure pain 
thresholds, vibration thresholds and sciatic nerve excursion. Whilst overall no 
significant differences were found, some important findings provide some original and 
valuable points for practice or research. 
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1. A 3 x 1minute SLR tensioner is not harmful even in non-severe, non-irritable 
individuals with neurological impairment. 
2. In individuals with spinally referred leg pain, the presence of neuropathic pain does 
not appear to determine the response to treatment. 
3. The frame-by-frame cross correlation technique for analysing longitudinal sciatic 
nerve excursion is repeatable even where large amounts of nerve excursion occur.  
4. Variations in amounts and direction of nerve excursion during SLR occur between 
individuals. These variations may depend on a number of factors, including 
predisposed physiological characteristics (e.g. connective tissue compliance), age and 
pathology.  
 
9.3 Suggestions for future work 
Changes to nerve mechanics, both in pathological groups and after treatment, are 
complex and difficult to clearly establish. Limitations of ultrasound scanning exist, 
because of the restricted field of view and inability to view structures through bone. In 
addition only nerve excursion, not strain was explored in the present study, which does 
not allow for the full exploration of changes to nerve mechanics. Whilst strain measures 
using a similar technique to the present study have been attempted for 2D B mode 
images of supraspinatus tendon (Kim et al., 2011), limitations of the technique threaten 
its validity (Slagmolen et al., 2012). The development of elastography for analysing 
tissue mechanics (Drakanoni et al., 2009; Lalitha et al., 2011) and 3D USI offers new 
opportunities for nerve excursion studies, so that exploration of the relationship of both 
nerve excursion and strain may be feasible in the future. The use of dynamic MRI may 
allow for better exploration of changes to tissue mechanics at the nerve root and along 
the course of the nerve after nerve treatment.  
 
Only immediate changes were analysed in the present study due to the length of time 
that participants were expected to devote to the study. Two sessions consisting of an 
hour, and an hour and a half were considered acceptable for the present study, since no 
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on-going treatment was offered to participants (although NHS participants commenced 
treatment after the laboratory part of the study). Even repeating the outcome measures 
after 15 minutes would have resulted in extending the laboratory session for an extra 50 
minutes, resulting in participants giving up almost 2 ½ hours of their time. However, by 
not including repeated measures after treatment, it is not known if an effect may have 
been established subsequent to the treatment. Therefore, future studies may consist of 
additional measures post treatment, but it may be that additional treatment sessions 
would need to be added to justify this additional time commitment for participants. In 
addition, only one treatment dose was explored. Currently the researcher is supervising 
groups of postgraduate students assessing the effects of different neurodynamic 
treatment doses in asymptomatic participants. It is planned that further development of 
this work will continue on symptomatic groups of participants.  
 
Vibration threshold testing has been considered an important measure of changes to 
nerve conduction for individuals with minor peripheral nerve disorders. However, 
changes to small diameter afferent nerve activity have also been documented, and it is 
unknown what the effects of neurodynamic treatments might have to these fibres. 
Measures such as hot or cold pain thresholds, and temporal summation may give an 
indication of changes to small diameter afferent activity.  
 
Some individuals in the study commented that they felt much better after the SLR 
treatment, and some were surprised that it hadn’t made them feel worse. It is unknown 
from the present study whether some of the individuals who improved after treatment 
fell into these groups. The effect of coming to the University to participate in the study 
may have had an impact on the pain measures, but perhaps less to the vibration 
thresholds (although since VT are a semi-objective measures of nerve conduction, 
relying on the individual to report the onset and disappearance of VT, some subjective 
element could have altered VT). However, overall there was no obvious Hawthorne 
effect seen, since a variation in measures was apparent between individuals, even within 
the same sub-group. The limitations of solely quantitative studies are that the 
individual’s experience, understanding and beliefs about the study (or their condition) 
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are not known or taken into account. Additional research which investigates these 
factors is essential to try to understand how individual attributes impact on outcome.  
 
Finally, the investigation of one form of physiotherapy intervention alone is useful in 
that it allows a detailed exploration of the effects of that one treatment. However, this 
does not replicate clinical practice, since a combination of treatment modalities is 
normally required. Whilst studies have looked at combining treatment modalities, often 
these have been pre-determined by the researchers regardless of the patient presentation. 
In these instances, this removes the clinician’s role in ascertaining the best treatment for 
the individual patient based on high levels of clinical reasoning. Pragmatic trials 
(Roland and Torgerson,1998) which allow for more active decision making by the 
clinician are needed to justify Physiotherapy management, but do detract from the 
justification of specific treatment modalities. Further work is needed in the future to 
establish best ways of establishing efficacy of treatment in individuals with spinally 
referred leg pain. 
9.4 Conclusion 
 
The use of frame-by-frame cross correlation analysis of B mode ultrasound images is 
repeatable for measuring sciatic nerve excursion during a modified side-lying SLR test. 
Vibration thresholds and pressure pain thresholds are reliable techniques for assessing 
pain response and conduction of the large diameter afferent nerves in individuals with 
spinally referred leg pain.  
 
There is no difference in the outcome of a single 3 x 1minute SLR tensioner treatment 
between sub-groups of individuals with spinally referred leg pain of greater than 3 
months duration. The results suggest that this treatment dose of SLR is not effective in 
changing pressure pain thresholds or vibration thresholds in these individuals. However, 
the results importantly suggest that there are no detrimental effects for this form of 
treatment, even in individuals with non-severe, non-irritable radiculopathy. In addition, 
a varied response to longitudinal nerve excursion was observed in the posterior thigh, 
with some individuals demonstrating an increase, and others a decrease in longitudinal 
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nerve excursion after treatment. However, there was a trend for individuals with pain 
referred below the knee in the radicular and radiculopathy groups, to show a decrease in 
excursion at the posterior thigh, which may reflect changes to the compliance of the 
nerve after treatment.    
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Key: DRs dorsal nerve roots, DRG dorsal root ganglion, NP nucleus pulposus, AF 
annulus fibrosus. 
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Appendix 2 Effects of nerve root compression and irritation on 
inflammation, nerve conduction and structure 
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Key: DNR/VNR dorsal/ventral nerve roots, DRG dorsal root ganglion, NR nerve root, NP nucleus 
pulposus, AF annulus fibrosus, CV conduction velocity, CNAP compound nerve action potential, EMG 
electromyography, CMAP compound motor action potential, CGS chromic gut suture, EBA evans blue 
albumin, HRP Horseradish peroxidase 
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Appendix 3 Recent studies investigating Somatic referral of leg pain 
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Appendix 4 Studies on dermatome mapping 
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Appendix 5 Studies for Psychosocial factors and disability in 
individuals with LBP  
R
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Appendix 6 Oswestry Disability Scale (Fairbank et al., 
1980) 
 
316 
 
Appendix 7 Fear Avoidance Beliefs Questionnaire 
(Waddell et al., 1993) 
 
12/LO/0397 Fear avoidance beliefs questionnaire version 1 16/04/2012 
Fear Avoidance Beliefs Questionnaire (FABQ) for patients with Back Pain 
Instructions: Here are some of the things which other patients have told us about their pain. For 
each statement please circle the number from 0 to 6 to say how much physical activities such as 
bending, lifting, walking and driving affect or would affect your back or leg pain. 
Rating 0 1 2 3 4 5 6 
Meaning Completely 
disagree 
  Unsure   Completely 
agree 
 
Statements 
1) My pain is caused by physical activity 0 1 2 3 4 5 6 
2) Physical activity makes my pain worse 0 1 2 3 4 5 6 
3) Physical activity might harm my back 0 1 2 3 4 5 6 
4) I should not do physical activity which  0 1 2 3 4 5 6 
(might) make my pain worse 
5) I cannot do physical activities which  0 1 2 3 4 5 6  
(might) make my pain worse 
 
The following statements are about how your normal work affects or would affect your back or leg 
pain. 
 
6) My pain was caused by my work or by 0 1 2 3 4 5 6 
 an accident at work 
7) My work aggravated my pain  0 1 2 3 4 5 6 
8) I have a claim for compensation for   0 1 2 3 4 5 6 
my pain  
9) My work is too heavy for me   0 1 2 3 4 5 6 
10) My work makes or would make my pain 0 1 2 3 4 5 6 
worse 
11) My work might harm my back  0 1 2 3 4 5 6 
12) I should not do my normal work with  0 1 2 3 4 5 6 
my present pain 
13) I cannot do my normal work with my  0 1 2 3 4 5 6 
present pain 
14) I cannot do my normal work till my   0 1 2 3 4 5 6 
pain is treated  
15) I do not think that I will be back to   0 1 2 3 4 5 6 
normal in 3 months 
16) I do not think that I will ever be able to  0 1 2 3 4 5 6 
go back to work 
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Appendix 8 Tampa Scale of Kinesiophobia 
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Appendix 9 Pain Catastrophising Scale 
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Appendix 10 Disability anxiety and Stress scale 21 
 
12/LO/0397 Depression anxiety and stress score, version 1, 
16/04/2012 
DAS S 21 Name: Date: 
Please read each statement and circle a number 0, 1, 2 or 3 which indicates how much the statement 
applied to you over the past week.  There are no right or wrong answers.  Do not spend too much time 
on any statement. 
The rating scale is as follows: 
0  Did not apply to me at all 
1  Applied to me to some degree, or some of the time 
2  Applied to me to a considerable degree, or a good part of time 
3  Applied to me very much, or most of the time 
 
1 I found it hard to wind down 0      1      2      3 
2 I was aware of dryness of my mouth 0      1      2      3 
3 I couldn't seem to experience any positive feeling at all 0      1      2      3 
4 I experienced breathing difficulty (eg, excessively rapid breathing, 
breathlessness in the absence of physical exertion) 
0      1      2      3 
5 I found it difficult to work up the initiative to do things 0      1      2      3 
6 I tended to over-react to situations 0      1      2      3 
7 I experienced trembling (eg, in the hands) 0      1      2      3 
8 I felt that I was using a lot of nervous energy 0      1      2      3 
9 I was worried about situations in which I might panic and make 
a fool of myself 
0      1      2      3 
10 I felt that I had nothing to look forward to 0      1      2      3 
11 I found myself getting agitated 0      1      2      3 
12 I found it difficult to relax 0      1      2      3 
13 I felt down-hearted and blue 0      1      2      3 
14 I was intolerant of anything that kept me from getting on with 
what I was doing 
0      1      2      3 
15 I felt I was close to panic 0      1      2      3 
16 I was unable to become enthusiastic about anything 0      1      2      3 
17 I felt I wasn't worth much as a person 0      1      2      3 
18 I felt that I was rather touchy 0      1      2      3 
19 I was aware of the action of my heart in the absence of physical 
exertion (eg, sense of heart rate increase, heart missing a beat) 
0      1      2      3 
20 I felt scared without any good reason 0      1      2      3 
21 I felt that life was meaningless 0      1      2      3 
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Appendix 11 Biomechanical studies during slump and SLR  
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d
 o
f 
m
e
as
u
re
m
en
t 
M
ar
ke
r 
p
la
ce
d
 o
n
 s
u
rf
ac
e 
o
f 
d
u
ra
m
at
er
 o
r 
sp
in
al
 c
o
rd
 (
in
ci
si
o
n
 o
r 
w
h
it
e 
th
re
ad
),
 s
ca
lp
el
 b
la
d
e 
in
se
rt
ed
 
in
to
 v
er
te
b
ra
l l
am
in
a.
 A
m
o
u
n
t 
o
f 
m
o
ve
m
en
t 
b
et
w
e
en
 s
ca
lp
el
 a
n
d
 
m
ar
ke
r.
 
O
b
se
rv
at
io
n
al
 m
et
h
o
d
s,
 d
et
ai
ls
 n
o
t 
d
is
cl
o
se
d
. 
Sa
w
ed
 m
o
n
ke
ys
 in
 h
al
f,
 
h
em
ila
m
in
ec
to
m
y 
p
er
fo
rm
ed
. P
in
s 
in
se
rt
ed
 in
to
 s
p
in
al
 c
o
rd
, d
o
rs
al
 n
er
ve
 
ro
o
ts
 a
n
d
 d
if
fe
re
n
t 
p
ar
ts
 o
f 
th
e 
sc
ia
ti
c 
an
d
 t
ib
ia
l n
er
ve
. N
ai
ls
 in
to
 b
o
n
y 
la
n
d
m
ar
ks
. L
at
er
al
 r
o
en
tg
en
o
gr
am
 t
o
 
an
al
ys
e 
m
o
ve
m
en
t.
 
P
in
s 
in
se
rt
ed
 t
h
ro
u
gh
 d
u
ra
 in
to
 c
o
rd
 
an
d
 p
ed
ic
le
s.
 
1
. P
ap
er
 m
ar
ke
rs
 a
n
ch
o
re
d
 o
n
 c
o
rd
 
d
u
ri
n
g 
ex
te
n
si
o
n
- 
se
p
ar
at
io
n
 o
f 
st
ri
p
s 
d
u
ri
n
g 
fl
ex
io
n
. 
2
. S
ilv
er
 p
in
 m
ar
ke
rs
 a
n
d
 w
ir
e 
in
d
ic
at
o
rs
- 
X
 r
ay
 in
 e
xt
en
si
o
n
 a
n
d
 
fl
ex
io
n
. 
M
o
ve
m
en
ts
 a
n
d
 r
e
gi
o
n
/s
 o
f 
n
e
rv
e
 s
tu
d
ie
d
 
1
. C
er
vi
ca
l f
le
xi
o
n
. D
u
ra
m
at
er
 a
n
d
 
sp
in
al
 c
o
rd
 in
 c
er
vi
ca
l r
eg
io
n
, m
id
-
th
o
ra
ci
c 
re
gi
o
n
 a
n
d
 c
o
n
u
s.
 
2
. U
n
ila
te
ra
l a
n
d
 b
ila
te
ra
l S
LR
- 
u
n
cl
ea
r 
w
h
ic
h
 r
eg
io
n
 s
tu
d
ie
d
. 
SL
R
 L
5
 a
n
d
 S
1
 n
er
ve
 r
o
o
ts
 
1
. F
ro
m
 f
u
ll 
ex
te
n
si
o
n
 t
o
 f
u
ll 
ce
rv
ic
al
 a
n
d
 t
ru
n
k 
fl
ex
io
n
. M
ar
ke
rs
 
al
o
n
g 
th
e 
sp
in
e 
2
. S
LR
 (
fr
o
m
 h
ip
 f
le
xi
o
n
/k
n
ee
 
fl
ex
io
n
 t
o
 h
ip
 f
le
xi
o
n
/ 
kn
ee
 
ex
te
n
si
o
n
).
 M
ar
ke
rs
 a
lo
n
g 
sp
in
e 
sc
ia
ti
c 
an
d
 t
ib
ia
l n
er
ve
s.
 
A
ll 
m
ea
su
re
s 
fr
o
m
 C
5
 t
h
ro
u
gh
 t
o
 
T1
2
. 
1
. F
le
xi
o
n
 h
ea
d
 a
n
d
 n
ec
k.
 
2
. F
le
xi
o
n
 n
ec
k 
an
d
 t
ru
n
k.
 
1
. C
er
vi
ca
l, 
th
o
ra
ci
c 
an
d
 lu
m
b
ar
 
sp
in
al
 c
o
rd
 f
ro
m
 f
u
ll 
tr
u
n
k 
an
d
 
n
ec
k 
ex
te
n
si
o
n
 t
o
 f
u
ll 
fl
ex
io
n
. 
2
. D
u
ra
 a
n
d
 n
er
ve
 r
o
o
ts
 (
N
R
s)
. 
P
ar
ti
ci
p
an
ts
 
4
 c
ad
av
er
s 
ag
ed
 4
4
-7
3 
3
 f
re
sh
 
ca
d
av
er
s,
 a
ge
s 
n
o
t 
d
is
cl
o
se
d
. 
4
 R
h
es
u
s 
m
o
n
ke
ys
 
1
8
 f
re
sh
 
ca
d
av
er
s 
ag
ed
 
1
5
-7
5
 y
ea
rs
 
1
4
3
 c
ad
av
er
s 
ag
ed
 2
3
-8
4
. 
A
u
th
o
r 
O
’C
o
n
n
el
l  
(1
9
4
6
) 
Fa
lc
o
n
er
 e
t 
al
. 
(1
9
4
8
) 
Sm
it
h
 (
1
9
5
6)
 
R
ei
d
 e
t 
al
. 
(1
9
6
0
) 
      B
re
ig
 (
1
9
6
0
) 
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R
e
su
lt
s 
1
. I
n
cr
ea
se
d
 t
en
si
o
n
 in
 c
au
d
a 
eq
u
in
a 
w
it
h
 C
x 
fl
ex
io
n
. S
ys
te
m
 t
o
o
 c
ru
d
e 
to
 g
iv
e 
m
ea
su
re
m
en
ts
. 
2
. D
u
ra
 a
n
d
 N
R
s 
m
o
ve
d
 c
ep
h
 b
y 
1
-2
m
m
. 
R
ed
u
ct
io
n
 in
 c
ro
ss
 s
ec
ti
o
n
 o
f 
d
u
ra
 a
n
d
 s
ac
ra
l 
co
n
e.
 
3
. D
u
ra
, N
R
s 
an
d
 r
o
o
t 
sl
ee
ve
s 
st
re
tc
h
ed
 in
 C
x 
fl
ex
io
n
 a
n
d
 N
R
s 
in
 c
o
n
ta
ct
 w
it
h
 p
ed
ic
le
s 
an
d
 
su
p
er
fi
ci
al
ly
 t
o
 r
o
o
t 
sl
ee
ve
s.
 
M
in
 d
is
ta
l m
o
vt
 L
4
 N
R
,  
m
o
st
 d
is
ta
l m
o
ve
m
en
t 
at
 s
ci
at
ic
 n
er
ve
 m
ea
n
; r
an
ge
 f
ro
m
 4
 (
>7
5
 
ye
ar
s)
 t
o
 7
.5
m
m
 (
<3
5
 y
ea
rs
).
 L
5
 a
n
d
 S
1
 N
R
 m
in
 
m
o
vt
 p
ro
xi
m
al
 t
o
 f
o
rm
at
io
n
 o
f 
N
R
, g
re
at
er
 a
t 
le
ve
l o
f 
IV
 f
o
ra
m
en
 (
1
.5
-3
m
m
 m
ea
n
 r
an
ge
 L
5
, 
2
-5
m
m
 m
ea
n
 r
an
ge
 S
1
).
 
O
n
 M
R
 in
cr
ea
se
 in
 r
es
is
ta
n
ce
 t
o
 p
re
ss
u
re
 o
ve
r 
sa
cr
al
 p
le
xu
s 
an
d
 in
cr
ea
se
d
 t
en
si
o
n
 in
 a
ll 
6
 
ca
d
av
er
s.
 H
ip
 M
R
 m
o
vt
 o
f 
m
ar
ke
rs
 f
ro
m
 2
-
1
0
m
m
 in
to
 g
re
at
er
 s
ci
at
ic
 f
o
ra
m
en
 (
G
SF
) 
(i
n
 4
 
ca
d
av
er
s)
. S
LR
 m
o
vt
 6
-1
0
 m
m
 t
o
w
ar
d
s 
G
SF
 (
in
 
3
 c
ad
av
er
s)
, H
ip
 a
d
d
u
ct
io
n
 m
o
vt
 3
m
m
 
to
w
ar
d
s 
G
SF
 (
in
 1
 c
ad
av
er
).
 
In
cr
ea
se
d
 p
re
ss
u
re
 a
ft
er
 3
0
 °
 S
LR
, g
re
at
es
t 
p
re
ss
u
re
s 
at
 L
5
-S
1
 le
ve
l, 
p
re
ss
u
re
 a
t 
L3
-4
 
<1
/1
0
th
 a
t 
L5
-S
1
. H
ip
 a
d
d
u
ct
io
n
 in
cr
ea
se
d
 
p
re
ss
u
re
, h
ip
 a
b
d
u
ct
io
n
 d
ec
re
as
ed
 t
h
e 
p
re
ss
u
re
. 
M
in
im
al
 m
o
ti
o
n
 <
3
0
° 
SL
R
. 
2
 d
ir
ec
ti
o
n
s 
o
f 
m
o
vt
- 
in
 li
n
e 
w
it
h
 d
ir
ec
ti
o
n
 o
f 
n
er
ve
 a
n
d
 p
er
p
en
d
ic
u
la
r 
to
 n
er
ve
. 
M
ea
n
 m
o
vt
s 
D
R
G
 a
t 
L4
 =
 1
.4
m
m
, L
5
= 
2
.1
m
m
, 
S1
= 
2
.5
m
m
 b
u
t 
va
ri
ed
 c
o
n
si
d
er
ab
ly
 b
et
w
ee
n
 
ca
d
av
er
s.
 L
es
s 
m
o
vt
 m
o
re
 p
ro
xi
m
al
ly
. 
St
ra
in
 3
.2
%
 L
4
, 2
.8
%
 L
5
, 3
.4
%
 S
1
. 
M
e
th
o
d
 o
f 
m
e
as
u
re
m
en
t 
1
. T
en
si
o
n
 2
/9
 c
ad
av
er
s 
la
m
in
ec
to
m
y,
 t
h
re
ad
 a
ro
u
n
d
 c
au
d
a 
eq
u
in
a 
at
 L
4
 le
ve
l a
tt
ac
h
ed
 t
o
 s
p
ri
n
g 
b
al
an
ce
. T
en
si
o
n
 o
f 
20
g 
ap
p
lie
d
 p
ri
o
r 
to
 m
vt
 t
o
 g
en
tl
y 
lif
t 
ca
u
d
a 
eq
u
in
a.
 
2
. 2
/9
 O
b
se
rv
at
io
n
 o
f 
d
ef
o
rm
at
io
n
 o
f 
N
R
s.
 
3
. 3
/9
 c
ad
av
er
s 
R
ec
o
rd
in
g 
o
f 
d
ef
o
rm
at
io
n
 b
y 
m
ye
lo
gr
ap
h
y.
 
 A
n
te
ri
o
r 
d
is
se
ct
io
n
 o
f 
so
ft
 t
is
su
e 
an
d
 
b
o
n
e.
 P
in
s 
in
se
rt
ed
 in
to
 p
er
in
eu
ri
u
m
 
an
d
 p
ap
er
 m
ar
ke
rs
 in
to
 a
d
jo
in
in
g 
b
o
n
e.
 
P
ap
er
 m
ar
ke
rs
 in
se
rt
ed
 in
to
 S
2
 a
n
d
 
S3
 N
R
s.
 P
h
o
to
gr
ap
h
ic
 r
ec
o
rd
in
gs
 in
 
4
/6
 c
ad
av
er
s.
 N
o
 o
th
er
 d
et
ai
ls
 o
f 
m
et
h
o
d
 g
iv
en
. 
R
u
b
b
er
 t
u
b
e 
in
se
rt
ed
 b
et
w
ee
n
 n
er
ve
 
ro
o
ts
 a
n
d
 lu
m
b
ar
 d
is
c.
 T
u
b
e 
fi
lle
d
 
w
it
h
 w
at
er
 a
n
d
 c
o
n
n
ec
te
d
 t
o
 a
 
p
re
ss
u
re
 t
ra
n
sd
u
ce
r.
 
M
et
al
 s
cr
ew
s 
p
ed
ic
le
s 
an
d
 t
ra
n
sv
er
se
 
p
ro
ce
ss
es
 L
4-
S1
. I
n
k 
d
o
ts
 o
n
 e
ac
h
 N
R
 
at
 4
m
m
 in
te
rv
al
s 
b
et
w
ee
n
 c
au
d
a 
eq
u
in
a 
an
d
 D
R
G
. P
h
o
to
gr
ap
h
s 
ta
ke
n
, 
p
ro
je
ct
ed
 t
ra
n
sp
ar
en
ci
es
 o
n
to
 p
ap
er
 
an
d
 n
er
ve
 m
o
ti
o
n
 c
o
m
p
ar
ed
 in
 
re
la
ti
o
n
 t
o
 t
h
e 
p
ed
ic
le
. 
St
ra
in
 m
ea
su
re
d
 c
o
m
p
ar
in
g 
le
n
gt
h
 o
f 
n
er
ve
 s
eg
m
en
t 
at
 0
° 
SL
R
 t
o
 6
0
° 
M
o
ve
m
en
ts
 a
n
d
 r
e
gi
o
n
/s
 
o
f 
n
e
rv
e
 s
tu
d
ie
d
 
C
er
vi
ca
l f
le
xi
o
n
 a
n
d
 e
xt
en
si
o
n
 
sa
cr
al
 c
o
n
e 
an
d
 n
er
ve
s 
o
f 
ca
u
d
a 
eq
u
in
a.
 
SL
R
 L
4
, 5
 a
n
d
 S
1
 (
ju
st
 a
b
o
ve
 
fo
rm
at
io
n
 o
f 
n
er
ve
 r
o
o
t 
an
d
 in
 
in
te
rv
er
te
b
ra
l (
IV
) 
fo
ra
m
en
),
 
lu
m
b
o
sa
cr
al
 c
o
rd
 a
n
d
 s
ci
at
ic
 
n
er
ve
 (
1
cm
 p
ro
xi
m
al
 t
o
 s
ci
at
ic
 
n
o
tc
h
).
 
1
.M
ed
ia
l r
o
ta
ti
o
n
 (
M
R
) 
h
ip
 
2
. S
LR
  
3
. H
ip
 a
d
d
u
ct
io
n
. 
Sa
cr
al
 p
le
xu
s 
SL
R
 L
3
-S
1
 r
eg
io
n
s 
SL
R
 L
4
-S
1
 N
R
s 
P
ar
ti
ci
p
an
ts
 
9
 c
ad
av
er
s,
 a
ge
s 
 
n
o
t 
d
is
cl
o
se
d
 
3
0
 u
n
em
b
al
m
ed
 
ca
d
av
er
s 
ag
ed
 
<3
5
 t
o
 >
7
5
. 
6
 f
re
sh
 c
ad
av
er
s,
 
5
 a
ge
d
 5
1
-8
3
, 1
 
ag
e 
u
n
kn
o
w
n
. 
5
 f
re
sh
 c
ad
av
er
s,
 
ag
es
 n
o
t 
d
is
cl
o
se
d
. 
1
0
 f
re
sh
 c
ad
av
er
s 
ag
ed
 5
5
-7
7
. 
A
u
th
o
r 
B
re
ig
 a
n
d
 
M
ar
io
n
s 
(1
9
6
3
) 
G
o
d
d
ar
d
 a
n
d
 
R
ei
d
 (
1
9
6
5
) 
B
re
ig
 a
n
d
 T
ro
u
p
 
(1
9
7
9
) 
 Su
gi
u
ra
 e
t 
al
. 
(1
9
7
9
) 
Sm
it
h
 e
t 
al
. 
(1
9
9
3
) 
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R
e
su
lt
s 
O
ve
ra
ll 
m
ax
 s
tr
ai
n
 o
f 
ce
rv
ic
al
 c
o
rd
 b
et
w
ee
n
 
6
.8
%
 a
n
d
 1
3
.6
%
 p
o
st
er
io
r 
su
rf
ac
e 
an
d
 3
.7
%
 
to
 8
.7
%
 a
n
te
ri
o
r 
su
rf
ac
e 
(p
<0
.0
1
 a
n
t:
 p
o
st
).
 
C
au
d
ad
 m
o
vt
 C
2
-3
 (
m
ea
n
 p
o
st
 c
o
rd
 2
.7
m
m
),
 
ce
p
h
el
ad
 m
o
vt
 C
6
-7
 (
m
ea
n
 p
o
st
 c
o
rd
 C
6
 
1
.1
m
m
, C
7
 2
.7
m
m
).
 L
it
tl
e
 d
is
p
la
ce
m
en
t 
C
4
-5
. 
In
 n
eu
tr
al
 h
ip
 p
o
si
ti
o
n
, k
n
ee
 e
xt
en
si
o
n
- 
m
ea
n
 in
cr
ea
se
d
 s
tr
ai
n
 t
o
 1
4
%
 (
ra
n
ge
 1
0
-
1
9
%
).
 H
ip
 4
5
° 
fl
ex
io
n
- 
 m
ea
n
 in
cr
ea
se
d
 s
tr
ai
n
 
2
6
%
 (
ra
n
ge
 1
9
-3
0
%
).
 
D
F 
h
ad
 g
re
at
es
t 
ef
fe
ct
 o
n
 c
h
an
ge
 in
 t
ib
ia
l 
n
er
ve
 (
TN
) 
st
ra
in
 a
t 
th
e 
an
kl
e 
(3
.2
8
%
),
 a
n
d
 
le
as
t 
at
 t
h
e 
sc
ia
ti
c 
n
er
ve
 (
SN
) 
at
 t
h
e 
h
ip
 (
-
0
.0
2
).
 H
F 
gr
ea
te
st
 e
ff
ec
t 
o
n
 S
N
 s
tr
ai
n
 (
6
.6
1
%
) 
an
d
 le
as
t 
o
n
 T
N
 a
t 
th
e 
an
kl
e 
(2
.3
%
).
 
D
ir
ec
ti
o
n
 o
f 
ex
cu
rs
io
n
 a
lw
ay
s 
to
w
ar
d
s 
m
o
vi
n
g 
jo
in
t.
 D
F 
-d
is
ta
l e
xc
u
rs
io
n
 T
N
 a
n
kl
e 
9
.5
m
m
, T
N
 k
n
ee
 3
.1
 m
m
, S
N
 0
, H
F 
p
ro
xi
m
al
 
ex
cu
rs
io
n
 S
N
 o
f 
2
8
 m
m
, 1
2
.2
 T
N
 k
n
ee
, 6
.4
 T
N
 
an
kl
e.
 
D
is
ta
l e
xc
u
rs
io
n
 p
ar
al
le
l t
o
 N
R
 a
xi
s 
w
as
 0
.5
3
, 
0
.4
8
, a
n
d
 0
.5
1
 m
m
 f
o
r 
L4
, L
5
, S
1
. 
P
er
p
en
d
ic
u
la
r 
to
 N
R
 a
xi
s 
w
as
 0
.1
7
, -
0
.0
4
 a
n
d
 
-0
.1
5
m
m
. S
tr
ai
n
 b
et
w
ee
n
 la
t 
re
ce
ss
 a
n
d
 
ex
tr
af
o
ra
m
in
al
 r
eg
io
n
 w
as
 -
0
.3
7
%
, -
0
.1
2
 a
n
d
 
-0
.9
4
%
 L
4
-S
1
 r
es
p
ec
ti
ve
ly
. N
o
 s
ig
 d
if
f 
st
ra
in
 
fr
o
m
 0
 t
o
 7
5
°.
 
W
it
h
 d
o
rs
if
le
xi
o
n
 a
n
d
 S
LR
, d
is
ta
l e
xc
u
rs
io
n
 
p
ar
al
le
l t
o
 N
R
 a
xi
s 
w
as
 -
0
.0
6
, 0
.0
4
 a
n
d
 
0
.2
m
m
 f
o
r 
L4
-S
1
. P
er
p
en
d
ic
u
la
r 
to
 N
R
 a
xi
s 
w
as
 -
0
.2
3
, -
0
.0
2
 a
n
d
 0
.1
5
m
m
. S
tr
ai
n
 
in
cr
ea
se
d
 t
o
 0
.5
6
%
, 0
.6
8
%
 a
n
d
 1
.8
9
%
 L
4
-S
1
. 
M
e
th
o
d
 o
f 
m
e
as
u
re
m
en
t 
M
o
ti
o
n
 t
ra
ck
in
g 
M
R
I s
ca
n
s-
 m
id
-s
ag
it
ta
l 
im
ag
es
. 
3
 o
r 
4
 m
ar
ke
rs
 d
ra
w
n
 o
n
to
 e
p
in
eu
ri
u
m
 o
f 
sc
ia
ti
c 
n
er
ve
. V
id
eo
-e
xt
en
so
m
et
ry
 u
se
d
 t
o
 
ca
lc
u
la
te
 s
tr
ai
n
. 
St
ra
in
 m
ea
su
re
d
 w
it
h
 li
n
ea
r 
d
is
p
la
ce
m
en
t 
tr
an
sd
u
ce
rs
. 
Ex
cu
rs
io
n
 u
si
n
g 
d
ig
it
al
 v
er
n
ie
r 
ca
lip
er
s-
 
fi
xe
d
 m
ar
ke
rs
 in
to
 c
o
rt
ic
al
 b
o
n
e,
 m
o
b
ile
 
m
ar
ke
rs
 s
u
tu
re
 a
ro
u
n
d
 n
er
ve
 c
lo
se
 t
o
 f
ix
ed
 
m
ar
ke
rs
. L
o
ca
ti
o
n
s-
 t
ib
ia
l n
er
ve
 p
ro
x 
to
 
an
kl
e 
an
d
 a
t 
th
e 
kn
ee
, s
ci
at
ic
 n
er
ve
 d
is
ta
l t
o
 
gr
ea
te
r 
tr
o
ch
an
te
r.
   
Im
p
la
n
ta
ti
o
n
 o
f 
h
el
ic
al
 m
et
al
 m
ar
ke
rs
 in
to
 
L4
, L
5
 a
n
d
 S
1
 N
R
s 
at
 3
 lo
ca
ti
o
n
s:
 
ex
tr
af
o
ra
m
in
al
, i
n
tr
af
o
ra
m
in
al
 a
n
d
 la
te
ra
l 
re
ce
ss
. C
ad
av
er
 s
ta
b
ili
se
d
 o
n
 a
 ji
g,
 b
o
lt
s 
sc
re
w
ed
 in
to
 il
iu
m
 t
o
 p
re
ve
n
t 
p
el
vi
c 
m
o
vt
s.
 
Fl
u
o
ro
sc
o
p
ic
 im
ag
es
 t
ak
en
 a
t 
ea
ch
 h
ip
 
p
o
si
ti
o
n
 d
u
ri
n
g 
SL
R
. 
M
et
h
o
d
 a
s 
ab
o
ve
 
M
o
ve
m
en
ts
 a
n
d
 r
e
gi
o
n
/s
 
o
f 
n
e
rv
e
 s
tu
d
ie
d
 
C
er
vi
ca
l f
le
xi
o
n
. C
2
-3
, C
4
-5
, C
6
-7
 
re
gi
o
n
s 
ex
am
in
ed
. 
SL
R
- 
h
ip
 in
 n
eu
tr
al
 a
n
d
 a
t 
4
5
° 
fl
ex
io
n
, e
xt
en
si
o
n
 o
f 
kn
ee
 f
ro
m
 
9
0
 t
o
 0
°-
 S
ci
at
ic
 n
er
ve
 
SL
R
- 
an
kl
e 
d
o
rs
if
le
xi
o
n
 (
D
F)
 
fo
llo
w
ed
 b
y 
h
ip
 f
le
xi
o
n
 (
H
F 
w
it
h
 
kn
ee
 in
 e
xt
en
si
o
n
).
 S
ci
at
ic
, t
ib
ia
l 
an
d
 p
la
n
ta
r 
n
er
ve
s.
 
SL
R
 u
p
 t
o
 7
5
° 
fl
ex
io
n
 w
it
h
 a
n
kl
e 
in
 n
eu
tr
al
. 
SL
R
 w
it
h
 a
n
kl
e 
d
o
rs
if
le
xi
o
n
 a
n
d
 
w
it
h
o
u
t 
an
kl
e 
d
o
rs
if
le
xi
o
n
. S
am
e 
N
R
s 
as
 a
b
o
ve
 
P
ar
ti
ci
p
an
ts
 
5
 h
ea
lt
h
y 
vo
lu
n
te
er
s 
(2
3
-4
9
 
ye
ar
s)
. 
1
0
 p
at
ie
n
ts
 (
6
0-
7
8 
ye
ar
s)
 p
re
se
n
ti
n
g 
fo
r 
to
ta
l h
ip
 
re
p
la
ce
m
en
t.
 
8
 e
m
b
al
m
ed
 
ca
d
av
er
s 
ag
ed
 7
6-
9
0
. 
5
 u
n
em
b
al
m
ed
 
ca
d
av
er
s 
ag
ed
 7
2-
8
8
. 
5
 u
n
em
b
al
m
ed
 
ca
d
av
er
s 
as
 a
b
o
ve
 
A
u
th
o
r 
Yu
an
 e
t 
al
., 
1
9
9
8 
Fl
em
in
g 
et
 a
l. 
(2
0
0
3
) 
C
o
p
p
ie
te
rs
 e
t 
al
. (
2
0
0
6
) 
            G
ilb
er
t 
et
 a
l. 
(2
0
0
7a
) 
G
ilb
er
t 
et
 a
l. 
(2
0
0
7
b
) 
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R
e
su
lt
s 
A
 m
ax
im
u
m
 s
tr
ai
n
 o
f 
ar
o
u
n
d
 8
%
 w
as
 f
o
u
n
d
 in
 
th
e 
SN
 d
u
ri
n
g 
b
o
th
 s
eq
u
en
ce
s 
an
d
 f
o
r 
th
e 
TN
 
w
it
h
 H
F 
fo
llo
w
ed
 b
y 
D
F.
 A
t 
th
e 
en
d
 o
f 
m
o
ve
m
en
t 
fo
r 
ei
th
er
 s
eq
u
en
ce
, t
h
er
e 
w
as
 
m
in
im
al
 d
if
fe
re
n
ce
 (
a 
m
ax
im
u
m
 o
f 
0
.8
%
 f
o
r 
TN
 a
n
kl
e 
w
it
h
 H
F/
D
F 
th
an
 D
F/
H
F)
 in
 s
tr
ai
n
. 
 E
xc
u
rs
io
n
 T
N
 a
n
kl
e 
an
d
 k
n
ee
 m
o
ve
 d
is
ta
l 
w
it
h
 D
F 
an
d
 p
ro
xi
m
al
 w
it
h
 H
F.
 R
an
ge
d
 f
ro
m
 
~4
m
m
 T
N
 k
n
ee
 w
it
h
 H
F 
to
 6
m
m
 T
N
 a
n
kl
e 
w
it
h
 D
F.
 
M
e
th
o
d
 o
f 
m
e
as
u
re
m
en
t 
D
if
fe
re
n
ti
al
 v
ar
ia
b
le
 r
el
u
ct
an
ce
 
tr
an
sd
u
ce
r 
in
se
rt
ed
 in
to
 e
ac
h
 
n
er
ve
 w
it
h
 2
 b
ar
b
ed
 p
in
s 
fo
r 
st
ra
in
. 
D
ig
it
al
 c
al
ip
er
 f
o
r 
ex
cu
rs
io
n
. 
D
is
ta
n
ce
 b
et
w
ee
n
 a
 f
ix
ed
 m
et
al
 
m
ar
ke
rs
 in
 a
d
ja
ce
n
t 
b
o
n
es
 a
n
d
 
d
is
ta
l b
ar
b
 o
f 
th
e 
tr
an
sd
u
ce
r 
to
 
d
et
er
m
in
e 
ex
cu
rs
io
n
. 
M
o
ve
m
en
ts
 a
n
d
 r
e
gi
o
n
/s
 
o
f 
n
e
rv
e
 s
tu
d
ie
d
 
2
 s
eq
u
en
ce
s 
o
f 
SL
R
: 
1
. H
F 
(w
it
h
 k
n
ee
 e
xt
en
d
ed
) 
th
en
 
D
F 
2
. D
F 
th
en
 H
F 
(w
it
h
 k
n
ee
 
ex
te
n
d
ed
) 
SN
 5
cm
s 
d
is
ta
l t
o
 is
ch
ia
l 
tu
b
er
o
si
ty
 (
st
ra
in
 o
n
ly
),
 T
N
 
P
ar
ti
ci
p
an
ts
 
1
0
 e
m
b
al
m
ed
 
ca
d
av
er
s 
ag
ed
 5
5
-
9
5
 y
ea
rs
 
A
u
th
o
r 
B
o
yd
 e
t 
al
. 
(2
0
1
3
) 
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Appendix 12 Slider and Tensioner Studies 
R
e
su
lt
s 
A
t 
w
ri
st
: S
ig
 >
 n
er
ve
 e
xc
u
rs
io
n
 s
lid
in
g 
p
o
si
ti
o
n
 
(m
ea
n
 1
2
.4
m
m
) 
th
an
 a
ll 
p
o
si
ti
o
n
s 
(P
<0
.0
0
0
2
) 
an
d
 lo
w
es
t 
p
ea
k 
st
ra
in
. T
en
si
o
n
er
 p
o
si
ti
o
n
 a
n
d
 
p
o
si
ti
o
n
s 
w
it
h
 E
E 
an
d
 W
E 
h
ad
 s
ig
> 
p
ea
k 
st
ra
in
 
(~
4
%
) 
th
an
 s
lid
er
 o
r 
m
vt
s 
o
f 
w
ri
st
 in
 e
lb
o
w
 
fl
ex
io
n
 (
p
<0
.0
0
0
5
).
 
A
t 
p
ro
x 
h
u
m
er
u
s:
 G
re
at
es
t 
ex
c 
an
d
 s
tr
ai
n
 w
it
h
 
te
n
si
o
n
er
 (
1
3
.7
m
m
 a
n
d
 ~
4
.2
%
 s
tr
ai
n
),
 a
n
d
 
o
th
er
 m
vt
s 
w
it
h
 E
E.
 G
re
at
es
t 
st
ra
in
 W
E 
w
it
h
 E
E 
(~
4
.6
%
).
 
N
o
 s
ta
t 
te
st
in
g 
p
er
fo
rm
ed
. M
ed
ia
n
 n
er
ve
 
re
su
lt
s 
si
m
ila
r 
to
 a
b
o
ve
 b
u
t 
gr
ea
te
r 
st
ra
in
 a
t 
w
ri
st
 d
u
ri
n
g 
te
n
si
o
n
er
 (
6
.8
%
),
 a
n
d
 g
re
at
er
 
ex
cu
rs
io
n
 a
t 
p
ro
x 
el
b
o
w
 w
it
h
 t
en
si
o
n
er
 
(1
6
.5
m
m
).
 U
ln
ar
 n
er
ve
 g
re
at
er
 p
ea
k 
st
ra
in
 
(3
.2
%
) 
an
d
 le
ss
 e
xc
u
rs
io
n
 (
3
.8
 m
m
) 
w
it
h
 
te
n
si
o
n
er
 c
o
m
p
ar
ed
 t
o
 s
lid
er
 (
0
.7
%
 a
n
d
 
8
.3
m
m
) 
Si
g 
gr
ea
te
r 
ex
cu
rs
io
n
 (
m
ea
n
 1
0
.2
m
m
) 
fo
r 
sl
id
er
 
te
ch
n
iq
u
e 
th
an
 a
ll 
o
th
er
 m
o
ve
m
en
ts
 
(p
=0
.0
0
0
1
).
 S
m
al
le
st
 e
xc
u
rs
io
n
 (
m
ea
n
 3
.3
 m
m
) 
fo
r 
m
o
ve
m
en
t 
o
f 
C
LL
F 
o
f 
n
ec
k 
w
it
h
 E
E 
(E
E 
p
re
p
o
si
ti
o
n
ed
).
 
Si
g 
d
if
f 
in
 n
er
ve
 e
xc
u
rs
io
n
 b
et
w
ee
n
 s
lid
er
 
(m
ea
n
 3
.2
m
m
 a
n
d
 t
en
si
o
n
er
 (
m
ea
n
 2
.6
m
m
) 
(p
=0
.0
0
8
).
 A
ls
o
 s
ig
 d
if
f 
(p
=0
.0
0
2)
 b
et
w
ee
n
 
sl
id
er
 a
n
d
 b
o
th
 s
in
gl
e 
jt
 m
vt
s;
 s
lu
m
p
 C
x 
ex
t 
(m
ea
n
 -
0
.1
m
m
 i.
e.
 p
ro
x 
m
vt
),
 s
lu
m
p
 k
n
ee
 e
xt
 
(m
ea
n
 2
.6
 m
m
) 
M
e
th
o
d
 o
f 
m
e
as
u
re
m
en
t 
an
d
 n
er
ve
 r
e
gi
o
n
s 
st
u
d
ie
d
 
St
ra
in
 w
it
h
 li
n
ea
r 
d
is
p
la
ce
m
en
t 
tr
an
sd
u
ce
rs
: 1
. M
ed
ia
n
 n
er
ve
 p
ro
x 
to
 w
ri
st
, 2
. M
ed
ia
n
 n
er
ve
 1
2
 c
m
s 
p
ro
x 
to
 m
ed
 e
p
ic
o
n
d
yl
e.
 
Ex
cu
rs
io
n
 w
it
h
 d
ig
it
al
 v
er
n
ie
r 
ca
lip
er
 c
o
m
p
ar
ed
 t
o
 f
ix
ed
 m
ar
ke
r 
d
is
ta
l r
ad
iu
s 
an
d
 d
is
ta
l h
u
m
er
u
s.
 
St
ra
in
 a
t 
w
ri
st
 a
n
d
 e
lb
o
w
 a
s 
ab
o
ve
 
fo
r 
m
ed
ia
n
 n
er
ve
 (
b
u
t 
10
cm
s 
p
ro
x 
to
 m
ed
 e
p
ic
o
n
d
yl
e)
, a
n
d
 u
ln
ar
 
n
er
ve
 ju
st
 p
ro
x 
to
 e
lb
o
w
. 
Ex
cu
rs
io
n
 a
s 
ab
o
ve
. 
U
lt
ra
so
u
n
d
 im
ag
in
g 
o
f 
m
ed
ia
n
 
n
er
ve
 in
 lo
n
gi
tu
d
in
al
 s
ec
ti
o
n
, 7
-1
0
 
cm
s 
p
ro
xi
m
al
 t
o
 m
ed
 e
p
ic
o
n
d
yl
e.
 
U
lt
ra
so
u
n
d
 im
ag
in
g 
o
f 
sc
ia
ti
c 
n
er
ve
 in
 p
o
st
er
io
r 
p
ro
xi
m
al
 t
h
ig
h
. 
M
o
ve
m
en
ts
 
6
 d
if
fe
re
n
t 
ve
rs
io
n
s 
o
f 
U
LN
T1
: 
sl
id
er
, t
en
si
o
n
er
 a
n
d
 s
im
p
le
 
si
n
gl
e 
jo
in
t 
m
vt
s 
in
 S
H
 A
B
D
 (
se
e 
fi
g 
4
.1
).
 N
o
 c
er
vi
ca
l m
vt
s.
 
1
. M
ed
ia
n
 n
er
ve
 s
am
e 
m
vt
s 
as
 
ab
o
ve
. 2
. U
ln
ar
 n
er
ve
 t
en
si
o
n
er
 
(W
E,
 E
F,
 S
H
 A
B
D
) 
an
d
 s
lid
er
 
(W
E,
 E
E,
 S
H
 A
B
D
 a
n
d
 W
E,
 E
F,
 
SH
 A
D
D
).
 
6
 d
if
fe
re
n
t 
ve
rs
io
n
s 
o
f 
U
LN
T 
1
: 
sl
id
er
 a
n
d
 t
en
si
o
n
er
 a
n
d
 IL
LF
 o
r 
C
LL
F 
o
f 
n
ec
k 
w
it
h
 E
F 
o
r 
EE
 a
n
d
 
vi
ce
 v
er
sa
. W
ri
st
 in
 n
eu
tr
al
 
4
 m
o
ve
m
en
ts
 in
 s
lu
m
p
 
p
o
si
ti
o
n
: t
en
si
o
n
er
 (
sl
u
m
p
 w
it
h
 
C
x 
F 
+K
E)
, S
lid
er
 (
sl
u
m
p
 w
it
h
 C
x 
E 
+ 
K
E)
, s
lu
m
p
 a
n
d
 C
x 
E,
 s
lu
m
p
 
an
d
 K
E.
 
P
ar
ti
ci
p
an
ts
 
6
 in
ta
ct
 e
m
b
al
m
ed
 
ca
d
av
er
s 
(6
5
-9
2
 
ye
ar
s 
at
 d
ea
th
).
 
2
 in
ta
ct
 e
m
b
al
m
ed
 
ca
d
av
er
s 
(7
8
 a
n
d
 
8
5
 y
ea
rs
 a
t 
d
ea
th
) 
1
5
 h
ea
lt
h
y 
vo
lu
n
te
er
s 
(m
ea
n
 
ag
e 
3
0
+/
- 
8
 y
ea
rs
).
 
3
1
 h
ea
lt
h
y 
vo
lu
n
te
er
s 
(2
1
-6
1
 
ye
ar
s)
 
A
u
th
o
r 
C
o
p
p
ie
te
rs
 a
n
d
 
A
ls
h
am
i, 
2
0
0
7 
C
o
p
p
ie
te
rs
 a
n
d
 
B
u
tl
er
, 2
0
0
8 
C
o
p
p
ie
te
rs
 e
t 
al
., 
2
0
0
9 
El
lis
 e
t 
al
., 
2
0
1
2
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Appendix 13 Effectiveness of neurodynamic treatment 
R
e
su
lt
s 
1
6
 p
la
ye
rs
 t
re
at
ed
 w
it
h
 u
su
al
 c
ar
e 
al
o
n
e,
 1
2
 
w
it
h
 u
su
al
 c
ar
e 
an
d
 s
lu
m
p
 s
tr
et
ch
in
g.
 O
n
ly
 1
 
p
la
ye
r 
tr
ea
te
d
 w
it
h
 s
lu
m
p
 a
n
d
 u
su
al
 c
ar
e 
m
is
se
d
 o
n
e 
m
at
ch
. A
ll 
u
su
al
 c
ar
e 
p
la
ye
rs
 
m
is
se
d
 a
t 
le
as
t 
o
n
e 
ga
m
e,
 w
it
h
 1
0
 m
is
si
n
g 
2
, 
an
d
 o
n
e 
m
is
si
n
g 
6
 g
am
es
. T
h
e 
d
if
fe
re
n
ce
 
b
et
w
ee
n
 m
is
si
n
g 
ga
m
es
 w
as
 s
ta
ti
st
ic
al
ly
 
si
gn
if
ic
an
tl
y 
(p
<0
.0
0
1
).
 
Si
gn
if
ic
an
t 
d
if
fe
re
n
ce
s 
w
er
e 
fo
u
n
d
 b
et
w
ee
n
 
co
n
tr
o
l a
n
d
 t
re
at
m
en
t 
gr
o
u
p
s 
fo
r 
R
O
M
 w
ri
st
 
ex
t,
 V
A
S,
 p
ai
n
 r
el
ie
f 
sc
o
re
; b
u
t 
n
o
 d
if
fe
re
n
ce
s 
b
et
w
ee
n
 lo
n
gi
tu
d
in
al
 o
r 
ca
rp
al
 b
o
n
e 
m
o
b
ili
sa
ti
o
n
s.
 C
o
n
ti
n
u
e
 t
o
 s
u
rg
er
y 
-2
/7
 n
er
ve
 
R
x,
 1
/7
 c
ar
p
al
 m
o
b
s,
 6
/7
 c
o
n
tr
o
l. 
N
o
 s
ig
 d
if
fe
re
n
ce
 b
et
w
ee
n
 g
ro
u
p
s 
in
 a
n
y 
o
f 
o
u
tc
o
m
e 
m
ea
su
re
s.
 L
o
o
ke
d
 a
t 
b
et
w
ee
n
 g
ro
u
p
 
d
if
fe
re
n
ce
s 
an
d
 o
n
 a
ll 
m
ea
su
re
s 
th
e 
m
ea
n
 
d
if
fe
re
n
ce
 s
u
gg
es
te
d
 a
 le
ss
 f
av
o
u
ra
b
le
 r
es
p
o
n
se
 
fo
r 
R
x 
th
an
 t
h
e 
co
n
tr
o
l g
ro
u
p
. 
 
O
u
tc
o
m
e
 m
e
as
u
re
s 
N
u
m
b
er
 o
f 
ga
m
es
 
m
is
se
d
 in
 t
h
e 
se
as
o
n
 
p
o
st
 h
am
st
ri
n
g 
in
ju
ry
. 
D
ai
ly
 p
ai
n
 s
co
re
s 
 
(V
A
S)
, f
u
n
ct
io
n
al
 b
o
x 
sc
al
e,
 P
ai
n
 r
el
ie
f 
sc
al
e,
 R
O
M
 w
ri
st
 e
xt
 
an
d
 f
le
x 
an
d
 t
h
e 
U
LN
T 
(+
ve
 o
r 
–v
e 
te
st
),
 p
ro
ce
ed
 t
o
 
su
rg
er
y.
 
G
lo
b
al
 p
er
ce
iv
ed
 
ef
fe
ct
, p
ai
n
 w
it
h
 
V
A
S,
 M
cG
ill
 p
ai
n
 
q
u
es
ti
o
n
n
ai
re
 a
n
d
 
Q
u
eb
ec
 d
is
ab
ili
ty
 
sc
al
e.
 
D
e
ta
il 
o
f 
tr
e
at
m
e
n
t 
N
o
 d
et
ai
l o
f 
se
ts
 o
r 
re
p
s 
o
r 
if
 s
u
st
ai
n
ed
 o
r 
o
sc
ill
at
o
ry
, 
o
r 
h
o
w
 o
ft
en
 s
lu
m
p
 w
as
 
p
er
fo
rm
ed
.  
  
N
o
t 
cl
ea
r 
w
h
o
 d
id
 t
h
e 
R
x.
 
G
ra
d
e,
 r
ep
s 
an
d
 
p
ro
gr
es
si
o
n
 b
as
ed
 o
n
 
p
at
ie
n
t 
p
re
se
n
ta
ti
o
n
. N
o
 
d
et
ai
l o
f 
n
u
m
b
er
 o
f 
tr
ea
tm
en
ts
 a
n
d
 if
 
co
m
p
ar
ab
le
 in
 e
ac
h
 
gr
o
u
p
. A
p
p
ea
re
d
 t
h
at
 
n
eu
ro
d
yn
am
ic
 t
ec
h
n
iq
u
e 
w
as
 a
 t
en
si
o
n
er
 b
u
t 
n
o
t 
cl
ea
r.
 
V
ag
u
e 
d
es
cr
ip
ti
o
n
 o
f 
ex
er
ci
se
s 
fo
r 
st
an
d
ar
d
 
ca
re
 (
is
o
m
et
ri
c 
an
d
 
d
yn
am
ic
) 
2
-3
 d
ai
ly
 f
o
r 
6
 
w
ee
ks
. N
eu
ra
l m
o
b
s 
gr
o
u
p
- 
d
ay
 1
 a
n
d
 2
 a
ct
iv
e 
SL
R
 b
o
th
 le
gs
 a
n
d
 p
as
si
ve
 
n
ec
k 
fl
ex
io
n
 p
ro
gr
es
s 
to
 
SL
R
 w
it
h
 c
er
vi
ca
l f
le
xi
o
n
 
d
ay
 3
. A
d
d
it
io
n
al
 n
eu
ra
l 
ex
s 
fo
r 
h
o
m
e 
b
u
t 
n
o
t 
sp
ec
if
ie
d
 
Tr
e
at
m
e
n
t 
gr
o
u
p
s 
U
su
al
 c
ar
e 
(n
o
t 
st
an
d
ar
d
is
ed
) 
p
lu
s 
sl
u
m
p
 s
tr
et
ch
in
g,
 
an
d
 u
su
al
 c
ar
e.
 
3
 g
ro
u
p
s:
 
lo
n
gi
tu
d
in
al
 
n
eu
ro
d
yn
am
ic
 
tr
ea
tm
en
t,
 c
ar
p
al
 
b
o
n
e 
m
o
b
ili
sa
ti
o
n
 o
r 
co
n
tr
o
l g
ro
u
p
. 
2
 t
re
at
m
en
t 
gr
o
u
p
s 
1
. s
ta
n
d
ar
d
 c
ar
e 
an
d
 
2
. s
ta
n
d
ar
d
 c
ar
e 
p
lu
s 
n
eu
ra
l m
o
b
 
P
ar
ti
ci
p
an
ts
 
2
8
 P
ro
fe
ss
io
n
al
 
A
u
st
ra
lia
n
 R
u
le
s 
fo
o
tb
al
le
rs
 w
it
h
 
h
am
st
ri
n
g 
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 b
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at
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 m
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 p
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 f
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n
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 m
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b
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 c
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 m
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p
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b
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 f
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D
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 C
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 m
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 m
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b
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 p
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p
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 d
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 c
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n
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ac
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 d
ai
ly
.  
G
ro
u
p
 2
 A
A
 p
lu
s 
te
n
si
o
n
er
 e
xc
 
ag
ai
n
st
 w
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ra
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 c
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 p
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b
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d
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R
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 f
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p
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b
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 c
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 d
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 d
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 b
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 D
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 b
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b
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 t
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Key VAS- visual analogue scale, ROM range of motion, NPRS numeric pain rating scale, ODI 
Oswestry disability index, FABQ fear avoidance beliefs questionnaire, PCS pain catastrophising scale, 
SDD smallest detectable difference, MCID minimal clinically important difference. 
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ultrasound reliability  
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Appendix 15 subject information sheet and consent 
form ultrasound repeatability study 
University of Brighton 
School of Health Professions 
 
Subject Information Sheet  
 
Intra rater reliability of B mode ultrasound on longitudinal and transverse 
movement of the sciatic nerve during the straight leg raise test. 
 
2  Invitation paragraph 
 
You are being invited to take part in a research study. Before you decide it is 
important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it 
with others if you wish. Ask if there is anything that is not clear or if you would like 
more information. Take time to decide whether or not you wish to take part. 
 
Thank you for reading this. 
 
3  What is the purpose of the study? 
 
The study aims to look at how consistent a specialised piece of equipment 
(ultrasound) is in measuring movement of the sciatic nerve (the major nerve which 
passes down the back of your thigh) during a standard physiotherapy test (the 
straight leg raise test (SLR)). The study will take approximately 30 minutes, and you 
will be required to attend two times in total, thus the overall time you will need to 
commit to this study will be one hour. 
 
4 Why have I been chosen? 
 
You have been chosen for the study as you are fit and well without low back pain. 
You will need to meet the requirements for eligibility into the study as described 
below. 
 The following conditions do not apply to you 
 
 Previous spinal surgery 
 Neck, mid or low back pain or hip, knee or ankle problems within the last year 
 Systemic disorders (eg Rheumatoid arthritis, diabetes, thyroid disease, 
HIV/AIDS) 
 Neurological disorders(eg stroke, multiple sclerosis) 
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 Restriction in your back, neck, hip, ankle or knee range of motion which 
prevents you from being able to be positioned into the SLR test (these will be 
tested prior to commencement of the study). 
 Cancer 
 Severe Osteoporosis 
 Pregnancy 
 Allergy to elastoplast tape 
 Body mass index greater than 30kg/m² (this will be calculated from your height 
and weight measurements) 
 
5 Do I have to take part? 
 
Your participation is entirely voluntary, if you are unsure about taking part then feel 
free to say no. If you do decide to take part you will be given this information sheet 
to keep and be asked to sign a consent form. If you decide to take part you are still 
free to withdraw at any time without giving a reason. A decision to withdraw at any 
time, or a decision not to take part, will not affect you in any way. 
 
6  What will happen to me if I take part? 
 
You will be asked to change into a pair of shorts and then a short series of tests will 
be applied to your leg to ensure that the range of motion of your legs will allow you 
to be positioned into the SLR position (this position is explained below). You will 
also have your reflexes, muscle strength and sensation in your legs tested. Your 
height and weight will be taken. 
 You will be positioned on your side on a plinth with your leg on a wooden table top 
and an ultrasound probe (small plastic device) will be applied to the back of your 
thigh, a layer of gel will be applied between the probe and your skin to improve the 
contact between you and the probe (this may feel cold). A small measuring device 
will be applied to your skin either side of your knee joint with double sided adhesive 
tape. Two plastic splints will be applied to your feet to keep your ankle joints in a set 
position. Your hip will be moved forwards by the researcher and then held into place 
with a board and strap, and you knee bent. The research assistant will then straighten 
your knee a set amount, before it is kept in a semi bent position. This will then be 
repeated until the knee is completely straight or until tightness in your leg prevents 
the knee from moving any further. Your hip will then be re-positioned a little further 
forward, and the same knee movements repeated. You will be asked to inform the 
researcher if you have any discomfort during these movements. Measurements will 
be taken during these movements. The same procedure will then be repeated with 
the ultrasound probe in a slightly different position on the back of your thigh.  
You will then be asked to return once more, on the same day of the week, at the 
same time.  
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7  What do I have to do? 
 
Please bring shorts with you and do not partake in any vigorous exercise 12 hours 
prior to the study.  
 
 
8 What are the possible disadvantages and risks of taking part? 
 
There have been no side effects recorded from using the ultrasound machine. In 
theory the temperature could rise inside your leg as a result of the ultrasound waves, 
however the type and dose of ultrasound used in this study is very safe, and thus this 
is very unlikely to happen. 
The SLR test is a commonly used test that physiotherapists use on a regular basis, 
and in some individuals some discomfort (such as a stretch feeling) is produced. You 
will be asked to inform the researcher if you have any discomfort during the test 
procedure and if you do, movements will be stopped. If you are unhappy at any 
point during the study, you are free to withdraw.  
 
9  What are the possible benefits of taking part? 
 
The benefits to you are minimal, however you will have the opportunity to 
contribute to a study that will enhance our knowledge of nerve examination and 
treatment.  
 
10 What if something goes wrong? 
 
You can contact the researcher or supervisor if any problems arise as a result of this 
study (contact details are given below), or if you would prefer to get in touch with 
someone independent of the study you should contact: 
 
Professor Valerie Hall 
Head of the Centre for Nursing and Midwifery Research 
University of Brighton 
Mayfield House, Falmer, 
Brighton BN1 9PH 
Tel 01273 644015  
Email v.hall@brighton.ac.uk 
 .  
11 Will my taking part in this study be kept confidential? 
 
All personal details will be kept separately from the actual data collected. These 
details will be stored on a computer that has a password only known to the 
researcher. The only other people that have access to these details are the 
dissertation supervisors.  
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12 What will happen to the results of the research study? 
 
The results of the study will form part of a PhD thesis. In addition the researcher 
hopes to publish the results of this study in a journal and present the findings at a 
national or international conference. In this case, no participants will be mentioned 
by name, hence your confidentiality will be upheld at all times. 
 
13 Who has reviewed the study? 
The study has been reviewed by the University of Brighton Faculty of Health 
research ethics and governance committee and the academic supervisors. 
 
14 Contacts for Further Information 
 
Researcher      Supervisors 
Colette Ridehalgh     Professor Ann Moore 
School of Health Professions  Clinical Research Centre for Health Professions   
Robert Dodd Building      Aldro Building, Eastbourne, BN20 7UR 
49 Darley Rd     01273 643647 
Eastbourne     Dr. Alan Hough 
BN20 7UR     Senior Lecturer     
01273 643686     Faculty of Health  
University of Plymouth 
Derriford Road, Plymouth PL6 8BH 
 01752 588837 
           
  
 
Thank you for taking part in this study 
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UNIVERSITY OF BRIGHTON 
SCHOOL OF HEALTH PROFESSIONS 
 
Participant Consent Form 
 
Intra rater reliability of B mode ultrasound on longitudinal and transverse 
measures of the sciatic nerve during the straight leg raise test. 
 I agree to take part in this research which is to look at how consistent a 
specialised piece of equipment (ultrasound) is in measuring movement of the 
sciatic nerve (the major nerve which passes down the back of your thigh) 
during a standard physiotherapy test (the SLR test).  
 
 The experimenter has explained to my satisfaction the purpose of the 
experiment and the possible risks involved. 
 
 I have had the principles and the procedure explained to me and I have also 
read the information sheet. I understand the principles and procedures fully 
 
 I am aware that I will be required to change into a pair of shorts, have a 
number of tests performed on me to look at range of motion of my legs and 
reflex, strength and sensation tests. I am also aware that I will have to lie on 
my side and have a plastic probe attached to the back of my thigh, before the 
researcher will place a support on my ankle and move my leg forward and 
take some measurements.   
 
 I understand that there may be a small amount of discomfort produced during 
the test and that I will inform the researcher if this does occur. 
 
 In understand that I will need to attend the human movement laboratory for 
2, 30 minute sessions. 
 
 I understand that any confidential information will be seen only by the 
researcher and will not be revealed to anyone else. 
 
 I understand that I am free to withdraw from the investigation at any time. 
 
 
Name (please print)…………………………………………………………………… 
 
Signed…………………………………………………………………………………. 
 
Date…………………………………………………………………………………….. 
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Appendix 16 Information sheet and consent form 
repeatability of pressure pain thresholds and vibration 
thresholds 
 
University of Brighton 
School of Health Professions 
 
Participant Information Sheet Study 1 
 
Reliability of measurements of vibration and pressure pain in people with leg pain 
thought to be referred from the spine 
 
2  Invitation paragraph 
 
You are being invited to take part in a research study. Before you decide whether to 
participate, it is important for you to understand why the research is being done and 
what it will involve. Please take time to read the following information carefully and 
discuss it with others if you wish. Ask if there is anything that is not clear or if you 
would like more information. Take time to decide whether or not you wish to take 
part. 
Thank you for reading this information. 
 
3  What is the purpose of the study? 
 
The study aims to look at if two commonly used measures of sensation and pain are 
reliable between sessions in people who suffer with leg pain thought to be coming 
from their spine.  
 
4 Why have I been chosen? 
 
You have been chosen for the study as you have had low back pain and/or leg pain 
for 3 months or longer and are not currently receiving any treatment for this 
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condition. You will need to meet the requirements for eligibility into the study as 
described below. 
 
 The following conditions do not apply to you  
 Previous spinal surgery 
 Current or previous medical diagnoses that may affect your participation in the 
study e.g. Rheumatoid Arthritis, diabetes, thyroid disease, HIV/AIDS, stroke, 
cancer, osteoporosis) 
 Currently Pregnant 
 Hip, knee or ankle disorders within the last year 
 New unexplained bladder and bowel problems, and/or pins and needles in your 
genital region) 
 Currently receiving treatment for the LBP/leg pain 
 On regular high levels of pain medication (over the counter pain medication is 
fine, but you will be asked to stop taking this for 24 hours prior to the study) 
 
5 Do I have to take part? 
 
Your participation is entirely voluntary. If you are unsure about taking part then feel 
free to decline. If you do decide to take part you will be given this information sheet 
to keep and be asked to sign a consent form and send it back to the researcher (by 
email cr19@bton.ac.uk or in the stamped addressed envelope sent to you). If you do 
not want to participate, you are still asked to send back the form, and sign in the 
section indicated on the form. If you decide to take part you are still free to withdraw 
at any time without giving a reason. A decision to withdraw at any time, or a 
decision not to take part, will not affect you in any way. 
 
6  What will happen to me if I take part? 
 
The researcher will first contact you by phone and ask you some questions to ensure 
that you are able to take part in the study (these will include questions about your 
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back pain and any relevant medical history). If you are eligible to take part in the 
study you will be given a convenient time for you to attend the Human movement 
laboratory at the University of Brighton, Darley Rd, Eastbourne. You will have 2 
specific tests performed twice in this session with a break of 30 minutes between 
them. The 2 specific tests will each take approximately ½ an hour. All appropriate 
travel costs will be met by the researcher and will be discussed prior to participation 
in the study.  
You will be asked a number of questions by the researcher who is an experienced 
Physiotherapist with 19 years experience about your back and /or leg problem. You 
will then be asked to change into a pair of shorts and bra top (for ladies) before a 
number of tests will be applied:  
 Your height and weight will be measured.  
 You will be asked to move your back and leg and let the researcher know if 
you have any of your pain during these movements. You will be asked to lie 
on your stomach and the researcher will press on your spine with her hand 
and you will again be asked if this brings on your pain. The strength in your 
legs will be tested and your reflexes will be checked (you may have had this 
done by the doctor before- where the tendon in your knee and ankle is tapped 
to see if your leg jumps). The researcher will then apply some cotton wool 
lightly to your leg (or tissue paper if you do not tolerate cotton wool), and 
you will be asked if you can feel it. 
 You will be asked to lie on your stomach whilst a small probe is applied to 
your pain free leg which will vibrate. You will be asked to let the researcher 
know when you feel the probe vibrating and then when it stops. Once you 
and the researcher are happy with this test it will be repeated on your painful 
leg.  
 Another probe will be applied to your pain free leg which will gradually 
increase the feeling of pressure and you will be asked to push a button when 
this pressure sensation changes to discomfort (this will stop any further 
pressure from being applied). Once you are familiar with this, then the same 
procedure will occur on your painful leg and also on your arm. The order in 
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which the vibration test and the pressure test are applied will vary from 
subject to subject.  
 
You will have a break of 30 minutes and then the vibration tests and pressure tests 
will be repeated. 
 
7  What do I have to do? 
 
Please do not drink caffeine, alcohol or take any pain medication for 24 hours prior 
to the study. You will need to remain in the laboratory between the test procedures 
where refreshments will be provided. However no caffeine will be given as it may 
affect the results of the study. Please could you bring a pair of shorts with you (if 
you do not have shorts, these will be provided by the researcher). 
 
8 What are the possible disadvantages and risks of taking part? 
 
There are no reported risks attached to the use of the two pieces of equipment.  
 
9  What are the possible benefits of taking part? 
 
There are no benefits to you directly from participating in the study, however the 
information from this study will be used in a larger study analysing the effects of a 
specific Physiotherapy treatment for patients with referred leg pain.  
 
10 What if something goes wrong? 
 
You can contact the researcher or supervisor if any problems arise as a result of this 
study (contact details are given below), or if you would prefer to get in touch with 
someone independent of the study you should contact: 
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Professor Valerie Hall 
Head of the Centre for Nursing and Midwifery Research 
University of Brighton 
Mayfield House, Falmer, 
Brighton BN1 9PH 
Tel 01273 644015  
Email v.hall@brighton.ac.uk 
 .  
 
11 Will my taking part in this study be kept confidential? 
 
All your personal details will be kept separately from the actual data collected. 
These details will be stored on a computer that has a password only known to the 
researcher. The only other people that have access to these details are the 
dissertation supervisors.  
 
12 What will happen to the results of the research study? 
 
The results of the study will form part of a PhD thesis. In addition the researcher 
hopes to publish the results of this study in a journal and present the findings at a 
national or international conference. In this case, no participants will be mentioned 
by name, hence your confidentiality will be upheld at all times. 
 
13 Who has reviewed the study? 
 
The study has been reviewed by the two academic supervisors and the University of 
Brighton faculty of research and governance committee. 
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14 Contacts for Further Information 
 
Researcher      Supervisors 
Colette Ridehalgh     Professor Ann Moore 
School of Health Professions  Clinical Research Centre for Health Professions   
Robert Dodd Building      Aldro Building, Eastbourne, BN20 7UR 
49 Darley Rd     01273 643647 
Eastbourne     Dr. Alan Hough 
BN20 7UR     Senior Lecturer     
01273 643686     Faculty of Health  
University of Plymouth 
Derriford Road, Plymouth PL6 8BH 
 01752 588837 
Thank you for reading this information. 
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UNIVERSITY OF BRIGHTON 
SCHOOL OF HEALTH PROFESSIONS 
 
Participant Consent Form 
 
Reliability of measurements of vibration and pressure pain in people with leg pain 
thought to be referred from the spine 
 
 I agree to take part in this research which is to assess if two commonly 
used measures of sensation and pain are reliable between sessions in 
people who suffer with leg pain thought to be coming from their spine.  
  
 The experimenter has explained to my satisfaction the purpose of the 
experiment and the possible risks involved. 
 
 I have had the principles and the procedure explained to me and I have 
also read the information sheet. I understand the principles and 
procedures fully 
 
 I am aware that I will be required to attend the Human Movement 
laboratory, University of Brighton, Eastbourne. 
 
 I am aware that the cost of travel will be met by the researcher. 
 
 I am aware that I will be asked a series of questions by the researcher and 
then be asked to undress to shorts and vest top and have a number of 
specific tests done to my back and leg, I also am aware that I will have a 
vibrating probe and probe that produces pressure applied to my leg and 
arm.  
 
 I understand that I will have 30 minutes to wait in the human movement 
laboratory before the two tests are repeated. 
 
 I also understand that I must not consume caffeine or alcohol for 24 
hours prior to participating in the study, or in the 30 minutes between 
sessions.  
 
 I understand that any confidential information will be seen only by the 
researcher and will not be revealed to anyone else. 
 
 I understand that the results from the study will form part of a doctoral 
study and may be published in an academic journal, but my identity will 
not be revealed at any time. 
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 I understand that I am free to withdraw from the investigation at any 
time. 
 
 
 
 
 
 
Name (please print)…………………………………………………………………… 
 
I do wish to participate in the study 
 
Signed…………………………………………………………………………………. 
 
Date…………………………………………………………………………………….. 
 
 
I do not wish to participate in the study 
 
Signed ………………………………………………………………………………… 
 
Date …………………………………………………………………………………… 
 
Please return this form by email to cr19@bton.ac.uk or place in the stamped addressed 
envelope provided and post by return.  
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Appendix 17 Research and governance approval for 
repeatability of pressure pain threshold and vibration 
threshold 
 
From: onbehalfof+J.Scholes+brighton.ac.uk@manuscriptcentral.com on behalf of  
J.Scholes@bton.ac.uk 
Sent: 17 December 2010 10:34 
To: Ridehalgh Colette 
Subject: Faculty of Health and Social Science Research Ethics and Governance  
Committee - Decision on Manuscript ID FREGC-10-040.R1 
 
17-Dec-2010 
 
Dear Ms. Ridehalgh: 
 
It is a pleasure to approve your application entitled "Is the response to  
neurodynamic treatment linked to specific group characteristics in people with  
referred posterior leg pain? : Part one repeatability and pilot studies".   
 
Please advise the Committee of any adverse incidents that occur whilst  
undertaking the research and make known any changes to the design of the  
project. 
 
We wish you well with the project 
 
Sincerely, 
Prof. Julie Scholes 
Chair, Faculty of Health and Social Science Research Ethics and Governance  
Committee J.Scholes@brighton.ac.uk 
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Appendix 18 Information sheet and consent form for 
non-NHS participants 
 
University of Brighton 
School of Health Professions 
 
Participant Information Sheet  
 
Straight leg raise; responses in patients with referred leg pain 
 
 
1  Invitation paragraph 
 
You are being invited to take part in a research study. Before you decide whether to 
participate, it is important for you to understand why the research is being done and 
what it will involve. Please take time to read the following information carefully and 
discuss it with others if you wish. Ask if there is anything that is not clear or if you 
would like more information. Take time to decide whether or not you wish to take 
part. 
 
Thank you for reading this information. 
 
2  What is the purpose of the study? 
 
The study aims to look at how different groups of people who suffer with leg pain 
thought to be coming from their spine respond to a particular treatment commonly 
given by Physiotherapists.  
 
3 Why have I been chosen? 
 
You have been chosen for the study as you have low back pain and/or leg pain for 3 
months or longer and are not currently receiving any treatment for this condition. 
You will need to meet the requirements for eligibility into the study as described 
below. 
 
Unfortunately you will be unable to take part in the study if you have any of the 
following conditions   
 
 Previous spinal surgery 
 Current or previous medical diagnoses that may affect your participation in the 
study e.g. Rheumatoid Arthritis, diabetes, thyroid disease, HIV/AIDS, stroke, 
cancer, osteoporosis) 
 Currently Pregnant 
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 Hip, knee or ankle disorders within the last year 
 New unexplained bladder and bowel problems, and/or pins and needles in your 
genital region) 
 Currently receiving treatment for the LBP/leg pain 
 On regular high levels of pain medication (over the counter pain medication such 
as paracetamol or ibuprofen is fine, but you will be asked to stop taking this for 3 
hours prior to the study) 
 
 
4 Do I have to take part? 
 
Your participation is entirely voluntary. If you are unsure about taking part then feel 
free to decline. If you do decide to take part you will be given this information sheet 
to keep for reference purposes and be asked to sign a consent form and send it back 
to the researcher by email (cr19@brighton.ac.uk) or in the stamped addressed 
envelope sent to you. If you decide to take part you are still free to withdraw at any 
time without giving a reason. A decision to withdraw at any time, or a decision not 
to take part, will not affect you in any way.  
 
5 What will happen to me if I take part? 
 
A qualified Physiotherapist will organise an appointment with you to attend the 
Human Movement Laboratory at Darley Rd, Eastbourne. An assessment will take 
place (as described below) which will take approximately 1 hour. This will be a 
standard Physiotherapy assessment, with some additional tests and questions, and 
will analyse what is most likely causing your pain as well as assessing if you are 
eligible to participate in the study. If you are eligible to participate in the study, you 
will be given a convenient time to return to the human movement laboratory. The 
session in the human movement laboratory will last approximately 1 ½ hours. All 
appropriate travel costs to the laboratory will be met by the researcher and will be 
discussed prior to participation in the study.  
 
 
Part 1 Initial assessment (Physiotherapy assessment) 
You will be asked a number of questions by the Physiotherapist about your back and 
/or leg problem. A number of questionnaires will be used to assess how your pain 
affects certain aspects of your life. 
You will then be asked to change into a pair of shorts and bra top (for ladies) before 
a number of tests will be applied. You will firstly be asked to move your back and 
leg and let the Physiotherapist know if any of your pain occurs. An example of some 
tests that might occur to your leg can been seen in the figures below.  
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The strength in your legs will be tested and your reflexes will be checked (you may 
have had this done by the doctor before- where the tendon in your knee and ankle is 
tapped to see if your leg jumps). The Physiotherapist will apply some cotton wool 
lightly to your leg (or tissue paper if you do not tolerate cotton wool), and you will 
be asked if you can feel it. The Physiotherapist will palpate certain areas on your leg 
to assess if any tenderness of these points occurs. 
You will be asked to lie on your stomach and the Physiotherapist will press on your 
spine with her hand and you will again be asked if this brings on your pain. 
Additional tests may be performed by the Physiotherapist depending on what your 
individual requirements are (e.g. looking at your stomach or back muscles).  
For some subjects, a piece of equipment which applies pressure to different aspects 
of your body will be placed on various points. You will be asked to let the researcher 
know what happens to the sensation of pressure as it increases up to a predetermined 
level 
If you are eligible to participate in the study, either the Physiotherapist will contact 
the researcher to organise an appointment directly, or if you would prefer, your 
contact details will be given to the researcher and she will contact you directly to 
organise the appointment. The physiotherapist will give you some advice on 
managing your condition before you leave. 
 
Part 2 Subsequent attendance 
You will be asked to change in to shorts and a vest top and have your height and 
weight measured. You will then be asked to lie on a plinth on your stomach if this is 
comfortable for you and a small plastic probe will be placed on your ankle bone of 
the unaffected side which will vibrate. You will be asked to let the researcher know 
when you feel the vibration and then when it disappears again. Once you and the 
researcher are happy with this test it will be repeated on your affected ankle bone 
and underneath surface of your foot.  
Once the vibration test is complete another probe will be applied to your unaffected 
calf (similar to the pressure probe in the Physiotherapy assessment if this was 
applied to you) which will gradually increase the feeling of pressure and you will be 
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asked to push a button when this pressure sensation changes to discomfort (the probe 
will then be removed). Once you are familiar with this, then the same procedure will 
occur on your affected leg (back of calf, behind your knee) and also on your 
opposite arm. The order of the vibration test and the pressure test will vary from 
subject to subject, so it may be that you have the pressure test applied first.  
  
You will then be asked to lie on your side and an ultrasound probe (small plastic 
device) will be applied to the back of your thigh, a layer of gel will be applied 
between the probe and your skin to improve the contact between you and the probe 
(this may feel cold).  Two plastic splints will be applied to your feet to keep your 
feet and ankles still during the procedure. With your knee straight, your leg will be 
moved forwards a little and then stopped. This will be repeated a few times until 
either you feel a worsening of any of your symptoms (if you have some symptoms 
all of the time) or start to feel any symptoms (if you do not have them all of the 
time) or until your leg does not move any more (you may let the researcher know 
that it doesn’t want to go any further, or the researcher may feel that the leg has 
reached its maximum movement). During these movements the ultrasound machine 
will build up pictures of your nerve moving.  
 
You will then be asked to lie on your back with one splint remaining on your foot, 
and your affected leg will be lifted from the plinth with your knee straight until you 
feel a worsening or onset of your symptoms (pain or other sensations) or the leg has 
reached its limit of movement as described above. Your knee will then be bent and 
straightened a few times (a Straight Leg Raise (SLR) mobilisation technique) before 
all of the measures taken previously are repeated (see figures below) 
 
 
 
 
Your referring Physiotherapist will then contact you for a follow up appointment, 
ensuring that this is within the time frame that you would have been seen if you had 
not participated in the study. 
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6  What do I have to do? 
 
Please do not drink caffeine or alcohol for 24 hours prior to the study, and do not 
take your pain medication for 3 hours prior to the study. Please bring a pair of shorts 
and vest top with you (if you do not have shorts, these will be provided by the 
researcher). 
 
 
 
7 What are the possible disadvantages and risks of taking part? 
 
The SLR is a test used by physiotherapists on a regular basis, and in some 
individuals the test may bring on your symptoms. You will be asked to inform the 
researcher if this occurs during the test procedure and if this happens, no additional 
movements will be added. The risks of increasing your symptoms after the study has 
completed will be minimised by asking you specific questions about your pain and 
doing certain tests to assess your eligibility into the study. If the researcher has 
concerns that your condition could be aggravated by the procedure you will be 
withdrawn from the study. 
 
8 What are the possible benefits of taking part? 
 
It is possible that the mobilisation technique applied to your leg may help to alleviate 
some of your symptoms, however this is not the aim of the study and any positive 
effects should be considered “a bonus”, and as such should not be expected. This 
form of treatment is only one of a number of possible treatments that could be given 
to you, and may not be the most beneficial; therefore you may not notice any 
improvement in your symptoms. The results of this study will provide important 
information about the use of this technique in people with different causes of back 
related leg pain.  
 
 
9  What if something goes wrong? 
 
You can contact the researcher or supervisors if any problems arise as a result of this 
study (contact details are given below), or if you would prefer to get in touch with 
someone independent of the study you should contact: 
 
 
Professor Valerie Hall 
Head of the Centre for Nursing and Midwifery Research 
University of Brighton 
Mayfield House, Falmer, 
Brighton BN1 9PH 
Tel 01273 644015  
Email v.hall@brighton.ac.uk 
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10 Will my taking part in this study be kept confidential? 
 
All personal details will be kept separately from the actual data collected. These 
details will be stored on a computer that has a password only known to the 
researcher. The only other people that have access to these details are the 
dissertation supervisors.  
 
11 What will happen to the results of the research study? 
 
The results of the study will form part of a PhD thesis. In addition the researcher 
hopes to publish the results of this study in a journal and present the findings at a 
national or international conference. In this case, no participants will be mentioned 
by name, hence your confidentiality will be upheld at all times. 
 
12 Who has reviewed the study? 
The study has been reviewed by the two academic supervisors, the University of 
Brighton faculty of research and governance committee. 
 
13 Contacts for Further Information 
 
Researcher      Supervisors 
Colette Ridehalgh     Professor Ann Moore 
School of Health Professions  Clinical Research Centre for Health Professions   
Robert Dodd Building      Aldro Building, Eastbourne, BN20 7UR 
49 Darley Rd     01273 643647 
Eastbourne     Dr. Alan Hough 
BN20 7UR     Senior Lecturer     
01273 643686     Faculty of Health  
University of Plymouth 
Derriford Road, Plymouth PL6 8BH 
 01752 588837 
 
 
 
 
Thank you for reading this information. 
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UNIVERSITY OF BRIGHTON 
SCHOOL OF HEALTH PROFESSIONS 
 
Participant Consent Form 
 
Straight leg raise; responses in patients with referred leg pain 
 
 I agree to take part in this research which is to look at how different 
groups of people who suffer from leg pain thought to be coming from 
their spine respond to a particular treatment commonly given by 
Physiotherapists.  
 
 The experimenter has explained to my satisfaction the purpose of the 
experiment and the possible risks involved. 
 
 I have had the principles and the procedure explained to me and I have 
also read the information sheet. I understand the principles and 
procedures fully 
 
 I am aware that I will be required to attend two sessions at the Human 
Movement laboratory, University of Brighton, Eastbourne. 
 
 I am aware that the cost of travel to the Human Movement Laboratory 
will be met by the researcher. 
 
 I am aware that I will be asked a series of questions by the 
Physiotherapist and then be asked to undress to shorts and bra top (for 
females) and have a number of specific tests done to my back and leg. I 
also am aware that I may have a probe which applies pressure to various 
points on my body. 
 
 At the second attendance, I am aware that I will be asked to undress to 
shorts and vest top and have a vibrating probe and probe that produces 
pressure applied to my leg and arm.  
 
 I understand that I will have to lie on my side and have an ultrasound 
probe placed to the back of my thigh before the researcher will move my 
leg and take some measurements. I am aware that some of my pain or 
other symptoms may be produced or made worse during the SLR test, 
and to inform the researcher if this occurs. I am aware my leg will be 
repeatedly moved (mobilisation treatment) after which the above 
measurements will be repeated. I also understand that I must not consume 
caffeine or alcohol for 24 hours and take any pain medication for 3 hours 
prior to participating in the study.  
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 I understand that any confidential information will be seen only by the 
researcher and will not be revealed to anyone else. 
 
 I understand that the results from the study will form part of a doctoral 
study, but my identity will not be revealed at any time. 
 
 I understand that I am free to withdraw from the investigation at any 
time. 
 
 
 
Name (please print)…………………………………………………………………… 
 
 
I wish to participate in the study 
 
Signed…………………………………………………………………………………. 
 
Date…………………………………………………………………………………….. 
 
 
 
Please return this form by email to cr19@brighton.ac.uk or place in the stamped 
addressed envelope provided and post by return.  
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Appendix 19 Information sheet and consent form for 
NHS participants 
                                                                                                    
 
 
Clinical Research Centre  
For Health Professions 
Colette Ridehalgh (MSc, MCSP, MMACP) 
Senior Lecturer 
Aldro Building 
49 Darley Rd 
Eastbourne, BN20 7UR 
www.brighton.ac.uk/sohp/research/ 
 
 
Participant Information Sheet  
 
Straight leg raise; responses in patients with referred leg pain 
 
 
1  Invitation paragraph 
 
You are being invited to take part in a research study. Before you decide whether to 
participate, it is important for you to understand why the research is being done and 
what it will involve. Please take time to read the following information carefully and 
discuss it with others if you wish. Ask if there is anything that is not clear or if you 
would like more information. Take time to decide whether or not you wish to take 
part. 
 
Thank you for reading this information. 
 
2  What is the purpose of the study? 
 
The study aims to look at how different groups of people who suffer with leg pain 
thought to be coming from their spine respond to a particular treatment commonly 
given by Physiotherapists.  
 
3 Why have I been chosen? 
 
You have been chosen for the study as you have low back pain and/or leg pain for 3 
months or longer and are not currently receiving any treatment for this condition. 
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You will need to meet the requirements for eligibility into the study as described 
below. 
 
Unfortunately you will be unable to take part in the study if you have any of the 
following conditions:   
 
 Previous spinal surgery 
 Current or previous medical diagnoses that may affect your participation in the 
study (e.g. Rheumatoid Arthritis, diabetes, thyroid disease, HIV/AIDS, stroke, 
cancer, osteoporosis) 
 Currently Pregnant 
 Hip, knee or ankle disorders within the last year 
 New unexplained bladder and bowel problems, and/or pins and needles in your 
genital region 
 Currently receiving treatment for the LBP/leg pain 
 On regular high levels of pain medication (over the counter pain medication such 
as paracetamol or ibuprofen is fine, but you will be asked to stop taking this for 3 
hours prior to the study) 
 
 
4 Do I have to take part? 
 
Your participation is entirely voluntary. If you are unsure about taking part then feel 
free to decline. If you do decide to take part please sign the enclosed consent form 
and send it back to the Researcher by email (cr19@brighton.ac.uk)) or in the 
stamped addressed envelope sent to you. If you decide to take part you are still free 
to withdraw at any time without giving a reason. A decision to withdraw at any time, 
or a decision not to take part, will not affect your treatment in any way.  
 
6 What will happen to me if I take part? 
 
The Researcher will contact your local hospital physiotherapy department and let 
them know you have consented to participate in this study.  The hospital 
physiotherapy team will organise an appointment for you to attend the hospital 
Physiotherapy department. An assessment will take place (as described below) 
which will take approximately 1 hour. This will be a standard Physiotherapy 
assessment and will analyse what is most likely causing your pain as well as 
assessing if you are eligible to participate in the study. If you are eligible to 
participate in the study, the physiotherapist will inform the Researcher, who will 
then contact you with a convenient time to attend the human movement laboratory at 
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the University of Brighton, Darley Rd, Eastbourne. If you are not eligible to 
participate in the study, you will continue to see your Physiotherapist in the usual 
way. The session in the human movement laboratory will last approximately 1 ½ 
hours.  
 
 
Part 1 Initial assessment (Physiotherapy department) 
The Physiotherapist will give you a number of questionnaires to complete to assess 
how your pain affects certain aspects of your life. You need to attend the department 
about 20 minutes early to fill these in, or they could be completed after your 
appointment has finished.  
You will be asked a number of questions by the hospital Physiotherapist about your 
back and /or leg problem.  
You will then be asked to change into a pair of shorts and bra top (for ladies) before 
a number of assessments will be carried out. You will firstly be asked to move your 
back and leg and let the Physiotherapist know if any of your pain occurs. An 
example of some assessments that might occur to your leg can be seen in the figures 
below.  
 
The strength in your legs will be tested and your reflexes will be checked (you may 
have had this done by the doctor before- where the tendon in your knee and ankle is 
tapped to see if your leg jumps). The Physiotherapist will apply some cotton wool 
lightly to your leg (or tissue paper if you do not tolerate cotton wool), and you will 
be asked if you can feel it. The Physiotherapist will palpate certain areas on your leg 
to assess if any tenderness of these points occurs. 
You will be asked to lie on your stomach and the Physiotherapist will press on your 
spine with her hand and you will again be asked if this brings on your pain. 
Additional tests may be performed by the Physiotherapist depending on what your 
individual requirements are (e.g. looking at your stomach or back muscles).  
For some participants, a piece of equipment which applies pressure to different 
aspects of your body will be placed on various points. You will be asked to let the 
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physiotherapist know what happens to the sensation of pressure as it increases up to 
a predetermined level. 
If you are eligible to participate in the study, the Physiotherapist will inform the 
researcher, who will then contact you directly to organise the appointment at the 
Human Movement Laboratory. The physiotherapist will give you some advice on 
managing your condition before you leave the Physiotherapy department. 
 
 
Part 2 Human Movement Laboratory (Eastbourne) 
You will then be asked to change in to shorts and a vest top and have your height 
and weight measured. You will then be asked to lie on a plinth on your stomach if 
this is comfortable for you and a small plastic probe will be placed on your ankle 
bone of the unaffected side which will vibrate. You will be asked to let the 
researcher know when you feel the vibration and then when it disappears again. 
Once you and the researcher are happy with this test it will be repeated on your 
affected ankle bone and underneath surface of your foot.  
Once the vibration test is complete another probe will be applied to your unaffected 
calf (similar to the pressure probe in the Physiotherapy assessment if this was 
applied to you) which will gradually increase the feeling of pressure and you will be 
asked to push a button when this pressure sensation changes to discomfort (the probe 
will then be removed). Once you are familiar with this, then the same procedure will 
occur on your affected leg (back of calf, behind your knee) and also on your 
opposite arm. The order of the vibration test and the pressure test will vary from 
participant to participant, so it may be that you have the pressure test applied first.  
  
You will then be asked to lie on your side and an ultrasound probe (small plastic 
device) will be applied to the back of your thigh, a layer of gel will be applied 
between the probe and your skin to improve the contact between you and the probe 
(this may feel cold).  Two plastic splints will be applied to your feet to keep your 
feet and ankles still during the procedure. With your knee straight, your leg will be 
moved forwards a little and then stopped. This will be repeated a few times until 
either you feel a worsening of any of your symptoms (if you have some symptoms 
all of the time) or start to feel any symptoms (if you do not have them all of the 
time) or until your leg does not move any more (you may let the researcher know 
that it doesn’t want to go any further, or the researcher may feel that the leg has 
reached its maximum movement). During these movements the ultrasound machine 
will build up pictures of your nerve moving.  
 
You will then be asked to lie on your back with one splint remaining on your foot, 
and your affected leg will be lifted from the plinth with your knee straight until you 
feel a worsening or onset of your symptoms (pain or other sensations) or the leg has 
reached its limit of movement as described above. Your knee will then be bent and 
straightened a few times (a Straight Leg Raise (SLR) mobilisation technique) before 
all of the measures taken previously are repeated (see figures below). 
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When the session is over, the Researcher will inform your hospital physiotherapist 
that your participation in the study is complete.  Your hospital Physiotherapist will 
then contact you to arrange further hospital appointment/s as necessary to treat your 
pain. 
 
6  Expenses and payments 
All appropriate travel costs to the laboratory will be met by the researcher and will 
be discussed prior to participation in the study.  
 
 
7 What do I have to do? 
 
Please do not drink caffeine or alcohol for 24 hours prior to attending the Human 
Movement Laboratory, and do not take your pain medication for 3 hours prior to 
attending the laboratory. Please could you bring a pair of shorts and vest top with 
you (if you do not have shorts, these will be provided by the researcher). 
 
 
8 What are the alternatives for diagnosis or treatment? 
 This form of treatment is an important treatment for patients with referred leg pain, 
but it is only of many possible options. Other available treatments include 
mobilisations to the joints in your spine or specific exercises. Your Physiotherapist 
may choose to offer these treatments to you when you attend for your second 
appointment at the Physiotherapy Department. There are no greater risks or benefits 
associated with the treatment that will be applied in the Human Movement 
Laboratory than the others that could be given. If you would like more information, 
please speak to your physiotherapist. 
 
9 What are the possible disadvantages and risks of taking part? 
 
The SLR is a test used by physiotherapists on a regular basis, and in some 
individuals the test may bring on your symptoms. You will be asked to inform the 
researcher if this occurs during the test procedure and if this happens, no additional 
movements will be added. The risks of increasing your symptoms after the study has 
completed will be minimised by asking you specific questions about your pain and 
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doing certain tests to assess your eligibility into the study. If the researcher has 
concerns that your condition could be aggravated by the procedure you will be 
withdrawn from the study. 
 
10 What are the possible benefits of taking part? 
 
It is possible that the mobilisation technique applied to your leg may help to alleviate 
some of your symptoms, however this is not the aim of the study and any positive 
effects should be considered “a bonus”, and as such should not be expected. This 
form of treatment is only one of a number of possible treatments that could be given 
to you, and may not be the most beneficial; therefore you may not notice any 
improvement in your symptoms. The results of this study will provide important 
information about the use of this technique in people with different causes of back 
related leg pain.  
 
 
11 What happens when the research study stops? 
 Your Hospital Physiotherapist will continue to treat you in the usual way. 
 
12 What will happen if I don’t want to carry on with the study? 
If you withdraw from the study, we will destroy all your identifiable data.  You 
hospital physiotherapist will be informed that your participation in the study is 
complete and you will be contacted by the hospital physiotherapy department to 
continue with standard NHS care. 
 
 
13  What if something goes wrong? 
 
You can contact the researcher or supervisors if any problems arise as a result of this 
study (contact details are given below), or if you would prefer to get in touch with 
someone independent of the study or wish to complain formally, you may do so by 
contacting: 
 
 
Professor Valerie Hall 
Head of the Centre for Nursing and Midwifery Research 
University of Brighton 
Mayfield House, Falmer, 
Brighton BN1 9PH 
Tel 01273 644015  
Email v.hall@brighton.ac.uk 
 . 
In the event that something goes wrong and you are harmed during the research and 
this is due to someone’s negligence, then you may have grounds for legal action for 
compensation against the University of Brighton, but you may have to pay legal 
costs. 
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14 Involvement of the General Practitioner/Family Doctor (GP) 
You will be asked for permission to contact your G.P. to inform her/him of your 
participation in the study. 
 
 
15 Will my taking part in this study be kept confidential? 
 
All personal details will be kept separately from the actual data collected. These 
details will be stored on a computer that has a password only known to the 
researcher. The only other person who will have access to your personal details will 
be the Physiotherapist who assessed you. 
 
 
16 What will happen to the results of the research study? 
 
The results of the study will form part of a PhD thesis. In addition the researcher 
hopes to publish the results of this study in a journal and present the findings at a 
national or international conference. In this case, no participants will be mentioned 
by name, hence your confidentiality will be upheld at all times. 
 
17 Who has reviewed the study? 
The study has been reviewed by the two academic supervisors, the University of 
Brighton faculty of research and governance committee and the NHS ethics 
committee. 
 
18 Who is organising and funding the research? 
 
The research is being sponsored and funded by the University of Brighton, and 
organised and conducted by the researcher who is a PhD student and lecturer at the 
University of Brighton. 
19 Contacts for Further Information 
 
Researcher      Supervisors 
Colette Ridehalgh     Professor Ann Moore 
School of Health Professions   Clinical Research Centre for Health Professions
   
Robert Dodd Building      Aldro Building, Eastbourne, BN20 7UR 
49 Darley Rd     01273 643647 
Eastbourne     Dr. Alan Hough 
BN20 7UR     Senior Lecturer     
01273 643686     Faculty of Health  
University of Plymouth 
Derriford Road, Plymouth PL6 8BH 
 01752 588837 
 
 
 
 
Thank you for reading this information. 
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Clinical Research Centre 
For Health Professions 
Colette Ridehalgh MSc, MCSP, MMACP 
Aldro Building 
49 Darley Rd 
Eastbourne, BN20 7UR 
www.brighton.ac.uk/sohp/research/                                                                      
   
Participant Consent Form 
 
Straight leg raise; responses in patients with referred leg pain 
 
 Please initial box 
 I confirm that I have read and understood the information sheet 
dated 21st June 2012 (version 3.0) for the above study.  I have had the 
opportunity to consider the information, ask questions and have had 
these answered satisfactorily. 
 
 I understand that relevant sections of my medical notes and data 
collected during the study may be looked at by individuals from the 
University of Brighton, from regulatory authorities or from the NHS 
Trust, where it is relevant to my taking part in this research.  I give 
permission for these individuals to access to my records. 
 
 I agree to my GP being informed of my participation in this study. 
 
 I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, without my medical 
care or legal rights being affected. 
 
 I agree to take part in the above study. 
 
 
 
Name (please print)…………………………………………………………………… 
 
 
 
Signed…………………………………………………………………………………. 
 
Date…………………………………………………………………………………….. 
 
 
Please return this form by email to cr19@brighton.ac.uk or place in the stamped 
addressed envelope provided and post by return.  
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Appendix 20 Letter of invitation 
 
 
 
Straight leg raise; responses in patients with referred leg pain 
 
Dear Sir/Madam,    
I am contacting you to see if you would like to participate in a study looking at how a 
standard Physiotherapy intervention affects different people with leg pain that is coming 
from their spine. This study forms the main part of a PhD which is being undertaken by a 
colleague at the University of Brighton. You are being sent this information as you are 
currently on the waiting list for physiotherapy treatment at Worthing hospital for referred 
leg pain.  
Please find attached an information sheet and consent form. Please take your time to read 
this information as it is important that you fully understand what will happen to you in the 
study if you agree to participate. If you are happy to participate after reading this 
information please fill in the consent form enclosed and return it by post (in the stamped 
addressed envelope provided), or by email to the Researcher, Colette Ridehalgh, at 
cr19@brighton.ac.uk. If you would like to discuss any of the details of the study before 
consenting to participate, please email the Researcher on the above email address or 
phone 01273 643686. 
If after reading the information sheet you decide that you would not like to participate, 
then no further action is required. You will be contacted by the hospital Physiotherapy 
department for an appointment in the usual way. Many thanks for taking the time to read 
this information. 
Yours Sincerely, 
Physiotherapy Department 
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Appendix 21 Faculty of Health research and 
governance committee ethical approval 
 
 
From: Scholes Julie 
Sent: 10 February 2012 10:00 
To: Ridehalgh Colette 
Cc: Moore Ann; Alanhough (alan.hough@plymouth.ac.uk); Flood Glynis 
Subject: RE: Faculty of Health and Social Science Research Ethics and 
Governance 
Committee - Decision on Manuscript ID FREGC-11-065 
Dear Colette. 
Thank you for sending this set of revisions to me. I am happy to 
approve the 
amendments by Chair's action. 
We will need to have the revised documents uploaded to MC dashboard for 
our 
records. However, please do proceed with booking a slot with IRAS. I am 
happy 
to provide my electronic signature for the IRAS and the R&D forms. 
You will need to remove the previous version to be able to upload this 
approved version. Please can you do this within a week - but as I have 
stated 
this should not delay you in the next stage of your IRAS submission. 
Kind regards 
 
Julie Scholes 
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Appendix 22 NRES Approval 
NRES Committee London - 
Chelsea 
Room 4W/12, 4th Floor West 
Charing Cross Hospital 
Fulham Palace Road 
London W6 8RF 
Telephone: 020 331 17282 
27 March 2012 
 
Ms Colette Ridehalgh 
Senior Lecturer 
University of Brighton 
Robert Dodd Building 
49 Darley Rd 
Eastbourne 
BN20 7UR 
 
Dear Ms Ridehalgh 
 
Study title: Is the response to neurodynamic treatment linked to 
specific group characteristics in people with referred leg 
pain? 
 
REC reference: 12/LO/0397 
 
Thank you for your letter of 26 March 2012, responding to the Committee’s request for 
further information on the above research and submitting revised documentation. 
The further information has been considered on behalf of the Committee by the Chair. 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation [as revised], subject to the conditions specified below. 
 
Ethical review of research sites 
NHS sites 
The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the 
start of 
the study (see "Conditions of the favourable opinion" below). 
Non-NHS sites 
The Committee has not yet been notified of the outcome of any site-specific 
assessment 
(SSA) for the non-NHS research site(s) taking part in this study. The favourable opinion 
does not therefore apply to any non-NHS site at present. We will write to you again as 
soon 
as one Research Ethics Committee has notified the outcome of a SSA. In the 
meantime no 
study procedures should be initiated at non-NHS sites. 
Conditions of the favourable opinion 
364 
 
The favourable opinion is subject to the following conditions being met prior to the start of 
the study. 
Management permission or approval must be obtained from each host organisation prior to 
the start of the study at the site concerned. 
Management permission ("R&D approval") should be sought from all NHS organisations 
involved in the study in accordance with NHS research governance arrangements. 
Guidance on applying for NHS permission for research is available in the Integrated 
Research Application System or at http://www.rdforum.nhs.uk. 
Where a NHS organisation’s role in the study is limited to identifying and referring potential 
participants to research sites ("participant identification centre"), guidance should be sought 
from the R&D office on the information it requires to give permission for this activity. 
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host organisation. 
Sponsors are not required to notify the Committee of approvals from host organisations 
It is the responsibility of the sponsor to ensure that all the conditions are 
complied 
with before the start of the study or its initiation at a particular site (as 
applicable). 
Approved documents 
The final list of documents reviewed and approved by the Committee is as follows: 
Document Version Date 
Covering Letter 16 February 2012 
Covering Letter 26 March 2012 
Evidence of insurance or indemnity 1 16 February 2012 
GP/Consultant Information Sheets 1 16 February 2012 
Investigator CV Ms Ridehalgh 16 February 2012 
Letter from Sponsor FREGC-1-065 16 February 2012 
Letter of invitation to participant 2 26 March 2012 
Other: Prof Ann Moore Supervisor 1 cv 16 February 2012 
Other: Dr Alan Hough Supervisor 2 cv 16 February 2012 
Other: Rejection letter 1 26 March 2012 
Participant Consent Form 2 26 March 2012 
Participant Information Sheet 2 26 March 2012 
Protocol 1 16 February 2012 
Questionnaire: Fear Avoidance Beliefs FABQ for patients with 
Back Pain 
1 16 February 2012 
Questionnaire: Depression anxiety & stress score DASS21 1 16 February 2012 
Questionnaire: Tampa Scale for Kinesiophobia validated 16 February 2012 
Questionnaire: Oswestry Disability Questionnaire validated 16 February 2012 
Questionnaire: Pain Catastophizing Scale validated 16 February 2012 
REC application 59355/294445/ 
1/700 
16 February 2012 
Response to Request for Further Information 26 March 2012 
Summary/Synopsis 1 16 February 2012 
Statement of compliance 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees and complies fully with the Standard Operating 
Procedures for 
Research Ethics Committees in the UK. 
After ethical review 
Reporting requirements 
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The attached document “After ethical review – guidance for researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including: 
Notifying substantial amendments 
Adding new sites and investigators 
Notification of serious breaches of the protocol 
Progress and safety reports 
Notifying the end of the study 
The NRES website also provides guidance on these topics, which is updated in the 
light of 
changes in reporting requirements or procedures. 
Feedback 
You are invited to give your view of the service that you have received from the 
National 
Research Ethics Service and the application procedure. If you wish to make your views 
known please use the feedback form available on the website. 
Further information is available at National Research Ethics Service website > After 
Review 
12/LO/0397 Please quote this number on all correspondence 
With the Committee’s best wishes for the success of this project 
Yours sincerely 
pp 
Dr Shelley Dolan 
Chair 
Email: lara.callaghan@imperial.nhs.uk 
 
Copy to: Professor Julie Scholes 
Ms Helen Vaughan, Western Sussex Hospital NHS Trust 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 23 R and D approval Brighton and Sussex 
University Hospitals Trust 
 
R&D MANAGEMENT OFFICE 
R&D Manager: Scott Harfield x7497 
Research Governance Officer: Linda Henderson x3538 
Please send all documents for approval to: 
r&d.approvals@bsuh.nhs.uk 
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E-mail: scott.harfield@bsuh.nhs.uk 
linda.henderson@bsuh.nhs.uk 
19/04/2012 
       Research & Development Directorate 
Clinical Investigation & Research Unit 
Royal Sussex County Hospital 
Level 5 Thomas Kemp Tower 
Eastern Road 
Brighton 
BN2 5BE 
www.bsuh.nhs.uk/research 
www.bsms.ac.uk/ciru 
Tel: 01273 696955 
Fax: 01273 664855 
Ms Colette Ridehalgh 
Robert Dodd Building 
49 Darley Rd 
Eastbourne 
BN20 7UR 
 
Dear Ms Colette Ridehalgh 
Full Study Title: Is the response to neurodynamic treatment linked to specific group 
characteristics in people with referred leg pain? 
R&D Ref No. : 12/070/RID 
REC Ref: 12/LO/0397 
I am writing to inform you that you have Trust approval to proceed with the above named 
project. This letter 
acknowledges that you have all the necessary internal and external regulatory approvals. 
Details of your 
research project and any associated supporting documentation will be stored on an electronic 
database 
administered by the R&D Department. The sites covered by this approval include: 
Royal Sussex County Hospital 
Princess Royal Hospital 
Conditions of Approval 
The approval covers the period stated in the Research Ethics Committee (REC) application and 
will be 
extended in line with any amendments agreed by the REC. Research must commence within 12 
months of 
the issue date of this letter. Any delay beyond this may require a new review of the project 
resources. 
Amendments 
Project amendment details dated after the issue of this approval letter should be emailed to the 
R&D Office 
for formal approval. 
ICH-GCP Monitoring 
The Trust has a duty to ensure that all research is conducted in accordance with the Research 
Governance 
Framework and to ICH-GCP standards. In order to ensure compliance the Trust undertakes 
random audits. If 
your project is selected you will be given 4 weeks notice to prepare all documentation for 
inspection. 
Pathology Services at BSUH 
If you will be using the pathology services at Brighton & Sussex University Hospitals to analyse 
samples for 
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research purposes only (i.e. not taken to inform standard clinical care), these samples must be 
booked in for 
processing by the CIRU laboratory assistants. Please call 01273 696955 extension 7668 for 
advice. 
Imaging services at BSUH 
R&D MANAGEMENT OFFICE 
R&D Manager: Scott Harfield x7497 
Research Governance Officer: Linda Henderson x3538 
Please send all documents for approval to: 
r&d.approvals@bsuh.nhs.uk 
E-mail: scott.harfield@bsuh.nhs.uk 
linda.henderson@bsuh.nhs.uk 
Page 2 of 2 
If research participants will undergo imaging investigations that are additional to standard care 
you are 
reminded that referrals should be clearly identified with a research sticker. For further advice 
please contact 
01273 696955 ext 7959. 
I wish you luck with your project and would be grateful if you could inform me when the project is 
complete, or due to be closed on this site. 
 
Yours sincerely 
Scott Harfield 
Research & Development Manager 
Cc 
Carbon Copy: (PI) Mr Andrew Laing 
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Appendix 24 R and D approval WSHT 
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Appendix 25 R and D approval East Sussex Healthcare 
 
 
Ms Colette Ridehalgh 
University of Brighton 
School of Health Professions  
Clinical Research Centre 
49 Darley Road 
Eastbourne 
Sussex 
BN20 7UR 
 
 
 
 
 
Dear Ms C Ridehalgh                                                                              12 th June 
2012 
 
I am writing to inform you that you have R&D approval to proceed with the study as 
named below. This letter acknowledges that you have all the necessary internal and 
external regulatory approvals.  The site covered by this approval is:  
Full Study : Neurodynamic – Straight leg raise; responses in patients with referred leg pain 
R&D Ref No. TN12-28 
REC Ref: 12/LO/0397  
CSP No 
 
The final list of documents reviewed and approved are:  
Document  Version DATE   
Evidence of Insurance  1 16th February 2012 
Letter from Sponsor 1 16th February 2012 
GP / Consultant Information Sheets 1 16th April 2012 
Letter on Invitation to Participant 2 16th April 2012 
CV / Carol McCrum   
CV / Colette Ridehalgh   
Rejection Letter 1 16th April 2012 
Participant Information Sheet 2 16th April 2012 
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Participant Consent Form 2 16th April 2012 
Protocol  1 16th April 2012 
Questionnaire: Fear Avoidance 
Beliefs (FABQ) for patients /back 
pain 
1 16th April 2012 
Questionnaire: Depression anxiety & 
stress score DASS21  
1 16th April 2012 
Questionnaire: Tampa Scale for 
Kinesiphobia 
1 16th April 2012 
Questionnaire : Oswestry Disability  1 16th April 2012 
Questionnaire : Pain Catastophizing 
Scale 
1 16th April 2012 
Summary/Synopsis (Flowchart) 1 16th April 2012 
Response to Request for further 
Information 
2 26th March 2012 
REC Application 3.4 16th February 2012 
Ethics Letter  27th March 2012 
 
 
Conditions of Approval  
 
The approval covers the period stated in the Research Ethics Committee (REC) 
application and will be extended in line with any amendments agreed by the REC. 
Research must commence within 12 months of the issue date of this letter. Any delay 
beyond this may require a new review of the study resources.  
 
 
Amendments  
 
Study amendment details dated after the issue of this approval letter should be emailed 
to the R&D Office for formal approval.  
 
 
ICH-GCP Monitoring  
 
The Trust has a duty to ensure that all research is conducted in accordance with the 
Research Governance Framework and to ICH-GCP standards. In order to ensure 
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compliance the Trust undertakes random monitoring. If your study is selected you will 
be given 4 weeks notice to prepare all documentation for inspection.  
 
I wish you luck with your study and would grateful if you could inform me when the 
study is complete, or due to be closed on this site. 
  
Yours sincerely 
 
Teresa Baumber  
Research Support Manager 
Research and Development. 
East Sussex Healthcare Trust. 
Telephone  01323 417400 Ex 3042  
Email: teresa.baumber@esht.nhs.uk 
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Appendix 26 Flow chart of physiotherapy assessment  
 
 
 Patient with suspected spinally referred leg pain 
Pain reproduced on spinal 
movements and spinal accessory 
movements?#  
YES 
NO 
EXCLUDE 
Positive SLR or slump test with 
structural differentiation 
SOMATIC 
REFERRED PAIN 
NO 
YES 
Positive neurological integrity (no 
more than 2 adjacent segments) 
NO 
RADICULAR 
PAIN 
YES 
RADICULOPATHY 
>2 levels or S+S 
Cauda equina 
EXCLUDE 
URGENT 
REFERRAL 
>2 S+S of central sensitisation?* 
*S+S CS pain> 6 months, widespread areas of pain, hypersensitivity to warmth, cold or touch 
>8 tender points tested with 
algometer 
NO 
Not centrally 
sensitised 
NO 
Not centrally 
sensitised 
YES 
Centrally sensitised 
†severity based on patient’s ability to be able to sustain their painful position. Irritability based on time to 
aggravate and time to ease symptoms on simple movements (Petty, 2011). 
# If pain not reproduced on planar movements, combined, repeated or sustained movements performed. 
PAIVMS performed in provocative position where indicated 
Severe and 
irritable† 
EXCLUDE 
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Appendix 27 tender point assessment (taken from 
Jensen 2010) 
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Appendix 28 Physiotherapist assessment sheet 
Neurodynamic research study patient participant 
findings 
 
Length of time of current symptoms 
SLR Test (DF/EV, DF/INV, PF/INV please detail) 
Slump Test (DF/EV, DF/INV, PF/INV please detail) 
 
Neurological Integrity findings 
Subjective signs of Central Sensitisation   YES/NO (please circle) 
Tender point assessment YES/NO (please circle) 
If yes, number of painful points? 
 
Final classification (please tick box) 
 
Somatic 
referred pain 
Radicular pain Radiculopathy 
 
Does patient meet the inclusion criteria for the study  YES/NO (please circle).  If no 
please detail reason……………………………………………………………………… 
code…………………………………. 
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Appendix 29 Statistical analyses repeatability studies 
(examples are given. Further analyses can be found in 
the attached CD) 
 
Analysis of Ultrasound Validity data 
 
Reliability 
 
Scale: ALL VARIABLES 
Case Processing Summary 
 N % 
Cases Valid 16 100.0 
Excluded
a
 0 .0 
Total 16 100.0 
a. Listwise deletion based on all variables in the 
procedure. 
 
Reliability Statistics 
Cronbach's 
Alpha N of Items 
.965 2 
 
ANOVA 
 Sum of Squares df Mean Square F Sig 
Between People 599.895 15 39.993   
Within People Between Items .778 1 .778 .551 .469 
Residual 21.180 15 1.412   
Total 21.958 16 1.372   
Total 621.854 31 20.060   
Grand Mean = 14.4766 
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Analysis of Ultrasound Reliability data 
 
Normality results for ultrasonographic data 
 
 
Tests of Normality 
 
Kolmogorov-Smirnov
a
 Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Test 1 Hip 30F .189 16 .130 .924 16 .195 
Test 2 Hip 30F .152 16 .200
*
 .934 16 .282 
Test 1 Hip 60F .123 16 .200
*
 .967 16 .784 
Test 2 Hip 60F .132 16 .200
*
 .958 16 .621 
a. Lilliefors Significance Correction    
*. This is a lower bound of the true significance.   
 
Intraclass correlation analysis hip 30 degrees flexion 
 
 
Case Processing Summary 
 N % 
Cases Valid 16 100.0 
Excluded
a
 0 .0 
Total 16 100.0 
a. Listwise deletion based on all variables in the 
procedure. 
 
Reliability Statistics 
Cronbach's Alpha N of Items 
.955 2 
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Reliability Statistics 
Cronbach's Alpha N of Items 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intraclass correlation analysis hip 30 degrees flexion 
 
 
Case Processing Summary 
 N % 
Cases Valid 16 100.0 
Excluded
a
 0 .0 
Total 16 100.0 
a. Listwise deletion based on all variables in the 
procedure. 
 
 
Reliability Statistics 
Cronbach's Alpha N of Items 
.978 2 
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Intraclass Correlation Coefficient 
 Intraclass 
Correlation 
95% Confidence Interval F Test with True Value 0 
Lower Bound Upper Bound Value df1 df2 Sig 
Single Measures .959 .890 .985 47.894 15 16 .000 
Average Measures .979 .942 .993 47.894 15 16 .000 
One-way random effects model where people effects are random.    
 
Analysis of Vibration Threshold Reliability data 
Normality results for vibration threshold data 
 
Tests of Normality 
 
Kolmogorov-Smirnov
a
 Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
VT Test 1 LM .249 11 .055 .921 11 .326 
a. Lilliefors Significance Correction    
 
Intraclass correlation analysis Vibration threshold data 
 
 
Case Processing Summary 
 N % 
Cases Valid 11 100.0 
Excluded
a
 0 .0 
Total 11 100.0 
a. Listwise deletion based on all variables in the 
procedure. 
 
Reliability Statistics 
Cronbach's 
Alpha N of Items 
.955 2 
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ANOVA 
 Sum of Squares df Mean Square F Sig 
Between People .736 10 .074   
Within People Between Items .013 1 .013 4.056 .072 
Residual .033 10 .003   
Total .047 11 .004   
Total .783 21 .037   
Grand Mean = -.3956 
 
 
 
Case Processing Summary 
 N % 
Cases Valid 11 100.0 
Excluded
a
 0 .0 
Total 11 100.0 
a. Listwise deletion based on all variables in the 
procedure. 
 
 
Cronbach's 
Alpha N of Items 
.996 2 
 
ANOVA 
 Sum of Squares df Mean Square F Sig 
Between People 3.642 10 .364   
Within People Between Items .007 1 .007 4.348 .064 
Residual .016 10 .002   
Total .023 11 .002   
Total 3.665 21 .175   
Grand Mean = -.1331 
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Calculation of SEM and SDD for VT data 
 
SEM = √residual mean square  
For lateral malleolus = √0.003 = 0.0548. Mean transformed data = 0.604 % SEM =9.1% 
For 1st MT = √0.002 = 0.0447. Mean transformed data = 0.867 % SEM = 5.16% 
 
SDD =1.96 x SEM x √2 
For lateral malleolus = 0.1519  % SDD= 0.1519/0.604 x100 =25.1% 
For 1st metatarsal =0.125  % SDD =0.125/0.867 x100 = 14.4 
Analysis of Pressure Pain Threshold data 
 
 
Intraclass correlation analysis Pressure Pain Threshold data 
 
Deltoid mean of 1 and 2 readings  
 
Case Processing Summary 
 N % 
Cases Valid 11 100.0 
Excluded
a
 0 .0 
Total 11 100.0 
a. Listwise deletion based on all variables in the 
procedure. 
 
 
Reliability Statistics 
Cronbach's 
Alpha N of Items 
.915 2 
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ANOVA 
 Sum of Squares df Mean Square F Sig 
Between People 38.391 10 3.839   
Within People Between Items .319 1 .319 .979 .346 
Residual 3.262 10 .326   
Total 3.581 11 .326   
Total 41.972 21 1.999   
Grand Mean = 4.5159 
 
 
 
RELIABILITY deltoid mean of all 3 readings 
  /VARIABLES=PPTDELT1M3 PPTDELT2M3 
   
 
Case Processing Summary 
 N % 
Cases Valid 11 100.0 
Excluded
a
 0 .0 
Total 11 100.0 
a. Listwise deletion based on all variables in the 
procedure. 
 
 
Reliability Statistics 
Cronbach's 
Alpha N of Items 
.924 2 
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ANOVA 
 Sum of Squares df Mean Square F Sig 
Between People 35.117 10 3.512   
Within People Between Items .002 1 .002 .007 .936 
Residual 2.677 10 .268   
Total 2.679 11 .244   
Total 37.796 21 1.800   
Grand Mean = 4.5242 
 
 
 
RELIABILITY deltoid mean of 2nd and 3rd readings 
   
 
Case Processing Summary 
 N % 
Cases Valid 11 100.0 
Excluded
a
 0 .0 
Total 11 100.0 
a. Listwise deletion based on all variables in the 
procedure. 
 
 
Reliability Statistics 
Cronbach's 
Alpha N of Items 
.923 2 
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ANOVA 
 Sum of Squares df Mean Square F Sig 
Between People 37.586 10 3.759   
Within People Between Items .480 1 .480 1.655 .227 
Residual 2.901 10 .290   
Total 3.381 11 .307   
Total 40.967 21 1.951   
Grand Mean = 4.5023 
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Appendix 30 Statistical analysis of chapter 8 (examples 
are given, further analyses can be found in the attached 
CD) 
 
Normal Distributions of 3 outcome measures 
 
Tests of Normality 
 Kolmogorov-Smirnov
a
 Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
SPPTDeltpor
e 
.181 11 .200
*
 .921 11 .328 
SPPTdeltpos
t 
.231 11 .105 .870 11 .077 
SPPPTTNPr
e 
.235 11 .090 .857 11 .053 
SPPTTNpost .155 11 .200
*
 .962 11 .796 
SPPTGpre .193 11 .200
*
 .924 11 .352 
SPPTGpost .191 11 .200
*
 .968 11 .861 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
Key SPPTDelt (somatic group PPT deltoid), SPPTTN (somatic group PPT tibial nerve), 
SPPTG (somatic group PPT gastrocnemius) 
 
 
Tests of Normality 
 Kolmogorov-Smirnov
a
 Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
RRPPTdeltpre .104 32 .200
*
 .939 32 .072 
RRPPTdetlpos
t 
.120 32 .200
*
 .935 32 .054 
RRPPTTNPre .165 32 .026 .907 32 .009 
RRPPTTNpost .157 32 .043 .940 32 .076 
RRPPTGPre .117 32 .200
*
 .950 32 .143 
RRPPTGpost .136 32 .137 .940 32 .075 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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Key RR= radicular group 
 
Tests of Normality 
 Kolmogorov-Smirnov
a
 Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
RYPPTdeltpre .113 23 .200
*
 .950 23 .300 
RYPPTdeltpost .102 23 .200
*
 .967 23 .607 
RYPPTTNpre .141 23 .200
*
 .959 23 .445 
RYPPTTHpost .116 23 .200
*
 .978 23 .877 
RYPPTGPre .103 23 .200
*
 .948 23 .264 
RYPPTGpost .157 23 .146 .943 23 .209 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
Key RY= radiculopathy group 
 
Tests of Normality 
 Kolmogorov-Smirnov
a
 Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
BCSVTLMPre .263 8 .110 .837 8 .070 
BCSVTLMpost .219 8 .200
*
 .898 8 .279 
BCSVT1MTpre .164 8 .200
*
 .945 8 .662 
BCSVT1MTpost .188 8 .200
*
 .910 8 .352 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
Key BCSVTLM = box-cox transformation somatic group vibration threshold lateral 
malleolus 
BCSVT1MT= box-cox transformation somatic group vibration threshold 1st metatarsal 
 
Tests of Normality 
 Kolmogorov-Smirnov
a
 Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
BCRRVTLMPre .124 30 .200
*
 .954 30 .217 
BCRRVTLMPost .191 30 .007 .922 30 .030 
BCRR1MTPre .076 30 .200
*
 .987 30 .961 
BCRR1MTpost .089 30 .200
*
 .957 30 .260 
*. This is a lower bound of the true significance. 
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a. Lilliefors Significance Correction 
Key RR= radicular groups 
 
 
Tests of Normality 
 Kolmogorov-Smirnov
a
 Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
BCRYLMPre .168 21 .126 .934 21 .165 
BCRYLMPost .155 21 .200
*
 .927 21 .122 
BCRY1MTPre .130 21 .200
*
 .975 21 .834 
BCRY1MTPost .108 21 .200
*
 .976 21 .863 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
Key RY= radiculopathy group 
 
Tests of Normality 
 Kolmogorov-Smirnov
a
 Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
SH30PRE .168 10 .200
*
 .951 10 .684 
SH30POST .170 10 .200
*
 .948 10 .642 
SH60PRE .206 10 .200
*
 .908 10 .270 
SH60POST .136 10 .200
*
 .939 10 .542 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
Key SH30= somatic group sciatic nerve excursion with hip flexed to 30° 
SH60= somatic group sciatic nerve excursion with hip flexed to 60° 
 
Tests of Normality 
 Kolmogorov-Smirnov
a
 Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
RRH30PRE .151 29 .087 .928 29 .047 
RRH30POST .088 29 .200
*
 .964 29 .421 
RRH60PRE .122 29 .200
*
 .957 29 .271 
RRH60POST .086 29 .200
*
 .978 29 .780 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
Key RR=radicular group 
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Tests of Normality 
 Kolmogorov-Smirnov
a
 Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
RYH30PRE .105 20 .200
*
 .950 20 .364 
RYH30POST .101 20 .200
*
 .974 20 .834 
RYH60PRE .151 20 .200
*
 .938 20 .224 
RYH60POST .217 20 .014 .890 20 .027 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
Key RY =radiculopathy group 
 
Examples of main analyses 
 
Mauchley’s test of sphericity for PPT readings 
  
 
 
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent variables is 
proportional to an identity matrix. 
a. Design: Intercept + Group  
 Within Subjects Design: Site + Time + Site * Time 
b. May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected tests are displayed in 
the Tests of Within-Subjects Effects table. 
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Mauchley’s test of sphericity for PPT readings controlling for BMI 
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Levene's Test of Equality of Error Variancesa 
 F df1 df2 Sig. 
deltoid_before 2.082 2 64 .133 
deltoid_after .532 2 64 .590 
TN_before .220 2 64 .803 
TN_after 1.813 2 64 .171 
Gastroc_before .747 2 64 .478 
Gastroc_after .411 2 64 .665 
Tests the null hypothesis that the error variance of the dependent 
variable is equal across groups. 
a. Design: Intercept + BMI + Group  
 Within Subjects Design: Site + Time + Site * Time 
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VT analysis 
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Age and VT between subject effects 
 
 
Assumption of homogeneity age:group (VT) 
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Sciatic Nerve excursion analysis 
 
 
 
 
Key- site 1 = H30° position 
Site 2 = H60° position 
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Adjustment in sciatic nerve excursion for for pain below the knee 
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Testing for assumption of homogeneity- see hip* time* below knee 
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